About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
2914 genotypes with 5169 annotations displayed of selected term and subterms
Searched Term: abnormal endocrine gland morphology
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\1700069L16Rikem1(IMPC)Mbp/\1700069L16Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700069L16Rikem1(IMPC)Mbp/Mmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\2510009E07Rikem1(IMPC)Ccpcz/\2510009E07Rikem1(IMPC)Ccpcz
(C57BL/6N-2510009E07Rikem1(IMPC)Ccpcz/Ccpcz) 		abnormal adrenal gland morphology J:211773
enlarged adrenal glands J:211773
\4933434E20Riktm1a(EUCOMM)Wtsi/\4933434E20Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933434E20Riktm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
absent lobe of thyroid gland J:239583
\Aw/\Aw
(involves: SM/J) 		abnormal adrenal gland x-zone morphology J:19308
\Ay/\a
(involves: KK) 		abnormal pancreatic islet morphology J:26460
degranulated pancreatic beta cells J:26460
\AA467197em1Nyam/\AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam) 		abnormal thymus cortex morphology J:347271
abnormal thymus medulla morphology J:347271
\Aadacem1(IMPC)Mbp/\Aadacem1(IMPC)Mbp
(C57BL/6NCrl-Aadacem1(IMPC)Mbp/Mmucd) 		abnormal thymus morphology J:211773
small thymus J:211773
\Aadacl4em1(IMPC)Ccpcz/\Aadacl4em1(IMPC)Ccpcz
(C57BL/6NCrl-Aadacl4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Abca1tm1Jdm/\Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm) 		enlarged adrenal glands J:60210
\Abca1tm1Jdm/\Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ) 		abnormal thymus morphology J:132254
\Abca1tm1Jdm/\Abca1tm1Jdm
\Tgm2tm1Gml/\Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ) 		abnormal thymus morphology J:132254
\Abca1tm1Wpfl/\Abca1tm1Wpfl
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adrenal gland morphology J:64390
abnormal thymus morphology J:64390
\Abca5em1(IMPC)Ccpcz/\Abca5em1(IMPC)Ccpcz
(C57BL/6NCrl-Abca5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Abca5tm1Akya/\Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj) 		abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
\Abca5tm1Akya/\Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR) 		abnormal thyroid follicle morphology J:99152
absent thyroid gland J:99152
\Abcb9tm1b(KOMP)Wtsi/\Abcb9tm1b(KOMP)Wtsi
(C57BL/6N-Abcb9tm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
\Abcc4tm1Kruh/\Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh) 		thymus cortex hypoplasia J:117326
\Abcc8tm1.1Fmas/\Abcc8+
(B6.129S2(Cg)-Abcc8tm1.1Fmas) 		abnormal pancreatic beta cell morphology J:208932
\Abcc8tm1.1Fmas/\Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas) 		abnormal pancreatic beta cell morphology J:208932
\Abcc10tm1Eah/\Abcc10tm1Eah
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus cortex hypoplasia J:172648
\Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J) 		abnormal adrenal cortex morphology J:94583
abnormal adrenal gland zona fasciculata morphology J:94583
abnormal adrenal gland zona reticularis morphology J:94583
\Abcd1tm1Kds/Y
\Abcd2tm1Apuj/\Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		abnormal adrenal cortex morphology J:94583
\Abl1m1/\Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2)) 		abnormal thymus morphology J:14644
decreased thymocyte number J:14644
thymus cortex hypoplasia J:14644
thymus hypoplasia J:14644
\Abl1tm1Mlg/\Abl1tm1Mlg
(involves: 129S/SvEv * C57BL/6J) 		decreased thymocyte number J:72875
thymus atrophy J:72875
\Abl1tm2.2Goff/\Abl1tm2.2Goff
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N) 		thymus atrophy J:166211
\Acdacd/\Acdacd
(involves: DW/J) 		abnormal adrenal gland morphology J:14144
\Acdacd/\Acdacd
(DW/J-Acdacd Pou1f1+) 		abnormal adrenal gland morphology J:18027
adrenal gland hypoplasia J:18027
small adrenal glands J:18027
\Ace2em1(IMPC)Ccpcz/\Ace2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ace2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Acoxlem1(IMPC)Mbp/\Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Acss3em1(IMPC)Ccpcz/\Acss3em1(IMPC)Ccpcz
(C57BL/6NCrl-Acss3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Actbtm4(cre/ERT2)Npa/\Actb+
\Sgpl1tm1.1Npa/\Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6) 		increased thymocyte number J:199525
\Actn4tm1a(EUCOMM)Wtsi/\Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Acvr1btm1.1(KOMP)Vlcg/\Acvr1b+
(C57BL/6N-Acvr1btm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Adatm1Mw/\Adatm1Mw
\Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:73418
small thymus J:73418
\Adam10tm1.1Khr/\Adam10tm1.1Khr
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N) 		small thymus J:179060
thymus hypoplasia J:179060
\Adam10tm1Zhu/\Adam10tm1.1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J) 		thymus hypoplasia J:139042
\Adam10tm1Zhu/\Adam10tm1Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J) 		thymus hypoplasia J:139042
\Adam19tm1Asf/\Adam19tm1Asf
(either: B6.129P2-Adam19tm1Asf or (involves: 129P2/OlaHsd * C57BL/6J)) 		abnormal adrenal gland morphology J:106261
\Adamts1tm1Hku/\Adamts1tm1Hku
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal adrenal medulla morphology J:62260
\Adamts3tm1b(KOMP)Wtsi/\Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
\Adamts6b2b1879.1Clo/\Adamts6b2b1879.1Clo
(C57BL/6J-Adamts6b2b1879.1Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2029Clo/\Adamts6b2b2029Clo
(C57BL/6J-Adamts6b2b2029Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2182Clo/\Adamts6b2b2182Clo
(C57BL/6J-Adamts6b2b2182Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2187.1Clo/\Adamts6b2b2187.1Clo
(C57BL/6J-Adamts6b2b2187.1Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2228Clo/\Adamts6b2b2228Clo
(C57BL/6J-Adamts6b2b2228Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2405Clo/\Adamts6b2b2405Clo
(C57BL/6J-Adamts6b2b2405Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2407Clo/\Adamts6b2b2407Clo
(C57BL/6J-Adamts6b2b2407Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2744Clo/\Adamts6b2b2744Clo
(C57BL/6J-Adamts6b2b2744Clo) 		thymus hypoplasia J:175213
\Adamts6b2b2966.2Clo/\Adamts6b2b2966.2Clo
(C57BL/6J-Adamts6b2b2966.2Clo) 		thymus hypoplasia J:175213
\Adipor2tm2Dgen/\Adipor2tm2Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		decreased pancreatic beta cell number J:129554
\Adkem1(IMPC)Ccpcz/\Adk+
(C57BL/6N-Adkem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Adnp2em3(IMPC)Tcp/\Adnp2+
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp) 		abnormal thymus morphology J:211773
absent adrenal gland J:211773
small adrenal glands J:211773
\Adrm1Gt(OST128063)Lex/\Adrm1Gt(OST128063)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		enlarged thymus J:166694
thymus hyperplasia J:166694
\Aff1Rob/\Aff1+
(involves: BALB/cAnNCrl * C3H/HeN) 		decreased thymus weight J:82265
thymus hypoplasia J:82265
\Aff1tm1Cim/\Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c) 		thymus hypoplasia J:63253
\Afmidtm1b(EUCOMM)Wtsi/\Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H) 		abnormal pancreatic islet morphology J:226537
decreased pancreatic islet number J:226537
\Ago2tm1.1Tara/\Ago2tm1.1Tara
\Lepob/\Lepob
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		increased pancreatic beta cell mass J:210552
increased pancreatic beta cell number J:210552
\Ago2tm1.1Tara/\Ago2tm1.1Tara
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		abnormal pancreatic beta cell morphology J:210552
decreased pancreatic beta cell mass J:210552
decreased pancreatic beta cell number J:210552
\Agpat2Gt(OST438470)Lex/\Agpat2Gt(OST438470)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		enlarged pancreatic islets J:186035
increased pancreatic beta cell number J:186035
\Agpat2tm1Garg/\Agpat2tm1Garg
(involves: 129S6/SvEvTac) 		enlarged pancreatic islets J:146649
increased pancreatic beta cell mass J:146649
\Agpat5em1(IMPC)Ccpcz/\Agpat5em1(IMPC)Ccpcz
(C57BL/6NCrl-Agpat5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Aicdatm1(cre)Mnz/\Aicda+
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased T cell derived lymphoma incidence J:153656
\Aif1ltm1b(EUCOMM)Wtsi/\Aif1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Aif1ltm1b(EUCOMM)Wtsi/Bay) 		small thymus J:211773
\Aim2em1(IMPC)Ccpcz/\Aim2em1(IMPC)Ccpcz
(C57BL/6N-Aim2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\AipGt(RRI002)Byg/\Aip+
(involves: 129P2/OlaHsd * C57BL/6) 		adrenal gland hyperplasia J:165349
increased pituitary adenoma incidence J:165349
increased prolactinoma incidence J:165349
\Airetm1.1Doi/\Airetm1.1Doi
(involves: 129S2/SvPas * C57BL/6) 		abnormal thymus medulla morphology J:83422
\Airetm1Mmat/\Airetm2Mmat
(involves: C57BL/6 * CBA) 		abnormal thymus morphology J:141379
\Airetm1Mmat/\Airetm2Mmat
\Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6 * CBA) 		abnormal thymus morphology J:141379
\Airetm1Pltn/\Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6) 		absent adrenal gland J:77873
thymus atrophy J:77873
\Airetm1Ptsn/\Airetm1Ptsn
(C57BL/6-Airetm1Ptsn) 		abnormal thymus medulla morphology J:145910
\Airetm2Mmat/\Airetm2Mmat
(involves: C57BL/6 * CBA) 		abnormal thymus morphology J:141379
absent Hassall's corpuscle J:141379
\Ak7em1(IMPC)Ccpcz/\Ak7+
(C57BL/6NCrl-Ak7em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Akap5tm1.1Jsco/\Akap5tm1.1Jsco
(involves: 129S * C57BL/6) 		abnormal pancreatic beta cell morphology J:190017
\Akt1tm1Nhy/\Akt1+
\Akt2tm1Rsg/\Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		decreased pancreatic beta cell number J:149156
enlarged pancreatic islets J:149156
\Akt1tm1Nhy/\Akt1+
\Akt2tm1Rsg/\Akt2tm1Rsg
\Ptentm1Ppp/\Pten+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ) 		enlarged pancreatic islets J:149156
\Akt1tm1Nhy/\Akt1tm1Nhy
(involves: 129/Sv * C57BL/6) 		abnormal thymus morphology J:71404
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Akt3tm1Mbb/\Akt3tm1Mbb
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		thymus hypoplasia J:135903
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		thymus hypoplasia J:135903
\Akt1tm1Pnt/\Akt1tm1Pnt
\Akt3tm1Mbb/\Akt3tm1Mbb
\Tg(Lck-cre)1Cwi/0
(Not Specified) 		thymus hypoplasia J:135903
\Akt2tm1.1Mbb/\Akt2tm1.1Mbb
(involves: 129P2/OlaHsd * C57BL/6) 		increased pancreatic islet number J:71491
\Akt2tm1Rsg/\Akt2tm1Rsg
(DBA/1LacJ-Akt2tm1Rsg) 		decreased pancreatic beta cell number J:84606
\Akt2tm1Rsg/\Akt2tm1Rsg
(involves: C57BL/6 * DBA/1LacJ) 		enlarged pancreatic islets J:149156
\Aladem1(IMPC)Tcp/\Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Cmmr) 		enlarged thymus J:211773
small adrenal glands J:211773
\Aldh1a2tm1Dll/\Aldh1a2tm1Ipc
(involves: CD-1) 		absent parathyroid glands J:81969
athymia J:81969
thymus hypoplasia J:81969
\Aldh1b1tm1.1(KOMP)Vlcg/\Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA) 		abnormal pancreatic beta cell differentiation J:232360
abnormal pancreatic islet morphology J:232360
increased pancreatic alpha cell number J:232360
increased pancreatic beta cell mass J:232360
increased pancreatic delta cell number J:232360
pancreatic islet hyperplasia J:232360
\Aldh2tm1a(EUCOMM)Wtsi/\Aldh2tm1a(EUCOMM)Wtsi
\Fancd2tm1Hou/\Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N) 		abnormal thymus morphology J:188123
increased T cell derived lymphoma incidence J:193232
\Alktm1.1Rhp/\Alktm1.1Rhp
(involves: 129 * C57BL/6N) 		decreased gonadotropin-releasing hormone neuron number J:226955
\Alms1Gt(XH152)Byg/\Alms1Gt(XH152)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		degranulated pancreatic beta cells J:100403
pancreatic islet hyperplasia J:100403
\Alox15tm1.1Nadl/\Alox15tm1.1Nadl
\Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		increased pancreatic beta cell mass J:224344
pancreatic islet hyperplasia J:224344
\Alpltm1Jlm/\Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J)) 		abnormal thymus cortex morphology J:39015
\Alx3tm1Hubr/\Alx3tm1Hubr
(involves: 129P2/OlaHsd) 		decreased pancreatic beta cell mass J:166436
small pancreatic islets J:166436
\am/\am
(involves: 101 * CBA) 		abnormal Rathke's pouch development J:6435
\Amelxem1(IMPC)Ccpcz/Y
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Amelxem1(IMPC)Ccpcz/\Amelxem1(IMPC)Ccpcz
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Amhr2tm3(cre)Bhr/\Amhr2+
\Nr5a1tm1Klp/\Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		small adrenal glands J:91352
\Angpt2em1(IMPC)Mbp/\Angpt2em1(IMPC)Mbp
(C57BL/6NCrl-Angpt2em1(IMPC)Mbp/Mmucd) 		abnormal thymus morphology J:211773
small thymus J:211773
\Ank1nb/\Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re)) 		abnormal thymus development J:30699
\Ankrd49em1(IMPC)Tcp/\Ankrd49+
(C57BL/6NCrl-Ankrd49em1(IMPC)Tcp/Cmmr) 		enlarged thymus J:211773
\Ano2em1(IMPC)Ccpcz/\Ano2em1(IMPC)Ccpcz
(C57BL/6NCrl-Ano2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\anx/\anx
(B6C3Fe a/a-anx/J) 		increased thymus weight J:7689
\Anxa1em1(IMPC)Ccpcz/\Anxa1em1(IMPC)Ccpcz
(C57BL/6NCrl-Anxa1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Anxa1tm1Rjf/\Anxa1tm1Rjf
(involves: 129 * C57BL) 		abnormal corticotroph morphology J:135972
abnormal folliculo-stellate cell morphology J:135972
abnormal gonadotroph morphology J:135972
abnormal lactotroph morphology J:135972
abnormal somatotroph morphology J:135972
decreased corticotroph cell size J:135972
thin adrenal cortex J:129587
\Anxa7tm1Pll/\Anxa7+
(Not Specified) 		abnormal pancreatic beta cell morphology J:58572
enlarged pancreatic islets J:58572
pancreatic islet hyperplasia J:58572
\Ap1g1fgt/\Ap1g1fgt
(C57BL/6-Ap1g1fgt/KjnBoc) 		abnormal thyroid follicle morphology J:230572
abnormal thyroid follicular cell morphology J:230572
abnormal thyroid gland morphology J:230572
\Ap2b1b2b2321Clo/\Ap2b1b2b2321Clo
(C57BL/6J-Ap2b1b2b2321Clo) 		thymus hypoplasia J:175213
\Apbb1ipem1(IMPC)Ccpcz/\Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\ApcMin/\Apc+
(B6.Cg-Brca2tm1Mbn ApcMin) 		adrenal gland hyperplasia J:67445
\ApcMin/\Apc+
\Brca2tm1Mbn/\Brca2+
(B6.Cg-Brca2tm1Mbn ApcMin) 		abnormal adrenal gland morphology J:67445
\Apctm1Kk/\Apctm1Kk
\Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		small thymus J:100461
thymus hypoplasia J:100461
\Apctm2Rak/\Apctm2Rak
\Tg(KRT14-cre)8Brn/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		abnormal Hassall's corpuscle morphology J:114152
abnormal thymus morphology J:114152
decreased thymocyte number J:114152
small thymus J:114152
\Apctm2Rak/\Apctm2Rak
\Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * C57BL/6J * FVB/N * SJL) 		decreased pancreatic beta cell mass J:234310
decreased pancreatic islet number J:234310
\Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun) 		decreased thymocyte number J:95267
thymus atrophy J:95267
\Apoa1tm1Unc/\Apoa1tm1Unc
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129-Ldlrtm1Her Apoa1tm1Unc) 		abnormal adrenal gland morphology J:85174
abnormal adrenal gland zona fasciculata morphology J:85174
\Apobec1em1(IMPC)Ccpcz/\Apobec1em1(IMPC)Ccpcz
(C57BL/6NCrl-Apobec1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Apoetm1Unc/\Apoetm1Unc
(B6.129P2-Apoetm1Unc) 		abnormal adrenal cortex morphology J:60585
abnormal adrenal gland morphology J:60585
abnormal adrenal medulla morphology J:60585
\Apoetm1Unc/\Apoetm1Unc
\Faslpr/\Faslpr
(B6.Cg-Apoetm1Unc Faslpr) 		enlarged thymus J:121671
\Aqp7tm1Chan/\Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic islet morphology J:125011
decreased pancreatic alpha cell number J:125011
decreased pancreatic beta cell number J:125011
decreased PP cell number J:125011
small pancreatic islets J:125011
\Artm1Chc/\Artm1.1Chc
\Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		enlarged thymus J:87193
\Araftm1Mmc/Y
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:33951
\Araftm1Mmc/\Araftm1Mmc
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:33951
\Arb2aem2(IMPC)Ccpcz/\Arb2aem2(IMPC)Ccpcz
(C57BL/6NCrl-Arb2aem2(IMPC)Ccpcz/Ph) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Arb2aTg(Tyr)TpNpln/\Arb2aTg(Tyr)TpNpln
(involves: FVB/N) 		thymus hypoplasia J:260599
\Arfgef3tm1Hong/\Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong) 		abnormal pancreatic beta cell morphology J:216529
\Arg2em1(IMPC)Ccpcz/\Arg2em1(IMPC)Ccpcz
(C57BL/6NCrl-Arg2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Arhgap1tm1Yizh/\Arhgap1tm1Yizh
(involves: 129S6/SvEvTac) 		thymus hypoplasia J:101418
\Arhgap5tm1Jset/\Arhgap5tm1Jset
(involves: 129S2/SvPas * C57BL/6J) 		small thymus J:76484
\Arhgap45em1Ciphe/\Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe) 		decreased DN1 thymic pro-T cell number J:309971
\Arhgdiatm1Ytk/\Arhgdiatm1Ytk
\Arhgdibtm1Miyo/\Arhgdibtm1Miyo
(involves: 129S/SvEv) 		abnormal thymus medulla morphology J:140671
\Arid5btm1Pjh/\Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c) 		abnormal adrenal gland zona reticularis morphology J:70658
thymus cortex hypoplasia J:70658
thymus hypoplasia J:70658
\Arl16em1(IMPC)Ccpcz/\Arl16em1(IMPC)Ccpcz
(C57BL/6NCrl-Arl16em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Armc5tm1Stra/\Armc5+
(involves: 129 * C57BL/6N * Swiss) 		abnormal adrenal cortex morphology J:244906
abnormal adrenal gland zona fasciculata morphology J:244906
thin adrenal cortex J:244906
\Arnt2tm1Yfk/\Arnt2tm1Yfk
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal neurohypophysis morphology J:74118
\ArpBALB/c/\ArpBALB/c
(involves: B10.D2 * BALB/c) 		thymus hyperplasia J:6549
\Arxtm1Gldn/\Arxtm1Gldn
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
\Tg(Ins2-cre)23Herr/0
(involves: 129 * Black Swiss * C57BL/6 * CBA/J * SJL) 		decreased pancreatic beta cell number J:177838
\Arxtm1Pgr/Y
(involves: 129/Sv * NMRI) 		abnormal pancreatic delta cell morphology J:86206
absent pancreatic alpha cells J:86206
increased pancreatic beta cell number J:86206
increased pancreatic delta cell number J:86206
\Asah1tm1.2Geno/\Asah1tm1.2Geno
(involves: C57BL/6) 		abnormal thymus morphology J:285931
\Asah1tm1Medin/\Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1) 		enlarged thymus J:232306
\Asb1em1(IMPC)Ccpcz/\Asb1em1(IMPC)Ccpcz
(C57BL/6N-Asb1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Asb5em1(IMPC)Ccpcz/\Asb5em1(IMPC)Ccpcz
(C57BL/6N-Asb5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Asb16em1(IMPC)Ccpcz/\Asb16em1(IMPC)Ccpcz
(C57BL/6N-Asb16em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ascl1tm1And/\Ascl1+
(involves: 129) 		decreased solitary pulmonary neuroendocrine cell number J:64088
\Ascl1tm1And/\Ascl1tm1And
(involves: 129) 		absent solitary pulmonary neuroendocrine cells J:64088, J:113000
\Ascl5em1(IMPC)Ccpcz/\Ascl5em1(IMPC)Ccpcz
(C57BL/6NCrl-Ascl5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Asltm1Brle/\Asltm1Brle
(involves: 129S7/SvEvBrd) 		thymus cortex hypoplasia J:180208
\Asphd1em1(IMPC)Ccpcz/\Asphd1em1(IMPC)Ccpcz
(C57BL/6NCrl-Asphd1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Asxl1tm1Bc/\Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thymus morphology J:155898
\Atad5Gt(RRF055)Byg/\Atad5+
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:176672
\Atcayji/\Atcayji
(Not Specified) 		abnormal adenohypophysis morphology J:14903
abnormal thymus cortex morphology J:14903
abnormal thymus medulla morphology J:14903
abnormal thymus morphology J:14903
abnormal thyroid follicle morphology J:14903
\Atf3tm1Dron/\Atf3tm1Dron
(B6.129X1-Atf3tm1Hai) 		abnormal pancreatic islet morphology J:91595
\Atf4tm1Tow/\Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss)) 		increased pancreatic beta cell mass J:152695
\Atg3tm1.1Ywh/\Atg3tm1.1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA) 		thymus hypoplasia J:172749
\Atg5tm1Nmz/\Atg5tm1Nmz
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis morphology J:110050
abnormal adrenal gland morphology J:110050
\Atg5tm1Nmz/\Atg5tm1Nmz
(involves: 129 * BALB/c * C57BL/6) 		abnormal thymus cortex morphology J:140583
\Atg5tm1Nmz/\Atg5tm1Nmz
\Tg(CAG-EGFP/Map1lc3b)53Nmz/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus morphology J:140583
\Atg16l1tm1a(EUCOMM)Wtsi/\Atg16l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal thymus topology J:239583
\Atl3em1(IMPC)Tcp/\Atl3em1(IMPC)Tcp
(C57BL/6N-Atl3em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Atmtm1.1Mmpl/\Atmtm1.1Mmpl
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:226414
\Atmtm1Awb/\Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		increased T cell derived lymphoma incidence J:34193
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell derived lymphoma incidence J:103922
\Atmtm1Awb/\Atmtm1Awb
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
\Atmtm1Awb/\Atmtm1Awb
(CByJ.129S6-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x B6.129S6-Atmtm1Awb)F1 or (B6.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(either: (129S6/SvEvTac-Atmtm1Awb x A.129S6-Atmtm1Awb)F1 or (A.129S6-Atmtm1Awb x 129S6/SvEvTac-Atmtm1Awb)F1) 		increased T cell derived lymphoma incidence J:208539
\Atmtm1Awb/\Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J) 		increased T cell derived lymphoma incidence J:226414
\Atmtm1Awb/\Atmtm1Awb
\Rad52tm1Aps/\Rad52tm1Aps
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:90941
\Atmtm1Bal/\Atmtm1Bal
(involves: 129S4/SvJae) 		decreased thymocyte number J:35914
increased T cell derived lymphoma incidence J:35914
small thymus J:35914
\Atmtm1Fwa/\Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:61201
increased T cell derived lymphoma incidence J:61201
\Atmtm1Led/\Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss) 		increased T cell derived lymphoma incidence J:69726
small thymus J:36561
thymus cortex hypoplasia J:36561
\Atmtm1Mfl/\Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J) 		decreased thymocyte number J:69726
increased T cell derived lymphoma incidence J:69726
small thymus J:69726
\Atmtm2.1Fwa/\Atmtm2.1Fwa
\Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac) 		decreased thymocyte number J:277750
increased T cell derived lymphoma incidence J:277750
\Atmintm1.1Jhh/\Atmintm1.1Jhh
(C57BL/6-Atmintm1.1Jhh) 		thymus hypoplasia J:167544
\Atp1a1em1(IMPC)Ccpcz/\Atp1a1+
(C57BL/6NCrl-Atp1a1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Atp6v1b2tm1b(KOMP)Wtsi/\Atp6v1b2+
(C57BL/6N-Atp6v1b2tm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
\Atp11atm1a(KOMP)Wtsi/\Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal thymus morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
\Atrtm1Bal/\Atrtm2Bal
\Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		decreased thymocyte number J:123200
\Atrtm1Ofc/\Atrtm1Ofc
(Not Specified) 		decreased thymus weight J:151542
\Atxn2tm1.1Aub/\Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6) 		increased pancreatic beta cell number J:135320
pancreatic islet hyperplasia J:135320
\Avpr1atm1Gzt/\Avpr1atm1Gzt
(involves: 129 * C57BL/6J) 		abnormal adrenal gland morphology J:110099
\Avpr1btm1Gzt/\Avpr1btm1Gzt
(involves: 129 * C57BL/6J) 		small adrenal glands J:87707
\awgTg(GBts1env)832Pkw/\awgTg(GBts1env)832Pkw
(involves: C57BL/6J * SJL) 		thymus atrophy J:43273
\b2b954Clo/\b2b954Clo
(C57BL/6J-b2b954Clo) 		thymus hypoplasia J:175213
\b2b1249Clo/\b2b1249Clo
(C57BL/6J-b2b1249Clo) 		thymus hypoplasia J:175213
\b2b1702Clo/\b2b1702Clo
(C57BL/6J-b2b1702Clo) 		thymus hypoplasia J:175213
\b2b1941Clo/\b2b1941Clo
(C57BL/6J-b2b1941Clo) 		athymia J:175213
\b2b2187Clo/\b2b2187Clo
(C57BL/6J-b2b2187Clo) 		thymus hypoplasia J:175213
\b2b2463Clo/\b2b2463Clo
(C57BL/6J-b2b2463Clo) 		thymus hypoplasia J:175213
\b2b2588Clo/\b2b2588Clo
(C57BL/6J-b2b2588Clo) 		thymus hypoplasia J:175213
\b2b2696.2Clo/\b2b2696.2Clo
(C57BL/6J-b2b2696.2Clo) 		thymus hypoplasia J:175213
\b2b2736.2Clo/\b2b2736.2Clo
(C57BL/6J-b2b2736.2Clo) 		thymus hypoplasia J:175213
\b2b2736Clo/\b2b2736Clo
(C57BL/6J-b2b2736Clo) 		thymus hypoplasia J:175213
\b2b2821Clo/\b2b2821Clo
(C57BL/6J-b2b2821Clo) 		thymus hypoplasia J:175213
\b2b2966Clo/\b2b2966Clo
(C57BL/6J-b2b2966Clo) 		thymus hypoplasia J:175213
\b2b3077.2Clo/\b2b3077.2Clo
(C57BL/6J-b2b3077.2Clo) 		thymus hypoplasia J:175213
\b2b3077Clo/\b2b3077Clo
(C57BL/6J-b2b3077Clo) 		thymus hypoplasia J:175213
\b2b3121Clo/\b2b3121Clo
(C57BL/6J-b2b3121Clo) 		enlarged adrenal glands J:175213
thymus hypoplasia J:175213
\b2b3260.2Clo/\b2b3260.2Clo
(C57BL/6J-b2b3260.2Clo) 		abnormal thymus morphology J:175213
thymus hypoplasia J:175213
\b2b3260Clo/\b2b3260Clo
(C57BL/6J-b2b3260Clo) 		abnormal thymus morphology J:175213
thymus hypoplasia J:175213
\B2mtm1Unc/\B2mtm1Unc
(NOD.129P2-B2mtm1Unc) 		abnormal pancreatic beta cell morphology J:17000
\B2mtm1Unc/\B2mtm1Unc
\Prkdcscid/\Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid) 		increased T cell derived lymphoma incidence J:102141
\B4galt1tm1Shur/\B4galt1tm1Shur
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal adenohypophysis development J:37846
abnormal adrenal cortex morphology J:37846
abnormal adrenal gland zona fasciculata morphology J:37846
abnormal adrenal gland zona reticularis morphology J:37846
small adenohypophysis J:37846
small adrenal glands J:37846
\B9d2tm1a(EUCOMM)Wtsi/\B9d2tm1a(EUCOMM)Wtsi
(C57BL/6N-B9d2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal adrenal gland morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal thymus topology J:239583
absent adenohypophysis J:239583
\Babam1em1(IMPC)Ccpcz/\Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Badtm1Meg/\Badtm1Meg
(involves: 129S4/SvJae) 		decreased thymus weight J:88139
small pancreatic islets J:133563
small thymus J:88139
thymus hypoplasia J:88139
\Badtm1Sjk/\Badtm1Sjk
(involves: 129X1/SvJ) 		increased pancreatic islet number J:133563
\Bag3tm1.1Jhl/\Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl) 		decreased thymus weight J:144416
thymus hypoplasia J:144416
\Bag4tm1Yeh/\Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:83559
\Baxtm1Sjk/\Baxtm1Sjk
(involves: 129X1/SvJ) 		increased thymocyte number J:29253
\Bbc3tm1Gpz/\Bbc3tm1Gpz
\Trp53tm1Brd/\Trp53tm8Xu
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		decreased thymocyte number J:170216
\Bbs5tm1a(EUCOMM)Wtsi/\Bbs5tm1a(EUCOMM)Wtsi
(C57BL/6-Bbs5tm1a(EUCOMM)Wtsi) 		abnormal pituitary gland morphology J:307098
small pituitary gland J:307098
\Bbs12em1(IMPC)Ccpcz/\Bbs12+
(C57BL/6NCrl-Bbs12em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Bcap31tm1.1Bwang/\Bcap31tm1.1Bwang
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		decreased thymocyte number J:274469
decreased thymus weight J:274469
small thymus J:274469
thymus hypoplasia J:274469
\Bcl2tm1Dlo/\Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:73660
\Bcl2tm1Sjk/\Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6) 		abnormal thymus morphology J:15224
small thymus J:15224
\Bcl2tm1Tsu/\Bcl2tm1Tsu
(involves: 129P2/OlaHsd * ICR) 		small thymus J:22391
thymus atrophy J:22391
\Bcl2l1tm1Ywh/\Bcl2l1tm1Ywh
\Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA) 		decreased thymocyte number J:99012
\Bcl2l11tm1.1Ast/\Bcl2l11tm1.1Ast
\Bmftm1Rjd/\Bmftm1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd) 		increased thymocyte number J:153652
\Bcl2l11tm1.1Boui/\Bcl2l11+
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:186117
\Bcl6tm1Rdf/\Bcl6tm1Rdf
(involves: 129S1/Sv) 		small thymus J:40769
\Bcl6tm2Rdf/\Bcl6tm2Rdf
(involves: 129S1/Sv) 		small thymus J:40769
\Bcl10tm1Mak/\Bcl10tm1Mak
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:67297
\Bcl11atm1Ngc/\Bcl11a+
(involves: 129S1/Sv) 		decreased DN2 thymocyte number J:194616
\Bcl11atm1Ngc/\Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J) 		small thymus J:83646
thymus hypoplasia J:83646
\Bcl11atm2.1Peli/\Bcl11atm2.1Peli
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv) 		decreased DN2 thymocyte number J:194616
\Bcl11btm1.2Leid/\Bcl11btm1.2Leid
(involves: C57BL/6 * SJL) 		thymus hypoplasia J:147182
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tcratm1Mom/\Tcratm1Mom
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2) 		thymus hypoplasia J:128515
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2) 		thymus hypoplasia J:128515
\Bcl11btm1Avram/\Bcl11btm1Avram
\Tg(Cd4-cre)1Cwi/?
\Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2) 		thymus hypoplasia J:128515
\Bcl11btm1Jpk/\Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA) 		abnormal thymus cortex morphology J:83651
abnormal thymus medulla morphology J:83651
absent thymus corticomedullary boundary J:83651
thymus hypoplasia J:83651
\Bcl11btm2.1Jpk/\Bcl11b+
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		decreased thymocyte number J:210122
\Betalinc1tm1Suss/\Betalinc1tm1Suss
(involves: 129 * C57BL/6) 		decreased pancreatic alpha cell number J:231585
decreased pancreatic beta cell number J:231585
decreased pancreatic epsilon cell number J:231585
increased pancreatic delta cell number J:231585
\Bhlhe40tm1Tan/\Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		thymus hyperplasia J:72651
\Bidtm1Sjk/\Bidtm1Sjk
(involves: 129X1/Sv * C57BL/6) 		abnormal pancreatic beta cell morphology J:116520
\Birc5tm1Mak/\Birc5tm1Mak
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd) 		abnormal thymus corticomedullary boundary morphology J:90892
decreased thymocyte number J:90892
small thymus J:90892
\Birc5tm1Wnt/\Birc5tm1Emc
\Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		thymus hypoplasia J:87435
\Bmal1tm1.2Shbi/\Bmal1tm1.2Shbi
(involves: C57BL/6J) 		enlarged pancreatic islets J:177865
\Bmal1tm1Bra/\Bmal1tm1Bra
(involves: 129/Sv * C57BL/6) 		decreased pancreatic islet number J:162641
\Bmerb1em1(IMPC)Ccpcz/\Bmerb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Bmerb1em1(IMPC)Ccpcz/Ph) 		abnormal adrenal gland morphology J:211773
enlarged adrenal glands J:211773
\Bmftm1.1Ast/\Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst) 		increased T cell derived lymphoma incidence J:133084
\Bmi1tm1Brn/\Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		decreased thymocyte number J:17712
thymus cortex hypoplasia J:17712
\Bmi1tm1Sgon/\Bmi1tm1Sgon
\Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca) 		abnormal thymus morphology J:221849
small thymus J:221849
thymus atrophy J:221849
\Bmp4tm1Blh/\Bmp4tm1Blh
(involves: 129S2/SvPas * Black Swiss) 		absent Rathke's pouch J:50517
\Bmp10b2b2711Clo/\Bmp10b2b2711Clo
(C57BL/6J-Bmp10b2b2711Clo) 		thymus hypoplasia J:175213
\Bmpr1atm1Bhr/\Bmpr1atm2.1Bhr
\Tg(Cga-cre)3Sac/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		abnormal pituitary gland development J:121318
abnormal Rathke's pouch development J:121318
\Boktm1.1Ast/\Boktm1.1Ast
(involves: BALB/cJ * C57BL/6) 		increased thymus weight J:203179
\Braftm1(ARAF)Urr/\Braftm1(ARAF)Urr
(involves: 129S1/Sv * C57BL/6 * CD-1) 		decreased thymus weight J:112971
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal thymus morphology J:170095
decreased thymocyte number J:170095
thymus atrophy J:170095
\Braftm1Bbd/\Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1) 		abnormal thymus morphology J:170095
decreased thymocyte number J:170095
increased pheochromocytoma incidence J:170095
thymus atrophy J:170095
\Braftm1Bbd/\Braf+
(B6.129-Braftm1Bbd) 		abnormal thymus morphology J:170095
decreased thymocyte number J:170095
thymus atrophy J:170095
\Braftm1Cpri/\Braftm1Cpri
\Gnastm3Lsw/\Gnastm3Lsw
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/NCr) 		increased thyroid tumor incidence J:168249
\Braftm1Cpri/\Braftm1Cpri
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr) 		increased thyroid carcinoma incidence J:168249
increased thyroid tumor incidence J:168249
\Braftm1Cpri/\Braftm1Cpri
\Tshrtm1Rmar/\Tshrtm1Rmar
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB/NCr) 		abnormal thyroid follicle morphology J:168249
increased thyroid tumor incidence J:168249
small thyroid gland J:168249
\Braftm1Mmcm/\Braf+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		increased thyroid carcinoma incidence J:208854
\Braftm1Mmcm/\Braf+
\Tg(Tg-cre/ERT2)#Mmcm/0
(involves: 129P2/OlaHsd) 		abnormal thyroid follicle morphology J:172205
abnormal thyroid gland morphology J:172205
enlarged thyroid gland J:172205
increased thyroid carcinoma incidence J:172205
\Braftm1Mmcm/\Braf+
\Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
\Braftm1Mmcm/\Braf+
\Tg(TPO-cre/ERT2)1139Tyj/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
\Braftm1Mmcm/\Braf+
\Trp53tm1Brn/\Trp53tm3.1Tyj
\Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
\Braftm1Mmcm/\Braf+
\Trp53tm3.1Tyj/\Trp53+
\Tg(TPO-cre/ERT2)1139Tyj/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac) 		increased thyroid carcinoma incidence J:208854
\Braftm1Sva/\Braftm1.1Sva
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adenohypophysis morphology J:121660
small adenohypophysis J:121660
\Braftm1Wds/\Braftm1.1Wds
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal adenohypophysis morphology J:121660
small adenohypophysis J:121660
\Braftm1Wds/\Braftm1Wds
\Raf1tm2Bacc/\Raf1tm2Bacc
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		abnormal thyroid gland morphology J:144862
small thymus J:144862
small thyroid gland J:144862
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		enlarged thymus J:81541
increased T cell derived lymphoma incidence J:81541
\Brca1tm2.1Cxd/\Brca1tm2.1Cxd
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:81541
\Brca1tm2Mak/\Brca1tm2Mak
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:63282
\Brca1tm2Mak/\Brca1tm2Mak
\Chek2tm1Mak/\Chek2tm1Mak
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:63282
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
\Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:63282
\Brca1tm2Mak/\Brca1tm2Mak
\Tg(Lck-cre)548Jxm/?
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:90512
\Brca1tm5.1Cxd/\Brca1tm5.1Cxd
(involves: 129S6/SvEvTac * FVB/N) 		increased T cell derived lymphoma incidence J:155810
\Brca2tm1Cam/\Brca2tm1Cam
(involves: 129S/SvEv * MF1) 		increased T cell derived lymphoma incidence J:46812
increased thymus weight J:46812
\Brca2tm1Cbl/\Brca2tm1Cbl
(either: (involves: 129S2/SvPas * C57BL/10) or (involves: 129S2/SvPas * C57BL/6 * DBA/2)) 		increased T cell derived lymphoma incidence J:44386
\Brca2tm1Mbn/\Brca2+
(B6.Cg-Brca2tm1Mbn ApcMin) 		adrenal gland hyperplasia J:67445
\Brd2em1(IMPC)Wtsi/\Brd2em1(IMPC)Wtsi
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg) 		abnormal adenohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
abnormal thymus topology J:239583
small thymus J:239583
small thyroid gland J:239583
\Brd2Gt(RRT234)Byg/\Brd2+
(B6.129P2-Brd2Gt(RRT234)Byg) 		abnormal pancreatic islet morphology J:159964
increased pancreatic beta cell number J:159964
increased pancreatic islet number J:159964
pancreatic islet hyperplasia J:159964
\Brd9em1(IMPC)Tcp/\Brd9+
(C57BL/6N-Brd9em1(IMPC)Tcp/Cmmr) 		small adrenal glands J:211773
\Brip1Gt(RRI409)Byg/\Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased pituitary adenoma incidence J:227115
\Bsgtm1.1Znc/\Bsgtm1.1Znc
\Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		decreased thymocyte number J:207886
decreased thymus weight J:207886
\Btbd3tm1b(EUCOMM)Hmgu/\Btbd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Btbd3tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Btbd7em1(IMPC)Ccpcz/\Btbd7em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd7em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Btbd18em1(IMPC)Ccpcz/\Btbd18em1(IMPC)Ccpcz
(C57BL/6NCrl-Btbd18em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cabin1em1(IMPC)Ccpcz/\Cabin1+
(C57BL/6NCrl-Cabin1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cacna1atg-6J/\Cacna1atg-6J
(involves: BALB/cByJ * C57BL/6J) 		thymus atrophy J:82238
\Cacna1dtm1Hssh/\Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J) 		abnormal pancreatic beta cell differentiation J:72316
abnormal pancreatic islet morphology J:72316
decreased pancreatic beta cell mass J:72316
decreased pancreatic beta cell number J:72316
decreased pancreatic islet number J:72316
increased pancreatic alpha cell number J:72316
\Cacna1etm1.1Tsch/\Cacna1etm1.1Tsch
(involves: C57BL/6) 		decreased pancreatic alpha cell number J:95377
\Cacna2d2du-td/\Cacna2d2du-td
(involves: DBA/2J) 		abnormal pituitary gland morphology J:12166
absent lactotrophs J:5596
\Cacna2d2tm1Svi/\Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J) 		thymus hypoplasia J:92396
\Cacnb4lh/\Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J) 		absent thymus corticomedullary boundary J:5281
small thymus J:5281
\Cacnb4lh/\Cacnb4lh
(BALB/cGn-Cacnb4lh) 		pituitary gland hyperplasia J:12166
\Cactinem1(IMPC)Ccpcz/\Cactin+
(C57BL/6NCrl-Cactinem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\CacybpGT(OST39970)Lex/\CacybpGT(OST39970)Lex
(involves: 129S5/SvEvBrd) 		decreased thymocyte number J:110899
small thymus medulla J:110899
thymus hypoplasia J:110899
\Cadm1tm1.2Brd/\Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd) 		increased pancreatic beta cell mass J:210552
increased pancreatic beta cell number J:210552
\Cadpstm1Bros/\Cadps+
\Cadps2tm1Bros/\Cadps2tm1Bros
(Not Specified) 		abnormal pancreatic beta cell morphology J:131014
\Calb1em1(IMPC)Ccpcz/\Calb1em1(IMPC)Ccpcz
(C57BL/6NCrl-Calb1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Calcatm1.1(cre/ERT2)Ptch/\Calca+
\Trp53tm1Brn/\Trp53tm1Brn
\Rb1tm2Brn/\Rb1tm2Brn
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased thyroid tumor incidence J:190366
\Calcatm1.1(cre/ERT2)Ptch/\Calca+
\Trp53tm1Brn/\Trp53tm1Brn
\Rb1tm2Brn/\Rb1tm2Brn
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N) 		increased thyroid tumor incidence J:190366
\Camk4em1(IMPC)Ccpcz/\Camk4em1(IMPC)Ccpcz
(C57BL/6N-Camk4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Camltm1Rjb/\Camltm2Rjb
\Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2) 		decreased thymocyte number J:100536
\Camltm1Rjb/\Camltm2Rjb
\Tg(Lck-cre)1Cwi/0
\Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2) 		decreased thymocyte number J:100536
\Canxem1(IMPC)Ccpcz/\Canx+
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Canxem1(IMPC)Ccpcz/\Canxem1(IMPC)Ccpcz
(C57BL/6NCrl-Canxem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Capza2tm1b(KOMP)Wtsi/\Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Car6em1(IMPC)Ccpcz/\Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Card11em1(IMPC)Ccpcz/\Card11em1(IMPC)Ccpcz
(C57BL/6NCrl-Card11em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Card14em1(IMPC)Ccpcz/\Card14em1(IMPC)Ccpcz
(C57BL/6NCrl-Card14em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Carm1tm2.1Mtb/\Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss) 		thymus hypoplasia J:159958
\Carmil2bas/\Carmil2bas
(involves: C3HeB/FeJ * C57BL/6) 		enlarged thymus J:205441
\Casp3tm1Flv/\Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6) 		decreased thymocyte number J:36821
\Casp8tm1.1Raz/\Casp8tm1.1Raz
\Ripk3tm1Vmd/\Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		enlarged thymus J:170814
\Casp14em1(IMPC)Ccpcz/\Casp14em1(IMPC)Ccpcz
(C57BL/6N-Casp14em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Casrtm1Ces/\Casrtm1Ces
(involves: 129X1/SvJ * Black Swiss) 		abnormal parathyroid gland chief cell morphology J:29900
enlarged parathyroid gland J:29900
parathyroid gland hyperplasia J:29900
pigmented parathyroid gland J:29900
\Catsper3em2(IMPC)Mbp/\Catsper3em2(IMPC)Mbp
(C57BL/6N-Catsper3em2(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
enlarged adrenal glands J:211773
\Cav1tm1Kur/\Cav1tm1Kur
(involves: 129X1/SvJ) 		abnormal thyroid follicular cell morphology J:119709
\Cav1tm1Mls/\Cav1tm1Mls
(STOCK Cav1tm1Mls/J) 		abnormal thyroid follicular cell morphology J:119709
\Cbfbtm1Itan/\Cbfbtm1Itan
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:125953
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1)) 		small thymus J:80670
\Cbfbtm1Spe/\Cbfbtm1Spe
\Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster)) 		small thymus J:80670
\Cbfbtm1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae) 		abnormal thymus cell ratio J:124224
abnormal thymus morphology J:124224
thymus hypoplasia J:124224
\Cbfbtm1Tok/\Cbfbtm1Tok
\Tg(Gata1-Cbfb)1Tok/0
(involves: 129P2/OlaHsd * C57BL/6J) 		small thymus J:80668
\Cbfbtm2.1Spe/\Cbfbtm2.1Spe
(involves: 129S4/SvJae) 		abnormal thymus cell ratio J:124224
abnormal thymus morphology J:124224
thymus hypoplasia J:124224
\Cbltm1.1Hua/\Cbltm1.1Hua
\Lattm1Les/\Lattm1Les
(involves: 129P2/OlaHsd) 		abnormal thymus development J:91369
thymus hypoplasia J:91369
\Cbltm1Ddlb/\Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6J) 		abnormal thymus cell ratio J:76895
\Cbltm1Ddlb/\Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus morphology J:103366
abnormal thymus size J:103366
thymus hypoplasia J:103366
\Cbltm2Wlan/\Cbltm2Wlan
(involves: 129X1/SvJ * C57BL/6) 		abnormal thymus morphology J:103366
abnormal thymus size J:103366
thymus hypoplasia J:103366
\Cbx4tm1.1Gxu/\Cbx4tm1.2Gxu
\Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J) 		abnormal thymus development J:194053
thymus atrophy J:194053
thymus hypoplasia J:194053
\Cbx4tm1.2Gxu/\Cbx4tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		abnormal thymus development J:194053
thymus hypoplasia J:194053
\Ccdc6tm1Afus/\Ccdc6tm1Afus
(involves: 129 * C57BL/6J) 		thyroid gland hyperplasia J:301625
\Ccdc80tm1Ftrm/\Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm) 		pancreatic islet hyperplasia J:189183
\Ccdc80tm1Ppal/\Ccdc80tm1Ppal
(Not Specified) 		increased thyroid adenoma incidence J:217742
\Ccdc198em1(IMPC)Ccpcz/\Ccdc198em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccdc198em1(IMPC)Ccpcz/Ph) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ccdc198em1Iad/\Ccdc198em1Iad
(FVB.Cg-Pde6b+ Tyrc-ch Ccdc198em1Iad/J) 		small adrenal glands J:337480
\Cckbrtm1Kpn/\Cckbrtm1Kpn
(involves: 129S2/SvPas) 		abnormal pancreatic delta cell morphology J:49320
\Ccl21atm1Yout/\Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		decreased thymocyte number J:244640
small thymus medulla J:244640
\Ccl28em1(IMPC)Ccpcz/\Ccl28em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccl28em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ccnb2tm1Thnt/\Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:47430
\Ccnctm1.1Pisc/\Ccnctm1.1Pisc
\Tg(Lck-LMO1)11Sjk/0
\Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:217695
\Ccnd1tm1Dsn/\Ccnd1tm1Dsn
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129 * C57BL/6) 		enlarged thymus J:66707
increased pituitary adenoma incidence J:66707
thymus hyperplasia J:66707
\Ccnd3tm1.1(Ccnd2)Iaai/\Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac) 		small thymus J:192031
thymus hypoplasia J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
(Not Specified) 		small thymus J:192031
thymus hypoplasia J:88120, J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor) 		thymus hypoplasia J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		thymus hypoplasia J:192031
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
\Ccnd3tm1Pisc/\Ccnd3tm1Pisc
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased T cell derived lymphoma incidence J:88120
\Ccnd3tm2.1Pisc/\Ccnd3tm2.1Pisc
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		small thymus J:192032
\Ccr3em1(IMPC)Ccpcz/\Ccr3em1(IMPC)Ccpcz
(C57BL/6NCrl-Ccr3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ccr7tm1Rfor/\Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor) 		abnormal thymus cortex morphology J:93960
small thymus medulla J:93960
\Ccr9tm1Ccb/\Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:94596
\Cd2aptm1Shaw/\Cd2aptm1Shaw
(involves: 129X1/SvJ) 		thymus atrophy J:57971
\Cd3em1Btlr/\Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr) 		abnormal thymus morphology J:132486
small thymus J:132486
\Cd3etm1.1Geno/\Cd3etm1.1Geno
(involves: C57BL/6) 		increased DN3 thymocyte number J:192604
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J) 		increased DN3 thymocyte number J:192604
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL) 		increased DN3 thymocyte number J:192604
\Cd3etm1.1Geno/\Cd3etm1.1Geno
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		abnormal thymus cell ratio J:192604
increased DN3 thymocyte number J:192604
\Cd3etm1Cpt/\Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6) 		thymus hypoplasia J:54756
\Cd3etm1Cpt/\Cd3etm1Cpt
\Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		thymus hypoplasia J:54756
\Cd3gtm1.1Cage/\Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage) 		decreased thymocyte number J:153813
\Cd3gtm1Amk/\Cd3gtm1Amk
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:114561
thymus hypoplasia J:77504
\Cd3gtm1Amk/\Cd3gtm1Amk
\Tg(Igh-Pim1)1Brn/0
(involves: 129P2/OlaHsd * C57BL/6LiA * CBA) 		decreased thymocyte number J:114561
\Cd4tm1Jrp/\Cd4tm1Jrp
\Tg(TcrAND)53Hed/0
(either: (involves: 129S2/SvPas * C57BL/6 * SJL) or (involves: 129S2/SvPas * C57BL/6 * C57BL/10 * SJL)) 		thymus hyperplasia J:45168
\Cd4tm1Mak/\Cd4tm1Mak
\Cd8atm1Mak/\Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		small thymus medulla J:12572
\Cd5ltm1Nto/\Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:52195
\Cd7tm1Bfh/\Cd7tm1Bfh
(involves: 129 * C57BL/6) 		increased thymocyte number J:48758
\Cd7tm1Bfh/\Cd7tm1Bfh
(B6.129-Cd7tm1Bfh) 		increased thymocyte number J:48758
\Cd8b1tm1Litt/\Cd8b1+
\Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased thymocyte number J:110916
\Cd8b1tm1Litt/\Cd8b1tm1Litt
(involves: 129S4/SvJae * C57BL/6J) 		decreased thymocyte number J:110916
\Cd8b1tm1Wpfl/\Cd8b1tm1Wpfl
(involves: 129S2/SvPas) 		decreased thymocyte number J:19928
\Cd19tm1(cre)Cgn/\Cd19+
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:160931
\Cd28tm1Mak/\Cd28tm1Mak
(involves: 129S2/SvPas) 		enlarged thymus J:205441
\Cd28tm1Mak/\Cd28tm1Mak
\Rc3h1san/\Rc3h1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Cd38em1(IMPC)Ccpcz/\Cd38em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd38em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cd38tm1Lnd/\Cd38tm1Lnd
(B6.129P2-Cd38tm1Lnd) 		decreased pancreatic beta cell mass J:116576
disorganized pancreatic islets J:116576
\Cd40tm1Kik/\Cd40tm1Kik
\Ltbrtm1Mmat/\Ltbrtm1Mmat
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal thymus epithelium morphology J:173115
abnormal thymus medulla morphology J:173115
\Cd40tm1Kik/\Cd40tm1Kik
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd) 		abnormal thymus epithelium morphology J:173115
\Cd247tm1Lov/\Cd247tm1Lov
(involves: 129S4/SvJae) 		decreased thymocyte number J:14170
\Cd247tm1Lov/\Cd247tm1Lov
\Fcer1gtm1Rav/\Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:46914
\Cd247tm1Mal/\Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6)) 		decreased thymocyte number J:15272
\Cd247tm1Mhu/\Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased thymocyte number J:15579
enlarged thymus cortex J:15579
small thymus J:15579
small thymus medulla J:15579
thymus hypoplasia J:15579
\Cd247tm1Tks/\Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:15271
small thymus medulla J:15271
\Cd247tm2.1Lov/\Cd247tm2.1Lov
(Not Specified) 		decreased thymocyte number J:192915
\Cdc73Gt(RRE190)Byg/\Cdc73+
(B6.129P2-Cdc73Gt(RRE190)Byg) 		increased parathyroid adenoma incidence J:243366
increased parathyroid gland tumor incidence J:243366
\Cdc73tm1Btt/\Cdc73+
\Tg(PTH-cre)4167Slib/0
(Not Specified) 		increased parathyroid adenoma incidence J:243366
increased parathyroid gland tumor incidence J:243366
\Cdc73tm1Btt/\Cdc73tm1Btt
\Tg(PTH-cre)4167Slib/0
(Not Specified) 		increased parathyroid adenoma incidence J:243366
increased parathyroid gland tumor incidence J:243366
\Cdh1tm2Kem/\Cdh1tm2Kem
\Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal pancreatic islet morphology J:196410
increased pancreatic beta cell mass J:196410
\Cdk4tm1.1Bbd/\Cdk4+
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		increased pancreatic beta cell number J:54534
\Cdk4tm1.1Bbd/\Cdk4+
\Krastm1Bbd/\Kras+
\Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased pituitary adenoma incidence J:86101
\Cdk4tm1.1Bbd/\Cdk4tm1.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		increased pancreatic beta cell number J:54534
\Cdk4tm1Bbd/\Cdk4tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal pancreatic islet morphology J:54534
small pancreatic islets J:54534
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6) 		abnormal pancreatic islet morphology J:57854
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
(involves: 129S1/Sv) 		adenohypophysis hypoplasia J:111333
decreased lactotroph cell number J:111333
\Cdk4tm1Kiyo/\Cdk4tm1Kiyo
\Lin9tm1Orc/\Lin9tm1Orc
(involves: 129S1/Sv) 		adenohypophysis hypoplasia J:111333
\Cdk6tm1Bbd/\Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal thymus morphology J:92529
thymus cortex atrophy J:92529
thymus hypoplasia J:92529
\Cdk6tm1Phin/\Cdk6+
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:144975
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae) 		decreased thymocyte number J:144975
thymus atrophy J:144975
thymus hypoplasia J:144975
\Cdk6tm1Phin/\Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6) 		decreased DN1 thymic pro-T cell number J:174697
decreased DN2 thymocyte number J:174697
increased DN3 thymocyte number J:174697
\Cdk6tm2.1Phin/\Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N) 		decreased DN1 thymic pro-T cell number J:174697
decreased DN2 thymocyte number J:174697
decreased DN4 thymocyte number J:174697
decreased thymocyte number J:174697
increased DN3 thymocyte number J:174697
small thymus J:174697
\Cdk6tm3.1Phin/\Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N) 		enlarged thymus J:174697
increased DN1 thymic pro-T cell number J:174697
increased thymocyte number J:174697
\Cdk6tm4.1Phin/\Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N) 		decreased DN1 thymic pro-T cell number J:174697
decreased DN2 thymocyte number J:174697
decreased DN4 thymocyte number J:174697
decreased thymocyte number J:174697
increased DN3 thymocyte number J:174697
small thymus J:174697
\Cdk8tm1a(EUCOMM)Hmgu/\Cdk8tm1a(EUCOMM)Hmgu
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased pancreatic beta cell mass J:281075
\Cdkal1tm1.1Tomik/\Cdkal1tm1.1Tomik
\Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn) 		abnormal pancreatic islet morphology J:178248
\Cdkn1atm1Tyj/\Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:70894
\Cdkn1btm1Ako/\Cdkn1b+
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(TPO-cre)1Shk/0
(129S1.Cg-Cdkn1btm1Ako Tg(TPO-cre)1Shk Ptentm2.1Ppp) 		increased thyroid adenoma incidence J:165293
increased thyroid carcinoma incidence J:165293
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6) 		abnormal pituitary intermediate lobe morphology J:50053
increased pituitary gland tumor incidence J:50053
increased thymocyte number J:33401
increased thymus weight J:33401
pituitary intermediate lobe hyperplasia J:50053, J:33401
\Cdkn1btm1Ako/\Cdkn1btm1Ako
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2) 		enlarged adrenal glands J:50053
enlarged pituitary gland J:50053
enlarged thymus J:50053
increased pituitary adenoma incidence J:50053
pituitary intermediate lobe hyperplasia J:50053
\Cdkn1btm1Ako/\Cdkn1btm1Ako
\Men1tm1.1Ctre/\Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		increased adrenal gland tumor incidence J:120835
increased parathyroid gland tumor incidence J:120835
increased pituitary gland tumor incidence J:120835
increased thyroid tumor incidence J:120835
\Cdkn1btm1Ako/\Cdkn1btm1Ako
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(TPO-cre)1Shk/0
(129S1.Cg-Cdkn1btm1Ako Tg(TPO-cre)1Shk Ptentm2.1Ppp) 		thyroid gland hyperplasia J:165293
\Cdkn1btm1Kin/\Cdkn1b+
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		enlarged pancreatic islets J:96047
increased pancreatic beta cell number J:96047
\Cdkn1btm1Kin/\Cdkn1b+
\Leprdb/\Leprdb
(involves: C57BL/6J * C57BLKS/J) 		abnormal pancreatic islet morphology J:96047
increased pancreatic beta cell number J:96047
\Cdkn1btm1Kin/\Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pituitary intermediate lobe morphology J:33402
adrenal medulla hyperplasia J:33402
enlarged adrenal glands J:33402
enlarged thymus J:33402
increased pituitary adenoma incidence J:33402
increased pituitary gland weight J:33402
pituitary intermediate lobe hyperplasia J:33402
thymus hyperplasia J:33402
\Cdkn1btm1Kin/\Cdkn1btm1Kin
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		enlarged pancreatic islets J:96047
increased pancreatic beta cell number J:96047
\Cdkn1btm1Kin/\Cdkn1btm1Kin
\Leprdb/\Leprdb
(involves: C57BL/6J * C57BLKS/J) 		abnormal pancreatic islet morphology J:96047
increased pancreatic beta cell number J:96047
\Cdkn1btm1Mlf/\Cdkn1b+
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * CBA * FVB) 		increased T cell derived lymphoma incidence J:88323
\Cdkn1btm1Mlf/\Cdkn1b+
\Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		abnormal thymus morphology J:33400
enlarged pituitary gland J:33400
enlarged thymus J:33400
increased pituitary adenoma incidence J:33400
pituitary gland hyperplasia J:33400
thymus hyperplasia J:33400
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor) 		enlarged thymus J:107588
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Tg(KRT5-CDK4)2303Mlrp/0
(involves: 129S4/SvJae * C57BL/6 * FVB * SENCAR * SSIN) 		enlarged thymus J:107588
thymus hyperplasia J:107588
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Trp53tm1Brd/\Trp53tm1Brd
(involves: C3H * C57BL/6J * NIH) 		increased T cell derived lymphoma incidence J:87536
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * C57BL/6J) 		increased T cell derived lymphoma incidence J:87536
\Cdkn1btm2Mlf/\Cdkn1btm2Mlf
\Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
\Cdkn1btm3Jro/\Cdkn1btm3Jro
(involves: 129S4/SvJaeSor) 		enlarged thymus J:103819
\Cdkn1btm3Mlf/\Cdkn1btm3Mlf
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
\Cdkn1ctm1.1(Cdkn1b*)Kei/\Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged adrenal glands J:147145
\Cdkn1ctm1Kat/\Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6J) 		enlarged adrenal glands J:147145
\Cdkn1ctm1Sje/\Cdkn1c+
(involves: 129S7/SvEvBrd * C57BL/6) 		enlarged adrenal glands J:40203
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:44427
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA) 		decreased thymocyte number J:241062
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased thymus weight J:71394
thymus hyperplasia J:71394
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:63299
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pheochromocytoma incidence J:63299
increased pituitary adenoma incidence J:63299
increased T cell derived lymphoma incidence J:63299
pituitary gland hyperplasia J:63299
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Cdkn2dtm1Maro/\Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		increased pheochromocytoma incidence J:68829
increased pituitary adenoma incidence J:68829
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2) 		abnormal pituitary intermediate lobe morphology J:50053
abnormal thymus size J:50053
enlarged adrenal glands J:50053
enlarged pituitary gland J:50053
increased pituitary adenoma incidence J:50053
pituitary gland hyperplasia J:50053
thymus hyperplasia J:50053
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
\Men1tm1.1Ctre/\Men1+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6) 		increased adrenal gland tumor incidence J:120835
increased parathyroid gland tumor incidence J:120835
increased thyroid tumor incidence J:120835
\Cebpbtm1.1Maka/\Cebpbtm1.1Maka
\Ins2Akita/\Ins2Akita
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J) 		abnormal pancreatic beta cell mass J:156725
\Cebpbtm1.1Maka/\Cebpbtm1.1Maka
\Leprdb/\Leprdb
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BLKS/J * CBA/J) 		increased pancreatic beta cell mass J:156725
\Cer1em1(IMPC)Ccpcz/\Cer1em1(IMPC)Ccpcz
(C57BL/6NCrl-Cer1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ces1dtm1Reli/\Ces1dtm1Reli
(involves: 129S6/SvEvTac) 		small pancreatic islets J:158743
\Cfap53em1(IMPC)Wtsi/\Cfap53em1(IMPC)Wtsi
(C57BL/6N-Cfap53em1(IMPC)Wtsi/Wtsi) 		abnormal thymus topology J:239583
\Cfap161em1(IMPC)Ccpcz/\Cfap161em1(IMPC)Ccpcz
(C57BL/6NCrl-Cfap161em1(IMPC)Ccpcz/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Cfdem1(IMPC)Mbp/\Cfdem1(IMPC)Mbp
(C57BL/6NCrl-Cfdem1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
small adrenal glands J:211773
\Cflartm1.1Pope/\Cflartm1.2Pope
\Lyz2tm1(cre)Ifo/\Lyz2+
(involves: 129P2/OlaHsd) 		abnormal thymus corticomedullary boundary morphology J:167430
abnormal thymus morphology J:167430
\Cgatm1Sac/\Cgatm1Sac
(involves: 129S2/SvPas * C57BL/6J) 		abnormal thyroid follicle morphology J:28450
absent lactotrophs J:28450
decreased lactotroph cell number J:28450
decreased somatotroph cell number J:28450
increased thyrotroph cell number J:28450
\Chd2Gt(RRBO46)Byg/\Chd2+
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:146176
\Chd4tm1.1Kge/\Chd4tm1.2Kge
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL) 		thymus hypoplasia J:109547
\Chd4tm1.2Kge/\Chd4tm1.2Kge
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		thymus hypoplasia J:109547
\Chd7Gt(RRR136)Byg/\Chd7+
(involves: 129P2/OlaHsd * C57BL/6) 		ectopic thymus J:154590
small thymus J:154590
thymus hypoplasia J:154590
\Chd7Gt(S20-7E1)Sor/\Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor) 		abnormal neurohypophysis median eminence morphology J:174086
decreased gonadotropin-releasing hormone neuron number J:174086
\Chd7Gt(S20-7E1)Sor/\Chd7Gt(S20-7E1)Sor
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6J) 		Rathke's pouch hypoplasia J:119812
\Chd7Gt(XK403)Byg/\Chd7+
\Tbx1tm1Bld/\Tbx1+
(either: (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * CD-1)) 		ectopic thymus J:154590
\Chd7Whi/\Chd7+
(C3HeB/FeJ-Chd7Whi) 		abnormal neurohypophysis median eminence morphology J:161880
decreased gonadotropin-releasing hormone neuron number J:161880
\Chgbtm1Ribo/\Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adrenal chromaffin cell morphology J:157697
\Chrdtm1Emdr/\Chrdtm1Emdr
(either: B6SJL.129-Chrdtm1Emdr or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL/J)) 		abnormal thyroid gland morphology J:83662
absent parathyroid glands J:83662
athymia J:83662
thyroid gland hypoplasia J:83662
\Chrdtm1Emdr/\Chrdtm1Emdr
(129S6.129-Chrdtm1Emdr) 		athymia J:146769
\Chrdtm1Emdr/\Chrdtm1Emdr
\Tbx1m1Jlk/\Tbx1m1Jlk
(129/Sv-Tbx1m1Jlk Chrdtm1Emdr) 		athymia J:146769
\Chst2em1(IMPC)Mbp/\Chst2em1(IMPC)Mbp
(C57BL/6N-Chst2em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Chst11tm1a(KOMP)Wtsi/\Chst11tm1a(KOMP)Wtsi
(C57BL/6N-Chst11tm1a(KOMP)Wtsi/Wtsi) 		abnormal thymus morphology J:239583
\Chtoptm1a(EUCOMM)Wtsi/\Chtoptm1a(EUCOMM)Wtsi
(C57BL/6N-Chtoptm1a(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
abnormal thyroid gland morphology J:239583
thyroid gland hypoplasia J:239583
\Chukem1(IMPC)Ccpcz/\Chuk+
(C57BL/6NCrl-Chukem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Churc1tm1b(EUCOMM)Wtsi/\Churc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Churc1tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cimap1bem1(IMPC)Ccpcz/\Cimap1bem1(IMPC)Ccpcz
(C57BL/6NCrl-Cimap1bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cir1tm3a(KOMP)Wtsi/\Cir1tm3a(KOMP)Wtsi
(C57BL/6N-Cir1tm3a(KOMP)Wtsi/Wtsi) 		abnormal thyroid gland morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
\Cishtm1.2Cdon/\Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon) 		thymus hyperplasia J:204829
\Cited2tm1Bha/\Cited2tm1Bha
(involves: 129P2/OlaHsd * C57BL/6J) 		absent adrenal gland J:76593
\Cited2tm1Bha/\Cited2tm1Bha
(involves: 129P2/OlaHsd) 		absent adrenal gland J:192202, J:102098
\Cited2tm1Bha/\Cited2tm2Bha
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: 129 * C57BL/6 * CBA * SJL) 		absent adrenal gland J:137951
\Cited2tm1Bha/\Cited2tm2Bha
\Tg(T-cre)1Lwd/0
(involves: 129 * C3H * C57BL/6 * SJL) 		absent adrenal gland J:137951
\Ciz1tm1.1Homy/\Ciz1tm1.1Homy
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		thymus hyperplasia J:198470
\Clec4dtm1.1Shoy/\Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus morphology J:203159
\Clec5aem1(IMPC)Mbp/\Clec5aem1(IMPC)Mbp
(C57BL/6NCrl-Clec5aem1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Clec16atm1.1Hhak/\Clec16atm1.1Hhak
\Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL) 		abnormal pancreatic alpha cell morphology J:214528
abnormal pancreatic beta cell morphology J:214528
\Clip2em1(IMPC)Ccpcz/\Clip2em1(IMPC)Ccpcz
(C57BL/6NCrl-Clip2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Clnkem1(IMPC)Ccpcz/\Clnkem1(IMPC)Ccpcz
(C57BL/6NCrl-Clnkem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Clockem1(IMPC)Ccpcz/\Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Clockm1Jt/\Clockm1Jt
(involves: C57BL/6J) 		abnormal pancreatic islet morphology J:162641
small pancreatic islets J:162641
\Clptq1NZB/BlNJ/\Clptq1NZB/BlNJ
(B6.NZB-(D4Mit193-D4Mit33)) 		enlarged thymus J:143646
\Cmiptm1a(EUCOMM)Wtsi/\Cmiptm1a(EUCOMM)Wtsi
(C57BL/6N-Cmiptm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
small thyroid gland J:239583
\Cngb3em1(IMPC)Ccpcz/\Cngb3em1(IMPC)Ccpcz
(C57BL/6NCrl-Cngb3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Coa5tm1b(KOMP)Wtsi/\Coa5+
(C57BL/6N-Coa5tm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
\Coblem1(IMPC)Ccpcz/\Coblem1(IMPC)Ccpcz
(C57BL/6NCrl-Coblem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cobll1em1(IMPC)Ccpcz/\Cobll1em1(IMPC)Ccpcz
(C57BL/6NCrl-Cobll1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Col1a1tm1(CAG-Mir22)Ppp/\Col1a1tm1(CAG-Mir22)Ppp
\Tg(Mx1-cre)1Cgn/0
(Not Specified) 		increased T cell derived lymphoma incidence J:199366
\Col1a1tm1(tetO-Lin28a)Gqda/\Col1a1+
(involves: 129S4/SvJae * C57BL/6 * CD-1) 		small pancreatic islets J:166568
\Col1a1tm2(tetO-Pou5f1)Jae/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		thymus atrophy J:98920
\Col1a1tm3(tetO-GFP/RNAi:Apc)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:171191
\Col1a1tm4(tetO-GFP/RNAi:Apc)Slowe/\Col1a1+
\Gt(ROSA)26Sortm1(rtTA*M2)Jae/\Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:171191
\Col4a2em1(IMPC)Wtsi/\Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu) 		abnormal thymus topology J:239583
abnormal thyroid gland isthmus morphology J:239583
abnormal thyroid gland morphology J:239583
absent thyroid gland isthmus J:239583
small thymus J:239583
small thyroid gland J:239583
\Col5a2em1(IMPC)Ccpcz/\Col5a2+
(C57BL/6NCrl-Col5a2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Col5a3tm1Dgr/\Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		decreased pancreatic beta cell mass J:171817
decreased pancreatic beta cell number J:171817
\Col10a1tm1Bhr/\Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased thymocyte number J:62230
decreased thymus weight J:62230
small thymus J:62230
thymus hypoplasia J:62230
\Cop1Gt(XR0653)1.1Wtsi/\Cop1Gt(XR0653)1.1Wtsi
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:178271
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		decreased thymocyte number J:132114
thymus medulla hypoplasia J:132114
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		decreased thymocyte number J:132114
\Cops5tm1Rpar/\Cops5tm1Rpar
\Tg(Lck-cre)548Jxm/0
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129 * C57BL/6 * CBA * SJL) 		decreased thymocyte number J:132114
\Cops8em1(IMPC)Ccpcz/\Cops8+
(C57BL/6NCrl-Cops8em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Coro1akoy/\Coro1akoy
(C57BL/6-Coro1akoy) 		decreased thymocyte number J:141431
\Coro1aptcd/\Coro1aptcd
(B6.CTS-Coro1aptcd) 		increased thymocyte number J:141431
\Coro1aptcd/\Coro1atm1Achn
(B6.Cg-Coro1aptcd Coro1atm1Achn) 		increased thymocyte number J:141431
\Coro1atm1Achn/\Coro1atm1Achn
(B6.129X1-Coro1atm1Achn) 		decreased thymocyte number J:141431
\Coro1ctm1a(KOMP)Wtsi/\Coro1ctm1a(KOMP)Wtsi
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Cox6b1em1(IMPC)Tcp/\Cox6b1+
(C57BL/6NCrl-Cox6b1em1(IMPC)Tcp/Tcp) 		absent adrenal gland J:211773
\Cpa3tm3(icre)Hrr/\Cpa3+
\Notch1tm1Agt/\Notch1tm1Agt
(involves: 129 * C57BL/6) 		thymus hypoplasia J:143731
\Cpaptm1a(EUCOMM)Wtsi/\Cpaptm1a(EUCOMM)Wtsi
(B6Brd;B6N-Tyrc-Brd Cpaptm1a(EUCOMM)Wtsi/Wtsi) 		retention of the adrenal gland x-zone J:194085
\Cpefat/\Cpefat
(involves: HRS/J) 		abnormal pancreatic beta cell morphology J:10872
degranulated pancreatic beta cells J:13651
increased pancreatic islet number J:13651
pancreatic islet hyperplasia J:10872
\Cpefat/\Cpefat
(BKSChpLt.HRS-Cpefat/J) 		abnormal pancreatic beta cell morphology J:24436
degranulated pancreatic beta cells J:10872
pancreatic islet hyperplasia J:10872
\Cplane2b2b2827Clo/\Cplane2b2b2827Clo
(C57BL/6J-Cplane2b2b2827Clo) 		thymus hypoplasia J:175213
\Crb1rd8+em1Boc/\Crb1rd8+em1Boc
\Jak3m1J/\Jak3m1J
(B6.Cg-Crb1rd8+em1Boc Jak3m1J/Boc) 		small thymus J:265859
\Crb1rd8/\Crb1rd8
\Jak3m1J/\Jak3m1J
(B6.Cg-Crb1rd8 Jak3m1J/BocJ) 		small thymus J:265859
\Crebbptm1Few/\Crebbp+
(Not Specified) 		abnormal pancreatic beta cell morphology J:91133
\Crebbptm1Few/\Crebbptm1Few
(Not Specified) 		abnormal pancreatic beta cell morphology J:91133
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA) 		decreased thymocyte number J:105505
increased T cell derived lymphoma incidence J:105505
small thymus J:105505
\Crebbptm1Jvd/\Crebbptm1Jvd
\Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB) 		increased T cell derived lymphoma incidence J:88323
\Crebbptm1Pkb/\Crebbptm1Pkb
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:98329
\Crhtm1Maj/\Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6J) 		abnormal adrenal gland morphology J:23082
decreased adrenal gland zona fasciculata size J:23082
\Crhtm1Maj/\Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6) 		abnormal solitary pulmonary neuroendocrine cell morphology J:53721
\Crhtm2.1Maj/\Crhtm2.1Maj
\Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		adrenal gland atrophy J:238330
decreased adrenal gland weight J:238330
\Crhtm2.2Maj/\Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		adrenal gland atrophy J:238330
\Crhr1tm1Klee/\Crhr1tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		adrenal gland atrophy J:77641
adrenal gland hypoplasia J:48280
decreased adrenal gland zona fasciculata size J:48280
\Crhr1tm1Klee/\Crhr1tm1Klee
\Crhr2tm1Klee/\Crhr2tm1Klee
(involves: 129S4/SvJae * C57BL/6) 		adrenal gland atrophy J:77641
decreased adrenal gland zona fasciculata size J:77641
\Crhr1tm1Wrst/\Crhr1tm1Wrst
(either: (involves: 129P2/OlaHsd * 129P/Ola) or (involves: 129P2/OlaHsd * CD-1)) 		abnormal adrenal medulla morphology J:76022
\Crip3tm1Mjb/\Crip3tm1Mjb
(either: (involves: 129S/Sv) or (involves: 129S/Sv * C57BL/6)) 		decreased thymocyte number J:72942
small thymus J:72942
thymus hypoplasia J:72942
\Crkltm1Imo/\Crkltm1Imo
(involves: 129S4/SvJaeSor * C57BL/6J) 		abnormal parathyroid gland development J:67826
abnormal thymus development J:67826
abnormal thyroid gland development J:67826
\Crxem1(IMPC)Ccpcz/\Crxem1(IMPC)Ccpcz
(C57BL/6N-Crxem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
small thymus J:211773
\Csf1op/\Csf1op
(C57BL/6J-Csf1op) 		abnormal thyroid parafollicular cell morphology J:5634
\Csf1op/\Csf1op
(B6C3Fe a/a-Csf1op/J) 		thymus cortex hypoplasia J:26978
thymus medulla atrophy J:26978
\Csf1op/\Csf1op
(involves: C3HeB/FeJ * C57BL/6J) 		abnormal thyroid parafollicular cell morphology J:5634
\Csf2tm1Mlg/\Csf2tm1Mlg
(B6.129S2-Csf2tm1Mlg) 		abnormal pancreatic islet morphology J:145518
\Csf2tm1Mlg/\Csf2tm1Mlg
\Ifngtm1Ts/\Ifngtm1Ts
\Il3tm1Glli/\Il3tm1Glli
(B6.129S-Csf2tm1Mlg Il3tm1Glli Ifngtm1TsIfngtm1Ts) 		increased pituitary adenoma incidence J:145518
\Csf2tm1Mlg/\Csf2tm1Mlg
\Il3tm1Glli/\Il3tm1Glli
(B6.129S2-Csf2tm1Mlg Il3tm1Glli) 		abnormal pancreatic islet morphology J:145518
decreased pancreatic beta cell number J:145518
\Csktm1Sor/\Csk+
\Ptprcltng/\Ptprcltng
(involves: 129S7/SvEvBrd * C57BL/6) 		thymus hypoplasia J:158876
\Csktm1Sor/\Csk+
\Ptprcltng/\Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6) 		thymus hypoplasia J:158876
\Csktm1Tara/\Csktm1Tara
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA) 		enlarged thymus J:49654
\Ctc1tm1.1Schg/\Ctc1tm1.1Schg
(involves: 129S7/SvEvBrd * C57BL/6) 		small thymus J:184809
\Ctcftm2Gal/\Ctcf+
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:143271
\Ctcftm2Gal/\Ctcftm2Gal
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:143271
\Ctf1tm1Msd/\Ctf1tm1Msd
(B6.Cg-Ctf1tm1Msd) 		enlarged pancreatic islets J:176727
increased pancreatic islet number J:176727
\Ctla4tm1All/\Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal thymus morphology J:42481
\Ctnnb1tm1Mmt/\Ctnnb1+
\Sox2tm1.1(cre/ERT2)Jpmb/\Sox2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		abnormal adenohypophysis morphology J:201265
increased pituitary gland tumor incidence J:201265
\Ctnnb1tm1Mmt/\Ctnnb1tm1Mmt
\Tg(Pitx1-cre)7Rsd/0
(involves: 129X1/SvJ * BALB/c * C57BL/6) 		absent pituitary gland J:114817
\Ctnnb1tm2Kem/\Ctnnb1tm2.1Kem
\Gt(ROSA)26Sortm1(Ctnnb1)Kem/\Gt(ROSA)26Sortm1(Ctnnb1)Kem
\Tg(Cdx1-cre)23Kem/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB) 		small adrenal glands J:187739
\Ctnnb1tm2Kem/\Ctnnb1tm2Kem
\Tg(Pitx1-cre)7Rsd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		abnormal adenohypophysis morphology J:114817
absent lactotrophs J:114817
absent somatotrophs J:114817
absent thyrotrophs J:114817
decreased gonadotroph cell number J:114817
increased corticotroph cell number J:114817
small adenohypophysis J:114817
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio) 		small thymus J:348981
thymus hypoplasia J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj) 		small thymus J:348981
thymus hypoplasia J:348981
\Ctps1tm1c(KOMP)Wtsi/\Ctps1tm1c(KOMP)Wtsi
\Tg(Cd4-cre)1Cwi/0
\Foxp3sf/Y
\Rag1tm1Mom/\Rag1+
(mixed) 		thymus hypoplasia J:348981
\Ctsbtm1Jde/\Ctsbtm1Jde
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thyroid gland morphology J:83877
\Ctsbtm1Jde/\Ctsbtm1Jde
\Ctsktm1Psa/\Ctsktm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		abnormal thyroid follicle morphology J:83877
abnormal thyroid follicular cell morphology J:83877
\Ctsdm1J/\Ctsdm1J
(C3HeB/FeJ-Ctsdm1J/GrsrJ) 		thymus atrophy J:229377
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre
\Edil3Tg(Sox2-cre)1Amc/\Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL) 		thymus atrophy J:227618
\Ctsdtm1.1Thre/\Ctsdtm1.1Thre
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL) 		abnormal thymus morphology J:227618
\Ctsdtm1Cptr/\Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd)) 		thymus hypoplasia J:28201
\Ctsktm1Psa/\Ctsktm1Psa
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J) 		abnormal thyroid follicle morphology J:83877
abnormal thyroid gland morphology J:83877
\Ctslnkt/\Ctslnkt
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * DBA/2)) 		thymus atrophy J:54856
\Ctslnkt/\Ctslnkt
(C.Cg-Ctslnkt) 		abnormal thymus corticomedullary boundary morphology J:99009
abnormal thymus lobule morphology J:99009
abnormal thymus morphology J:99009
enlarged thymus cortex J:99009
\Ctsltm1Cptr/\Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thyroid gland morphology J:83877
\Cul4a/Pcid2tm2Ktc/\Cul4a/Pcid2tm2Ktc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N) 		small thymus J:138468
\Cul4a/Pcid2tm2Ktc/\Cul4a/Pcid2tm2Ktc
\Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N) 		small thymus J:138468
\Cul9em1(IMPC)Ccpcz/\Cul9em1(IMPC)Ccpcz
(C57BL/6N-Cul9em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Cul9tm1.2Yxi/\Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
\Cul9tm1.2Yxi/\Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
\Cux1tm1Rhsc/\Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J) 		decreased thymocyte number J:100055
small thymus J:100055
thymus cortex hypoplasia J:100055
thymus hypoplasia J:100055
\Cxadrtm1.1Ics/\Cxadrtm1.1Ics
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA) 		enlarged thymus J:174138
increased thymocyte number J:174138
\Cxcr2tm1(IL8RB)Dktr/\Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6) 		small adrenal glands J:113489
\Cxcr2tm1Mwm/\Cxcr2tm1Mwm
(involves: 129S2/SvPas * BALB/c) 		decreased thymus weight J:113489
\Cxcr4tm1.1Bala/\Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala) 		abnormal thymus morphology J:186735
\Cxcr4tm1Yiw/\Cxcr4tm1Yiw
\Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:164872
\Cyb5r4tm1Hfb/\Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN) 		abnormal pancreatic islet morphology J:91486
decreased pancreatic beta cell number J:91486
\Cycstm1Mak/\Cycstm1Mak
(involves: C57BL/6) 		abnormal pituitary gland morphology J:98949
thymus atrophy J:98949
thymus hypoplasia J:98949
\Cyldtm1Lex/\Cyldtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		thymus hyperplasia J:114972
\Cyp1a1tm1.1Dwn/\Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn) 		decreased thymus weight J:163973
\Cyp1a1tm1.1Dwn/\Cyp1a1tm1.1Dwn
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:122409
\Cyp1a1tm4.1Dwn/\Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn) 		decreased thymus weight J:163973
\Cyp1atm1Dwn/\Cyp1atm1Dwn
(B6.129-Cyp1atm1Dwn) 		small thymus J:122409
\Cyp11a1tm1.1Bcc/\Cyp11a1tm1.1Bcc
(B6.129(FVB)-Cyp11a1tm1.1Bcc) 		abnormal adrenal gland morphology J:191801
abnormal adrenocortical cell morphology J:191801
absent adrenal chromaffin cells J:191801
\Cyp11a1tm1Bcc/\Cyp11a1tm1Bcc
(involves: 129 * C57BL/6) 		abnormal adrenal cortex morphology J:78062
enlarged adrenocortical cells J:78062
small adrenal glands J:78062
\Cyp11a1tm2Bcc/\Cyp11a1tm2Bcc
(Not Specified) 		abnormal adrenal cortex morphology J:133007
abnormal adrenal gland morphology J:133007
abnormal adrenal gland zona fasciculata morphology J:133007
abnormal adrenal gland zona glomerulosa morphology J:133007
enlarged adrenal glands J:133007
\Cyp11b1tm1Chjk/\Cyp11b1tm1Chjk
(involves: 129P2/OlaHsd * C57BL/6J) 		adrenal gland hyperplasia J:147610
decreased thymus weight J:147610
enlarged adrenal glands J:147610
increased adrenal gland zona fasciculata size J:147610
pituitary gland hyperplasia J:147610
\Cyp11b2tm1.1(cre)Brlt/\Cyp11b2+
\Nr5a1tm2Klp/\Nr5a1tm2Klp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal adrenal gland zona glomerulosa morphology J:204614
\Cyp11b2tm1Hsk/\Cyp11b2tm1Hsk
(involves: 129S6/SvEvTac) 		abnormal adrenal cortex morphology J:99269
abnormal adrenal gland zona glomerulosa morphology J:99269
abnormal adrenocortical cell morphology J:99269
\Cyp27a1tm1Elt/\Cyp27a1tm1Elt
(involves: 129/Sv * C57BL/6J) 		enlarged adrenal glands J:115373
enlarged adrenocortical cells J:115373
increased adrenal gland weight J:115373
\Cyp27b1tm1Star/\Cyp27b1tm1Star
(involves: 129S1/Sv * 129X1/SvJ) 		enlarged parathyroid gland J:71928
\Cys1cpk/\Cys1cpk
(involves: C57BL/6J * CD-1) 		thymus hypoplasia J:33739
\Cys1cpk/\Cys1cpk
(C.B6(Cg)-Cys1cpk) 		absent pancreatic islets J:99616
\Cys1cpk/\Cys1cpk
(D2J.B6(Cg)-Cys1cpk) 		absent pancreatic islets J:99620
\Dab1scm-4J/\Dab1scm-4J
(CBA/J-Dab1scm-4J/GrsrJ) 		thymus atrophy J:153275
\Dach1tm1Krs/\Dach1tm1Krs
(involves: 129P2/OlaHsd) 		decreased pancreatic alpha cell number J:166952
decreased pancreatic beta cell number J:166952
small pancreatic islets J:166952
\Dad1tm1Kni/\Dad1+
(involves: 129S/SvEv) 		decreased thymus weight J:99897
\Daglatm1a(EUCOMM)Wtsi/\Daglatm1a(EUCOMM)Wtsi
(C57BL/6N-Daglatm1a(EUCOMM)Wtsi/Nju) 		small thymus J:211773
\Dcaf15tm1a(EUCOMM)Hmgu/\Dcaf15tm1a(EUCOMM)Hmgu
(C57BL/6NCrl-Dcaf15tm1a(EUCOMM)Hmgu/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Dckmemi/\Dckmemi
(C57BL/6J-Dckmemi) 		small thymus J:184080
thymus hypoplasia J:184080
\Dcktm1.1Radu/\Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J) 		abnormal thymus morphology J:158373
thymus hypoplasia J:158373
\Dclre1atm1Rleg/\Dclre1atm1Rleg
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:102381
\Dclre1cm1Brck/\Dclre1cm1Brck
(involves: C57BL/6) 		decreased DN1 thymic pro-T cell number J:207533
decreased DN4 thymocyte number J:207533
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:80995
\Dclre1ctm1Fwa/\Dclre1ctm1Fwa
(involves: 129S6/SvEvTac) 		decreased thymocyte number J:147864
\Dclre1ctm1Jsek/\Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:147864
\Dclre1ctm2.2Jpdv/\Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv) 		decreased thymocyte number J:153841
\Dclre1ctm2Mcow/\Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6) 		absent thymus cortex J:96535
decreased thymocyte number J:96535
decreased thymus weight J:96535
\Dcntm1Ioz/\Dcn+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		increased T cell derived lymphoma incidence J:53511
\Dcntm1Ioz/\Dcntm1Ioz
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129/Sv * Black Swiss * C57BL/6) 		enlarged thymus J:53511
increased T cell derived lymphoma incidence J:53511
thymus hyperplasia J:53511
\Ddb1em1(IMPC)Ccpcz/\Ddb1+
(C57BL/6N-Ddb1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\dde/\dde
(CByJ(Cg)-dde/GrsrJ) 		thyroid gland cyst J:159016
\Ddosttm1.1(KOMP)Vlcg/\Ddost+
(C57BL/6N-Ddosttm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Ddr2slie/\Ddr2slie
(BKSChpLt.Cg-Tg(Ins2-Cpe)1Lt Cpefat/LtJng) 		small pituitary gland J:134371
\Ddx24em1(IMPC)Mbp/\Ddx24+
(C57BL/6NCrl-Ddx24em1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Del(2Duoxa2-Duoxa1)1Sref/\Del(2Duoxa2-Duoxa1)1Sref
(involves: 129S6/SvEvTac * C57BL/6J) 		enlarged adenohypophysis J:205165
enlarged thyroid gland J:205165
thyroid gland hyperplasia J:205165
\Del(3Bglap2-Bglap)2Kry/\Del(3Bglap2-Bglap)2Kry
(involves: 129S7/SvEvBrd) 		abnormal pancreatic islet morphology J:126780
decreased pancreatic beta cell mass J:126780
decreased pancreatic islet number J:126780
small pancreatic islets J:126780
\Del(7)Tyrc-3H/\Del(7)Tyrc-3H
(involves: 101/H * C3H/HeH) 		abnormal thymus morphology J:5063
\Del(7Hmx3-Hmx2)2Tlu/\Del(7Hmx3-Hmx2)2Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J)) 		small adenohypophysis J:92940
small pituitary gland J:92940
\Del(9Cd3g-Cd3d)1Cpt/\Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6) 		thymus hypoplasia J:76991
\Del(11Jmjd6-Mettl23)1Ysfk/\Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6) 		abnormal thymus development J:90288
thymus hypoplasia J:90288
\Del(11Stat5a-Stat5b)1Mam/\Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6) 		small thymus J:122463
\Del(16Dgcr2-Hira)1Rak/\+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * FVB/N * SJL) 		absent parathyroid glands J:67796
\Del(16Pi4ka-Hira)1Atai/\+
(C57BL/6N-Del(16Pi4ka-Hira)1Atai) 		thymus hypoplasia J:285407
\Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA) 		increased pancreatic alpha cell number J:92536
increased pancreatic beta cell number J:92536
pancreatic islet hyperplasia J:92536
\Dffbtm1Osa/\Dffbtm1Osa
\Dnase2atm1Osa/\Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus morphology J:81474
small thymus J:81474
thymus hypoplasia J:81474
\Dh/\Dh+
\Foxn1nu/\Foxn1nu
(involves: N:NIH(S)) 		athymia J:6062
\Dhrs7bGt(OST255410)Lex/\Dhrs7bGt(OST255410)Lex
(B6;129S5-Dhrs7bGt(OST255410)Lex/Mmucd) 		thymus atrophy J:171883
\Dhtkd1tm1Zgwg/\Dhtkd1tm1Zgwg
(involves: C57BL/6) 		abnormal pancreatic islet morphology J:267178
\Dhx8em1(IMPC)Mbp/\Dhx8+
(C57BL/6NCrl-Dhx8em1(IMPC)Mbp/Mmucd) 		enlarged thymus J:211773
\Dhx35tm1b(EUCOMM)Wtsi/\Dhx35tm1b(EUCOMM)Wtsi
(C57BL/6N-Dhx35tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
\Dhx36tm1.2Pmt/\Dhx36tm1.2Pmt
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca) 		thymus hypoplasia J:185179
\Dicer1tm1Bdh/\Dicer1+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129 * C57BL/6 * CBA/J) 		abnormal thymus development J:166758
\Dicer1tm1Bdh/\Dicer1tm1Bdh
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129 * C57BL/6 * CBA/J) 		athymia J:166758
\Dicer1tm1Mmk/\Dicer1tm1Mmk
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased thymocyte number J:98192
\Dicer1tm1Tara/\Dicer1tm1Tara
\Foxn1tm3(cre)Nrm/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd) 		abnormal thymus cortex morphology J:180783
abnormal thymus epithelium morphology J:180783
abnormal thymus medulla morphology J:180783
abnormal thymus morphology J:180783
\Dip2cem1(IMPC)Tcp/\Dip2c+
(C57BL/6N-Dip2cem1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Dip2cem1(IMPC)Tcp/\Dip2cem1(IMPC)Tcp
(C57BL/6N-Dip2cem1(IMPC)Tcp/Tcp) 		enlarged adrenal glands J:211773
\Disp1icb/\Disp1tm1Amc
(involves: 129X1/SvJ * C57BL/6J) 		absent pituitary gland J:92058
\Disp1tm1Amc/\Disp1tm1Amc
(involves: 129X1/SvJ) 		pituitary gland hypoplasia J:92058
\Dkc1tm1Ppp/Y
(involves: 129S1/Sv) 		increased pheochromocytoma incidence J:81054
\Dlgap1em1(IMPC)Tcp/\Dlgap1em1(IMPC)Tcp
(C57BL/6NCrl-Dlgap1em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Dll4tm1Frad/\Dll4tm1Frad
\Foxn1tm3(cre)Nrm/\Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm) 		abnormal thymus cell ratio J:143472
decreased thymocyte number J:143472
\Dll4tm1Kaho/\Dll4tm1Kaho
\Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2) 		thymus hypoplasia J:143473
\Dmdmdx/\Dmdmdx
(C57BL/10ScSn-Dmdmdx) 		abnormal corticotroph morphology J:18080
increased somatotroph cell size J:18080
\Dmtf1tm1Cjs/\Dmtf1+
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1+
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:63444
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmtf1tm1Cjs/\Dmtf1tm1Cjs
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:126002
\Dmxl2tm1a(EUCOMM)Wtsi/\Dmxl2tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Dmxl2tm1a(EUCOMM)Wtsi/WtsiH) 		multiple persisting craniopharyngeal ducts J:239583
\Dmxl2tm1c(EUCOMM)Wtsi/\Dmxl2+
\Tg(Nes-cre)1Atp/0
(involves: C57BL/6N * FVB/N) 		decreased gonadotropin-releasing hormone neuron number J:217623
\Dnajb9Gt(KST256)Byg/\Dnajb9Gt(KST256)Byg
(B6.129P2-Dnajb9Gt(KST256)Byg) 		abnormal pancreatic alpha cell morphology J:226674
abnormal pancreatic beta cell morphology J:226674
increased pancreatic alpha cell number J:226674
\Dnajb9Gt(KST256)Byg/\Dnajb9Gt(KST256)Byg
\Tg(CAG-XBP1*/Venus)#Miur/?
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pancreatic alpha cell morphology J:226674
abnormal pancreatic beta cell morphology J:226674
decreased pancreatic beta cell number J:226674
\Dnajc3tm8663Wcl/\Dnajc3tm8663Wcl
(C57BL/6-Dnajc3tm8663Wcl/Mmmh) 		abnormal pancreatic beta cell morphology J:98194
decreased pancreatic beta cell mass J:98194
decreased pancreatic beta cell number J:98194
\Dnajc11spc/\Dnajc11spc
(B6.Cg-Dnajc11spc) 		decreased thymus weight J:221543
enlarged thymus medulla J:221543
increased DN1 thymic pro-T cell number J:221543
thymus cortex atrophy J:221543
thymus hypoplasia J:221543
\Dnase2atm1Osa/\Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus morphology J:81474
small thymus J:81474
thymus hypoplasia J:81474
\Dnmt3atm1Jae/\Dnmt3atm1Jae
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sor+
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
\Tg(Ins2-cre)23Herr/0
(involves: 129S/Sv * Black Swiss * C57BL/6 * CBA/J * SJL) 		abnormal pancreatic beta cell differentiation J:177838
\Dnmt3atm1Jae/\Dnmt3atm1Jae
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
\Tg(Ins2-cre)23Herr/0
(involves: Black Swiss * C57BL/6 * CBA/J * SJL) 		decreased pancreatic beta cell number J:177838
increased pancreatic alpha cell number J:177838
\Dnmt3btm1Enl/\Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:106540
small thymus J:106540
\Dnmt3btm1Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:106540
small thymus J:106540
\Dnmt3btm6Enl/\Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:106540
small thymus J:106540
\Dnmt3btm6Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:106540
\Dnmt3btm7Enl/\Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6) 		decreased thymocyte number J:106540
small thymus J:106540
\Dock1b2b3190Clo/\Dock1b2b3190Clo
(C57BL/6J-Dock1b2b3190Clo) 		thymus hypoplasia J:175213
\Dock10tm1a(EUCOMM)Hmgu/\Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg) 		abnormal thymus cell ratio J:238172
\Dock11tm1.1Mmar/\Dock11tm1.1Mmar
(Not Specified) 		abnormal thymus cell ratio J:238172
\Dok1tm1Yyam/\Dok1tm1Yyam
\Dok2tm1Yyam/\Dok2tm1Yyam
\Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6) 		enlarged thymus J:95335
\Dok1tm1Yyam/\Dok1tm1Yyam
\Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6) 		enlarged thymus J:95335
\Dok2tm1Yyam/\Dok2tm1Yyam
\Tg(Tec-BCR/ABL1)5Hhi/0
(involves: C57BL/6) 		enlarged thymus J:95335
\Drd2tm1.1Mrub/\Drd2tm1.1Mrub
\Tg(Nes-cre)1Kln/?
(involves: 129S4/SvJae * C57BL/6 * SJL) 		decreased somatotroph cell number J:194227
\Drd2tm1Ebo/\Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		abnormal adrenal gland zona fasciculata morphology J:110599
abnormal adrenal gland zona reticularis morphology J:110599
abnormal melanotroph morphology J:110599
adenohypophysis hyperplasia J:41857
adrenal cortical hyperplasia J:110599
decreased lactotroph cell size J:41857
decreased somatotroph cell number J:41857
enlarged adrenocortical cells J:110599
enlarged pituitary gland J:41857
increased lactotroph cell number J:41857
increased pituitary adenoma incidence J:41857
increased thyrotroph cell number J:41857
pituitary gland hyperplasia J:41857
pituitary intermediate lobe hyperplasia J:110599, J:41857
\Drd2tm1Low/\Drd2tm1Low
(either: B6.129S2-Drd2tm1Low or (involves: 129S2/SvPas * C57BL/6)) 		abnormal adenohypophysis morphology J:41858
abnormal pituitary gland morphology J:41858
adenohypophysis hyperplasia J:41858
adenohypophysis hypertrophy J:41858
adenohypophysis peliosis J:41858
decreased gonadotroph cell number J:41858
enlarged pituitary gland J:41858
increased lactotroph cell number J:41858
increased pituitary gland weight J:41858
\Drd2tm1Mok/\Drd2tm1Mok
(involves: 129S/SvEv * C57BL/6J * DBA/2J) 		enlarged pituitary intermediate lobe J:97838
\Drgxem1(IMPC)Mbp/\Drgx+
(C57BL/6N-Drgxem1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\Droshatm1Litt/\Droshatm1.1Litt
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N) 		decreased thymocyte number J:138683
\Dtx4em1(IMPC)Ccpcz/\Dtx4+
(C57BL/6N-Dtx4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Duox2thyd/\Duox2thyd
(B6(129)-Duox2thyd/J) 		abnormal adenohypophysis morphology J:121821
abnormal thyroid follicle morphology J:121821
thyroid gland hyperplasia J:121821
\Dusp5tm1.1Achn/\Dusp5tm1.1Achn
(involves: C57BL/6NCrl) 		increased thymocyte number J:218203
\Dusp12em1(IMPC)Mbp/\Dusp12+
(C57BL/6N-Dusp12em1(IMPC)Mbp/Ucd) 		abnormal adrenal gland morphology J:211773
\Dvl3b2b2866Clo/\Dvl3b2b2866Clo
(C57BL/6J-Dvl3b2b2866Clo) 		thymus hypoplasia J:175213
\dwt/\dwt
(TAIII) 		decreased somatotroph cell number J:14660
decreased somatotroph cell size J:14660
\Dyrk1atm1Jdc/\Dyrk1atm1Jdc
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J) 		decreased thymocyte number J:223138
\E2f1Tg(Wnt1-cre)2Sor/\E2f1+
\Snrpbem1Lajm/\Snrpb+
(involves: C3H * C57BL/6 * C57BL/6J * CD1) 		athymia J:326544
\E2f1tm1Meg/\E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6)) 		enlarged thymus J:33100
increased T cell derived lymphoma incidence J:33100
increased thymocyte number J:33100
increased thymus weight J:33100
\E2f1tm1Meg/\E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg) 		abnormal pancreatic islet morphology J:93708
enlarged thymus J:93708
increased thymocyte number J:93708
\E2f1tm1Meg/\E2f1tm1Meg
\E2f3tm2.1Gle/\E2f3tm2.1Gle
(involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		abnormal adrenal cortex morphology J:138289
\E2f1tm1Njd/\E2f1+
\Rb1tm1Tyj/\Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		increased thyroid adenoma incidence J:47108
\E2f1tm1Njd/\E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6) 		abnormal pancreatic beta cell morphology J:89720
abnormal pancreatic islet morphology J:89720
decreased pancreatic islet number J:89720
small pancreatic islets J:89720
\E2f1tm1Njd/\E2f1tm1Njd
\Rb1tm1Tyj/\Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		abnormal thyroid gland morphology J:47108
adrenal medulla hyperplasia J:47108
increased pituitary gland tumor incidence J:47108
increased thyroid adenoma incidence J:47108
\E2f2tm1Zubi/\E2f2tm1Zubi
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J) 		thymus hypoplasia J:76318
\E2f4tm1Jrn/\E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:64192
thymus hypoplasia J:64192
\E2f4tm1Lees/\E2f4+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082
increased thyroid tumor incidence J:81082
\E2f6em1(IMPC)Ccpcz/\E2f6em1(IMPC)Ccpcz
(C57BL/6NCrl-E2f6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
small thymus J:211773
\Ece1tm1Reh/\Ece1tm1Reh
(involves: 129S6/SvEvTac * C57BL/6) 		parathyroid hypoplasia J:46640
persistent cervical thymus J:46640
thyroid gland hypoplasia J:46640
\Ecscrtm1.1(KOMP)Vlcg/\Ecscrtm1.1(KOMP)Vlcg
(C57BL/6N-Ecscrtm1.1(KOMP)Vlcg/Ucd) 		abnormal thymus morphology J:211773
small thymus J:211773
\Ednratm1Ywa/\Ednratm1Ywa
(129S/SvEv-Ednratm1Ywa) 		ectopic thymus J:46639
thymus hypoplasia J:46639
\Eef1a2wst/\Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J) 		decreased thymus weight J:6766
\Eef1a2wst/\Eef1a2wst
(Not Specified) 		thymus atrophy J:50410
\Efna5tm1b(EUCOMM)Wtsi/\Efna5tm1b(EUCOMM)Wtsi
(C57BL/6N-Efna5tm1b(EUCOMM)Wtsi/Ieg) 		enlarged adrenal glands J:211773
\Efnb1tm1.1Jwu/\Efnb1tm1.1Jwu
\Efnb2tm1.1Jwu/\Efnb2tm1.1Jwu
\Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm) 		decreased DN4 thymocyte number J:178148
decreased thymus weight J:178148
increased DN3 thymocyte number J:178148
small thymus J:178148
thymus hypoplasia J:178148
\Egfrtm1Rdk/\Egfrtm1Rdk
(involves: 129X1/SvJ * Black Swiss) 		abnormal pancreatic beta cell morphology J:62160
disorganized pancreatic islets J:62160
\Egln3tm1Pjr/\Egln3tm1Pjr
(involves: 129S/SvEv * Swiss) 		abnormal adrenal chromaffin cell morphology J:136034
abnormal adrenal medulla morphology J:136034
\Egr1tm1Jmi/\Egr1tm1Jmi
(involves: 129 * C57BL/6) 		increased T cell derived lymphoma incidence J:123870
\Egr1tm1Pch/\Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J) 		adenohypophysis hypoplasia J:45064
decreased somatotroph cell number J:45064
\Ehd4tm1.1Haba/\Ehd4tm1.1Haba
(involves: C57BL/6 * C57BL/6J * FVB/N) 		abnormal pancreatic islet morphology J:160188
pancreatic islet hyperplasia J:160188
\Eif2ak3tm1Drc/\Eif2ak3tm1Drc
(involves: 129S6/SvEvTac) 		abnormal pancreatic alpha cell morphology J:76661
absent pancreatic alpha cells J:76661
absent pancreatic beta cells J:76661
decreased pancreatic beta cell number J:76661, J:129974
small pancreatic islets J:76661
\Eif2ak3tm1Dron/\Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster) 		abnormal pancreatic islet morphology J:70005
decreased pancreatic beta cell number J:70005
increased pancreatic alpha cell number J:70005
\Eif4btm1.1Smoc/\Eif4btm1.1Smoc
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
(involves: 129 * C57BL/6) 		small thymus J:311140
\Elavl1tm1.1Thla/\Elavl1+
(involves: 129S1/Sv) 		thymus hypoplasia J:155109
\Elavl1tm1Dkon/\Elavl1tm1Dkon
\Tg(Lck-cre)I57Jxm/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo) 		increased thymocyte number J:148866
\Elavl1tm1Thla/\Elavl1tm1Thla
\Gt(ROSA)26Sortm1(cre/ERT2)Alj/\Gt(ROSA)26Sor+
(involves: 129) 		thymus hypoplasia J:155109
\Elk4tm1Rtr/\Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6)) 		decreased thymocyte number J:88515
\Elovl6Gt(OST222498)Lex/\Elovl6Gt(OST222498)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal pancreatic islet morphology J:130031
\Emv30b/\Emv30b
\Prkdcscid/\Prkdcscid
(NOD.Cg-Emv30b Prkdcscid/Dvs) 		increased T cell derived lymphoma incidence J:29951
\Emx1tm1(cre)Ito/\Emx1+
\Hes1tm1Fgu/\Hes1tm1Hojo
\Hes5tm1Fgu/\Hes5tm1Fgu
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ) 		abnormal neurohypophysis morphology J:121843
abnormal pituitary diverticulum morphology J:121843
abnormal pituitary gland development J:121843
abnormal pituitary gland morphology J:121843
abnormal pituitary infundibular stalk morphology J:121843
absent pituitary intermediate lobe J:121843
increased somatotroph cell number J:121843
pituitary gland hypoplasia J:121843
\Emx2tm1Sia/\Emx2tm1Sia
\Otx2tm1Sia/\Otx2+
(involves: C57BL/6 * CBA) 		abnormal adenohypophysis morphology J:70745
\Enpp1em1(IMPC)Ccpcz/\Enpp1em1(IMPC)Ccpcz
(C57BL/6NCrl-Enpp1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
small thymus J:211773
\Ep300tm1Pkb/\Ep300+
\Mybtm1Ssp/\Myb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		decreased thymocyte number J:98329
\Ep300tm1Pkb/\Ep300tm1Pkb
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:98329
\Ep300tm2Pkb/\Ep300tm2Pkb
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:105505
small thymus J:105505
\Epm2aTg(TcraK,TcrbK)TG-BFlv/\Epm2a+
(involves: C57BL/6 * C57BL/10 * C57BR/cd * CBA/J) 		increased T cell derived lymphoma incidence J:112696
\Erap1tm1Dgen/\Erap1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hyperplasia J:101679
\Erbb3tm1Gne/\Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6) 		absent adrenergic chromaffin cells J:45302
\Erbb3tm2Cbm/\Erbb3tm2Cbm
(involves: 129P2/OlaHsd) 		abnormal adrenal gland morphology J:48515
absent adrenergic chromaffin cells J:48515
\Erlin1em1(IMPC)Tcp/\Erlin1em1(IMPC)Tcp
(C57BL/6N-Erlin1em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Ero1bGt(P077G11)Wrst/\Ero1b+
\Ins2Akita/\Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc) 		small pancreatic islets J:158805
\Ero1bGt(P077G11)Wrst/\Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6) 		disorganized pancreatic islets J:158805
\Errfi1tm1Gvw/\Errfi1tm1Gvw
(Not Specified) 		enlarged thymus J:100927
\Esr1tm1.2Awo/\Esr1tm1.2Awo
\Tg(Cga-cre)1Awo/0
(involves: C57BL/6 * SJL) 		decreased gonadotroph cell number J:152925
\Esr1tm1.2Mma/\Esr1tm1.2Mma
\Tg(Cyp17a1-icre)AJako/0
(involves: 129S2/SvPas * C57BL/6 * SJL) 		increased gonadotroph cell number J:151908
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J) 		thymus hypoplasia J:110416
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd) 		decreased lactotroph cell number J:40607
\Esr1tm1Ksk/\Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N) 		decreased thymocyte number J:111590
decreased thymus weight J:111590
\Esr1tm1Ksk/\Esr1tm1Ksk
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J) 		thymus hypoplasia J:110416
\Esr2tm1Unc/\Esr2tm1Unc
(involves: 129P2/OlaHsd) 		enlarged pancreatic islets J:151012
\Ets1tm1.1Dds/\Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds) 		abnormal thymus morphology J:121460
enlarged thymus J:121460
increased thymus weight J:121460
\Ets1tm1.1Dds/\Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds) 		abnormal thymus cortex morphology J:121460
abnormal thymus morphology J:121460
abnormal thymus subcapsular epithelium morphology J:121460
enlarged thymus J:121460
increased thymus weight J:121460
\Ets1tm1Jml/\Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6) 		thymus hypoplasia J:125056
\Ets1tm2Jml/\Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:50627
\Ewsr1tm1(ERG)Thr/\Ewsr1+
\Rag1tm1(cre)Thr/\Rag1+
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:98679
\Ewsr1tm1Sblee/\Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss) 		thymus hypoplasia J:122058
\Extl3tm1.1Okam/\Extl3tm1Okam
\Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR) 		decreased pancreatic beta cell mass J:148348
decreased pancreatic beta cell number J:148348
disorganized pancreatic islets J:148348
\Exz1BALB/c/\Exz1BALB/c
(involves: BALB/c * C57BL/6) 		early degeneration of the adrenal gland x-zone J:8718
\Exz1BALB/c/\Exz1C57BL/6
(involves: BALB/c * C57BL/6) 		early degeneration of the adrenal gland x-zone J:8718
\Exz2BALB/c/\Exz2BALB/c
(involves: BALB/c * C57BL/6) 		early degeneration of the adrenal gland x-zone J:8718
\Exz2BALB/c/\Exz2C57BL/6
(involves: BALB/c * C57BL/6) 		early degeneration of the adrenal gland x-zone J:8718
\Eya1tm1Rilm/\Eya1tm1Rilm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		absent parathyroid glands J:57313
absent thyroid gland isthmus J:79848
athymia J:79848, J:57313
persistent ultimobranchial bodies J:79848
thyroid gland hypoplasia J:79848
\Eya1tm1Rilm/\Eya1tm1Rilm
\Six1tm1Rsd/\Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		pituitary gland hypoplasia J:86619
small pituitary gland J:86619
\Eya2tm2Px/\Eya2tm2Px
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		small thymus J:311538
\Eya4tm1b(KOMP)Wtsi/\Eya4+
(C57BL/6N-Eya4tm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
\Ezh2tm2Sho/\Ezh2tm2.1Sho
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased thymocyte number J:182211
\Ezh2tm2Sho/\Ezh2tm2Sho
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		decreased thymocyte number J:182211
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd)33Wnt/0
\Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR) 		thymus hypoplasia J:69617
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd)33Wnt/0
\Tg(Lck-cre)I57Jxm/0
\Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL) 		thymus hypoplasia J:69617
\Faddtm1Wnt/\Faddtm1Wnt
\Tg(Fadd/EGFP)#Jizh/?
\Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA) 		thymus hypoplasia J:168722
\Fads2tm1Mtna/\Fads2tm1Mtna
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal thymus cortex morphology J:153293
small thymus J:153293
\Fahtm1Mgo/\Fahtm1Mgo
(involves: 129S7/SvEvBrd * C57BL) 		increased pancreatic alpha cell number J:27735
\Fam32aem1(IMPC)Mbp/\Fam32a+
(C57BL/6N-Fam32aem1(IMPC)Mbp/Ucd) 		abnormal adrenal gland morphology J:211773
\Fam53aem1(IMPC)Ccpcz/\Fam53aem1(IMPC)Ccpcz
(C57BL/6N-Fam53aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam81aem1(IMPC)Ccpcz/\Fam81aem1(IMPC)Ccpcz
(C57BL/6N-Fam81aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam83dem1(IMPC)Ccpcz/\Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam120cem1(IMPC)Ccpcz/\Fam120cem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam120cem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam124aem1(IMPC)Ccpcz/\Fam124aem1(IMPC)Ccpcz
(C57BL/6N-Fam124aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam161bem1(IMPC)Ccpcz/\Fam161bem1(IMPC)Ccpcz
(C57BL/6N-Fam161bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam167aem1(IMPC)Ccpcz/\Fam167aem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam167aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam185aem1(IMPC)Ccpcz/\Fam185aem1(IMPC)Ccpcz
(C57BL/6N-Fam185aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam219aem1(IMPC)Ccpcz/\Fam219aem1(IMPC)Ccpcz
(C57BL/6N-Fam219aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fam227bem1(IMPC)Ccpcz/\Fam227bem1(IMPC)Ccpcz
(C57BL/6NCrl-Fam227bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Faslpr/\Faslpr
(MRL/Mp-Faslpr) 		abnormal thymus medulla morphology J:28885
abnormal thyroid follicle morphology J:28171
abnormal thyroid gland morphology J:28171
enlarged thymus J:13757
increased thymus weight J:28885
thymus atrophy J:27634
thymus cortex atrophy J:13757, J:28885
\Faslpr/\Faslpr
(MRL/Mp-Agtpbp1atms Faslpr) 		enlarged thymus J:103944
\Fasldel1Hong/\Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6)) 		abnormal thymus cell ratio J:112563
enlarged thymus J:112563
\Fat3em1(IMPC)Ccpcz/\Fat3em1(IMPC)Ccpcz
(C57BL/6NCrl-Fat3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fbln1Gt(XST011)Byg/\Fbln1Gt(XST011)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:137690
thyroid gland hypoplasia J:137690
\Fbln1tm1Tmpl/\Fbln1tm1Tmpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus hypoplasia J:137690
\Fbn1tm1Rmz/\Fbn1tm1Rmz
(involves: 129S4/SvJae * C57BL/6J) 		increased solitary pulmonary neuroendocrine cell number J:137934
\Fbrsl1em1(IMPC)Tcp/\Fbrsl1em1(IMPC)Tcp
(C57BL/6N-Fbrsl1em1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Fbxo7tm1a(EUCOMM)Wtsi/\Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		thymus atrophy J:272313
thymus hypoplasia J:272313
\Fbxo9tm1b(EUCOMM)Hmgu/\Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp) 		small adrenal glands J:211773
\Fbxo25em1(IMPC)Ccpcz/\Fbxo25em1(IMPC)Ccpcz
(C57BL/6N-Fbxo25em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai
\Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:137138
\Fbxw7tm1Iaai/\Fbxw7tm1Iaai
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA) 		thymus hypoplasia J:137138
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged thymus J:128523
\Fbxw7tm1Kei/\Fbxw7tm1Kei
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:128523
\Fbxw9tm1a(EUCOMM)Wtsi/\Fbxw9tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbxw9tm1a(EUCOMM)Wtsi/Bay) 		abnormal thyroid gland morphology J:211773
\Fbxw16em1(IMPC)Ccpcz/\Fbxw16+
(C57BL/6N-Fbxw16em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
small thymus J:211773
\Fbxw18em1(IMPC)Ccpcz/\Fbxw18+
(C57BL/6N-Fbxw18em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fbxw20em1(IMPC)Ccpcz/\Fbxw20em1(IMPC)Ccpcz
(C57BL/6N-Fbxw20em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fbxw25em1(IMPC)Ccpcz/\Fbxw25em1(IMPC)Ccpcz
(C57BL/6NCrl-Fbxw25em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fcmrtm1b(KOMP)Wtsi/\Fcmrtm1b(KOMP)Wtsi
(C57BL/6N-Fcmrtm1b(KOMP)Wtsi/Ucd) 		enlarged adrenal glands J:211773
\Fdxrtm1Xch/\Fdxr+
(B6.Cg-Fdxrtm1Xch) 		increased T cell derived lymphoma incidence J:244082
\Fen1tm1Rak/\Fen1+
(involves: 129/Sv * C57BL/6 * SJL/J) 		thymus atrophy J:77962
\Fen1tm2.1Bhsh/\Fen1tm2.1Bhsh
(involves: 129S1/Sv) 		increased thymus tumor incidence J:218627
\Festm1Mcs/\Festm1Mcs
(involves: 129X1/SvJ) 		thymus hypoplasia J:64748
\Ffar4tm1Gdds/\Ffar4tm1Gdds
(involves: 129 * C57BL/6) 		enlarged pancreatic islets J:182599
\Fgd1em1(IMPC)Tcp/\Fgd1+
(C57BL/6NCrl-Fgd1em1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Fgf8tm1.1Mrt/\Fgf8tm1.2Mrt
(involves: 129P2/OlaHsd) 		abnormal pituitary gland morphology J:178252
\Fgf8tm1.3Mrt/\Fgf8tm1.4Mrt
\Tg(Tbx1-cre)1Joe/0
(involves: 129P2/OlaHsd) 		abnormal thymus morphology J:88814
small thymus J:88814
\Fgf8tm1.4Mrt/\Fgf8+
\Tbx1tm1Bld/\Tbx1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * ICR) 		thymus hypoplasia J:78686
\Fgf8tm1Mrc/\Fgf8tm1Moon
\Hoxa3tm1(cre)Moon/\Hoxa3+
(involves: 129/Sv * C57BL/6) 		abnormal parathyroid gland morphology J:87304
absent parathyroid glands J:87304
ectopic parathyroid gland J:87304
ectopic thymus J:87304
parathyroid hypoplasia J:87304
thymus hypoplasia J:87304
\Fgf8tm1Mrc/\Fgf8tm2Mrc
\Hoxa3tm1(cre)Moon/\Hoxa3+
(involves: 129/Sv * C57BL/6) 		abnormal parathyroid gland morphology J:87304
absent parathyroid glands J:87304
ectopic parathyroid gland J:87304
ectopic thymus J:87304
parathyroid hypoplasia J:87304
thymus hypoplasia J:87304
\Fgf10tm1Ska/\Fgf10tm1Ska
(involves: C57BL/6 * CBA) 		abnormal neurohypophysis development J:114183
abnormal Rathke's pouch apoptosis J:114183
absent adenohypophysis J:114183
absent pituitary gland J:114183
absent Rathke's pouch J:114183
absent thyroid gland J:114183
decreased pancreatic beta cell number J:114183
small thymus J:114183
\Fgf14em1(IMPC)Ccpcz/\Fgf14em1(IMPC)Ccpcz
(C57BL/6N-Fgf14em1(IMPC)Ccpcz/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Fgf20em1(IMPC)Ccpcz/\Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fgf23tm1Tyam/\Fgf23tm1Tyam
(involves: C57BL/6 * CBA) 		thymus atrophy J:88172
\Fgfr2tm1.1Dsn/\Fgfr2tm1.1Dsn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pituitary gland development J:59285
abnormal Rathke's pouch apoptosis J:59285
abnormal Rathke's pouch development J:59285
absent adenohypophysis J:59285
absent Rathke's pouch J:59285
\Fgfr2tm1Ewj/\Fgfr2+
\Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal thymus morphology J:101174
\Fgfr2tm3Dsn/\Fgfr2tm3Dsn
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adrenal gland development J:67731
abnormal thymus development J:67731
absent adenohypophysis J:67731
absent thyroid gland J:67731
\Fhip2bem1(IMPC)Ccpcz/\Fhip2bem1(IMPC)Ccpcz
(C57BL/6N-Fhip2bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fli1tm1Ber/\Fli1tm1Ber
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)) 		decreased thymocyte number J:33052
\Flt3tm1Irl/\Flt3tm1Irl
\KitW/\KitW-v
(involves: 129S/SvEv * C57BL/6) 		thymus hypoplasia J:27238
\fm/\fm
(involves: CBA/H) 		abnormal thymus morphology J:275
\Fmo3em1(IMPC)Mbp/\Fmo3em1(IMPC)Mbp
(C57BL/6N-Fmo3em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fnip1em1(IMPC)Ccpcz/\Fnip1+
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
small thymus J:211773
\Fnip1em1(IMPC)Ccpcz/\Fnip1em1(IMPC)Ccpcz
(C57BL/6NCrl-Fnip1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Fostm1Wag/\Fostm1Wag
(involves: 129S2/SvPas * C57BL/6) 		abnormal thymus size J:3493
decreased thymocyte number J:3493
\Foxa1tm1Khk/\Foxa1+
\Foxa2tm1Khk/\Foxa2tm1Khk
\Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL) 		decreased pancreatic beta cell number J:143476
pancreatic islet hypoplasia J:143476
\Foxa1tm1Khk/\Foxa1tm1Khk
\Foxa2tm1Khk/\Foxa2tm1Khk
\Tg(Pdx1-cre)6Cvw/0
(involves: 129 * C57BL/6 * CBA * SJL) 		decreased pancreatic beta cell number J:143476
pancreatic islet hypoplasia J:143476
\Foxa2tm1Khk/\Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		abnormal pancreatic beta cell morphology J:70409
disorganized pancreatic islets J:70409
\Foxa2tm1Khk/\Foxa2tm1Khk
\Tg(Foxa3-cre)1Khk/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA) 		decreased pancreatic alpha cell number J:96332
disorganized pancreatic islets J:96332
\Foxc1ch/\Foxc1ch
(involves: CBA * STOCK Tyrc f) 		abnormal pituitary diverticulum morphology J:5191
abnormal pituitary gland development J:75733
\Foxd1tm1Lai/\Foxd1tm1Lai
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6J)) 		abnormal adrenal gland morphology J:33767
small adrenal glands J:33767
\Foxe1tm1Rdl/\Foxe1tm1Rdl
(B6.129-Foxe1tm1Rdl) 		abnormal thyroid gland development J:95017
\Foxe1tm1Rdl/\Foxe1tm1Rdl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thyroid gland development J:48970
absent thyroid gland J:48970
\Foxh1b2b2662Clo/\Foxh1b2b2662Clo
(C57BL/6J-Foxh1b2b2662Clo) 		thymus hypoplasia J:175213
\Foxi3em3Akg/\Foxi3tm1.2Akg
(involves: 129X1/SvJ * C57BL/6) 		athymia J:336768
\Foxm1tm1Rhc/\Foxm1tm1Rhc
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal pancreatic beta cell morphology J:111026
abnormal pancreatic islet morphology J:111026
decreased pancreatic beta cell mass J:111026
decreased pancreatic beta cell number J:111026
increased pancreatic alpha cell number J:111026
small pancreatic islets J:111026
\Foxn1nu-2J/\Foxn1nu-2J
(B6(SJL)-Foxn1nu-2J/GrsrJ) 		athymia J:192383
\Foxn1nu-StL/\Foxn1nu-StL
(involves: C57BL/6) 		athymia J:63313
\Foxn1nu-StL/\Foxn1tm1Tbo
(involves: 129S1/Sv * C57BL/6) 		abnormal thymus development J:63313
athymia J:63313
\Foxn1nu-str/\Foxn1nu-str
(AKR/J-Foxn1nu-str/J) 		athymia J:24755
\Foxn1nu-Y/\Foxn1nu-Y
(101/HY-Foxn1nu-Y) 		abnormal thymus development J:4060
athymia J:4060, J:29022
\Foxn1nu/\Foxn1+
(C.Cg-Foxn1nu) 		small thymus J:7330
\Foxn1nu/\Foxn1+
(NFS.Cg-Foxn1nu) 		abnormal thymus morphology J:7330
small thymus J:7330
\Foxn1nu/\Foxn1+
(B6N.Cg-Foxn1nu) 		small thymus J:7330
\Foxn1nu/\Foxn1+
(C3N.Cg-Foxn1nu) 		small thymus J:7330
\Foxn1nu/\Foxn1nu
(involves: NMRI) 		abnormal thymus development J:6363
\Foxn1nu/\Foxn1nu
(Not Specified) 		abnormal thymus morphology J:202297
athymia J:202296, J:5059
\Foxn1nu/\Foxn1nu
(involves: C57BL/10Sn * C57BR/cd) 		abnormal thymus development J:7898
\Foxn1nu/\Foxn1nu
(involves: CD-1) 		athymia J:106251
\Foxn1nu/\Foxn1nu
\Map3k14aly/\Map3k14aly
(involves: BALB/cAJcl * C57BL/6J) 		athymia J:96579
\Foxn1nu/\Foxn1nu
\Tg(Foxn1)E1Hon/0
(involves: CD-1) 		athymia J:33866
\Foxn1nu/\Foxn1tm1.1Dmsu
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL) 		abnormal thymus epithelium morphology J:159773
decreased thymocyte number J:159773
\Foxn1sepe/\Foxn1sepe
(BALB/c-Foxn1sepe) 		athymia J:227974
\Foxn1tm1.1(KOMP)Vlcg/\Foxn1tm1.1(KOMP)Vlcg
(C57BL/6N-Foxn1tm1.1(KOMP)Vlcg/Tcp) 		abnormal thymus morphology J:211773
athymia J:211773
\Foxn1tm1.1Cbln/\Foxn1+
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hyperplasia J:177992
\Foxn1tm1.1Cbln/\Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6) 		increased DN1 thymic pro-T cell number J:177992
thymus hypoplasia J:177992
\Foxn1tm1.1Cbln/\Foxn1tm1Tbo
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		small thymus J:177992
\Foxn1tm1.1Dmsu/\Foxn1tm1.1Dmsu
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL) 		abnormal thymus morphology J:159773
decreased thymocyte number J:159773
small thymus J:159773
thymus atrophy J:159773
\Foxn1tm1.1Dmsu/\Foxn1tm1.1Dmsu
\Tg(KRT5-cre/ERT2)2Ipc/0
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal thymus corticomedullary boundary morphology J:159773
abnormal thymus medulla morphology J:159773
decreased thymocyte number J:159773
small thymus J:159773
thymus atrophy J:159773
\Foxn1tm1Dmsu/\Foxn1tm1Dmsu
(involves: 129/Sv * C57BL/6) 		athymia J:159773
\Foxn1tm1Nrm/\Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J) 		abnormal thymus development J:86255
abnormal thymus epithelium morphology J:86255
absent thymus cortex J:86255
absent thymus medulla J:86255
decreased thymocyte number J:86255
small thymus J:86255
thymus cyst J:86255
\Foxn1tm1Tbo/\Foxn1tm1Tbo
(involves: 129S1/Sv) 		abnormal thymus development J:33796
abnormal thymus epithelium morphology J:177992
abnormal thymus morphology J:33796
athymia J:33796
\Foxn1tm3(cre)Nrm/\Foxn1+
\Gt(ROSA)26Sortm1(Tbx1)Rche/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NHsd) 		abnormal thymus development J:214094
abnormal thymus epithelium morphology J:214094
decreased thymocyte number J:214094
thymus hypoplasia J:214094
\Foxn1tm3(cre)Nrm/\Foxn1+
\Mir205hgtm1Oers/\Mir205hgtm1Oers
(B6(Cg)-Mir205hgtm1Oers Foxn1tm3(cre)Nrm) 		decreased thymocyte number J:278363
decreased thymus weight J:278363
thymus hypoplasia J:278363
\Foxo1tm1Rdp/\Foxo1tm1Rdp
\Foxo3tm1Rdp/\Foxo3tm1Rdp
\Foxo4tm1Rdp/\Foxo4tm1Rdp
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J) 		abnormal pancreatic beta cell differentiation J:215526
\Foxo1tm1Rdp/\Foxo1tm1Rdp
\Foxo3tm1Rdp/\Foxo3tm1Rdp
\Foxo4tm1Rdp/\Foxo4tm1Rdp
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		increased T cell derived lymphoma incidence J:118179
\Foxo1tm1Whb/\Foxo1+
\Pdpk1tm1Maka/\Pdpk1tm1Maka
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		increased pancreatic beta cell number J:109010
\Foxo3tm1.1Rdp/\Foxo3+
\Foxo4tm1.1Rdp/\Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
\Foxo3tm1.1Rdp/\Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased prolactinoma incidence J:118179
\Foxo3tm1.1Rdp/\Foxo3tm1.1Rdp
\Foxo4tm1.1Rdp/\Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
\Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR)) 		abnormal thymus cortex morphology J:11262
abnormal thymus morphology J:11262
small thymus J:11262
\Foxp3tm1.1Ayr/\Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus hypoplasia J:125405
\Foxp3tm1.1Mal/\Foxp3tm1.1Mal
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6) 		thymus hypoplasia J:131351
\Foxp3tm1Ayr/\Foxp3tm1Ayr
\Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		thymus hypoplasia J:125405
\Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch) 		thymus hypoplasia J:120636
\Foxp3tm3Tch/\Foxp3+
(C.129X1-Foxp3tm3Tch) 		decreased thymocyte number J:120636
\Fshrtm1Saco/\Fshrtm1Saco
(involves: C57BL/6) 		adenohypophysis hyperplasia J:50933
increased gonadotroph cell number J:50933
increased thyrotroph cell number J:50933
\Fstl3tm1Alsc/\Fstl3tm1Alsc
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		abnormal pancreatic beta cell morphology J:119526
abnormal pancreatic islet morphology J:119526
enlarged pancreatic islets J:119526
increased pancreatic beta cell number J:119526
\Ftotm1Urt/\Ftotm1Urt
\Lepob/\Lepob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		enlarged pancreatic islets J:219118
\Fts/\Fts+
(involves: C57BL/6 * SJL) 		thymus hyperplasia J:20159
\Fts/\Fts+
(B6.Cg-Fts) 		increased thymocyte number J:108193
thymus hyperplasia J:108193
\Fubp1tm1.1Dlev/\Fubp1tm1.1Dlev
(involves: 129 * C57BL/6) 		thymus hypoplasia J:229985
\FusGt(U3NeoSV1)HO14Ggh/\FusGt(U3NeoSV1)HO14Ggh
(B6.129S2-FusGt(U3NeoSV1)HO14Ggh) 		small thymus J:60213
\FuzGt(OSTGST001398)Lex/\FuzGt(OSTGST001398)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		abnormal pituitary diverticulum morphology J:177881
\Fyb1tm1Gak/\Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ) 		decreased thymocyte number J:111368
\Fyntm1Rmp/\Fyntm1Rmp
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas) 		thymus hypoplasia J:37062, J:37940
\Fyntm1Yik/\Fyntm1Yik
\Ptk2tm1Lfr/\Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased thymocyte number J:110771
thymus cortex atrophy J:110771
\Fzd9tm1Uta/\Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ) 		thymus atrophy J:98133
\G6pc3tm1Rmob/\G6pc3tm1Rmob
(involves: 129S5/SvEvBrd * C57BL/6J) 		increased pancreatic alpha cell number J:117664
\GabpaGt(XH074)Byg/\GabpaGt(XH074)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:92671
small thymus J:92671
\Gabra5em1(IMPC)Ccpcz/\Gabra5em1(IMPC)Ccpcz
(C57BL/6N-Gabra5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gadd45atm1Ajf/\Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6)) 		increased thymocyte number J:57882
increased thymus weight J:57882
\Gadd45gip1tm2Kong/\Gadd45gip1tm2Kong
\Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		abnormal pancreatic beta cell morphology J:220742
abnormal pancreatic islet morphology J:220742
decreased pancreatic beta cell mass J:220742
decreased pancreatic beta cell number J:220742
\Gakem1(IMPC)Ccpcz/\Gak+
(C57BL/6NCrl-Gakem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Galtm1Wyn/\Galtm1Wyn
(129P2-Galtm1Wyn) 		decreased lactotroph cell number J:78046
\Garin1aem1(IMPC)Ccpcz/\Garin1aem1(IMPC)Ccpcz
(C57BL/6N-Garin1aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Garin1bem1(IMPC)Ccpcz/\Garin1bem1(IMPC)Ccpcz
(C57BL/6N-Garin1bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Garin2em1(IMPC)Ccpcz/\Garin2em1(IMPC)Ccpcz
(C57BL/6N-Garin2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gas2l2tm1a(KOMP)Wtsi/\Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi) 		abnormal thymus topology J:239583
\Gata2tm1Sac/\Gata2tm1Sac
\Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL) 		abnormal pituitary gland development J:108963
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(DO11.10)10Dlo/0
\Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6) 		small thymus J:86996
\Gata3tm1Iho/\Gata3tm1Iho
\Tg(Lck-cre)1Cwi/0
(involves: BALB/c) 		decreased thymocyte number J:86996
small thymus J:86996
\Gata3tm2Jeng/\Gata3tm2Jeng
(Not Specified) 		decreased thymocyte number J:155686
\Gba1tm1.1Pmis/\Gba1tm1.1Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal thymus morphology J:167081
\Gba1tm1.1Pmis/\Gba1tm1.2Pmis
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		abnormal thymus morphology J:167081
\Gbx2tm1.1Mrt/\Gbx2tm1.1Mrt
\Fgf8tm1.4Mrt/\Fgf8+
(B6.129-Gbx2tm1.1Mrt Fgf8tm1.4Mrt) 		abnormal thymus development J:100584
\Gcgtm1Yhys/\Gcgtm1Yhys
(B6.129S6-Gcgtm1Yhys) 		abnormal pancreatic alpha cell morphology J:154694
increased pancreatic islet number J:154694
\Gcgrem2Smoc/\Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc) 		abnormal pancreatic alpha cell morphology J:300368
\Gcgrtm1Jcp/\Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp) 		abnormal pancreatic alpha cell differentiation J:176507
abnormal pancreatic alpha cell morphology J:176507
abnormal pancreatic islet morphology J:176507
enlarged pancreatic islets J:176507
pancreatic islet hyperplasia J:176507
\Gcgrtm1Mjch/\Gcgrtm1Mjch
(involves: 129/Sv * C57BL/6J * SJL) 		abnormal pancreatic alpha cell morphology J:251829
increased pancreatic alpha cell number J:251829
pancreatic islet hyperplasia J:251829, J:81772
\Gcgrtm1Mjch/\Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL) 		increased pancreatic alpha cell mass J:208604
increased pancreatic alpha cell number J:208604
increased pancreatic beta cell mass J:208604
\Gcgrtm1Mjch/\Gcgrtm1Mjch
\Slc38a5tm1(KOMP)Vlcg/\Slc38a5tm1(KOMP)Vlcg
(involves: 129/Sv * C57BL/6 * C57BL/6J * C57BL/6NTac * SJL) 		abnormal pancreatic alpha cell morphology J:251829
pancreatic islet hyperplasia J:251829
\Gcgrtm2.1Mjch/\Gcgrtm2.1Mjch
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: C57BL/6 * DBA * SJL) 		increased pancreatic alpha cell number J:208604
increased pancreatic beta cell mass J:208604
\GckGls006/\Gck+
(C3HeB/FeJ-GckGls006) 		decreased pancreatic beta cell mass J:189544
small pancreatic islets J:189544
\GckGls006/\GckGls006
(C3HeB/FeJ-GckGls006) 		abnormal pancreatic beta cell morphology J:189544
abnormal pancreatic islet morphology J:189544
decreased pancreatic beta cell mass J:189544
small pancreatic islets J:189544
\Gckm1Rge/\Gck+
(involves: C3HeB/FeJ) 		decreased pancreatic beta cell mass J:162903
small pancreatic islets J:162903
\Gcktm1Tka/\Gck+
\Irs1tm1Tka/\Irs1tm1Tka
(involves: 129X1/SvJ * C57BL/6 * CBA * ICR) 		increased pancreatic beta cell mass J:38899
pancreatic islet hyperplasia J:38899
\Gcktm1Ydor/\Gck+
\Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6 * C57BL/6J * CD-1) 		increased pancreatic beta cell mass J:302600
\Gcktm1Ydor/\Gck+
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		decreased pancreatic beta cell mass J:302600
increased pancreatic beta cell mass J:302600
\Gcm2tm1.2Malx/\Gcm2tm1.2Malx
(involves: 129S1/SvImJ * 129S4/SvJae * C57BL/6N) 		parathyroid hypoplasia J:213334
\Gcm2tm1Kry/\Gcm2tm1Kry
(involves: 129S7/SvEvBrd) 		absent parathyroid glands J:63291
\Gcm2tm1Kry/\Gcm2tm1Kry
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal parathyroid gland development J:121311
absent parathyroid glands J:121311
\Gdap1tm2b(KOMP)Wtsi/\Gdap1tm2b(KOMP)Wtsi
(C57BL/6N-Gdap1tm2b(KOMP)Wtsi/Ucd) 		abnormal adrenal gland morphology J:211773
abnormal thymus morphology J:211773
small adrenal glands J:211773
small thymus J:211773
\Gdf6em1(IMPC)Ccpcz/\Gdf6+
(C57BL/6NCrl-Gdf6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gdf11tm1Sjl/\Gdf11+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased pancreatic alpha cell mass J:94455
increased pancreatic islet number J:94455
small pancreatic islets J:94455
\Gdf11tm1Sjl/\Gdf11tm1Sjl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal pancreatic beta cell differentiation J:94455
decreased pancreatic beta cell mass J:94455
increased pancreatic alpha cell mass J:94455
pancreatic islet hyperplasia J:94455
small pancreatic islets J:94455
\Gfi1tm1.1Wep/\Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep) 		small thymus J:117105
thymus hypoplasia J:117105
\Gfi1tm1Tmo/\Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:75143
\Gfi1tm1Tmo/\Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased thymocyte number J:192927
\Gfi1tm2Tmo/\Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:93337
\Gfi1tm4Tmo/\Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ) 		decreased thymocyte number J:116870
\Gfi1bem1(IMPC)Ccpcz/\Gfi1b+
(C57BL/6NCrl-Gfi1bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gfm2em1(IMPC)Mbp/\Gfm2+
(C57BL/6N-Gfm2em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\GhSma1/\Gh+
(C3HeB/FeJ-GhSma1) 		abnormal adenohypophysis morphology J:89518
absent lactotrophs J:89518
absent somatotrophs J:89518
decreased pituitary gland weight J:89518
small adenohypophysis J:89518
small pituitary gland J:89518
\GhSma1/\GhSma1
(C3HeB/FeJ-GhSma1) 		abnormal adenohypophysis morphology J:89518
absent lactotrophs J:89518
absent somatotrophs J:89518
decreased pituitary gland weight J:89518
small adenohypophysis J:89518
small pituitary gland J:89518
\Ghrtm1.1Dlr/\Ghrtm1.1Dlr
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased pancreatic beta cell mass J:284574
\Ghrtm1.1Dlr/\Ghrtm1.1Dlr
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA) 		decreased pancreatic beta cell mass J:173909
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c) 		decreased pituitary gland weight J:53777
\Ghrtm1Jjk/\Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		decreased pancreatic beta cell mass J:107763
small pancreatic islets J:107763
\Ghrhtm1Salv/\Ghrhtm1Salv
(involves: 129 * C57BL/6) 		pituitary gland hypoplasia J:91828
\Ghrhrlit/\Ghrhrlit
(C57BL/6J-Ghrhrlit) 		abnormal somatotroph morphology J:7211
absent somatotroph secretory granules J:7211
decreased somatotroph cell number J:7211
decreased somatotroph cell size J:7211
decreased somatotroph secretory granule number J:7211
small pituitary gland J:5647
\Gimap1tm1.1Gwb/\Gimap1tm1.1Gwb
\Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca) 		decreased thymocyte number J:160782
\Gimap3tm1.1Yout/\Gimap3tm1.1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		decreased thymocyte number J:209926
\Gimap5m1Btlr/\Gimap5m1Btlr
(involves: C57BL/6J) 		thymus atrophy J:160090
\Gimap5m1Btlr/\Gimap5m1Btlr
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J) 		decreased thymocyte number J:160090
\Gin1em1(IMPC)Mbp/\Gin1em1(IMPC)Mbp
(C57BL/6N-Gin1em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gli1tm1Alj/\Gli1tm1Alj
\Gli2tm1Alj/\Gli2tm1Alj
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		absent pituitary gland J:60986
\Gli3Pdn/\Gli3Pdn
(involves: Jcl:ICR) 		absent pineal gland J:17581
\Gli3tm1Urt/\Gli3tm1Urt
(involves: 129P2/OlaHsd * C57BL/6) 		absent adrenal gland J:76496
\Gli3Xt/\Gli3Xt
(involves: 101/H * C3H/HeH * CBA/H) 		absent pineal gland J:5049
ectopic adrenal gland J:5049
\Glis3tm1.2Chan/\Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J) 		absent pancreatic alpha cells J:177082
absent pancreatic beta cells J:177082
decreased pancreatic alpha cell number J:177082
decreased pancreatic beta cell number J:177082
decreased pancreatic delta cell number J:177082
decreased pancreatic epsilon cell number J:177082
disorganized pancreatic islets J:177082
small pancreatic islets J:177082
\Glis3tm1Hiha/\Glis3tm1Hiha
(involves: C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:150077
decreased pancreatic alpha cell number J:150077
decreased pancreatic beta cell number J:150077
decreased pancreatic delta cell number J:150077
small pancreatic islets J:150077
\Glra1nmf11/\Glra1nmf11
(C57BL/6J-Glra1nmf11/J) 		thymus atrophy J:78134
\Glrbspa/\Glrbspa
(Not Specified) 		abnormal adrenal cortex morphology J:5196
enlarged adrenal glands J:5196
\Gls2em1Xen/\Gls2em1Xen
(involves: C57BL/6NTac) 		increased pancreatic alpha cell number J:271619
\Glud1tm1.1Pma/\Glud1tm1.1Pma
\Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL) 		disorganized pancreatic islets J:145558
\Gm5148em1(IMPC)Ccpcz/\Gm5148+
(C57BL/6NCrl-Gm5148em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gm10851em1(IMPC)Ccpcz/\Gm10851em1(IMPC)Ccpcz
(C57BL/6NCrl-Gm10851em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gm15551em1(IMPC)Ccpcz/\Gm15551em1(IMPC)Ccpcz
(C57BL/6NCrl-Gm15551em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gm26330em1Liuq/\Gm26330em1Liuq
(C57BL/6-Gm26330em1Liuq) 		enlarged pancreatic islets J:341056
\Gmnntm1.1Kio/\Gmnntm1.2Kio
\Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca) 		decreased DN1 thymic pro-T cell number J:159657
decreased DN4 thymocyte number J:159657
decreased thymocyte number J:159657
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm2Soff/\Gnaqtm2Soff
\Tg(PTH-cre)4167Slib/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal parathyroid gland morphology J:116986
small thyroid gland J:116986
\Gna11tm1Soff/\Gna11tm1Soff
\Gnaqtm2Soff/\Gnaqtm2Soff
\Tg(Tg-cre)1Soff/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6) 		abnormal thyroid follicular cell morphology J:127484
abnormal thyroid gland morphology J:127484
\Gna12tm1Citb/\Gna12tm1Citb
\Gna13tm2.1Soff/\Gna13tm2.1Soff
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		thymus hyperplasia J:149560
\Gnai2tm1Lbi/\Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J)) 		increased thymocyte number J:24434
\Gnao1tm4Lbi/\Gnao1tm4Lbi
\Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		decreased pancreatic beta cell mass J:169627
\Gnastm1Lsw/\Gnas+
(involves: 129S4/SvJae * CD-1) 		thymus cortex atrophy J:49340
\Gnastm5.1Lsw/\Gnastm5.1Lsw
\Tg(Alb1-cre)1Dlr/?
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		pancreatic islet hyperplasia J:102504
\Golph3em1(IMPC)Tcp/\Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Golt1btm1b(EUCOMM)Wtsi/\Golt1btm1b(EUCOMM)Wtsi
(C57BL/6N-Golt1btm1b(EUCOMM)Wtsi/Ieg) 		enlarged thymus J:211773
\Gp2em1(IMPC)Mbp/\Gp2em1(IMPC)Mbp
(C57BL/6N-Gp2em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\Gpc2tm1.1(KOMP)Vlcg/\Gpc2tm1.1(KOMP)Vlcg
(C57BL/6N-Gpc2tm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Gpr39tm1Dgen/\Gpr39tm1Dgen
(B6.129P2-Gpr39tm1Dgen) 		abnormal pancreatic islet morphology J:151806
\Gpr83em1(IMPC)Ccpcz/\Gpr83em1(IMPC)Ccpcz
(C57BL/6NCrl-Gpr83em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gprc6atm1.1(KOMP)Vlcg/\Gprc6atm1.1(KOMP)Vlcg
(C57BL/6N-Gprc6atm1.1(KOMP)Vlcg/Ucd) 		increased thymus weight J:211773
\Gramd1bem1Pton/\Gramd1bem1Pton
(involves: C57BL/6N) 		abnormal adrenal cortex morphology J:266462
abnormal adrenal gland morphology J:266462
abnormal adrenal gland zona fasciculata morphology J:266462
\Grap2tm1Amch/\Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ) 		decreased thymocyte number J:76696
\Grap2tm1Eac/\Grap2tm1Eac
(involves: C57BL/6) 		decreased thymocyte number J:92023
\Grb2tm1.1Hua/\Grb2tm1.1Hua
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6) 		decreased thymocyte number J:161294
\Grb2tm1Paw/\Grb2+
\Ptentm1Mak/\Pten+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased adrenal gland tumor incidence J:93530
\Grb2tm1Paw/\Grb2+
\Ptentm2Mak/\Ptentm2Mak
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:93530
\Grb10tm1.1Fliu/\Grb10tm1.1Fliu
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal pancreatic beta cell morphology J:208498
increased pancreatic beta cell mass J:208498
\Gsdma3Ae/\Gsdma3+
(involves: C57BL/6J * CAST/Ei) 		enlarged thymus J:180149
\Gsk3btm1Jrw/\Gsk3b+
\Insrtm1Dac/\Insr+
(involves: 129 * C57BL/6J) 		decreased pancreatic beta cell mass J:135659
\Gsx1tm1Ssp/\Gsx1tm1Ssp
(involves: 129P2/OlaHsd) 		decreased lactotroph cell number J:31764
decreased somatotroph cell number J:31764
small adenohypophysis J:31764
small pituitary gland J:31764
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129P2/OlaHsd * FVB/N) or (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-Foxo1*)Jcbr/\Gt(ROSA)26Sor+
\Pdpk1tm1Jcbr/\Pdpk1tm1Jcbr
\Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		decreased corticotroph cell number J:134336
\Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J) 		abnormal pancreatic alpha cell morphology J:146650
abnormal pancreatic islet morphology J:146650
decreased pancreatic alpha cell number J:146650
decreased pancreatic beta cell number J:146650
decreased pancreatic islet number J:146650
small pancreatic islets J:146650
\Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/\Gt(ROSA)26Sor+
\Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * C57BL/6) 		adrenal medulla hyperplasia J:222527
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
\Tacc3tm1.1Tno/\Tacc3+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
\Tacc3tm1.1Tno/\Tacc3tm1.2Tno
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:179414
\Gt(ROSA)26Sortm1(cre/ERT)Nat/\Gt(ROSA)26Sor+
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129 * 129S4/SvJae * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:130367
\Gt(ROSA)26Sortm1(CTNNB1)Nerl/\Gt(ROSA)26Sortm1(CTNNB1)Nerl
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA) 		thymus hypoplasia J:112660
\Gt(ROSA)26Sortm1(DTA)Lky/\Gt(ROSA)26Sor+
\Tg(LHX3-cre)#Sjr/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6) 		abnormal adenohypophysis morphology J:211401
decreased gonadotroph cell number J:211401
\Gt(ROSA)26Sortm1(DTA)Vlcg/\Gt(ROSA)26Sortm1(DTA)Vlcg
\Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N) 		decreased pancreatic beta cell mass J:201507
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Hprt1tm1(Ins2-HBEGF)Herr/Y
\Tg(Gcg-rtTA)#Herr/0
\Tg(tetO-cre)1Jaw/0
(involves: 129X1/SvJ * C57BL/6) 		abnormal pancreatic alpha cell differentiation J:159291
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Hprt1tm1(Ins2-HBEGF)Herr/Y
\Tg(Ins2-cre/ERT)1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:159291
\Gt(ROSA)26Sortm1(Gck)Ydor/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased pancreatic beta cell mass J:210493
\Gt(ROSA)26Sortm1(H1/tetO-RNAi:Pdpk1)Mrl/\Gt(ROSA)26Sor+
\Ptentm1.1Hwu/\Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased thyroid adenoma incidence J:170965
\Gt(ROSA)26Sortm1(HBEGF)Awai/\Gt(ROSA)26Sor+
\Tg(Gh1-cre)bKnmn/0
(involves: C57BL/6 * FVB/N) 		decreased somatotroph cell number J:169459
small adenohypophysis J:169459
\Gt(ROSA)26Sortm1(ITK/SYK)Jrld/\Gt(ROSA)26Sor+
\Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:160931
\Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6) 		abnormal pancreatic alpha cell morphology J:144715
abnormal pancreatic beta cell morphology J:144715
abnormal pancreatic islet morphology J:144715
decreased pancreatic beta cell number J:144715
increased pancreatic alpha cell number J:144715
\Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/?
\Krt19tm1(cre/ERT)Ggu/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Krt19tm1(cre/ERT)Ggu) 		increased pancreatic beta cell number J:215154
\Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe/?
\Tg(Pdx1-cre)6Tuv/?
(B6.Cg-Gt(ROSA)26Sortm1(Neurog3*S183A*S187A)Axbe Tg(Pdx1-cre)6Tuv) 		increased pancreatic beta cell number J:215154
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Neurod1-cre)1Able/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:190530
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Neurog3-cre)C1Able/0
(involves: 129S4/SvJaeSor) 		absent pancreatic islets J:190530
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Neurog3-cre/Esr1*)1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		absent pancreatic alpha cells J:86975
\Gt(ROSA)26Sortm1(Notch1)Dam/\Gt(ROSA)26Sor+
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * ICR) 		abnormal endocrine pancreas morphology J:86975
decreased pancreatic alpha cell number J:86975
decreased pancreatic beta cell number J:86975
\Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu/\Gt(ROSA)26Sor+
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Gt(ROSA)26Sortm1(NOTCH1/GFP)Xhsu Tg(Lck-cre)548Jxm) 		increased T cell derived lymphoma incidence J:185287
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\Tg(MMTV-cre)#Tfln/0
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:170898
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(MMTV-cre)#Tfln/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:170898
\Gt(ROSA)26Sortm1(rtTA)Awu/\Gt(ROSA)26Sortm1(rtTA)Awu
\Xisttm1Awu/Y
(involves: 129S4/SvJae) 		abnormal thymus morphology J:112954
decreased thymocyte number J:112954
small thymus J:112954
thymus hypoplasia J:112954
\Gt(ROSA)26Sortm1(rtTA)Awu/\Gt(ROSA)26Sortm1(rtTA)Awu
\Xisttm1Awu/\Xisttm1Awu
(involves: 129S4/SvJae) 		small thymus J:112954
\Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/\Gt(ROSA)26Sor+
\Tg(CAG-cre)1Nagy/0
\Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N * ICR) 		thymus atrophy J:99607
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased T cell derived lymphoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased T cell derived lymphoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6113Njen/0
(involves: C3H * C57BL/6) 		increased T cell derived lymphoma incidence J:102234
pituitary gland hyperplasia J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc3)12740Njen/0
(involves: C3H * C57BL/6J) 		increased pheochromocytoma incidence J:153656
increased T cell derived lymphoma incidence J:153656
\Gt(ROSA)26Sortm1(Tbx1/GFP)Bem/\Gt(ROSA)26Sor+
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		athymia J:204435
\Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J) 		abnormal thymus corticomedullary boundary morphology J:163919
abnormal thymus morphology J:163919
enlarged thymus J:163919
\Gt(ROSA)26Sortm1(tTA,tetO-Mir155)Fjsl/\Gt(ROSA)26Sor+
\Tg(Nes-cre)1Wmz/0
(involves: 129 * C57BL/6 * FVB/N * SJL/J) 		thymus hyperplasia J:185598
\Gt(ROSA)26Sortm1.1(Maml1/EGFP)Hri/?
\Foxa2tm3.1(icre)Heli/\Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal pancreatic beta cell differentiation J:184814
\Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/?
(involves: 129 * C57BL/6) 		increased pancreatic islet number J:201964
\Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		decreased pancreatic beta cell mass J:286108
small pancreatic islets J:286108
\Gt(ROSA)26Sortm1Fia/\Gt(ROSA)26Sor+
\Hprt1tm1(CMV-cre)Brd/\Hprt1+
\Nf1tm1Fcr/\Nf1tm1Fcr
(involves: 129S/SvEv * 129S/SvEvBrd) 		adrenal medulla hyperplasia J:114455
\Gt(ROSA)26Sortm1Fia/\Gt(ROSA)26Sor+
\Nf1tm1Par/\Nf1tm1Par
\Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		small adenohypophysis J:138868
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N) 		enlarged thymus J:202090
\Gt(ROSA)26Sortm1Jus/\Gt(ROSA)26Sor+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA) 		enlarged thymus J:202090
\Gt(ROSA)26Sortm2(myc*T58A)Rcse/\Gt(ROSA)26Sortm2(myc*T58A)Rcse
\Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased pituitary gland tumor incidence J:169403
\Gt(ROSA)26Sortm2.1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * C57BL/6 * C57BL/6J) 		increased T cell derived lymphoma incidence J:153656
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/?
\Tnfaip3tm1Homy/\Tnfaip3tm1Homy
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		thymus atrophy J:212681
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
\Ripk3tm1Arte/\Ripk3tm1Arte
(involves: C57BL/6NTac) 		thymus atrophy J:209137
\Gt(ROSA)26Sortm18(Zeb2)Jhai/\Gt(ROSA)26Sor+
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\Gt(ROSA)26Sortm18(Zeb2)Jhai/\Gt(ROSA)26Sortm18(Zeb2)Jhai
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * CD-1 * SJL) 		increased thymus tumor incidence J:263520
\Gt(ROSA)26Sortm18(Zeb2)Jhai/\Gt(ROSA)26Sortm18(Zeb2)Jhai
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\Gtf2ird1em1(IMPC)Ccpcz/\Gtf2ird1em1(IMPC)Ccpcz
(C57BL/6NCrl-Gtf2ird1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Gulosfx/\Gulosfx
(BALB/cBy-Gulosfx/J) 		small thymus J:66648
\H1f0tm1Ais/\H1f0tm1Ais
\H1f2tm2Ais/\H1f2tm2Ais
\H1f4tm2Ais/\H1f4tm2Ais
(involves: 129/Sv * C57BL/6 * SJL) 		small thymus J:83954
\H1f2tm2Ais/\H1f2tm2Ais
\H1f3tm2Ais/\H1f3+
\H1f4tm2Ais/\H1f4tm2Ais
(involves: 129/Sv * C57BL/6 * SJL) 		small thymus J:83954
\H2-Aab-tm1Blt/\H2-Aab-tm1Blt
(C57BL/6-H2-Aab-tm1Blt) 		enlarged thymus J:16372
thymus hyperplasia J:16372
\H2-Ab1b-tm1Gru/\H2-Ab1b-tm1Gru
\Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/\Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell) 		enlarged thyroid gland J:113509
\H2b/\H2b
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:131357
\H2b/\H2b
\Ptcratm1Vbo/\Ptcratm1Vbo
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased thymocyte number J:131357
\H2b/\H2b
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased thymocyte number J:131357
\H2b/\H2d
\Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6) 		small thymus J:133645
\H2b/\H2k
\Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c) 		small thymus J:133645
\H2b/\H2s
\Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss) 		small thymus J:133645
\H2d/\H2d
\Tcra/Tcrdtm1.1(Tcra)Rsky/\Tcra/Tcrdtm1.1(Tcra)Rsky
\Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased thymocyte number J:131357
\H2u/\H2u
\Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J) 		abnormal thymus cell ratio J:92992
decreased thymocyte number J:92992
increased T cell derived lymphoma incidence J:92992
\H2u/\H2u
\Tg(TCRA)B1Jg/0
\Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg) 		abnormal thymus cell ratio J:92992
increased T cell derived lymphoma incidence J:92992
\H2axtm1Fwa/\H2ax+
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:84879
\H2axtm1Fwa/\H2axtm1Fwa
(involves: 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:84879
\H2axtm1Fwa/\H2axtm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:84879
\H4c16em1(IMPC)Mbp/\H4c16em1(IMPC)Mbp
(C57BL/6N-H4c16em1(IMPC)Mbp/MbpMmucd) 		enlarged thymus J:211773
\H6pdtm1Pmst/\H6pdtm1Pmst
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged adrenal glands J:189132, J:108281
\H6pdtm1Pmst/\H6pdtm1Pmst
\Hsd11b1tm1.1Ggla/\Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		enlarged adrenal glands J:189132
\H13tm1b(KOMP)Wtsi/\H13tm1b(KOMP)Wtsi
(C57BL/6N-H13tm1b(KOMP)Wtsi/Wtsi) 		abnormal thymus topology J:239583
multiple persisting craniopharyngeal ducts J:239583
small thyroid gland J:239583
\Hace1tm1Pngr/\Hace1tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:125183
\Hadhtm1Csta/\Hadhtm1Csta
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss) 		abnormal pancreatic alpha cell morphology J:166803
\Hand2tm1Cse/\Hand2+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * C57BL/6J * CBA/J) 		abnormal thymus development J:155265
\Hax1tm1.1Gach/\Hax1tm1.1Gach
(involves: BALB/c) 		decreased thymocyte number J:174159
thymus hypoplasia J:174159
\Hcktm1Hev/\Hcktm1Hev
\Srctm1Sor/\Srctm1Sor
(involves: 129S7/SvEvBrd * C57BL/6J) 		thymus hypoplasia J:31647
\Hcls1em1(IMPC)Ccpcz/\Hcls1em1(IMPC)Ccpcz
(C57BL/6NCrl-Hcls1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2+
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		enlarged thymus J:194769
thymus hypoplasia J:194769
\Hdac1tm1.1Shmc/\Hdac1tm1.1Shmc
\Hdac2tm1.1Shmc/\Hdac2tm1.1Shmc
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		abnormal thymus corticomedullary boundary morphology J:194769
decreased thymocyte number J:194769
enlarged thymus J:194769
increased T cell derived lymphoma incidence J:194769
increased thymocyte number J:194769
\Hectd3tm1(NCOM)Cmhd/\Hectd3tm1(NCOM)Cmhd
(C57BL/6N-Hectd3tm1(NCOM)Cmhd/Nju) 		small thymus J:211773
\Hellstm1Kmu/\Hellstm1Kmu
(involves: 129S1/Sv) 		small thymus J:61948
\Hellstm1Rarc/\Hellstm1Rarc
(involves: 129X1/SvJ * C57BL/6J) 		small thymus J:107145
thymus hypoplasia J:107145
\HelqGt(RRF112)Byg/\Helq+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
\HelqGt(RRF112)Byg/\HelqGt(RRF112)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
\Hephl1cw/\Hephl1cw
(CWD/LeJ) 		enlarged thymus J:24875
\Hes1tm1.1Frad/\Hes1tm1.1Frad
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		decreased DN1 thymic pro-T cell number J:167000
decreased DN2 thymocyte number J:167000
decreased DN3 thymocyte number J:167000
decreased DN4 thymocyte number J:167000
increased DN1 thymic pro-T cell number J:167000
thymus hypoplasia J:167000
\Hes1tm1Fgu/\Hes1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased solitary pulmonary neuroendocrine cell number J:64088
\Hes1tm1Fgu/\Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		increased solitary pulmonary neuroendocrine cell number J:64088
\Hes1tm1Fgu/\Hes1tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pituitary gland development J:121843
pituitary gland hypoplasia J:121843
\Hes1tm1Kag/\Hes1tm1Kag
\Foxa2tm3.1(icre)Heli/\Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal pancreatic beta cell differentiation J:184814
\Hesx1tm1Icar/\Hesx1tm1Icar
(involves: 129P2/OlaHsd * C57BL/6) 		absent pituitary infundibular stalk J:47920
absent Rathke's pouch J:47920
bifurcated Rathke's pouch J:47920
small adenohypophysis J:47920
\Hesx1tm2Jpmb/\Hesx1tm2Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal adenohypophysis morphology J:142649
ectopic pituitary gland J:142649
\Hesx1tm3Jpmb/\Hesx1tm3Jpmb
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal adenohypophysis morphology J:142649
abnormal pituitary gland morphology J:142649
abnormal Rathke's pouch development J:142649
ectopic adenohypophysis J:142649
ectopic pituitary gland J:142649
\Hhatem1(IMPC)Ccpcz/\Hhat+
(C57BL/6NCrl-Hhatem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Hhextm1Cwb/\Hhextm1Cwb
(involves: 129X1/SvJ * C57BL/6J) 		abnormal thyroid gland development J:93580
\Hhextm1Rbe/\Hhextm1Rbe
(B6.129P2-Hhextm1Rbe) 		abnormal thyroid gland development J:95017
\Hhextm1Rbe/\Hhextm1Rbe
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thyroid gland development J:62027
abnormal thyroid gland morphology J:62027
absent Rathke's pouch J:62027
\Hhiptm1Amc/\Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pancreatic islet morphology J:85472
disorganized pancreatic islets J:85472
small pancreatic islets J:85472
\Hip1tm4Tsr/\Hip1+
\Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:151974
\Hipk3Gt(OST51087)Lex/\Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd) 		abnormal pancreatic islet morphology J:194563
small pancreatic islets J:194563
\Hivep2tm1Sis/\Hivep2tm1Sis
(involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal thymus cortex morphology J:72249
abnormal thymus lobule morphology J:72249
abnormal thymus medulla morphology J:72249
enlarged thymus cortex J:72249
\Hk3em1(IMPC)Tcp/\Hk3em1(IMPC)Tcp
(C57BL/6N-Hk3em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Hmga1tm1Brun/\Hmga1tm1Brun
(Not Specified) 		abnormal pancreatic islet morphology J:99652
small pancreatic islets J:99652
\Hmga2pg-Tg40ACha/\Hmga2+
(involves: C57BL/6J * CBA/J) 		small adrenal glands J:21153
\Hmga2pg-Tg40ACha/\Hmga2pg-Tg40ACha
(involves: C57BL/6J * CBA/J) 		small adrenal glands J:21153
\Hmgn1tm1Mbus/\Hmgn1tm1Mbus
(involves: 129X1/SvJ) 		increased pheochromocytoma incidence J:100773
\Hnf1atm1.1Ylee/\Hnf1atm1.1Ylee
(involves: 129X1/SvJ * C57BL/6J) 		abnormal pancreatic islet morphology J:47008
decreased pancreatic beta cell number J:47008
\Hnf1atm1Mya/\Hnf1atm1Mya
(involves: 129S2/SvPas) 		decreased pancreatic beta cell mass J:48230
small pancreatic islets J:48230
\Hnf1btm2Ics/\Hnf1b+
(involves: 129 * C57BL/6N) 		decreased pancreatic islet number J:306082
small pancreatic islets J:306082
\Hnf4atm1b(EUCOMM)Hmgu/\Hnf4a+
(C57BL/6N-Hnf4atm1b(EUCOMM)Hmgu/Ieg) 		enlarged thyroid gland J:211773
\Hnrnpltm1.1Tmo/\Hnrnpltm1.1Tmo
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm) 		thymus hypoplasia J:188749
\Hormad2em1(IMPC)Ccpcz/\Hormad2em1(IMPC)Ccpcz
(C57BL/6NCrl-Hormad2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Hoxa1tm3.1Mrc/\Hoxa1tm3.1Mrc
(involves: 129S1/Sv * 129X1/SvJ) 		absent parathyroid glands J:178887
parathyroid hypoplasia J:178887
thymus hypoplasia J:178887
\Hoxa1tm3.1Mrc/\Hoxa1tm3.1Mrc
\Hoxb1tm3Mrc/\Hoxb1+
(involves: 129S1/Sv * 129X1/SvJ) 		absent parathyroid glands J:41540
small thymus J:41540
\Hoxa1tm3.1Mrc/\Hoxa1tm3.1Mrc
\Hoxb1tm3Mrc/\Hoxb1tm3Mrc
(involves: 129S1/Sv * 129X1/SvJ) 		absent parathyroid glands J:41540
athymia J:41540
\Hoxa3tm1Kth/\Hoxa3tm1Kth
(involves: 129S1/Sv * 129X1/SvJ) 		athymia J:60296
\Hoxa3tm1Kth/\Hoxa3tm1Kth
\Hoxd3tm3(Hoxa3)Mrc/\Hoxd3+
(involves: 129S1/Sv * 129X1/SvJ) 		athymia J:60296
\Hoxa3tm1Mrc/\Hoxa3+
\Hoxb3tm1Mrc/\Hoxb3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		ectopic parathyroid gland J:46523
ectopic thymus J:46523
\Hoxa3tm1Mrc/\Hoxa3+
\Hoxd3tm1Mrc/\Hoxd3tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6J) 		ectopic parathyroid gland J:46523
ectopic thymus J:46523
\Hoxa3tm1Mrc/\Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd) 		abnormal thyroid gland isthmus morphology J:161296
abnormal thyroid gland morphology J:161296
abnormal ultimobranchial body morphology J:161296
absent parathyroid glands J:17753, J:161296
absent thyroid gland isthmus J:161296
athymia J:17753, J:161296
small thyroid gland J:17753
\Hoxa3tm1Mrc/\Hoxa3tm1Mrc
\Hoxb3tm1Mrc/\Hoxb3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		abnormal thyroid gland isthmus morphology J:46523
abnormal ultimobranchial body morphology J:46523
absent thyroid gland isthmus J:46523
absent ultimobranchial body J:46523
persistent ultimobranchial bodies J:46523
\Hoxa3tm1Mrc/\Hoxa3tm1Mrc
\Hoxd3tm1Mrc/\Hoxd3tm1Mrc
(involves: 129S7/SvEvBrd * C57BL/6J) 		abnormal thyroid gland morphology J:46523
athymia J:19447
persistent ultimobranchial bodies J:46523
\Hoxa3tm1Mrc/\Hoxa3tm2Nrm
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd) 		absent parathyroid glands J:161296
athymia J:161296
\Hoxa3tm1Mrc/\Hoxa3tm3.1Nrm
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S7/SvEvBrd * C57BL/6J * CBA/J) 		ectopic parathyroid gland J:161296
ectopic thymus J:161296
\Hoxa3tm1Nrm/\Hoxa3tm1Mrc
(involves: 129S7/SvEvBrd * C3H * C57BL/6 * C57BL/6NHsd) 		absent parathyroid glands J:161296
athymia J:161296
\Hoxa3tm1Nrm/\Hoxa3tm1Nrm
(involves: C3H * C57BL/6 * C57BL/6NHsd) 		absent parathyroid glands J:161296
athymia J:161296
\Hoxa3tm2Nrm/\Hoxa3tm2Nrm
(involves: C3H * C57BL/6 * C57BL/6NHsd) 		absent parathyroid glands J:161296
athymia J:161296
\Hoxa3tm2Nrm/\Hoxa3tm3.1Nrm
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C3H * C57BL/6 * CBA/J) 		ectopic parathyroid gland J:161296
ectopic thymus J:161296
\Hoxa5tm1Rob/\Hoxa5tm1Rob
(129S(Cg)-Hoxa5tm1Rob) 		abnormal thyroid gland development J:84449
\Hoxa7tm1Mrc/\Hoxa7tm1Mrc
\Hoxb7tm1Mrc/\Hoxb7tm1Mrc
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ) 		small thymus J:50942
\Hoxb3tm1Mrc/\Hoxb3tm1Mrc
\Hoxd3tm1Mrc/\Hoxd3tm1Mrc
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6J) 		abnormal ultimobranchial body morphology J:46523
\Hoxb9tm1Mrc/\Hoxb9tm1Mrc
(involves: 129S7/SvEvBrd) 		small thymus J:37847
\Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6) 		abnormal pancreatic islet morphology J:159291
decreased pancreatic beta cell mass J:159291
decreased pancreatic beta cell number J:159291
increased pancreatic beta cell mass J:159291
\Hps6em1(IMPC)Tcp/\Hps6em1(IMPC)Tcp
(C57BL/6N-Hps6em1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Hrrh-R/\Hrrh-R
(involves: 101 * C3H/Rl * C57BL/RlEl * C57BL/10Rl * SEC/El) 		decreased thymus weight J:156542
\Hrrh/\Hrrh
(RHJ/LeJ) 		thymus atrophy J:57947
\Hrrhsl/\Hrrhsl
(involves: BALB/c) 		thymus atrophy J:98859
\HrUSP/\HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2)) 		thymus cortex atrophy J:21316
\Hrastm1Jaf/\Hrastm1Jaf
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr) 		increased thyroid tumor incidence J:231492
\Hrastm1Jaf/\Hrastm1Jaf
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/NCr) 		increased thyroid tumor incidence J:231492
\Hrastm1Jaf/\Hrastm1Jaf
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr) 		increased thyroid tumor incidence J:231492
\Hsd11b1tm1.1Ggla/\Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd) 		enlarged adrenal glands J:189059
\Hsd11b1tm1.1Ggla/\Hsd11b1tm1.1Ggla
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		enlarged adrenal glands J:189132
\Hsd11b1tm1Ggla/\Hsd11b1tm1Ggla
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA) 		enlarged adrenal glands J:189059
\Hsd11b1tm1Yko/\Hsd11b1tm1Yko
(involves: 129P2/OlaHsd * MF1) 		enlarged adrenal glands J:37960, J:45085
\Hsd17b3tm1.2Mpo/\Hsd17b3tm1.2Mpo
(involves: 129S6/SvEvTac * C57BL/6N * C57BL/6NCrl) 		decreased pituitary gland weight J:301756
\Hsd17b4em1(IMPC)Tcp/\Hsd17b4em1(IMPC)Tcp
(C57BL/6NCrl-Hsd17b4em1(IMPC)Tcp/Tcp) 		enlarged adrenal glands J:211773
\htd/\htd
(C3H/HeJ-htd/J) 		abnormal thyroid follicular cell morphology J:68094
\Htr2btm1Kry/\Htr2btm1Kry
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J) 		decreased pancreatic beta cell mass J:284574
\Htra2mnd2/\Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei) 		abnormal thymus morphology J:12780
\Htra2tm1.1Hohj/\Htra2tm1.1Hohj
\Tg(Nes-cre)1Kln/0
(involves: C57BL/6J) 		thymus atrophy J:225666
\Htra2tm1.2Hohj/\Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J) 		thymus atrophy J:225666
\Htra2tm1Jdo/\Htra2tm1Jdo
(involves: 129P/Ola * C57BL/6) 		small thymus J:94227
\Huwe1tm1Wgu/Y
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J) 		decreased pancreatic beta cell number J:182446
disorganized pancreatic islets J:182446
\Hycc1em1(IMPC)Ccpcz/\Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz) 		enlarged thymus J:211773
\Hydinhyrh/\Hydinhyrh
(involves: C57BL/6J * C57BL/10J * RIII) 		thymus atrophy J:137815
\Icostm1Flv/\Icos+
(NOD.129S1-Icostm1Flv) 		decreased pancreatic islet number J:131529
\Icostm1Flv/\Icostm1Flv
\Rc3h1san/\Rc3h1+
(involves: 129S1/Sv * C57BL/6 * C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Id1tm1Zhu/\Id1tm1Zhu
\Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:44278
increased T cell derived lymphoma incidence J:44278
\Id3tm2.1Cmu/\Id3tm2.1Cmu
(Not Specified) 		decreased thymocyte number J:176462
\Id3tm2.1Cmu/\Id3tm2.1Cmu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * DBA/2) 		decreased thymocyte number J:176462
\Idstm1Muen/Y
(involves: C57BL/6) 		increased thyroid gland weight J:259752
\Ier3ip1tm1Arvn/\Ier3ip1tm1Arvn
\Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1) 		abnormal pancreatic beta cell differentiation J:336782
abnormal pancreatic beta cell morphology J:336782
\Ier3ip1tm1Arvn/\Ier3ip1tm1Arvn
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA) 		abnormal pancreatic beta cell differentiation J:336782
abnormal pancreatic beta cell morphology J:336782
decreased pancreatic beta cell mass J:336782
small pancreatic islets J:336782
\Ifngtm1.1Hayg/\Ifngtm1.1Hayg
(involves: 129S4/SvJae * C57BL/6J) 		thymus atrophy J:220784
\Ifngtm1Ts/\Ifngtm1Ts
(B6.129S7-Ifngtm1Ts) 		increased T cell derived lymphoma incidence J:77491
\Ifngtm1Ts/\Ifngtm1Ts
\Socs1tm1Wehi/\Socs1tm1Wehi
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6) 		enlarged thymus medulla J:57474
\Igbp1tm1Cbt/Y
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased thymocyte number J:93221
\Igbp1tm1Cbt/\Igbp1+
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased thymocyte number J:93221
\Igbp1tm1Imku/Y
\Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR) 		abnormal thymus cortex morphology J:84395
abnormal thymus corticomedullary boundary morphology J:84395
decreased thymocyte number J:84395
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * C57BL/6J) 		adrenal gland cyst J:77413
\Igfbp3tm1Jep/\Igfbp3tm1Jep
\Igfbp4tm1Jep/\Igfbp4tm1Jep
\Igfbp5tm1Jep/\Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J) 		abnormal pancreatic beta cell morphology J:112029
\Igh-Vtm1(Igh-Vx24)Hmb/\Igh-Vtm1(Igh-Vx24)Hmb
(involves: 129/Sv * C57BL/6) 		increased T cell derived lymphoma incidence J:54380
\Ightm1(PAX5)Mbu/\Igh+
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal thymus morphology J:118111
enlarged thymus J:118111
increased T cell derived lymphoma incidence J:118111
thymus hypoplasia J:118111
\Ightm1(PAX5)Mbu/\Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu) 		abnormal thymus morphology J:118111
enlarged thymus J:118111
increased T cell derived lymphoma incidence J:118111
thymus hypoplasia J:118111
\Ighmtm1Cgn/\Ighm+
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1) 		thymus hypoplasia J:99033
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:110548
\Ighmtm1Cgn/\Ighmtm1Cgn
\Tgfb1tm1Doe/\Tgfb1tm1Doe
(involves: 129S2/SvPas * C57BL/6 * CF-1) 		thymus hypoplasia J:99033
\Igs2em5(CAG-Mir802)Gpt/\Igs2em5(CAG-Mir802)Gpt
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA) 		abnormal pancreatic beta cell differentiation J:287584
decreased pancreatic beta cell mass J:287584
decreased pancreatic beta cell number J:287584
\Igsf1tm1Zuk/Y
(either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J)) 		abnormal pituitary gland morphology J:190867
\Ikbkgtm1Mka/\Ikbkg+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		small thymus J:63054
\Ikzf1plstc/\Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc) 		decreased thymocyte number J:84569
increased T cell derived lymphoma incidence J:84569
\Ikzf1plstc/\Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc) 		thymus hypoplasia J:84569
\Ikzf1tm1(Pax5)Mbu/\Ikzf1+
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:118111
\Ikzf1tm1(Pax5)Mbu/\Ikzf1tm1(Pax5)Mbu
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		thymus hypoplasia J:80815
\Ikzf1tm1.1(Pax5)Mbu/\Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged thymus J:118111
increased T cell derived lymphoma incidence J:118111
thymus hypoplasia J:118111
\Ikzf1tm1.1Smale/\Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale) 		decreased DN1 thymic pro-T cell number J:208211
thymus hypoplasia J:208211
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * C57BL/6) 		abnormal thymus lobule morphology J:29355
abnormal thymus medulla morphology J:29355
enlarged thymus J:29355
thymus cortex hypoplasia J:29355
\Ikzf1tm1Kge/\Ikzf1+
(involves: 129S4/SvJae * BALB/c) 		abnormal thymus lobule morphology J:29355
abnormal thymus medulla morphology J:29355
enlarged thymus J:29355
thymus cortex hypoplasia J:29355
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6) 		abnormal thymus cortex morphology J:20671
abnormal thymus morphology J:20671
thymus hypoplasia J:20671
\Ikzf1tm1Kge/\Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c) 		abnormal thymus cortex morphology J:20671
abnormal thymus morphology J:20671
thymus hypoplasia J:20671
\Ikzf1tm2.1Smale/\Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale) 		decreased DN2 thymocyte number J:208211
decreased DN3 thymocyte number J:208211
thymus cortex hypoplasia J:208211
thymus hypoplasia J:208211
\Ikzf1tm2Kge/\Ikzf1tm2Kge
(involves: 129S4/SvJae) 		abnormal thymus development J:37317
thymus hypoplasia J:37317
\Ikzf1tm3.1Mbu/\Ikzf1tm3.1Mbu
\Il7rtm1.1(icre)Hrr/\Il7r+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:209928
\Ikzf1tm3Kge/\Ikzf1tm3Kge
\Tg(CD2-icre)4Kio/?
(involves: C57BL/10 * CBA/Ca) 		increased T cell derived lymphoma incidence J:209927
\Il2rbtm1Mak/\Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas)) 		thymus hypoplasia J:25940
\Il2rgtm1Cgn/Y
(involves: 129 * CB20) 		thymus hypoplasia J:111821, J:22521
\Il2rgtm1Cgn/\Il2rgtm1Cgn
(involves: 129 * CB20) 		thymus hypoplasia J:22521
\Il2rgtm1Krf/\Il2rgtm1Krf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * FVB/N)) 		decreased thymocyte number J:114561
\Il2rgtm1Krf/\Il2rgtm1Krf
\Tg(BCL2/IGH)1Tjd/0
(either: (involves: 129P2/OlaHsd * C3H/He * C57BL/6) or (involves: 129P2/OlaHsd * C3H/He * C57BL/6 * FVB/N)) 		decreased thymocyte number J:114561
\Il2rgtm1Krf/\Il2rgtm1Krf
\Tg(Igh-Pim1)1Brn/0
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)) 		decreased thymocyte number J:114561
\Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6)) 		decreased thymocyte number J:31167
small thymus J:31167
thymus cortex hypoplasia J:31167
thymus hypoplasia J:31167
\Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6) 		small thymus J:24117
small thymus cortex J:24117
thymus hyperplasia J:108209
\Il2rgtm1Wjl/Y
\Crlf2tm1Wjl/\Crlf2tm1Wjl
(involves: 129S4/SvJae * C57BL/6) 		thymus hypoplasia J:108209
\Il2rgtm1Wjl/Y
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz) 		abnormal thymus morphology J:109833
\Il2rgtm1Wjl/Y
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ) 		abnormal thymus morphology J:140388
absent thymus cortex J:140388
absent thymus medulla J:140388
thymus cyst J:140388
\Il2rgtm1Wjl/\Il2rgtm1Wjl
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz) 		abnormal thymus morphology J:109833
thymus cyst J:109833
\Il3tm1Glli/\Il3tm1Glli
(B6.129S2-Il3tm1Glli) 		abnormal pancreatic islet morphology J:145518
\Il6tm1Kopf/\Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J) 		abnormal pancreatic alpha cell mass J:139138
\Il6sttm1Kish/\Il6sttm1Kish
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:75419
\Il6sttm1Wme/\Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:67677
\Il7hlb368/\Il7hlb368
(C57BL/6J-Il7hlb368/J) 		small thymus J:118450
thymus hypoplasia J:118450
\Il7m1Jyen/\Il7m1Jyen
(involves: C3H * C57BL/6) 		thymus hypoplasia J:136470
\Il7tm1.1Mysl/\Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl) 		decreased thymocyte number J:200544
thymus hypoplasia J:200544
\Il7tm1Dnax/\Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymus weight J:24165
small thymus J:24165
thymus hypoplasia J:24165
\Il7tm1Dnax/\Il7tm1Dnax
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:64861
\Il7tm1Hms/\Il7tm1Hms
(involves: 129S6/SvEvTac) 		thymus hypoplasia J:43971
\Il7rtm1Abra/\Il7rtm1Abra
(B6.129S4-Il7rtm1Abra) 		decreased thymocyte number J:125360
\Il7rtm1Iku/\Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J) 		small thymus J:34658
thymus hypoplasia J:34658
\Il7rtm1Imx/\Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd) 		thymus hypoplasia J:21135
\Il7rtm1Imx/\Il7rtm1Imx
(B6.129S7-Il7rtm1Imx) 		decreased thymocyte number J:125360
\Il7rtm1Imx/\Il7rtm1Imx
(involves: 129S7/SvEvBrd) 		decreased thymocyte number J:64861
\Il7rtm1Imx/\Il7rtm1Imx
\Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL) 		decreased thymocyte number J:66400
\Il7rtm2Iku/\Il7rtm2Iku
\Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		increased thymocyte number J:193283
\Il10tm1Cgn/\Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6) 		increased thymus weight J:107077
thymus hyperplasia J:107077
\Il10tm1Cgn/\Il10tm1Cgn
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:107077
thymus hypoplasia J:107077
\Il13ra1tm1Zagh/\Il13ra1tm1Zagh
(involves: BALB/c * C57BL/6) 		abnormal thymus development J:183111
\Il15tm1Imx/\Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac) 		abnormal thymus cell ratio J:111786
\Il15tm1Imx/\Il15tm1Imx
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6) 		abnormal thymus cell ratio J:111786
\Ildr2Dbsm1-DBA/2J/\Ildr2Dbsm1-DBA/2J
\Lepob/\Lepob
(B6.Cg-Ildr2Dbsm1-DBA/2J Lepob) 		decreased pancreatic beta cell mass J:138216
\Ildr2W87*/\Ildr2W87*
(involves: C3HeB/FeJ) 		abnormal pancreatic beta cell differentiation J:138216
decreased pancreatic beta cell mass J:138216
decreased pancreatic beta cell number J:138216
\Ing1Gt(OST206270)Lex/\Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		decreased thymocyte number J:118602
\Inhatm1Bay/\Inhatm1Bay
(involves: 129S7/SvEvBrd * C57BL/6) 		increased adrenal gland tumor incidence J:125349, J:20450
\Inhatm1Bay/\Inhatm1Bay
\Smad3tm1Par/\Smad3+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/Sv * C57BL/6) 		increased adrenal gland tumor incidence J:125349
\Ino80tm1.1Schg/\Ino80+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:221224
\Inpp5del20/\Inpp5del20
(B6.129-Inpp5del20) 		decreased thymocyte number J:173266
small thymus J:173266
\Inpp5dm1Btlr/\Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr) 		enlarged thymus J:140987
\Ins1tm1.1(cre)Thor/\Ins1+
\Med15tm1c(KOMP)Wtsi/\Med15tm1c(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N) 		abnormal pancreatic beta cell differentiation J:355262
\Ins1tm1Jja/\Ins1tm1Jja
(involves: 129S2/SvPas) 		increased pancreatic beta cell mass J:77595
increased pancreatic beta cell number J:77595
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2+
(involves: 129S2/SvPas * C57BL/6) 		increased pancreatic alpha cell mass J:106827
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
(involves: 129S2/SvPas) 		enlarged pancreatic islets J:40377
increased pancreatic beta cell number J:77595
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Jja/\Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6) 		enlarged pancreatic islets J:106827
increased pancreatic alpha cell mass J:106827
increased pancreatic beta cell mass J:106827
\Ins1tm1Jja/\Ins1tm1Jja
\Ins2tm1Mnt/\Ins2tm1Mnt
\Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		decreased pancreatic beta cell number J:152798
\Ins2Akita/\Ins2+
(C57BL/6-Ins2Akita) 		abnormal pancreatic beta cell morphology J:47883
degranulated pancreatic beta cells J:47883
\Ins2Akita/\Ins2+
(C57BL/6-Ins2Akita/J) 		abnormal pancreatic islet morphology J:321591
decreased pancreatic beta cell number J:321591
\Ins2Akita/\Ins2+
(involves: C57BL/6NSlc) 		abnormal pancreatic islet morphology J:200802
\Ins2Akita/\Ins2+
\Or12d17em1Cya/\Or12d17em1Cya
(C57BL/6-Ins2Akita Or12d17em1Cya) 		abnormal pancreatic islet morphology J:321591
\Ins2Akita/\Ins2+
\Prf1tm1Sdz/\Prf1tm1Sdz
\Rag1tm1Mom/\Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz) 		abnormal pancreatic islet morphology J:138005
\Ins2Akita/\Ins2+
\Rnf213tm1.1Akoi/\Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc) 		abnormal pancreatic islet morphology J:200802
decreased pancreatic beta cell number J:200802
\Ins2Akita/\Ins2Akita
(C57BL/6-Ins2Akita) 		abnormal pancreatic alpha cell morphology J:47883
abnormal pancreatic beta cell morphology J:47883
small pancreatic islets J:47883
\Ins2Akita/\Ins2Akita
(involves: C57BL/6NSlc) 		decreased pancreatic beta cell mass J:156725
\Ins2Akita/\Ins2Akita
\Jazf1tm1c(EUCOMM)Wtsi/\Jazf1tm1c(EUCOMM)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J) 		decreased pancreatic beta cell mass J:303318
\Ins2C95S/\Ins2+
(C3HeB/FeJ-Ins2C95S) 		abnormal pancreatic beta cell morphology J:122098
abnormal pancreatic islet morphology J:122098
decreased pancreatic beta cell number J:122098
disorganized pancreatic islets J:122098
increased pancreatic alpha cell number J:122098
\Ins2em#Arak/\Ins2+
(C.129-Rag2tm1Fwa Ins2em#Arak Jak3tm1Tks/Arak) 		abnormal pancreatic beta cell morphology J:294041
abnormal pancreatic islet morphology J:294041
small pancreatic islets J:294041
\Ins2tm1Delt/\Ins2+
(involves: 129S2/SvPas * Black Swiss) 		absent pancreatic beta cells J:94589
decreased pancreatic alpha cell number J:94589
small pancreatic islets J:94589
\Ins2tm1Delt/\Ins2tm1Jja
(involves: 129S2/SvPas) 		decreased pancreatic beta cell number J:94589
\Ins2tm1Jja/\Ins2tm1Jja
(involves: 129S2/SvPas) 		increased pancreatic beta cell mass J:77595
increased pancreatic beta cell number J:77595
\Insl5tm1Imad/\Insl5tm1Imad
(129(B6)-Insl5tm1Imad) 		decreased pancreatic beta cell number J:189146
small pancreatic islets J:189146
\Insm1tm1.1(GFP/cre)Mgn/\Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL) 		abnormal endocrine pancreas morphology J:214095
\Insm1tm1Cbm/\Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6 * CD-1) 		absent PP cells J:112173
decreased pancreatic alpha cell number J:112173
decreased pancreatic beta cell number J:112173
decreased pancreatic delta cell number J:112173
decreased pancreatic epsilon cell number J:112173
increased PP cell number J:112173
pancreatic islet hypoplasia J:112173
\Insm1tm1Cbm/\Insm1tm1Cbm
(involves: 129P2/OlaHsd * C57BL/6) 		decreased pancreatic beta cell number J:112173
\Insm1tm1Cbm/\Insm1tm1Cbm
(involves: 129P2/OlaHsd) 		abnormal pituitary gland development J:206319
absent somatotrophs J:206319
absent thyrotrophs J:206319
small pituitary gland J:206319
\Insrtm1Dac/\Insr+
(involves: 129 * C57BL/6J) 		increased pancreatic beta cell mass J:135659
\Insrtm1Dac/\Insr+
(B6.129S4-Insrtm1Dac/J) 		increased pancreatic beta cell mass J:246319
\Insrtm1Dac/\Insr+
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		absent pancreatic beta cells J:80826
\Insrtm1Dac/\Insr+
\Ppp2r2aigt10/\Ppp2r2a+
(involves: 129S4/SvJae * C3H/HeH * C57BL/6J) 		increased pancreatic beta cell mass J:246319
\Insrtm1Dac/\Insrtm1Dac
\Tg(TTR-INSR)L1Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		decreased pancreatic beta cell mass J:91350
\Insrtm1Dac/\Insrtm1Dac
\Tg(TTR-INSR)L2Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		abnormal pancreatic islet morphology J:91350
increased pancreatic beta cell mass J:91350
\Insrtm1Dac/\Insrtm1Dac
\Tg(TTR-INSR)L3Dac/0
(involves: 129S4/SvJae * C57BL/6 * FVB) 		abnormal pancreatic islet morphology J:91350
increased pancreatic beta cell mass J:91350
\Insrtm1Khn/\Insrtm1Khn
\Pdx1tm1Ted/\Pdx1+
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased pancreatic beta cell mass J:92861
\Insrtm1Khn/\Insrtm1Khn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB) 		increased pancreatic beta cell mass J:63878, J:92861
pancreatic islet hyperplasia J:92861
\Insrtm1Khn/\Insrtm1Khn
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		increased pancreatic beta cell mass J:121640
\Insrtm1Khn/\Insrtm1Khn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		decreased pancreatic beta cell mass J:121640
\Insrtm1Khn/\Insrtm1Khn
\Tg(Slc2a4-cre)546Dac/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB) 		abnormal pancreatic beta cell morphology J:169404
abnormal pancreatic islet morphology J:169404
decreased pancreatic beta cell number J:169404
\Invsinv/\Invsinv
(involves: FVB/N) 		abnormal pancreatic islet morphology J:50117
disorganized pancreatic islets J:50117
pancreatic islet hyperplasia J:50117
\Iqcmem1(IMPC)Tcp/\Iqcmem1(IMPC)Tcp
(C57BL/6NCrl-Iqcmem1(IMPC)Tcp/Cmmr) 		enlarged adrenal glands J:211773
\Irak4em1(IMPC)Ccpcz/\Irak4em1(IMPC)Ccpcz
(C57BL/6NCrl-Irak4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Irf1tm1Cwe/\Irf1tm1Cwe
(involves: 129/Sv * C57BL/6) 		abnormal thymus cell ratio J:36025
\Irf4em1(IMPC)Mbp/\Irf4em1(IMPC)Mbp
(C57BL/6N-Irf4em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Irs1tm1Jos/\Irs1+
\Irs2tm2Mfw/\Irs2tm2Mfw
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell morphology J:93415
\Irs1tm1Jos/\Irs1tm1Jos
\Irs3tm1Lhd/\Irs3tm1Lhd
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased pancreatic beta cell mass J:80976
pancreatic islet hyperplasia J:80976
\Irs1tm2.1Mfw/\Irs1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal pancreatic beta cell morphology J:156999
\Irs1tm2.1Mfw/\Irs1tm2.1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N) 		abnormal pancreatic beta cell morphology J:156999
\Irs2tm1Mfw/\Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal pancreatic beta cell morphology J:96047
decreased gonadotroph cell number J:64791
decreased pancreatic beta cell mass J:135659, J:46134
decreased pancreatic beta cell number J:94000
small pancreatic islets J:96047
small pituitary gland J:64791
small pituitary intermediate lobe J:74303
\Irs2tm1Mfw/\Irs2tm1Mfw
\Ptpn1tm1Bbk/\Ptpn1tm1Bbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell morphology J:87249
pancreatic islet hyperplasia J:87249
\Irs2tm1Mfw/\Irs2tm1Mfw
\Tg(Ins2-Irs2)13Mfw/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell morphology J:94000
\Irs2tm1Tka/\Irs2tm1Tka
(involves: C57BL/6 * CBA) 		abnormal pancreatic beta cell morphology J:65485
decreased pancreatic beta cell mass J:65485
\Irs2tm1With/\Irs2tm1With
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased pancreatic beta cell number J:97406
\Irs2tm1With/\Irs2tm1With
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6J) 		increased pancreatic beta cell mass J:97406
\Irs2tm2Mfw/\Irs2tm2Mfw
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell morphology J:93415
\Irs2tm2Tka/\Irs2tm2Tka
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6) 		decreased pancreatic beta cell mass J:93416
\Isl1tm1(cre)Sev/\Isl1+
\Pax9tm1Rbal/\Pax9tm1.1Hpt
(involves: 129 * C57BL/6J) 		ectopic thymus J:311535
thymus hypoplasia J:311535
\Isl1tm1Tmj/\Isl1tm1Tmj
(involves: 129S1/Sv) 		abnormal pancreatic islet morphology J:37641
abnormal Rathke's pouch development J:50517
absent pancreatic alpha cells J:37641
small Rathke's pouch J:50517
\Ism1em1(IMPC)Ccpcz/\Ism1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ism1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Itgb1tm1Ref/\Itgb1tm1Ref
\Tg(Ins2-cre)1Heed/?
(involves: 129 * C57BL/6 * CBA) 		disorganized pancreatic islets J:122649
increased pancreatic alpha cell number J:122649
\Itgb6em1(IMPC)Ccpcz/\Itgb6em1(IMPC)Ccpcz
(C57BL/6NCrl-Itgb6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Itktm1Litt/\Itktm1Litt
(involves: 129S4/SvJae * C57BL/6) 		abnormal thymus cell ratio J:111786
\Itktm1Litt/\Itktm1Litt
\Vav1tm2Bbd/\Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd) 		decreased thymocyte number J:141390
\Itpkbtm1Ssch/\Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		absent thymus medulla J:86257
\Jag2tm1Grid/\Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J) 		abnormal thymus medulla morphology J:46930
abnormal thymus morphology J:46930
\Jak1tm1Rds/\Jak1tm1Rds
(involves: 129) 		decreased thymocyte number J:47300
small thymus J:47300
\Jak3bfy/\Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb) 		decreased thymocyte number J:104190
small thymus J:104190
\Jak3m1J/\Jak3m1J
(B6.Cg-Crb1+ Jak3m1J/Boc) 		decreased thymus weight J:265859
small thymus J:265859
\Jak3M1Pgrs/\Jak3M1Pgrs
(involves: C57BL/6J * C57BL/10J) 		small thymus J:185217
\Jak3tm1Flv/\Jak3tm1Flv
(involves: 129S1/Sv) 		thymus hypoplasia J:95794
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6) 		small thymus J:29722
thymus hypoplasia J:29722
\Jak3tm1Ljb/\Jak3tm1Ljb
(involves: 129S4/SvJae) 		abnormal thymus cell ratio J:128694
decreased thymocyte number J:64861
thymus hypoplasia J:128694
\Jak3tm1Tks/\Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus cortex morphology J:31231
abnormal thymus corticomedullary boundary morphology J:31231
abnormal thymus medulla morphology J:31231
absent Hassall's corpuscle J:31231
decreased thymocyte number J:31231
small thymus medulla J:31231
thymus cortex hypoplasia J:31231
thymus hypoplasia J:31231
\Jak3X887Y/\Jak3X887Y
(Not Specified) 		abnormal thymus morphology J:112658
\Jarid2jumonji/\Jarid2jumonji
(C.129P2-Jarid2jumonji) 		abnormal thymus cell ratio J:42772
thymus hypoplasia J:42772
\Jarid2jumonji/\Jarid2jumonji
(either: B6.129P2-Jarid2jumonji or D2.129P2-Jarid2jumonji) 		thymus hypoplasia J:42772
\Jazf1tm1c(EUCOMM)Wtsi/\Jazf1tm1c(EUCOMM)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA/J) 		decreased pancreatic beta cell mass J:303318
\Jmjd6tm1Gbf/\Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf) 		small thymus J:102098
thymus hypoplasia J:102098
\Kat6atm1.1Glac/\Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymus weight J:148955
thymus hypoplasia J:148955
\Kat6atm1Avo/\Kat6a+
(involves: 129 * BALB/c * FVB/N) 		small thymus J:188772
\Kat6atm1Avo/\Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N) 		abnormal thymus development J:108453
athymia J:188772
small thymus J:108453, J:188772
thymus hypoplasia J:108453
\Kat6atm2.2Avo/\Kat6a+
\Tbx1tm1Bld/\Tbx1+
(involves: 129S7/SvEvBrd * C57BL/6) 		small thymus J:188772
\Katnipem1(IMPC)Mbp/\Katnip+
(C57BL/6NCrl-Katnipem1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Kbtbd3em1(IMPC)Ccpcz/\Kbtbd3em1(IMPC)Ccpcz
(C57BL/6NCrl-Kbtbd3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Kcne3tm1Gwab/\Kcne3tm1Gwab
(involves: C57BL/6) 		abnormal adrenal gland morphology J:210381
\Kcnh6em1Jkya/\Kcnh6em1Jkya
(involves: C57BL/6N) 		decreased pancreatic beta cell mass J:271003
decreased pancreatic beta cell number J:271003
increased pancreatic alpha cell number J:271003
\Kcnn4em1(IMPC)Ccpcz/\Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
small thymus J:211773
\Kdelr1m1Btlr/\Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr) 		thymus hypoplasia J:158794
\Kdm1atm1.1Rsd/\Kdm1atm1.1Rsd
\Tg(Pitx1-cre)7Rsd/0
(involves: BALB/c * C57BL/6) 		abnormal pituitary gland development J:121427
\Kdm5atm1.1Kael/\Kdm5a+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
increased thyroid tumor incidence J:175625
\Kdm5atm1.1Kael/\Kdm5atm1.1Kael
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
increased thyroid tumor incidence J:175625
\Kdm5atm1Kael/\Kdm5atm1Kael
\Men1tm2.1Mmey/\Men1tm2.1Mmey
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N) 		abnormal pancreatic islet morphology J:175625
pancreatic islet hyperplasia J:175625
\Kif5btm1Njen/\Kif5btm1.1Njen
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL) 		abnormal pancreatic beta cell morphology J:170198
increased pancreatic beta cell number J:170198
small pancreatic islets J:170198
\Kif16bem1(IMPC)Ccpcz/\Kif16bem1(IMPC)Ccpcz
(C57BL/6NCrl-Kif16bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Kifbptm1a(KOMP)Wtsi/\Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
\Kiss1tm1Coll/\Kiss1tm1Coll
(involves: 129S/SvEv * 129S6/SvEvTac) 		abnormal adrenal gland morphology J:122381
retention of the adrenal gland x-zone J:122381
\Kiss1rtm1.1(KOMP)Vlcg/\Kiss1rtm1.1(KOMP)Vlcg
(C57BL/6N-Kiss1rtm1.1(KOMP)Vlcg/Ucd) 		increased thymus weight J:211773
\Kiss1rtm1.1Lex/\Kiss1rtm1.1Lex
(involves: 129S4/SvJae) 		decreased adrenal gland weight J:181650
increased thymus weight J:181650
\Kiss1rtm1Coll/\Kiss1rtm1Coll
(involves: 129S6/SvEvTac) 		abnormal adrenal cortex morphology J:96442
retention of the adrenal gland x-zone J:96442
\Kiss1rtm1Gstn/\Kiss1rtm1Gstn
(involves: 129P2/OlaHsd) 		increased thymus weight J:102113
\KitW-vkd/\KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB) 		decreased thymocyte number J:79128
\KitW/\KitW
\Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6) 		decreased thymocyte number J:79128
\KitlSl/\KitlSl-d
(involves: C57BL/6 * WC) 		thymus atrophy J:5758
\Kitltm3.1Pbes/\Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		decreased thymocyte number J:157170
\Klkl/\Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J)) 		abnormal adenohypophysis morphology J:44109
abnormal gonadotroph morphology J:44109
decreased somatotroph cell size J:44109
decreased somatotroph secretory granule number J:44109
thymus atrophy J:44109
\Klkl/\Klkl
(involves: C3H/J * C57BL/6J) 		abnormal pancreatic beta cell morphology J:66078
small pancreatic islets J:66078
\Klf13tm1Kren/\Klf13tm1Kren
(B6.129-Klf13tm1Kren) 		decreased thymocyte number J:145839
increased thymocyte number J:145839
thymus hyperplasia J:145839
\Klhl1em1(IMPC)Ccpcz/\Klhl1em1(IMPC)Ccpcz
(C57BL/6N-Klhl1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Klhl6em1(IMPC)Ccpcz/\Klhl6em1(IMPC)Ccpcz
(C57BL/6NCrl-Klhl6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Klhl12em1(IMPC)Tcp/\Klhl12em1(IMPC)Tcp
(C57BL/6N-Klhl12em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Klk10em1(IMPC)Ccpcz/\Klk10em1(IMPC)Ccpcz
(C57BL/6NCrl-Klk10em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Klk11em1(IMPC)Ccpcz/\Klk11em1(IMPC)Ccpcz
(C57BL/6N-Klk11em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Kmt2atm1Thr/\Kmt2a+
\Mllt3tm2Thr/\Mllt3+
\Tg(Lck-cre)1Thr/?
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:100794
\Kmt2bGena263/\Kmt2b+
(involves: BALB/c * C3H/HeH) 		enlarged pancreatic islets J:203736
\Kmt2etm1.1Hjf/\Kmt2e+
(B6.129P2-Kmtetm1.1Hjf) 		decreased thymocyte number J:145579
thymus hypoplasia J:145579
\Kmt2etm1.1Hjf/\Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf) 		decreased thymocyte number J:145579
small thymus J:145579
thymus hypoplasia J:145579
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas) 		increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm2Tyj/\Kras+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:68981
\Krastm3Tyj/\Kras+
\Mir21atm1.1Eno/\Mir21atm1.1Eno
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:164198
\Krastm3Tyj/\Krastm3Tyj
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:237900
\Krastm4Tyj/\Kras+
\Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/\Gt(ROSA)26Sor+
\Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6) 		thymus atrophy J:247853
\Krastm4Tyj/\Kras+
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp) 		enlarged thyroid gland J:147732
increased thyroid carcinoma incidence J:147732
\Krastm4Tyj/\Kras+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA) 		increased lymphoblastic lymphoma incidence J:88163
\Krastm4Tyj/\Kras+
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		enlarged pancreatic islets J:87196
\Krastm4Tyj/\Kras+
\Trp53tm2Tyj/\Trp53+
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:98936
\Krastm4Tyj/\Krastm4Tyj
\Trim33tm1Los/\Trim33tm1Los
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 * DBA/2) 		disorganized pancreatic islets J:151781
\Krt1em1(IMPC)Ccpcz/\Krt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krt27em1(IMPC)Ccpcz/\Krt27em1(IMPC)Ccpcz
(C57BL/6N-Krt27em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krt33aem1(IMPC)Ccpcz/\Krt33aem1(IMPC)Ccpcz
(C57BL/6N-Krt33aem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krt33bem1(IMPC)Ccpcz/\Krt33bem1(IMPC)Ccpcz
(C57BL/6N-Krt33bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krt34em1(IMPC)Ccpcz/\Krt34em1(IMPC)Ccpcz
(C57BL/6NCrl-Krt34em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krt72em1(IMPC)Ccpcz/\Krt72em1(IMPC)Ccpcz
(C57BL/6N-Krt72em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krtap7-1em1(IMPC)Ccpcz/\Krtap7-1em1(IMPC)Ccpcz
(C57BL/6NCrl-Krtap7-1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Krtap9-5em1(IMPC)Ccpcz/\Krtap9-5em1(IMPC)Ccpcz
(C57BL/6N-Krtap9-5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Lair1tm1.1Jco/\Lair1tm1.1Jco
(involves: C57BL/6) 		decreased thymocyte number J:180203
\Lama2tm1Stk/\Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c) 		abnormal thymus corticomedullary boundary morphology J:61802
thymus cortex hypoplasia J:61802
\Lama5b2b2966.1Clo/\Lama5b2b2966.1Clo
(C57BL/6J-Lama5b2b2966.1Clo) 		thymus hypoplasia J:175213
\Lamp1em1(IMPC)Mbp/\Lamp1em1(IMPC)Mbp
(C57BL/6N-Lamp1em1(IMPC)Mbp/MbpMmucd) 		small adrenal glands J:211773
\Lamp2tm1Psa/\Lamp2tm1Psa
(either: (involves: 129P2/OlaHsd * 129/Sv * C57BL/6J) or (involves: 129P2/OlaHsd * 129/Sv)) 		abnormal thymus morphology J:64151
\Lamtor4em1(IMPC)Ccpcz/\Lamtor4+
(C57BL/6N-Lamtor4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Lamtor5tm1Lye/\Lamtor5tm1Lye
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA) 		abnormal pancreatic islet morphology J:258406
\Lattm1.1Lov/\Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		decreased thymocyte number J:77099
small thymus J:77099
\Lattm1.1Mal/\Lattm1.1Mal
(involves: 129S2/SvPas) 		thymus hypoplasia J:77098
\Lattm1Bpay/\Lattm1Bpay
(involves: 129S2/SvPas) 		decreased thymocyte number J:103904
small thymus J:103904
\Lattm1Les/\Lattm1.1Wz
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased thymocyte number J:147946
small thymus J:147946
\Lattm1Les/\Lattm1Les
(Not Specified) 		decreased thymocyte number J:54059
small thymus J:54059
\Lattm1Les/\Lattm1Les
\Tg(CD2-LAT2)1Wz/0
(Not Specified) 		small thymus J:116964
\Lattm2.1Lov/\Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		small thymus J:77695
\Lattm2.1Mal/\Lattm2.1Mal
(involves: 129S2/SvPas) 		thymus hypoplasia J:94074
\Lattm3.1Mal/\Lattm3.1Mal
(involves: 129S2/SvPas) 		abnormal thymus cell ratio J:94074
\Lattm4.1Mal/\Lattm4.1Mal
(involves: 129P2/OlaHsd) 		abnormal thymus cell ratio J:94074
\Lats1tm1Tx/\Lats1tm1Tx
(involves: 129S2/SvPas * C57BL/6J) 		adenohypophysis hyperplasia J:52536
\Lbrlym3/\Lbrlym3
(C57BL/6-Lbrlym3) 		thymus hypoplasia J:180355
\Lcattm1Hgc/\Lcattm1Hgc
(involves: C57BL/6 * DBA) 		abnormal adrenal gland morphology J:41208
\Lckm1Btlr/\Lckm1Btlr
(C57BL/6J-Lckm1Btlr) 		thymus atrophy J:144695
thymus hypoplasia J:144695
\Lcktm1.1Litt/\Lcktm1.1Litt
(Not Specified) 		abnormal thymus morphology J:152472
\Lcktm1Dbs/\Lcktm1Dbs
(involves: C3H * C57BL/6) 		decreased thymocyte number J:114660
\Lcktm1Mak/\Lcktm1Mak
(involves: 129S2/SvPas) 		decreased thymocyte number J:1119
thymus atrophy J:1119
thymus hypoplasia J:37062, J:37940
\Lcn2tm1Mrgr/\Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr) 		thymus hyperplasia J:173490
\Lcp2tm1.1Wz/\Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz) 		decreased thymocyte number J:150304
small thymus J:150304
\Lcp2tm2Gak/\Lcp2tm2Gak
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		thymus hypoplasia J:107467
\Lcp2tm5(Lat/Lcp2)Gak/\Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ) 		thymus hypoplasia J:147721
\Lcp2twm/\Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu) 		decreased thymocyte number J:104190
\Ldlrtm1Her/\Ldlrtm1Her
(B6.129S7-Ldlrtm1Her/J) 		abnormal adrenal gland morphology J:85174
\Lepob/\Lepob
(involves: C57BL/6J) 		enlarged pancreatic islets J:219118
\Lepob/\Lepob
(B6.Cg-Lepob/J) 		enlarged pancreatic islets J:5400
\Lepob/\Lepob
(D2.Cg-Lepob/Chua) 		abnormal pancreatic islet morphology J:78850
decreased pancreatic beta cell number J:78850
increased pancreatic beta cell number J:78850
\Lepob/\Lepob
(involves: 129 * C57BL/6) 		abnormal pancreatic islet morphology J:121534
enlarged pancreatic islets J:121534
increased pancreatic islet number J:121534
\Lepob/\Lepob
(BKS.Cg-Lepob/J) 		small pancreatic islets J:5400
\Lepob/\Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs) 		abnormal pancreatic beta cell morphology J:7702
increased pancreatic beta cell mass J:7702
increased pancreatic beta cell number J:7702
\Lepob/\Lepob
(involves: BTBR * C57BL/6 * V stock) 		decreased pancreatic beta cell number J:65486
disorganized pancreatic islets J:65486
pancreatic islet hyperplasia J:65486
\Lepob/\Lepob
(BTBR.Cg-Lepob/WiscJ) 		abnormal pancreatic islet morphology J:106121
decreased pancreatic beta cell mass J:106121
small pancreatic islets J:106121
\Lepob/\Lepob
\Mir375tm1Stf/\Mir375tm1Stf
(B6.Cg-Mir375tm1Stf Lepob) 		decreased pancreatic beta cell mass J:147572
decreased pancreatic beta cell number J:147572
increased pancreatic alpha cell number J:147572
\Lepob/\Lepob
\Ppargtm2Avp/\Ppargtm2Avp
(involves: 129 * C57BL/6) 		abnormal pancreatic islet morphology J:121534
disorganized pancreatic islets J:121534
\Lepob/\Lepob
\Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J) 		decreased pancreatic beta cell mass J:210552
\Leptm1.2Gvcao/\Leptm1.2Gvcao
(involves: 129S4/SvJaeSor * FVB/NJ * FVB/NTac) 		decreased somatotroph cell number J:218720
\Leprdb-3J/\Leprdb-3J
(129P3/J-Leprdb-3J/J) 		increased pancreatic alpha cell number J:6337
increased pancreatic beta cell number J:6337
pancreatic islet hyperplasia J:6337
\Leprdb-5J/\Leprdb-5J
(NOD/ShiLtJ-Leprdb-5J/LtJ) 		degranulated pancreatic beta cells J:87061
pancreatic islet hyperplasia J:87061
\Leprdb-5J/\Leprdb-5J
(NOD/ShiLt-Leprdb-5J) 		abnormal pancreatic islet morphology J:118305
degranulated pancreatic beta cells J:118305
\Leprdb-9J/\Leprdb-9J
(involves: C57BL/6 * CBA * SWR) 		abnormal adrenal gland zona reticularis morphology J:129982
abnormal pancreatic beta cell morphology J:129982
absent adrenal medulla J:129982
degranulated pancreatic beta cells J:129982
enlarged adrenal glands J:129982
\Leprdb-dmpg/\Leprdb-dmpg
(involves: B10.D2-H8b/Sn * C57BL/6) 		abnormal pancreatic beta cell morphology J:83762
\Leprdb-rlpy/\Leprdb-rlpy
(involves: NU/J) 		abnormal pancreatic beta cell morphology J:83762
\Leprdb-rtnd/\Leprdb-rtnd
(involves: C57BL/6 * CBA/J) 		abnormal pancreatic beta cell morphology J:83762
\Leprdb/\Lepr+
\Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H * C57BL/6 * C57BLKS/J) 		increased pancreatic beta cell mass J:186924
\Leprdb/\Leprdb
(involves: C57BLKS/J) 		abnormal pancreatic beta cell morphology J:96047
abnormal pancreatic islet morphology J:96047
\Leprdb/\Leprdb
(FVB.BKS-Leprdb) 		increased pancreatic beta cell number J:78850
pancreatic islet hyperplasia J:78850
\Leprdb/\Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/Jcl) 		increased pancreatic beta cell mass J:156725
\Leprdb/\Leprdb
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA) 		abnormal pancreatic islet morphology J:170206
\Leprm1Clo/\Leprm1Clo
(STOCK Leprm1Clo/GrsrJ) 		pancreatic islet hyperplasia J:232775
\Leprtm1.1Chua/\Lepr+
\Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB) 		decreased somatotroph cell number J:173444
\Leprtm1.1Chua/\Leprtm1.1Chua
\Tg(Gh1-cre)bKnmn/0
(involves: 129 * C57BL/6 * FVB) 		decreased somatotroph cell number J:173444
\Lgals9tm1.1Cfg/\Lgals9tm1.1Cfg
(involves: C57BL/6) 		thymus hyperplasia J:217719
\Lgr6em1(IMPC)Ccpcz/\Lgr6em1(IMPC)Ccpcz
(C57BL/6NCrl-Lgr6em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Lhcgrtm1(KOMP)Vlcg/\Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju) 		small thymus J:211773
\Lhcgrtm1Hht/\Lhcgrtm1Hht
(involves: 129S7/SvEvBrd * C57BL/6J) 		enlarged adrenal glands J:105533
increased adrenal gland weight J:105533
\Lhx3tm1(cre)Slp/\Lhx3tm1(cre)Slp
(involves: 129S1/Sv) 		abnormal Rathke's pouch apoptosis J:119270
abnormal Rathke's pouch development J:119270
absent adenohypophysis J:119270
small pituitary intermediate lobe J:119270
\Lhx3tm1.1Sjr/\Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N) 		abnormal pituitary gland morphology J:169035
abnormal thyroid follicle morphology J:169035
adenohypophysis hypoplasia J:169035
decreased gonadotroph cell number J:169035
decreased lactotroph cell number J:169035
\Lhx3tm1Lmgd/\Lhx3tm1Lmgd
(involves: 129S4/SvJae) 		abnormal corticotroph morphology J:33050
abnormal pituitary gland development J:33050
abnormal Rathke's pouch development J:33050
absent adenohypophysis J:33050, J:51420
absent lactotrophs J:33050
absent pituitary intermediate lobe J:33050, J:51420
absent somatotrophs J:33050
absent thyrotrophs J:33050
adrenal cortical hyperplasia J:33050
decreased gonadotroph cell number J:33050
\Lhx4tm1Ssp/\Lhx4tm1Ssp
(involves: 129S2/SvPas * CF-1) 		abnormal Rathke's pouch development J:79850
decreased gonadotroph cell number J:79850
small adenohypophysis J:79850
small Rathke's pouch J:79850
\Lhx4tm1Ssp/\Lhx4tm1Ssp
\Prop1df/\Prop1df
(involves: 129S2/SvPas * C57BL/6 * CF-1 * Goodale large mice * pink-eyed stock) 		abnormal Rathke's pouch apoptosis J:79850
abnormal Rathke's pouch development J:79850
absent adenohypophysis J:79850
absent gonadotrophs J:79850
small Rathke's pouch J:79850
\Lhx5em1(IMPC)Ccpcz/\Lhx5+
(C57BL/6N-Lhx5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Lig4em1(IMPC)Ccpcz/\Lig4+
(C57BL/6NCrl-Lig4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Lig4tm1Fwa/\Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:63078
small thymus J:50865
\Lig4tm1Fwa/\Lig4tm1Fwa
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd) 		decreased thymocyte number J:63078
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		abnormal thymus morphology J:157574
decreased thymocyte number J:157574
decreased thymus weight J:157574
increased T cell derived lymphoma incidence J:157574
small thymus J:157574
\Lipatm1Hodu/\Lipatm1Hodu
(involves: 129P2/OlaHsd * CF-1) 		abnormal adrenal gland morphology J:49674
\Lipetm1Land/\Lipetm1Land
(involves: 129 * C57BL/6J) 		increased pancreatic beta cell mass J:85540
pancreatic islet hyperplasia J:85540
\Lipetm2Rze/\Lipetm2Rze
\Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA) 		abnormal pancreatic beta cell morphology J:144744
increased pancreatic beta cell mass J:144744
\ll/\ll
X/\Yaa
(BXSB/MpJScr-ll) 		increased T cell derived lymphoma incidence J:10973
\Lmnatm1.1Otin/\Lmnatm1.1Otin
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:177632
\Lmnatm1Stw/\Lmnatm1Stw
(involves: 129S1/Sv) 		thymus atrophy J:58702
\Lmod3em1(IMPC)Mbp/\Lmod3+
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd) 		abnormal adrenal gland morphology J:211773
\Lmod3em1(IMPC)Mbp/\Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd) 		enlarged thymus J:211773
\Lrfn2Tg(CD2-Myb/en)5Kmw/\Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA) 		abnormal thymus cortex morphology J:126456
abnormal thymus medulla morphology J:126456
small thymus J:126456
\Lrig3em1(IMPC)Ccpcz/\Lrig3em1(IMPC)Ccpcz
(C57BL/6NCrl-Lrig3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Lrp2b2b2671Clo/\Lrp2b2b2671Clo
(C57BL/6J-Lrp2b2b2671Clo) 		thymus hypoplasia J:175213
\Lrpap1tm1Her/\Lrpap1tm1Her
(B6.129S7-Lrpap1tm1Her) 		abnormal thyroid gland morphology J:107358
\Lrrc8atm1.1Geha/\Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha) 		abnormal thymus medulla morphology J:211308
abnormal thymus morphology J:211308
absent thymus corticomedullary boundary J:211308
decreased DN2 thymocyte number J:211308
decreased DN3 thymocyte number J:211308
decreased DN4 thymocyte number J:211308
decreased thymocyte number J:211308
small thymus J:211308
small thymus cortex J:211308
thymus hypoplasia J:211308
\Lrrc17em1(IMPC)Ccpcz/\Lrrc17em1(IMPC)Ccpcz
(C57BL/6N-Lrrc17em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ltatm1Dch/\Ltatm1Dch
(involves: 129S2/SvPas) 		abnormal thymus epithelium morphology J:173115
abnormal thymus medulla morphology J:173115
small thymus medulla J:173115
\Ltatm1Dch/\Ltatm1Dch
\Tg(Ins2-Cxcl13)1Cys/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:110548
\Ltatm1Dch/\Ltatm1Dch
\Tnfsf14tm1Lpc/\Tnfsf14tm1Lpc
(involves: 129S2/SvPas * 129X1/SvJ) 		abnormal thymus epithelium morphology J:173115
small thymus medulla J:173115
\Ltatm1Jods/\Ltatm1Jods
(involves: C57BL/6) 		abnormal thymus epithelium morphology J:125864
\Ltbrtm1Mmat/\Ltbrtm1Mmat
(involves: C57BL/6 * CBA) 		abnormal thymus epithelium morphology J:173115
abnormal thymus medulla morphology J:173115
small thymus medulla J:173115
\Ltbrtm1Mmat/\Ltbrtm1Mmat
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal thymus epithelium morphology J:173115
\Ly6etm1Zmt/\Ly6etm1Zmt
(involves: 129S1/Sv) 		abnormal adrenal cortex morphology J:73972
\LyarGt(RRG292)Byg/\LyarGt(RRG292)Byg
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:263530
\Lyntm1b(EUCOMM)Hmgu/\Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H) 		small thymus J:211773
\Lystbg-J/\Lystbg-J
\Prkdcscid/\Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz) 		abnormal thymus morphology J:34814
small thymus J:34814
thymus cyst J:34814
\Lztfl1tm1.2Zpl/\Lztfl1tm1.2Zpl
\Tg(Camk2a-cre)#Stl/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL * C57BL/6 * C57BL/6N) 		pancreatic islet hyperplasia J:287261
\Lztfl1tm1.3Zpl/\Lztfl1tm1.3Zpl
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N) 		pancreatic islet hyperplasia J:287261
\Macroh2a2em1(IMPC)Hmgu/\Macroh2a2em1(IMPC)Hmgu
(C57BL/6NCrl-Macroh2a2em1(IMPC)Hmgu/Ieg) 		abnormal thymus morphology J:211773
\Maddtm1Bpra/\Maddtm1Bpra
\Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal pancreatic beta cell morphology J:225256
abnormal pancreatic islet morphology J:225256
\Mafatm1Staka/\Mafatm1Staka
(involves: ICR) 		abnormal pancreatic islet morphology J:99126
\Maml1tm1Mkit/\Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:122286
\Man2b2tm1b(KOMP)Wtsi/\Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
\Manbatm1Khf/\Manbatm1Khf
(B6.129-Manbatm1Khf) 		abnormal thyroid follicle morphology J:105427
\Manftm1a(KOMP)Wtsi/\Manftm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * ICR) 		abnormal pancreatic beta cell differentiation J:211812
decreased pancreatic beta cell mass J:211812
decreased pancreatic beta cell number J:211812
decreased pancreatic islet number J:211812
\Map2k6tm1Ina/\Map2k6tm1Ina
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		abnormal thymus cell ratio J:100093
\Map3k3tm1Kuro/\Map3k3tm1Kuro
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6) 		decreased thymocyte number J:147103
\Map3k14aly/\Map3k14aly
(involves: C57BL/6J) 		abnormal thymus corticomedullary boundary morphology J:87993
abnormal thymus medulla morphology J:87993
small thymus J:147681
thymus cyst J:147681
\Map3k14aly/\Map3k14aly
(involves: AEJ/GnRk * C57BL/6J) 		absent thymus corticomedullary boundary J:16865, J:54529
\Map3k14tm1.2Gne/\Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne) 		abnormal thymus cell ratio J:240453
\Map3k14tm1Rds/\Map3k14tm1Rds
(involves: 129/Sv * C57BL/6) 		abnormal thymus morphology J:68125
\Mapk1tm1Gela/\Mapk1tm1Gela
\H2az2Tg(Wnt1-cre)11Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal thymus morphology J:144862
abnormal thyroid gland morphology J:144862
\Mapk1tm1Gela/\Mapk1tm1Gela
\Mapk3tm1Gela/\Mapk3+
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal thymus morphology J:144862
abnormal thyroid gland morphology J:144862
\Mapk1tm1Gela/\Mapk1tm1Gela
\Mapk3tm1Gela/\Mapk3tm1Gela
\H2az2Tg(Wnt1-cre)11Rth/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal thyroid gland morphology J:144862
athymia J:144862
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		decreased thymocyte number J:113280
small thymus J:113280
\Mapk1tm1Hed/\Mapk1tm1Hed
\Mapk3tm1Gpg/\Mapk3tm1Gpg
\Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:113280
\Mapk1tm1Hed/\Mapk1tm1Hed
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6) 		decreased thymocyte number J:113280
\Mapk8tm1Rjd/\Mapk8tm1Rjd
\Mapk9tm2.1Rjd/\Mapk9tm2.1Rjd
\Lyz2tm1(cre)Ifo/\Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd) 		small pancreatic islets J:192551
\Mapk8ip1tm1Rjd/\Mapk8ip1tm1Rjd
\Mapk8ip2tm1Rjd/\Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ) 		abnormal pancreatic beta cell morphology J:152617
\Mapkapk3em1(IMPC)Ccpcz/\Mapkapk3em1(IMPC)Ccpcz
(C57BL/6N-Mapkapk3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Marchf3tm1b(EUCOMM)Hmgu/\Marchf3tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf3tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mark2Gt(pSABetageo)38Bss/\Mark2Gt(pSABetageo)38Bss
(involves: 129S2/SvPas * MF1) 		small pituitary gland J:57958
\Marveld2tm1.1Sria/\Marveld2tm1.1Sria
(involves: 129X1/SvJ * C57BL/6J) 		abnormal thyroid follicle morphology J:201580
\Marveld3em1(IMPC)Ccpcz/\Marveld3em1(IMPC)Ccpcz
(C57BL/6NCrl-Marveld3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mb21d2em1(IMPC)Mbp/\Mb21d2em1(IMPC)Mbp
(C57BL/6N-Mb21d2em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\Mbd2tm1Bh/\Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh) 		abnormal pancreatic islet morphology J:323838
\Mbd5tm1.2Gxu/\Mbd5tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J) 		small pituitary gland J:192212
\Mc2rtm1Dchi/\Mc2rtm1Dchi
(B6.129P2-Mc2rtm1Dchi) 		abnormal adrenal gland capsule morphology J:127445
abnormal adrenal gland zona fasciculata morphology J:127445
adrenal gland hypoplasia J:127445
increased thymus weight J:127445
\Mc2rtm1Dgen/\Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J) 		adrenal cortical hyperplasia J:82809
adrenal gland hypoplasia J:82809
\Mcl1tm1Ywh/\Mcl1tm1Ywh
\Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA) 		thymus hypoplasia J:137400
\Mcl1tm2Sjk/\Mcl1tm3Sjk
\Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased thymocyte number J:86906
\MclrRF/J/\MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
\MclrSWR/J/\MclrSWR/J
(involves: RF/J * SWR/J) 		increased T cell derived lymphoma incidence J:9614
\Mcm2Gt(AB0178)Wtsi/\Mcm2+
\Mcm4chaos3/\Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:165667
\Mcm4chaos3/\Mcm4chaos3
(involves: C57BL/6J) 		increased T cell derived lymphoma incidence J:165667
\Mcm4Sdla/\Mcm4+
(involves: C57BL/6) 		decreased DN1 thymic pro-T cell number J:194117
\Mdc1Gt(OST441263)Lex/\Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		small thymus J:137341
\Mdm2tm1.1Ypz/\Mdm2tm1.1Ypz
\Tg(IghMyc)22Bri/0
(B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri) 		enlarged thymus J:164200
\Mdm2tm1Bay/\Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased thymocyte number J:81065
decreased thymus weight J:81065
thymus hypoplasia J:81065
\Mdm2tm1Glo/\Mdm2+
\Mdm4tm1Glo/\Mdm4+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		thymus atrophy J:123661
thymus hypoplasia J:123661
\Mdm2tm1Glo/\Mdm2+
\Trp53tm2Wahl/\Trp53tm2Wahl
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6) 		small thymus J:174375
\Mdm2tm1Mep/\Mdm2tm1.1Mep
(involves: 129S7/SvEvBrd * C57BL/6 * FVB) 		decreased thymus weight J:81065
\Mdm2tm2.1Snj/\Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:189297
\Megf8b2b1702.2Clo/\Megf8b2b1702.2Clo
(C57BL/6J-Megf8b2b1702.2Clo) 		thymus hypoplasia J:175213
\Meis3tm1b(EUCOMM)Hmgu/\Meis3tm1b(EUCOMM)Hmgu
(C57BL/6N-Meis3tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Men1tm1.1Ctre/\Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		pancreatic islet hyperplasia J:67128
\Men1tm1.1Ctre/\Men1+
(involves: 129S6/SvEvTac * FVB/N) 		increased adrenal gland tumor incidence J:133299
increased parathyroid adenoma incidence J:133299
increased pheochromocytoma incidence J:133299
increased pituitary adenohypophysis tumor incidence J:133299
\Men1tm1.1Ctre/\Men1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased adrenal gland tumor incidence J:120835
increased parathyroid gland tumor incidence J:120835
increased pituitary gland tumor incidence J:120835
increased thyroid tumor incidence J:120835
\Men1tm1.1Ctre/\Men1+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N) 		increased adrenal gland tumor incidence J:133299
increased parathyroid gland tumor incidence J:133299
increased pheochromocytoma incidence J:133299
increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
increased thyroid C-cell carcinoma incidence J:133299
\Men1tm1.1Gfk/\Men1+
(involves: 129T2/SvEms * C57BL/6) 		abnormal pituitary gland morphology J:116086
increased adrenal gland adenoma incidence J:116086
increased parathyroid adenoma incidence J:116086
increased pituitary adenoma incidence J:116086
increased prolactinoma incidence J:116086
pancreatic islet hyperplasia J:116086
parathyroid gland hyperplasia J:116086
thyroid gland hyperplasia J:116086
\Men1tm1.2Ctre/\Men1tm1.2Ctre
\Tg(Ins2-cre)1Dh/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		pancreatic islet hyperplasia J:85042
\Men1tm1.2Ctre/\Men1tm1.2Ctre
\Tg(Ins2-cre)1Heed/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		pancreatic islet hyperplasia J:85042
\Men1tm1.2Ctre/\Men1tm1.2Ctre
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		pancreatic islet hyperplasia J:85042
\Men1tm1.2Ctre/\Men1tm1.2Ctre
\Tg(PTH-cre)4167Slib/0
(Not Specified) 		enlarged parathyroid gland J:86642
\Men1tm1.2Zqw/\Men1tm1.2Zqw
\Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J) 		pancreatic islet hyperplasia J:85133
\Men1tm1Ctre/\Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased adrenal gland tumor incidence J:67128
increased parathyroid adenoma incidence J:67128
increased pheochromocytoma incidence J:67128
increased pituitary adenoma incidence J:67128
increased prolactinoma incidence J:67128
increased thyroid adenoma incidence J:67128
pancreatic islet hyperplasia J:67128
thyroid gland cyst J:67128
\Men1tm1Ctre/\Men1tm1Ctre
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N) 		abnormal pancreatic islet morphology J:146440
enlarged pancreatic islets J:146440
pancreatic islet hyperplasia J:146440
\Men1tm1Gfk/\Men1tm1Gfk
\Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA) 		increased prolactinoma incidence J:89898
pancreatic islet hyperplasia J:89898
\Men1tm1Mmey/\Men1+
(involves: 129S6/SvEvTac * FVB/N) 		increased pancreatic beta cell number J:102494
\Men1tm1Rvt/\Men1+
(involves: 129 * C57BL/6) 		increased adrenal cortical tumor incidence J:191261
increased parathyroid adenoma incidence J:191261
increased parathyroid gland tumor incidence J:191261
increased pituitary adenohypophysis tumor incidence J:191261
increased pituitary gland tumor incidence J:191261
increased thyroid tumor incidence J:191261
pancreatic islet hyperplasia J:191261
parathyroid gland hyperplasia J:191261
\Men1tm1Zqw/\Men1+
(involves: 129/Sv * 129P2/OlaHsd) 		enlarged adrenal glands J:85302
enlarged pituitary gland J:85302
increased adrenal cortical tumor incidence J:85302
increased adrenal gland adenoma incidence J:85302
increased adrenal gland tumor incidence J:85302
increased adrenocortical adenoma incidence J:85302
increased parathyroid adenoma incidence J:85302
increased pituitary adenohypophysis tumor incidence J:85302
increased prolactinoma incidence J:85302
increased thyroid carcinoma incidence J:85302
increased thyroid tumor incidence J:85302
thyroid gland hyperplasia J:85302
\Men1tm2.1Gfk/\Men1+
(involves: 129T2/SvEms * C57BL/6) 		abnormal pituitary gland morphology J:116086
increased parathyroid adenoma incidence J:116086
increased pituitary adenoma incidence J:116086
thyroid gland hyperplasia J:116086
\Men1tm2.1Mmey/\Men1tm2.1Mmey
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA/J * FVB/N) 		abnormal pancreatic islet morphology J:175625
pancreatic islet hyperplasia J:175625
\Mesp1tm2(cre)Ysa/\Mesp1+
\Tbx1tm1Bld/\Tbx1tm3Bld
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		athymia J:112457
thymus hypoplasia J:112457
\Mesp1tm2(cre)Ysa/\Mesp1+
\Tbx1tm1Bld/\Tbx1tm5Bld
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		athymia J:112457
\Mettm1Sst/\Mettm1Sst
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:196854
decreased pancreatic beta cell mass J:196854
\Mfngem1(IMPC)Ccpcz/\Mfngem1(IMPC)Ccpcz
(C57BL/6NCrl-Mfngem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mgmttm1Lds/\Mgmttm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		small pancreatic islets J:118148
\Mgmttm1Mse/\Mgmttm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mgmttm1Mse/\Mgmttm1Mse
\Mlh1tm1Mse/\Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mib1tm2Kong/\Mib1tm2Kong
\Foxa2tm3.1(icre)Heli/\Foxa2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal pancreatic beta cell differentiation J:184814
\Mief1em1(IMPC)Mbp/\Mief1em1(IMPC)Mbp
(C57BL/6N-Mief1em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\Minar1em1(IMPC)Tcp/\Minar1em1(IMPC)Tcp
(C57BL/6NCrl-Minar1em1(IMPC)Tcp/Tcp) 		abnormal thymus morphology J:211773
\Mir26a-1em1Xfu/\Mir26a-1em1Xfu
\Mir26a-2em1Xfu/\Mir26a-2em1Xfu
(involves: C57BL/6) 		abnormal pancreatic alpha cell morphology J:286108
decreased pancreatic islet number J:286108
enlarged pancreatic islets J:286108
pancreatic islet hyperplasia J:286108
\Mir146tm1.1Bal/\Mir146tm1.1Bal
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:173230
\Mir184tm1Ics/\Mir184tm1Ics
(Not Specified) 		increased pancreatic beta cell mass J:210552
\Mir205hgtm1.1Oers/\Mir205hgtm1.1Oers
(B6(Cg)-Mir205hgtm1.1Oers) 		small thymus J:278363
\Mir375tm1Stf/\Mir375tm1Stf
(B6.129-Mir375tm1Stf) 		abnormal pancreatic islet morphology J:147572
decreased pancreatic beta cell mass J:147572
decreased pancreatic beta cell number J:147572
disorganized pancreatic islets J:147572
increased pancreatic alpha cell number J:147572
\Mir802em3Gpt/\Mir802em3Gpt
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA) 		abnormal pancreatic beta cell differentiation J:287584
increased pancreatic beta cell number J:287584
\Mirc14tm1.1Czc/\Mirc14tm1.1Czc
\Gt(ROSA)26Sortm1(cre/ERT2)Tyj/\Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6)) 		thymus hypoplasia J:188125
\Mirc14tm1.2Czc/\Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)) 		decreased DN3 thymocyte number J:188125
decreased thymocyte number J:188125
\Mirc14tm1.2Flv/\Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL) 		decreased DN1 thymic pro-T cell number J:203157
decreased thymocyte number J:203157
\Mirc33tm1.1Cwh/\Mirc33tm1.1Cwh
(involves: 129X1/SvJ) 		thymus hypoplasia J:189763
\Mlh1tm1Mse/\Mlh1tm1Mse
(involves: 129S/SvEv) 		increased T cell derived lymphoma incidence J:47642
\Mlh1tm1Rak/\Mlh1+
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:53451
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:53451
\Mlh1tm1Rak/\Mlh1tm1Rak
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased T cell derived lymphoma incidence J:153684
\Mllt6em1(IMPC)Tcp/\Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Mmp13em1(IMPC)Ccpcz/\Mmp13em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp13em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mmp15tm1b(KOMP)Wtsi/\Mmp15tm1b(KOMP)Wtsi
(C57BL/6N-Mmp15tm1b(KOMP)Wtsi/Bay) 		abnormal thyroid gland morphology J:211773
athymia J:211773
\Mmp20em1(IMPC)Ccpcz/\Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mmuttm1Cpv/\Mmuttm1Cpv
(involves: 129S/SvEv * C57BL/6 * FVB/N) 		abnormal pancreatic beta cell morphology J:147313
\Mnx1tm1Jhk/\Mnx1tm1Jhk
(involves: 129P2/OlaHsd) 		abnormal pancreatic delta cell morphology J:57314
abnormal pancreatic islet morphology J:57314
decreased pancreatic beta cell number J:57314
small pancreatic islets J:57314
\Mnx1tm1Tmj/\Mnx1tm1Tmj
(involves: 129S1/Sv) 		abnormal pancreatic islet morphology J:57317
decreased pancreatic beta cell number J:57317
decreased pancreatic delta cell number J:57317
\Mogstm1(KOMP)Vlcg/\Mogs+
(C57BL/6N-Mogstm1(KOMP)Vlcg/Bay) 		abnormal thyroid gland morphology J:211773
absent adrenal gland J:211773
enlarged thymus J:211773
\Morc2aem1(IMPC)Wtsi/\Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		abnormal adrenal gland morphology J:239583
abnormal pineal gland morphology J:239583
abnormal pituitary gland morphology J:239583
abnormal thymus topology J:239583
abnormal thyroid gland morphology J:239583
absent pituitary gland J:239583
athymia J:239583
small adrenal glands J:239583
small thymus J:239583
small thyroid gland J:239583
\Mpgtm1Lds/\Mpgtm1Lds
(involves: 129P2/OlaHsd * C57BL/6) 		small pancreatic islets J:118148
\Mplem1(IMPC)Ccpcz/\Mplem1(IMPC)Ccpcz
(C57BL/6NCrl-Mplem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mpv17lem1Riida/\Mpv17lem1Riida
(C57BL/6N-Mpv17lem1Riida) 		enlarged pancreatic islets J:319850
\Mraptm1.2Geno/\Mraptm1.2Geno
(involves: C57BL/6) 		abnormal adrenal gland capsule morphology J:278935
abnormal adrenal gland development J:278935
small adrenal glands J:278935
\Mrgprb2em1(IMPC)Tcp/\Mrgprb2em1(IMPC)Tcp
(C57BL/6NCrl-Mrgprb2em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Msh2tm1Htr/\Msh2tm1Htr
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB)) 		increased T cell derived lymphoma incidence J:27469
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:45433
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd * FVB) 		increased T cell derived lymphoma incidence J:45433
\Msh2tm1Whl/\Msh2tm1Whl
(involves: 129P2/OlaHsd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
\Msh2tm1Whl/\Msh2tm1Whl
\Rb1tm1Brd/\Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:79016
increased pheochromocytoma incidence J:79016
increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
increased thyroid C-cell carcinoma incidence J:79016
\Msi2Gt(E035H03)Wrst/\Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst) 		decreased DN2 thymocyte number J:174870
decreased DN3 thymocyte number J:174870
small thymus J:174870
thymus hypoplasia J:174870
\Msx1tm1Bero/\Msx1tm1Bero
(B6.129P2-Msx1tm1Bero) 		abnormal subcommissural organ morphology J:84975
\Msx1tm1Rilm/\Msx1+
\Pax9tm1Rbal/\Pax9tm1Rbal
(involves: 129 * CD-1) 		ectopic thymus J:311535
thymus hypoplasia J:311535
\Mtapem1(IMPC)Mbp/\Mtap+
(C57BL/6N-Mtapem1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Mtf1Thyls-BALB/c/\Mtf1Thyls-BALB/c
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:71358
\Mtf1Thyls-BALB/c/\Mtf1Thyls-MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:85264, J:71358
\Mtortm1.2Koz/\Mtortm1.2Koz
\Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2) 		abnormal thymus cell ratio J:150108
\Mtortm1Lgm/\Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6) 		decreased thymocyte number J:168600
\MybM303V/\MybM303V
(involves: 129S1/SvlmJ * C57BL/6) 		decreased thymocyte number J:96507
\Mybtm1Cgn/\Mybtm1.1Cgn
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		thymus hypoplasia J:91122
\Mybtm1Cgn/\Mybtm1Cgn
\Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		thymus hypoplasia J:91122
\Mybtm1Cgn/\Mybtm1Cgn
\Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		thymus hypoplasia J:91122
\Mybtm1Epr/\Mybtm1Epr
\Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		thymus hypoplasia J:93481
\Mybtm1Epr/\Mybtm1Epr
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		thymus hypoplasia J:93481
\Mybtm1Jof/\Mybtm1Jof
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:85344
\Mybtm1Jof/\Mybtm1Ssp
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:85344
\Mybphltm1b(KOMP)Wtsi/\Mybphltm1b(KOMP)Wtsi
(C57BL/6N-Mybphltm1b(KOMP)Wtsi/Wtsi) 		abnormal thymus morphology J:239583
abnormal thyroid gland morphology J:239583
\Myd88tm1Aki/\Myd88tm1Aki
(involves: 129P2/OlaHsd) 		abnormal pancreatic beta cell morphology J:148283
decreased pancreatic beta cell mass J:148283
small pancreatic islets J:148283
\Myriptm1Tiz/\Myriptm1Tiz
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		abnormal pancreatic beta cell morphology J:258210
abnormal pancreatic islet morphology J:258210
\Naa10em1(IMPC)Mbp/Y
(C57BL/6NCrl-Naa10em1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Naa25em1(IMPC)Tcp/\Naa25+
(C57BL/6NCrl-Naa25em1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Naa38em1(IMPC)Ccpcz/\Naa38+
(C57BL/6N-Naa38em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nabp2tm1.1Kkha/\Nabp2tm1.1Kkha
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:195140
\Nampttm1Oleo/\Nampttm1Oleo
\Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca) 		thymus hypoplasia J:141448
\NbeaTg(GH1)240BNec/\Nbea+
(involves: C57BL/6 * SJL) 		abnormal pituitary gland development J:128767
\Nbnem7Jpt/\Nbntm2Zqw
\Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:277750
increased T cell derived lymphoma incidence J:277750
\Nbntm1Xu/\Nbntm1Xu
(Not Specified) 		increased T cell derived lymphoma incidence J:75272
thymus hypoplasia J:75272
\Nbntm1Zqw/\Nbn+
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:86563
increased thyroid adenoma incidence J:86563
\Ncaph2nes/\Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu) 		abnormal thymus cell ratio J:123300
abnormal thymus cortex morphology J:123300
abnormal thymus corticomedullary boundary morphology J:123300
decreased thymocyte number J:123300
thymus hypoplasia J:123300
\Ncaph2nes/\Ncaph2nes
\Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd) 		abnormal thymus cell ratio J:123300
\Nckap1lm1Iri/\Nckap1lm1Iri
(involves: C57BL/6) 		abnormal thymus lobule morphology J:141377
thymus hypoplasia J:141377
\Ncoa5tm1Hxia/\Ncoa5+
(involves: 129 * C57BL/6) 		decreased pancreatic islet number J:207622
small pancreatic islets J:207622
\Ncor1tm1Rsd/\Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small thymus J:65417
\Ndor1Tg(UBC-cre/ERT2)1Ejb/\Ndor1+
\Rnpc3tm1c(EUCOMM)Wtsi/\Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N) 		decreased thymus weight J:267519
thymus atrophy J:267519
thymus cortex atrophy J:267519
thymus medulla atrophy J:267519
\Ndrg2tm1Kmori/\Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
\Ndrg2tm1Kmori/\Ndrg2tm1Kmori
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:210264
\Ndst1b2b2230Clo/\Ndst1b2b2230Clo
(C57BL/6J-Ndst1b2b2230Clo) 		thymus hypoplasia J:175213
\Ndst1tm1.1Grob/\Ndst1tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		pituitary gland hypoplasia J:100425
\Nell1em1(IMPC)Mbp/\Nell1em1(IMPC)Mbp
(C57BL/6N-Nell1em1(IMPC)Mbp/MbpMmucd) 		small adrenal glands J:211773
\Neurod1tm1Mjts/\Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal pancreatic beta cell morphology J:43010
absent pancreatic islets J:43010
decreased pancreatic alpha cell number J:43010
decreased pancreatic beta cell number J:43010
decreased pancreatic delta cell number J:43010
\Neurod1tm1Mjts/\Neurod1tm1Mjts
(involves: 129X1/SvJ) 		decreased solitary pulmonary neuroendocrine cell number J:137934
\Neurog3tm1(EGFP)Khk/\Neurog3tm1(EGFP)Khk
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal pancreatic alpha cell morphology J:77398
abnormal pancreatic beta cell morphology J:77398
abnormal pancreatic delta cell morphology J:77398
\Neurog3tm1.1(cre/ERT)Ggu/\Neurog3+
\Pdx1tm1Macd/\Pdx1+
\Tg(tetO-Myt1)2Ggu/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ) 		abnormal pancreatic islet morphology J:136131
\Neurog3tm1Fgu/\Neurog3tm1Fgu
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		absent pancreatic alpha cells J:60642
absent pancreatic beta cells J:60642
absent pancreatic islets J:60642
\Neurog3tm1Fgu/\Neurog3tm3.1Ggr
\Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal pancreatic islet morphology J:161480
small pancreatic islets J:161480
\Neurog3tm1Heed/\Neurog3tm1Heed
(Not Specified) 		abnormal endocrine pancreas morphology J:147764
\Neurog3tm3.1Ggr/\Neurog3tm3.1Ggr
\Tg(Vil1-cre)20Syr/0
(involves: 129S2/SvPas * C57BL/6 * CD-1 * DBA/2 * SJL) 		abnormal pancreatic islet morphology J:161480
small pancreatic islets J:161480
\Nf1tm1Fcr/\Nf1tm1Par
\Pax3tm1(cre)Joe/\Pax3+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ) 		adrenal medulla hyperplasia J:114455
\Nf1tm1Par/\Nf1tm1Par
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal adrenal cortex morphology J:80323
abnormal adrenal gland morphology J:80323
abnormal adrenergic chromaffin cell morphology J:80323
enlarged adrenal glands J:80323
increased pheochromocytoma incidence J:80323
thin adrenal cortex J:80323
\Nf1tm1Par/\Nf1tm1Par
\Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal pituitary gland development J:138868
abnormal pituitary gland morphology J:138868
small adenohypophysis J:138868
small pituitary gland J:138868
\Nf1tm1Par/\Nf1tm1Par
\Tg(Mpz-cre)94Imeg/0
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adrenal cortex morphology J:80323
abnormal adrenal gland morphology J:80323
abnormal adrenergic chromaffin cell morphology J:80323
enlarged adrenal glands J:80323
increased pheochromocytoma incidence J:80323
thin adrenal cortex J:80323
\Nf1tm1Par/\Nf1tm1Par
\Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal adrenal cortex morphology J:80323
abnormal adrenal gland morphology J:80323
abnormal adrenergic chromaffin cell morphology J:80323
enlarged adrenal glands J:80323
increased pheochromocytoma incidence J:80323
thin adrenal cortex J:80323
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased adrenal gland tumor incidence J:18542
increased pheochromocytoma incidence J:18542
\Nf2tm2Gth/\Nf2tm2Gth
\Ptgdstm1.1(cre)Gvn/\Ptgds+
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:173718
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr) 		abnormal thyroid gland morphology J:231492
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:132943
\Nfam1em1(IMPC)Ccpcz/\Nfam1em1(IMPC)Ccpcz
(C57BL/6N-Nfam1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nfat5tm1Snh/\Nfat5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus hypoplasia J:91482
\Nfatc2tm1Srf/\Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged thymus J:110686
thymus hyperplasia J:110686
\Nfatc3tm1Glm/\Nfatc3tm1Glm
\Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6) 		small thymus J:50124
\Nfatc3tm1Grc/\Nfatc3tm1Grc
\Tg(Lck-cre)I57Jxm/0
(involves: ICR) 		decreased thymocyte number J:141917
thymus hypoplasia J:141917
\Nfe2l2em1(IMPC)Ccpcz/\Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nfil3tm1.1(KOMP)Vlcg/\Nfil3tm1.1(KOMP)Vlcg
(C57BL/6N-Nfil3tm1.1(KOMP)Vlcg/Ucd) 		abnormal thymus morphology J:211773
small thymus J:211773
\Nfkb1tm1Bal/\Nfkb1tm1Bal
\Nfkb2tm1Sbn/\Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae) 		abnormal thymus cortex morphology J:45119
abnormal thymus medulla morphology J:45119
thymus hypoplasia J:45119
\Nfkb2Lym1/\Nfkb2Lym1
(involves: BALB/c) 		abnormal thymus cell ratio J:154812
abnormal thymus size J:154812
\Nfkb2tm1Brv/\Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:43469
thymus atrophy J:43469
\Nfkbiatm1.1Pjc/\Nfkbiatm1.1Pjc
(involves: C57BL/6) 		increased thymocyte number J:163686
\Nfkbiatm1Bal/\Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		thymus atrophy J:30058
\Nfkbiatm1Fey/\Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:110817
thymus atrophy J:110817
\Nhej1tm1.1Ics/\Nhej1+
(involves: 129 * C57BL/6) 		decreased thymocyte number J:194422
\Nhej1tm1.1Ics/\Nhej1tm1.1Ics
(involves: 129 * C57BL/6) 		decreased thymocyte number J:194422
\Nhej1tm1Fwa/\Nhej1tm1Fwa
(involves: 129) 		thymus hypoplasia J:138774
\Nhej1tm1Fwa/\Nhej1tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129) 		increased T cell derived lymphoma incidence J:138774
\Nhej1tm1Fwa/\Nhej1tm1Fwa
\Xrcc5tm1Nus/\Xrcc5tm1Nus
(involves: 129S6/SvEvTac * C57BL/6) 		athymia J:236776
\Niban3em1(IMPC)Mbp/\Niban3em1(IMPC)Mbp
(C57BL/6N-Niban3em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nidd5BALB/cA/\Nidd5TSOD
(involves: BALB/cA * TSOD) 		abnormal pancreatic beta cell morphology J:55285
\Nidd5TSOD/\Nidd5TSOD
(involves: BALB/cA * TSOD) 		abnormal pancreatic beta cell morphology J:55285
\NiddsSJL/NBom/?
(involves: NZO/HlBom * SJL/NBom) 		abnormal pancreatic beta cell morphology J:78920
\Nkaptm1.1Viss/Y
\Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ) 		decreased DN4 thymocyte number J:165961
decreased thymocyte number J:165961
increased DN3 thymocyte number J:165961
thymus hypoplasia J:165961
\Nkx2-1tm1Jaw/\Nkx2-1tm1Jaw
(B6.129-Nkx2-1tm1Jaw) 		abnormal thyroid gland development J:169693
\Nkx2-1tm1Shk/\Nkx2-1tm1Shk
(B6.129S4-Nkx2-1tm1Shk) 		abnormal thyroid gland development J:169693
absent pituitary gland J:169693
absent thyroid gland J:169693
small thyroid gland J:95017
\Nkx2-1tm1Shk/\Nkx2-1tm1Shk
(involves: 129S4/SvJae) 		abnormal adenohypophysis development J:50517
abnormal adrenal cortex morphology J:30559
abnormal Rathke's pouch apoptosis J:50517
abnormal Rathke's pouch development J:50517
abnormal thyroid gland development J:110629
absent pituitary gland J:30559
absent pituitary infundibular stalk J:50517
absent thyroid gland J:30559
\Nkx2-1tm2Rdl/\Nkx2-1tm2Rdl
(B6.129-Nkx2-1tm2Rdl) 		abnormal pituitary gland development J:169693
abnormal Rathke's pouch development J:169693
abnormal thyroid gland development J:169693
absent infundibular recess of third ventricle J:169693
absent pituitary gland J:169693
absent thyroid gland J:169693
\Nkx2-1tm2Shk/\Nkx2-1tm2Shk
(involves: 129S4/SvJae * 129X1/SvJ) 		abnormal thyroid follicle morphology J:111027
\Nkx2-1tm2Shk/\Nkx2-1tm2Shk
\Tg(TPO-cre)1Shk/0
(involves: 129X1/SvJ * FVB/NCr) 		abnormal thyroid follicle morphology J:111027
small thyroid gland J:111027
\Nkx2-1tm3Rdl/\Nkx2-1tm3Rdl
(B6.129-Nkx2-1tm3Rdl) 		abnormal thyroid gland development J:169693
absent thyroid gland J:169693
\Nkx2-2tm1Jlr/\Nkx2-2tm1Jlr
(involves: 129X1/SvJ) 		abnormal pancreatic beta cell differentiation J:48576
abnormal pancreatic islet morphology J:48576
absent pancreatic beta cells J:48576
decreased pancreatic alpha cell number J:48576
decreased PP cell number J:48576
\Nkx2-2tm1Jlr/\Nkx2-2tm1Jlr
\Nkx6-1tm1Jlr/\Nkx6-1tm1Jlr
(involves: 129 * 129X1/SvJ * C57BL/6J) 		decreased pancreatic alpha cell number J:65594
decreased pancreatic beta cell number J:65594
decreased PP cell number J:65594
disorganized pancreatic islets J:65594
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * C57BL/6J * SJL) 		decreased pancreatic beta cell number J:177838
disorganized pancreatic islets J:177838
increased pancreatic alpha cell number J:177838
increased pancreatic epsilon cell number J:177838
small pancreatic islets J:177838
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
\Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA/J * SJL) 		abnormal pancreatic beta cell differentiation J:177838
\Nkx2-2tm2.1Suss/\Nkx2-2tm2.1Suss
\Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/\Gt(ROSA)26Sor+
\Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA * SJL) 		abnormal pancreatic beta cell differentiation J:177838
\Nkx2-2tm5.1Suss/\Nkx2-2tm5.1Suss
\Tg(Pdx1-cre)6Tuv/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * NTac:NIHBS * SJL) 		decreased pancreatic alpha cell number J:204869
decreased pancreatic beta cell number J:204869
increased pancreatic epsilon cell number J:204869
\Nkx2-5tm1(cre)Rjs/\Nkx2-5+
\Tbx1tm1Bld/\Tbx1tm3Bld
(involves: 129S7/SvEvBrd * C57BL/6) 		small thymus J:91013
\Nkx6-1tm1.1Msan/\Nkx6-1+
\Pdx1tm1Cvw/\Pdx1+
\Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal pancreatic islet morphology J:195153
decreased pancreatic beta cell number J:195153
increased pancreatic alpha cell number J:195153
\Nkx6-1tm1Jlr/\Nkx6-1tm1.1Msan
\Gt(ROSA)26Sortm1(EYFP)Cos/\Gt(ROSA)26Sor+
\Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57BL/6 * DBA * SJL) 		abnormal pancreatic beta cell differentiation J:195153
decreased pancreatic beta cell number J:195153
increased pancreatic delta cell number J:195153
\Nkx6-1tm1Jlr/\Nkx6-1tm1.1Msan
\Tg(CAG-Bgeo/GFP)21Lbe/0
\Tg(Neurog3-cre)C1Able/0
(involves: 129/Sv * C57BL/6 * SJL) 		abnormal pancreatic beta cell differentiation J:195153
decreased pancreatic beta cell number J:195153
increased pancreatic alpha cell number J:195153
increased pancreatic delta cell number J:195153
increased pancreatic epsilon cell number J:195153
\Nkx6-1tm1Jlr/\Nkx6-1tm1.2Msan
(involves: 129S6/SvEvTac * C57BL * DBA * SJL) 		decreased pancreatic beta cell number J:195153
\Nkx6-1tm1Jlr/\Nkx6-1tm1Jlr
(involves: 129 * C57BL/6J) 		decreased pancreatic beta cell number J:65594
small pancreatic islets J:65594
\Nle1tm1Cba/\Nle1tm1.1Cota
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S2/SvPas) 		thymus hypoplasia J:204063
\Nlktm1Tbo/\Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo) 		decreased thymocyte number J:73353
thymus hypoplasia J:73353
\nmf4/\nmf4
(C57BL/6J-nmf4/J) 		thymus cortex atrophy J:78134
\Nmf15/\Nmf15+
(C57BL/6J-Nmf15/J) 		enlarged pancreatic islets J:82238
\nmf356/\nmf356
(C57BL/6J-nmf356/J) 		pancreatic islet hyperplasia J:87349
thymus atrophy J:87349
\Nmt1tm1.1Poru/\Nmt1tm1.1Poru
\Nmt2tm1.1Poru/\Nmt2tm1.1Poru
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL) 		decreased DN4 thymocyte number J:226234
small thymus medulla J:226234
\Nnattm1.2Geno/\Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno) 		abnormal pancreatic beta cell morphology J:265677
abnormal pancreatic islet morphology J:265677
\NntC57BL/6J/\NntC57BL/6J
(C57BL/6J) 		abnormal adrenocortical cell morphology J:185986
disorganized adrenal gland zona fasciculata J:185986
\Noc2ltm1.1Arte/\Noc2ltm1.1Arte
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca) 		abnormal thymus cell ratio J:216490
abnormal thymus morphology J:216490
decreased DN3 thymocyte number J:216490
decreased DN4 thymocyte number J:216490
small thymus J:216490
thymus hypoplasia J:216490
\Nogtm1Amc/\Nogtm1Amc
(either: (involves: 129S1/Sv * CD-1) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal pituitary gland development J:121318
abnormal Rathke's pouch apoptosis J:121318
abnormal Rathke's pouch development J:121318
absent adenohypophysis J:121318
absent pituitary gland J:121318
absent pituitary infundibular stalk J:121318
absent Rathke's pouch J:121318
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:241062
\Nop53tm2.1Asuz/\Nop53tm2.1Asuz
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Lck-cre)#Jxm/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA) 		decreased thymocyte number J:241062
\Notch1tm1Agt/\Notch1tm1Agt
\Notch2tm1Frad/\Notch2tm1Frad
\Ptf1atm1(cre)Hnak/\Ptf1a+
(involves: 129 * BALB/cJ) 		abnormal endocrine pancreas morphology J:139250
decreased pancreatic islet number J:139250
\Notch1tm1Agt/\Notch1tm1Agt
\Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA) 		abnormal thymus cell ratio J:55400, J:143472
abnormal thymus morphology J:55400
decreased thymocyte number J:55400
small thymus J:55400
\Notch1tm2Pst/\Notch1tm2Pst
(B6.Cg-Notch1tm2Pst) 		decreased thymocyte number J:131563
\Notch2tm3Grid/\Notch2tm3Grid
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		small pituitary gland J:130929
\Notch3tm1Khan/\Notch3tm1Khan
(involves: C57BL/6 * CBA) 		decreased thymocyte number J:98284
small thymus J:98284
\Noxa1em1(IMPC)Ccpcz/\Noxa1em1(IMPC)Ccpcz
(C57BL/6NCrl-Noxa1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Npattm1b(EUCOMM)Wtsi/\Npattm1b(EUCOMM)Wtsi
(C57BL/6N-Npattm1b(EUCOMM)Wtsi/Wtsi) 		abnormal adrenal gland morphology J:239583
multiple persisting craniopharyngeal ducts J:239583
\Npc1m1N/\Npc1m1N
(involves: BALB/c) 		abnormal adenohypophysis morphology J:91430
adenohypophysis hypoplasia J:91430
decreased lactotroph cell number J:91430
\Npc2tm1e.1(EUCOMM)Wtsi/\Npc2+
(C57BL/6N-Npc2tm1e.1(EUCOMM)Wtsi/Tcp) 		small adrenal glands J:211773
\Nr0b1tm1.1Lja/Y
(involves: 129S1/Sv * 129X1/SvJ) 		retention of the adrenal gland x-zone J:51292
\Nr1h2tm1.1Gstr/\Nr1h2tm1.1Gstr
\Nr1h3tm1.1Gstr/\Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal neurohypophysis median eminence morphology J:81790
\Nr3c1Gt(ESKN92)Hgs/\Nr3c1+
(B6.Cg-Nr3c1Gt(ESKN92)Hgs) 		abnormal adrenal gland morphology J:141205
abnormal adrenal gland zona fasciculata morphology J:141205
abnormal adrenal gland zona glomerulosa morphology J:141205
enlarged adrenal glands J:141205
\Nr3c1tm1.1Jda/\Nr3c1tm1.1Jda
\Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm) 		thymus hypoplasia J:189951
\Nr3c1tm1Dage/\Nr3c1+
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL) 		decreased adrenal gland zona fasciculata size J:147914
small adrenal glands J:147914
thin adrenal cortex J:147914
\Nr3c1tm1Dage/\Nr3c1tm1Dage
(involves: 129P1/ReJ * C57BL/6 * C57BL/6J * SJL) 		decreased adrenal gland zona fasciculata size J:147914
small adrenal glands J:147914
thin adrenal cortex J:147914
\Nr3c1tm1Gsc/\Nr3c1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adrenal chromaffin cell morphology J:27441
abnormal adrenal cortex morphology J:27441
abnormal adrenal gland morphology J:27441
abnormal adrenal gland zona reticularis morphology J:27441
absent adrenal medulla J:27441
absent adrenergic chromaffin cells J:27441
enlarged adrenal glands J:27441
enlarged adrenocortical cell nuclei J:27441
enlarged adrenocortical cells J:27441
increased adrenal gland zona fasciculata size J:27441
\Nr3c1tm1Gsc/\Nr3c1tm1Gsc
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:54931
\Nr3c1tm2.1Gsc/\Nr3c1tm2.1Gsc
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:54931
\Nr4a1tm1Jmi/\Nr4a1tm1Jmi
\Nr4a3tm1Omc/\Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		abnormal thymus morphology J:121903
\Nr5a1em1Kemi/\Nr5a1+
(involves: C57BL/6 * DBA/2) 		small adrenal glands J:277036
\Nr5a1em1Kemi/\Nr5a1em1Kemi
(involves: C57BL/6 * DBA/2) 		absent adrenal gland J:277036
\Nr5a1tm1.1Hain/\Nr5a1+
(Not Specified) 		retention of the adrenal gland x-zone J:175843
\Nr5a1tm1.1Hain/\Nr5a1tm1.1Hain
(Not Specified) 		retention of the adrenal gland x-zone J:175843
small adrenal glands J:175843
\Nr5a1tm1Enl/\Nr5a1tm1Enl
(involves: 129S4/SvJae) 		abnormal pituitary gland morphology J:28971
absent adrenal gland J:28971
decreased gonadotroph cell number J:28971
\Nr5a1tm1Jmi/\Nr5a1tm1Jmi
(involves: 129X1/SvJ) 		absent adrenal gland J:35577
\Nr5a1tm1Klp/\Nr5a1tm1Klp
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		absent adrenal gland J:35576
\Nr5a1tm2.1Klp/\Nr5a1tm2.1Klp
(involves: 129P2/OlaHsd) 		absent adrenal gland J:66593
\Nr5a1tm3Klp/\Nr5a1tm3Klp
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		absent adrenal gland J:28763
\Nrastm1.1Emfu/\Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N) 		abnormal thymus morphology J:189834
\Nrp1tm1Hfu/\Nrp1tm2Ddg
\Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL) 		decreased gonadotropin-releasing hormone neuron number J:175836
\Nsmftm1a(KOMP)Wtsi/\Nsmftm1a(KOMP)Wtsi
(involves: C57BL/6N) 		decreased gonadotroph cell number J:222116
\Nsun2tm1a(EUCOMM)Wtsi/\Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal thymus capsule morphology J:239583
\Ntrk2tm1Mini/\Ntrk2+
(involves: 129P2/OlaHsd * C57BL/6) 		adrenal cortical hyperplasia J:210229
increased adrenal gland zona fasciculata size J:210229
\Ntrk2tm2Kln/\Ntrk2tm2Kln
\Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA) 		adrenal cortical hyperplasia J:210229
increased adrenal gland zona fasciculata size J:210229
\Nudcd3em1(IMPC)Wtsi/\Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi) 		increased DN3 thymocyte number J:351330
thymus hypoplasia J:351330
\Nuggcem1(IMPC)Ccpcz/\Nuggcem1(IMPC)Ccpcz
(C57BL/6NCrl-Nuggcem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nxntm1b(EUCOMM)Wtsi/\Nxn+
(C57BL/6N-Nxntm1b(EUCOMM)Wtsi/Ucd) 		small adrenal glands J:211773
\Nxnl2em1(IMPC)Ccpcz/\Nxnl2+
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Nxnl2em1(IMPC)Ccpcz/\Nxnl2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nxnl2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Oas1cem1(IMPC)Ccpcz/\Oas1cem1(IMPC)Ccpcz
(C57BL/6N-Oas1cem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Odad3b2b1885Clo/\Odad3b2b1885Clo
(C57BL/6J-Odad3b2b1885Clo) 		abnormal adrenal gland morphology J:175213
\Odaphem1(IMPC)Ccpcz/\Odaphem1(IMPC)Ccpcz
(C57BL/6NCrl-Odaphem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ogttm1Gwh/Y
\Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		decreased thymocyte number J:93112
\Olfm1tm1.1Lex/\Olfm1tm1.1Lex
(involves: 129S/SvEvBrd * 129S4/SvJae) 		decreased gonadotropin-releasing hormone neuron number J:226939
\Onecut1tm1.1Mga/\Onecut1tm1.1Mga
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL) 		absent pancreatic islets J:155058
decreased pancreatic alpha cell number J:155058
decreased pancreatic beta cell number J:155058
\Onecut1tm1Flem/\Onecut1tm1Flem
(involves: 129S1/Sv * 129X1/SvJ * Swiss) 		abnormal pancreatic islet morphology J:62595
absent pancreatic alpha cells J:121610
absent pancreatic beta cells J:121610
decreased pancreatic alpha cell number J:62595
decreased pancreatic beta cell number J:62595
decreased pancreatic delta cell number J:62595
disorganized pancreatic islets J:62595
\Opa1tm1.1Hise/\Opa1tm1.2Hise
\Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL) 		abnormal pancreatic beta cell morphology J:183074
decreased pancreatic beta cell number J:183074
small pancreatic islets J:183074
\Oprm1tm1Jep/\Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep) 		enlarged pancreatic islets J:147786
\Or1e32em1(IMPC)Mbp/\Or1e32em1(IMPC)Mbp
(C57BL/6NCrl-Or1e32em1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Osmrtm1Mtan/\Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan) 		increased pancreatic beta cell number J:214124
\Osr1tm1Jian/\Osr1tm1Jian
(either: (involves: 129S1/Sv * C57BL/6J) or (involves: 129S1/Sv * ICR)) 		absent adrenal gland J:104942
\Otcem1(IMPC)Tcp/\Otc+
(C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Otop1em1(IMPC)Ccpcz/\Otop1em1(IMPC)Ccpcz
(C57BL/6NCrl-Otop1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Otptm1Tlu/\Otptm1Tlu
(either: 129/Sv-Otptm1Tlu or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal neurohypophysis median eminence morphology J:65759
abnormal neurohypophysis morphology J:65759
\Otud5tm1Vmd/\Otud5tm1Vmd
\Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased thymocyte number J:219495
\Otx2tm1Pas/\Otx2+
(involves: C57BL/6 * FVB/N) 		abnormal gonadotroph morphology J:210118
decreased gonadotroph cell number J:210118
\Otx2tm1Sia/\Otx2+
(involves: C57BL/6 * CBA) 		abnormal adenohypophysis morphology J:29682
\Otx2tm2(Otx1)Sia/\Otx2tm2(Otx1)Sia
(involves: C57BL/6 * CBA) 		absent pituitary gland J:51989
\Pabir2em1(IMPC)Ccpcz/Y
(C57BL/6NCrl-Pabir2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pabir2em1(IMPC)Ccpcz/\Pabir2em1(IMPC)Ccpcz
(C57BL/6NCrl-Pabir2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pag1tm1Kplm/\Pag1tm1Kplm
(involves: 129P2/OlaHsd * C57BL/6) 		increased thymocyte number J:101365
\Pahem1(IMPC)Tcp/\Pahem1(IMPC)Tcp
(C57BL/6NCrl-Pahem1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Pargtm1Zqw/\Pargtm1Zqw
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pancreatic beta cell morphology J:92244
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J) 		thymus atrophy J:116017
\Parltm1.1Bdes/\Parltm1.1Bdes
(involves: 129P2/OlaHsd) 		thymus atrophy J:269785
\Parltm1Bdes/\Parltm1Bdes
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		thymus atrophy J:269785
\Patz1tm1.1Welm/\Patz1tm1.1Welm
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:158947
\Paupartm1.1Suss/\Paupartm1.1Suss
(involves: 129 * C57BL/6J) 		abnormal pancreatic alpha cell morphology J:282894
decreased pancreatic alpha cell mass J:282894
increased pancreatic alpha cell number J:282894
increased pancreatic beta cell mass J:282894
\Pax1un-i/\Pax1+
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		decreased thymocyte number J:100951
\Pax1un-i/\Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)) 		decreased thymocyte number J:100951
\Pax21Neu/\Pax21Neu
(involves: 102) 		increased pancreatic beta cell mass J:89465
increased pancreatic islet number J:89465
pancreatic islet hyperplasia J:89465
\Pax21Neu/\Pax2+
(involves: 102) 		increased pancreatic beta cell mass J:89465
increased pancreatic islet number J:89465
pancreatic islet hyperplasia J:89465
\Pax3Sp-1H/\Pax3Sp-1H
(involves: 101/H * C3H/HeH * C57BL/6) 		abnormal thymus morphology J:88412
abnormal thyroid gland morphology J:88412
absent thyroid gland J:88412
absent ultimobranchial body J:88412
small thyroid gland J:88412
\Pax3tm1(FOXO1A)Gcg/\Pax3+
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI)) 		abnormal thymus lobule morphology J:79365
ectopic thymus J:79365
\Pax4tm1(cre/ERT2)Sosa/\Pax4tm1(cre/ERT2)Sosa
(Not Specified) 		absent pancreatic beta cells J:130423
absent pancreatic delta cells J:130423
\Pax4tm1Pgr/\Pax4tm1.1Aman
\Tg(CMV-cre)1Cgn/0
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL) 		absent pancreatic beta cells J:192683
absent pancreatic delta cells J:192683
increased pancreatic alpha cell number J:192683
\Pax4tm1Pgr/\Pax4tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * NMRI)) 		abnormal pancreatic islet morphology J:40439
absent pancreatic delta cells J:39028
decreased pancreatic beta cell number J:39208
\Pax4tm1Pgr/\Pax4tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ) 		absent pancreatic beta cells J:130423
absent pancreatic delta cells J:130423
\Pax6Sey-Neu/\Pax6Sey-Neu
(involves: 102 * C3H * CD-1) 		absent pancreatic alpha cells J:41624
absent pancreatic beta cells J:41624
\Pax6tm1Pgr/\Pax6tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		absent pancreatic alpha cells J:40439
disorganized pancreatic islets J:40439
\Pax6tm1Pgr/\Pax6tm2Pgr
\Tg(Pax6-cre,GFP)1Pgr/0
(involves: 129S1/Sv * 129X1/SvJ * FVB * NMRI) 		decreased pancreatic alpha cell number J:90642
decreased pancreatic beta cell number J:90642
\Pax6tm2Pgr/\Pax6tm2Pgr
\Tg(Pax6-cre,GFP)1Pgr/0
(involves: FVB * NMRI) 		decreased pancreatic alpha cell number J:90642
decreased pancreatic beta cell number J:90642
\Pax6tm2Pgr/\Pax6tm2Pgr
\Tg(Pdx1-cre)6Cvw/0
(involves: FVB * NMRI) 		decreased pancreatic alpha cell number J:90642
decreased pancreatic beta cell number J:90642
\Pax8tm1(cre)Mbu/\Pax8tm1(cre)Mbu
(involves: 129P2/OlaHsd * C3H/He * C57BL/6) 		absent thyroid gland J:80208
\Pax8tm1Pgr/\Pax8tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		abnormal adenohypophysis morphology J:117324
abnormal thyroid diverticulum morphology J:47310
abnormal thyroid gland development J:47310
abnormal thyroid gland morphology J:47310
absent thyroid follicular cells J:47310
decreased lactotroph cell number J:117324
decreased somatotroph cell number J:117324
increased thyrotroph cell number J:117324
small thyroid gland J:47310
\Pax8tm1Rdl/\Pax8tm1.1(cre)Mbu
(B6.129(Cg)-Pax8tm1Rdl Pax8tm1.1(cre)Mbu) 		abnormal thyroid follicle morphology J:220108
abnormal thyroid follicular cell morphology J:220108
abnormal thyroid gland morphology J:220108
small thyroid gland J:220108
\Pax9tm1.1Hpt/\Pax9tm1.1Hpt
\Tg(Pgk1-cre)1Lni/?
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL) 		abnormal thymus lobule morphology J:125026
absent parathyroid glands J:125026
\Pax9tm1Rbal/\Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		absent parathyroid glands J:49857
absent ultimobranchial body J:49857
athymia J:49857
\Pax9tm1Rbal/\Pax9tm1Rbal
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		ectopic thymus J:311535
thymus hypoplasia J:311535
\Paxxem1Spj/\Paxxem1Spj
\Nhej1tm1Fwa/\Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac) 		athymia J:236776
\Pbx1em1Dunw/\Pbx1em1Dunw
(C57BL/6J-Pbx1em1Dunw) 		adrenal gland hypoplasia J:320934
ectopic thymus J:320934
thymus hypoplasia J:320934
\Pbx1tm1.1Febe/\Pbx1+
(involves: C57BL/6) 		decreased adrenal gland zona fasciculata size J:129552
small adrenal glands J:129552
\Pbx1tm1Mlc/\Pbx1+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal pancreatic islet morphology J:75811
\Pbx1tm1Mlc/\Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6) 		absent adrenal gland J:87270
absent pancreatic islets J:75811
ectopic thymus J:71996
\Pbx1tm1Mlc/\Pbx1tm3.1Mlc
\Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		abnormal thymus morphology J:149799
small thymus J:149799
thymus hypoplasia J:149799
\Pcgf2tm1Hko/\Pcgf2tm1Hko
(involves: BALB/c * C57BL/6) 		decreased thymocyte number J:71268
\Pclaftm1.1Lkd/\Pclaftm1.1Lkd
(involves: C57BL/6) 		thymus hypoplasia J:177782
\Pcsk1em2Irli/\Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli) 		abnormal pancreatic islet morphology J:324309
\Pcsk2tm1Dfs/\Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell differentiation J:85590
abnormal pancreatic islet morphology J:41505
decreased pancreatic beta cell number J:41505
increased pancreatic alpha cell mass J:41505
increased pancreatic delta cell number J:41505
\Pcsk2tm1Dfs/\Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J) 		abnormal pancreatic alpha cell differentiation J:236905
abnormal pancreatic alpha cell morphology J:236905
enlarged pancreatic islets J:236905
increased pancreatic alpha cell number J:236905
pancreatic islet hyperplasia J:236905
\Pcsk5vcc/\Pcsk5vcc
(involves: C57BL/6J) 		abnormal thymus lobule morphology J:136243
small thymus J:136243
\Pcsk9em1(IMPC)Ccpcz/\Pcsk9em1(IMPC)Ccpcz
(C57BL/6NCrl-Pcsk9em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pdgfraem1(IMPC)Ccpcz/\Pdgfra+
(C57BL/6NCrl-Pdgfraem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pdgfratm8Sor/\Pdgfratm8Sor
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(Not Specified) 		small thymus J:81153
\Pdgfratm8Sor/\Pdgfratm8Sor
\Pdgfrbtm1Mdt/\Pdgfrbtm1Mdt
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: C57BL/6 * CBA) 		abnormal thymus development J:122584
thymus hypoplasia J:122584
\Pdgfratm8Sor/\Pdgfratm8Sor
\Pdgfrbtm11Sor/\Pdgfrbtm11Sor
\Tg(Nr5a1-cre)2Klp/0
(either: (involves: 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6)) 		abnormal adrenal cortex morphology J:142042
abnormal adrenal gland morphology J:142042
small adrenal glands J:142042
\Pdgfrbb2b2903Clo/\Pdgfrbb2b2903Clo
(C57BL/6J-Pdgfrbb2b2903Clo) 		thymus hypoplasia J:175213
\Pdia6em1Btlr/\Pdia6m1Btlr
(involves: C57BL/6J) 		thymus hypoplasia J:288824
\Pdia6tm1b(EUCOMM)Hmgu/\Pdia6+
(C57BL/6N-Pdia6tm1b(EUCOMM)Hmgu/Ieg) 		enlarged thyroid gland J:211773
\Pdik1lem1(IMPC)Mbp/\Pdik1lem1(IMPC)Mbp
(C57BL/6NCrl-Pdik1lem1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Pdpk1tm1Dral/\Pdpk1tm1Dral
(B6.129P2-Pdpk1tm1Dral) 		decreased adrenal gland zona fasciculata size J:136089
pancreatic islet hyperplasia J:136089
pancreatic islet hypoplasia J:136089
\Pdpk1tm1Jcbr/\Pdpk1tm1Jcbr
\Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N) 		abnormal melanotroph morphology J:134336
decreased corticotroph cell number J:134336
\Pdpk1tm1Maka/\Pdpk1tm1Maka
\Tg(CAG-cat,-lacZ)11Miya/0
\Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N) 		abnormal pituitary intermediate lobe morphology J:162892
\Pdpk1tm1Maka/\Pdpk1tm1Maka
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		abnormal pancreatic beta cell morphology J:109010
small pancreatic islets J:109010
\Pdss1em1(IMPC)Mbp/\Pdss1+
(C57BL/6NCrl-Pdss1em1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Pdx1tm1.1Stof/\Pdx1+
(involves: 129/Sv * C57BL/6) 		decreased pancreatic beta cell mass J:152582
\Pdx1tm1.1Stof/\Pdx1tm1.1Stof
(involves: 129/Sv * C57BL/6) 		abnormal pancreatic delta cell morphology J:152582
abnormal pancreatic epsilon cell morphology J:152582
abnormal PP cell morphology J:152582
decreased pancreatic alpha cell mass J:152582
decreased pancreatic beta cell mass J:152582
pancreatic islet hypoplasia J:152582
\Pdx1tm1Cvw/\Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic islet size J:165268
decreased pancreatic beta cell number J:165268
disorganized pancreatic islets J:165268
small pancreatic islets J:165268
\Pdx1tm1Cvw/\Pdx1+
\Pbx1tm1Mlc/\Pbx1+
(involves: 129S6/SvEvTac * C57BL/6) 		disorganized pancreatic islets J:75811
\Pdx1tm1Cvw/\Pdx1+
\SpopGt(BGB118)Byg/\Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pancreatic beta cell morphology J:165268
disorganized pancreatic islets J:165268
\Pdx1tm1Cvw/\Pdx1tm1Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal pancreatic beta cell differentiation J:32017
abnormal pancreatic islet morphology J:32017
\Pdx1tm1Cvw/\Pdx1tm4Cvw
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA) 		decreased pancreatic beta cell number J:130389
disorganized pancreatic islets J:130389
increased pancreatic alpha cell number J:130389
increased pancreatic delta cell number J:130389
\Pdx1tm1Heed/\Pdx1tm1Heed
\Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:48516
decreased pancreatic beta cell number J:48516
disorganized pancreatic islets J:48516
increased pancreatic alpha cell number J:48516
\Pdx1tm1Macd/\Pdx1+
\Tg(tetO-Sox17,-EGFP)1Jaw/0
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal endocrine pancreas morphology J:151981
\Pdx1tm1Macd/\Pdx1tm1Macd
\Tg(tetO-Ipf1,-EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		abnormal pancreatic beta cell morphology J:101742
small pancreatic islets J:101742
\Pdx1tm1Ted/\Pdx1+
(involves: 129P2/OlaHsd) 		abnormal pancreatic islet morphology J:82969
decreased pancreatic beta cell mass J:82969
decreased pancreatic islet number J:82969
small pancreatic islets J:82969
\Pdx1tm2Cvw/\Pdx1+
\Slc2a4tm1Mch/\Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL) 		pancreatic islet hyperplasia J:97234
\Pdx1tm2Cvw/\Pdx1tm2Cvw
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss) 		abnormal pancreatic beta cell differentiation J:32017
abnormal pancreatic islet morphology J:32017
\Pdx1tm3Cvw/\Pdx1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N) 		disorganized pancreatic islets J:104617
increased pancreatic alpha cell number J:104617
increased PP cell number J:104617
\Pex2tm1Plf/\Pex2tm1Plf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adrenal cortex morphology J:44975
\Pex7tm1Nbra/\Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6) 		abnormal adrenal gland morphology J:158845
\Pex13tm1.1Crne/\Pex13tm1.1Crne
(involves: 129T2/SvEms * C57BL/6J) 		abnormal adrenocortical cell morphology J:84795
\Pfdn1Gt(GTR1.3)1Rul/\Pfdn1Gt(GTR1.3)1Rul
(involves: 129) 		abnormal thymus cell ratio J:137415
abnormal thymus morphology J:137415
decreased thymus weight J:137415
thymus hypoplasia J:137415
\Pgap1oto/\Pgap1oto
(involves: STOCK In(1)1Rk/J) 		absent Rathke's pouch J:41878
\Pgbd1em1(IMPC)Tcp/\Pgbd1em1(IMPC)Tcp
(C57BL/6NCrl-Pgbd1em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Pgcem1(IMPC)Ccpcz/\Pgcem1(IMPC)Ccpcz
(C57BL/6NCrl-Pgcem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pglyrp4em1(IMPC)Ccpcz/\Pglyrp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Pglyrp4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
small thymus J:211773
\Pgrtm1Bwo/\Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J) 		increased pancreatic beta cell number J:125584
pancreatic islet hyperplasia J:125584
\Phc1tm1Os/\Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6) 		decreased thymus weight J:43764
parathyroid hypoplasia J:43764
\Phf6em1Wencc/Y
\Tg(Vav1-cre)#Cgp/0
(Not Specified) 		abnormal thymus cell ratio J:278804
\Phf6em1Wencc/\Phf6em1Wencc
\Tg(Vav1-cre)#Cgp/0
(Not Specified) 		abnormal thymus cell ratio J:278804
\Phf6tm1.1Avo/Y
\Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL) 		decreased DN2 thymocyte number J:276228
\Phf6tm1.2Avo/Y
(involves: BALB/c * BALB/cJ * C57BL/6 * FVB/N) 		small pituitary gland J:299742
\Phf20Gt(XN131)Byg/\Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:228714
small thymus J:228714
thymus hypoplasia J:228714
\Pigvb2b2859Clo/\Pigvb2b2859Clo
(C57BL/6J-Pigvb2b2859Clo) 		thymus hypoplasia J:175213
\Pik3catm1Bvan/\Pik3ca+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pancreatic beta cell number J:109024
\Pik3cbtm1.1Ehi/\Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi) 		pancreatic islet hyperplasia J:152332
\Pik3cdtm1Tnr/\Pik3cdtm1Tnr
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) 		abnormal thymus lobule morphology J:125791
small thymus J:125791
thymus hypoplasia J:125791
\Pik3cgtm1Pngr/\Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:60347
thymus hypoplasia J:60347
\Pik3r1tm1.1Geno/\Pik3r1+
(involves: C57BL/6 * C57BL/6J) 		pancreatic islet hyperplasia J:234657
\PikfyveGt(AT0926)Wtsi/\PikfyveGt(AT0926)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus morphology J:190368
thymus hypoplasia J:190368
\Piptm1Myal/\Piptm1Myal
(involves: 129S/SvEv * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:202016
enlarged thymus J:202016
enlarged thymus medulla J:202016
\PitpnaGt(OST1152)Lex/\PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd) 		abnormal pancreatic islet morphology J:85204
decreased pancreatic islet number J:85204
\Pitpnatm1Vab/\Pitpnatm1Vab
(involves: 129S7/SvEvBrd) 		abnormal pancreatic islet morphology J:85204
decreased pancreatic islet number J:85204
\Pitx1tm1Jdr/\Pitx1+
\Pitx2tm1Sac/\Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
\Pitx1tm1Jdr/\Pitx1tm1Jdr
\Pitx2tm1Sac/\Pitx2+
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
\Pitx1tm1Jdr/\Pitx1tm1Jdr
\Pitx2tm1Sac/\Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal Rathke's pouch development J:73774
\Pitx1tm1Rsd/\Pitx1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pituitary gland morphology J:53310
decreased gonadotroph cell number J:53310
decreased thyrotroph cell number J:53310
\Pitx2tm1.1Dmm/\Pitx2tm2Sac
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J) 		pituitary gland hypoplasia J:181058
\Pitx2tm1.1Sac/\Pitx2tm2Sac
\Tg(Tshb-cre)4Sac/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		small thyroid gland J:197591
\Pitx2tm1Rsd/\Pitx2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pituitary gland development J:57673
pituitary gland hypoplasia J:57673
\Pitx2tm1Sac/\Pitx2tm1Sac
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis morphology J:73774
absent gonadotrophs J:73774
decreased somatotroph cell number J:73774
decreased thyrotroph cell number J:73774
\Pitx2tm1Sac/\Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ) 		small Rathke's pouch J:73774
\Pitx2tm2Sac/\Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal adenohypophysis development J:51160
abnormal Rathke's pouch apoptosis J:99227
abnormal Rathke's pouch development J:99227, J:51160
\Pitx2tm2Sac/\Pitx2tm2Sac
(involves: 129S1/Sv * 129X1/SvJ) 		adenohypophysis hypoplasia J:73774
\Pkd1tm1Jzh/\Pkd1+
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		decreased pancreatic islet number J:72627
\Pkd1tm1Jzh/\Pkd1tm1Jzh
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c)) 		decreased pancreatic islet number J:43193
\Pkn3tm1.1Mrl/\Pkn3+
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J) 		enlarged thymus J:216983
\Pkn3tm1.1Mrl/\Pkn3tm1.1Mrl
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J) 		enlarged thymus J:216983
\Pknox1Gt(OST71835)Lex/\Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		thymus hypoplasia J:103769
\Pla2g5em1(IMPC)Ccpcz/\Pla2g5em1(IMPC)Ccpcz
(C57BL/6NCrl-Pla2g5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Plcg1tm1Gcrp/\Plcg1tm1Rwen
\Tg(Cd4-cre)1Cwi/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		thymus hyperplasia J:157757
\Plppr5em1(IMPC)Ccpcz/\Plppr5em1(IMPC)Ccpcz
(C57BL/6NCrl-Plppr5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\plt/\plt
(B6.DDD-plt) 		abnormal thymus cortex morphology J:93960
small thymus medulla J:93960
\Plxnd1b2b1863Clo/\Plxnd1b2b1863Clo
(C57BL/6J-Plxnd1b2b1863Clo) 		thymus hypoplasia J:175213
\Plxnd1b2b3150Clo/\Plxnd1b2b3150Clo
(C57BL/6J-Plxnd1b2b3150Clo) 		thymus hypoplasia J:175213
\Pmltm1.1Ews/\Pmltm1.1Ews
(involves: 129 * 129P2/OlaHsd) 		increased T cell derived lymphoma incidence J:262172
\Pmltm1Ppp/\Pml+
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased T cell derived lymphoma incidence J:317504
\Pmltm1Ppp/\Pmltm1Ppp
\Trp53tm3.1Glo/\Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo) 		increased T cell derived lymphoma incidence J:317504
\Pms2tm1.1Wed/\Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr) 		increased T cell derived lymphoma incidence J:162378
\Pnpe/\Pnpe
(C57BL/6J-Pnpe) 		thymus hypoplasia J:39328
\Pnpf/\Pnpf
(C57BL/6J-Pnpf) 		thymus hypoplasia J:39328
\Pnpg/\Pnpg
(involves: C57BL/6 * DBA/2J) 		thymus hypoplasia J:39328
\Poats1C57BL/6JCrl/\Poats1C57BL/6JCrl
(involves: C57BL/6JCrl * DBA/2JCrl) 		increased adrenal gland tumor incidence J:131752
\Pofut1tm2Pst/\Pofut1tm1Pst
\Shhtm2(cre/ERT2)Cjt/\Shh+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL) 		increased solitary pulmonary neuroendocrine cell number J:150051
\Polbtm1a(KOMP)Wtsi/\Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi) 		adrenal gland hypoplasia J:239583
small thyroid gland J:239583
\Pold1tm1.1Bdp/\Pold1tm1.1Bdp
(B6.129-Pold1tm1.1Bdp) 		increased T cell derived lymphoma incidence J:153684
\Pold1tm1.1Bdp/\Pold1tm1.1Bdp
\Poletm1.1Bdp/\Poletm1.1Bdp
(B6.129-Poletm1.1Bdp Pold1tm1.1Bdp) 		increased T cell derived lymphoma incidence J:153684
\Pold1tm1.1Uchi/\Pold1tm1.1Uchi
(C57BL/6-Pold1tm1.1Uchi) 		enlarged thymus J:144992
\Pold1tm1Bdp/\Pold1tm1Bdp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:100685
\Pold1tm1Uchi/\Pold1tm1.1Uchi
(C57BL/6-Pold1tm1Uchi/Pold1tm1.1Uchi) 		enlarged thymus J:144992
\Pole3em1Tbo/\Pole3em1Tbo
(FVB-Pole3em1Tbo) 		decreased thymocyte number J:298827
\Pole3em2Tbo/\Pole3em2Tbo
(FVB-Pole3em2Tbo) 		decreased thymocyte number J:298827
\Pole3em3Tbo/\Pole3em3Tbo
(FVB-Pole3em3Tbo) 		decreased DN4 thymocyte number J:298827
decreased thymocyte number J:298827
increased DN3 thymocyte number J:298827
small thymus J:298827
\Pole3em4Tbo/\Pole3em4Tbo
(FVB-Pole3em4Tbo) 		decreased DN4 thymocyte number J:298827
decreased thymocyte number J:298827
increased DN3 thymocyte number J:298827
\Pole3tm1(KOMP)Vlcg/\Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB) 		decreased DN4 thymocyte number J:298827
increased DN3 thymocyte number J:298827
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N) 		abnormal thymus morphology J:261973
absent thymus cortex J:261973
athymia J:261973
increased T cell derived lymphoma incidence J:261973
\Pole4tm1(KOMP)Vlcg/\Pole4tm1(KOMP)Vlcg
\Trp53tm1Brd/\Trp53+
(involves: C57BL/6J * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:261973
\Polgtm1Prol/\Polgtm1Prol
(B6J.129S7-Polgtm1Prol) 		decreased thymocyte number J:154187
\Polr1bem1(IMPC)Tcp/\Polr1b+
(C57BL/6NCrl-Polr1bem1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Pomctm1Low/\Pomc+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:119240
\Pomctm1Low/\Pomc+
\Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased pituitary adenoma incidence J:119240
\Pomctm1Low/\Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		decreased adrenal gland zona fasciculata size J:119240
disorganized adrenal gland zona fasciculata J:119240
increased pituitary adenoma incidence J:119240
small adrenal glands J:119240
\Pomctm1Low/\Pomctm1Low
\Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		enlarged adrenal glands J:119240
increased adrenal gland zona fasciculata size J:119240
increased pituitary adenoma incidence J:119240
\Pomctm2Ute/\Pomctm2Ute
(involves: 129S1/Sv * 129X1/SvJ) 		absent adrenal gland J:57503
\Pou1f1dw/\Pou1f1dw
(Not Specified) 		absent lactotrophs J:6754
absent somatotrophs J:7211
decreased thyrotroph cell number J:12161
\Pou1f1dw/\Pou1f1dw
(DW/J Pou1f1dw) 		abnormal adenohypophysis morphology J:108961
absent lactotrophs J:7211
absent somatotrophs J:7211
adenohypophysis hypoplasia J:108961
\Pou2f1tm1Shrp/\Pou2f1tm1Shrp
\Sox2tm1.1Vep/\Sox2+
(involves: 129S4/SvJae * C3H/HeN * C57BL/6) 		abnormal adenohypophysis morphology J:119175
abnormal pituitary diverticulum morphology J:119175
\Pou3f2tm1Rsd/\Pou3f2tm1Rsd
(involves: 129S4/SvJae * C57BL/6) 		abnormal neurohypophysis morphology J:30430
abnormal pituicyte morphology J:30430
abnormal pituitary gland morphology J:30430
\Pou3f2tm1Tno/\Pou3f2tm1Tno
(involves: 129S4/SvJae * C57BL/6J) 		abnormal neurohypophysis morphology J:30429
\Ppargtm1.1Gonz/\Ppargtm1.1Gonz
\Tg(Ins2-cre)25Mgn/0
(involves: 129 * C57 * FVB) 		pancreatic islet hyperplasia J:89959
\Ppargtm1Mae/\Pparg+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal endocrine pancreas morphology J:91362
\Ppargtm2(tTA)Yba/\Pparg+
(involves: 129S1/SvImJ * C57BL/6) 		pancreatic islet hyperplasia J:125992
\Ppargtm2Avp/\Ppargtm2Avp
(involves: 129/Sv * C57BL/6) 		abnormal pancreatic islet morphology J:121534
\Ppargc1atm1Aztc/\Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc) 		increased adrenal gland weight J:82809
increased thymus weight J:82809
\Ppargc1atm1Brsp/\Ppargc1atm2Brsp
\Tg(Myog-cre)1Eno/0
(involves: 129 * C57BL/6 * FVB/N) 		abnormal pancreatic beta cell morphology J:127403
enlarged pancreatic islets J:127403
increased pancreatic beta cell mass J:127403
\Ppm1dtm1Lad/\Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6) 		small thymus J:74284
\Ppp2r2aigt10/\Ppp2r2a+
(involves: C3H/HeH * C57BL/6J) 		increased pancreatic beta cell mass J:246319
\Ppp3cbtm1Jmk/\Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymus weight J:75775
thymus hypoplasia J:77729
\Ppp3r1tm2Grc/\Ppp3r1tm2Grc
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2) 		decreased thymocyte number J:89771
thymus hypoplasia J:89771
\Ppp4r3btm1b(EUCOMM)Hmgu/\Ppp4r3btm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp4r3btm1b(EUCOMM)Hmgu/Ieg) 		abnormal thymus morphology J:211773
\Prdm2tm1Shg/\Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
\Prdm2tm1Shg/\Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
\Prdm8em1(IMPC)Wtsi/\Prdm8+
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prdm8em1(IMPC)Wtsi/\Prdm8em1(IMPC)Wtsi
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prdx1tm1Rave/\Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6) 		increased T cell derived lymphoma incidence J:84677
\Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.B6-Prf1tm1Sdz) 		decreased pancreatic beta cell number J:43468
\Prf1tm1Sdz/\Prf1tm1Sdz
(C.B6-Prf1tm1Sdz) 		increased T cell derived lymphoma incidence J:77491
\Prkar1atm1.1Lsk/\Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ) 		increased thyroid tumor incidence J:98799
\Prkar1atm1.1Lsk/\Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased thyroid tumor incidence J:160299
\Prkar1atm1.2Lsk/\Prkar1atm1.2Lsk
\Ptentm1.1Mwst/\Ptentm1.1Mwst
\Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		enlarged thyroid gland J:225245
increased thyroid carcinoma incidence J:225245
\Prkar1atm1.2Lsk/\Prkar1atm1.2Lsk
\Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased pituitary gland tumor incidence J:130264
\Prkar1atm1.2Lsk/\Prkar1atm1.2Lsk
\Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr) 		abnormal thyroid gland morphology J:241066
enlarged thyroid gland J:241066
increased thyroid carcinoma incidence J:225245, J:241066
\Prkar1atm1Lsk/\Prkar1atm1Lsk
\Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal adrenal cortex morphology J:161521
abnormal adrenal gland zona glomerulosa morphology J:161521
adrenal cortical hyperplasia J:161521
decreased adrenal gland zona fasciculata size J:161521
disorganized adrenal gland zona fasciculata J:161521
retention of the adrenal gland x-zone J:161521
\Prkcdtm1Kin/\Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal pancreatic beta cell morphology J:120293
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL) 		decreased DN1 thymic pro-T cell number J:186080
decreased DN4 thymocyte number J:186080
thymus hypoplasia J:186080
\Prkchtm1.2Gasc/\Prkchtm1.2Gasc
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL) 		decreased DN1 thymic pro-T cell number J:186080
decreased DN4 thymocyte number J:186080
\Prkcitm1Rfar/\Prkci+
\Tg(Ckmm-cre)5Khn/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		pancreatic islet hyperplasia J:123964
\Prkcitm1Rfar/\Prkcitm1Rfar
\Tg(Ckmm-cre)5Khn/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB) 		pancreatic islet hyperplasia J:123964
\Prkcqtm1Litt/\Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6) 		decreased DN1 thymic pro-T cell number J:186080
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(BCL2)25Wehi/0
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6 * C57BL/6JWehi * SJL/JWehi) 		decreased thymocyte number J:236298
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6) 		decreased thymocyte number J:236298
small thymus medulla J:236298
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J) 		decreased thymocyte number J:236298
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraTcrb)425Cbn/0
(involves: 129 * BALB/c * C57BL/6) 		decreased thymocyte number J:236298
\Prkd2tm1.1Shoy/\Prkd2tm1.1Shoy
\Prkd3tm1.1Shoy/\Prkd3tm1.1Shoy
\Tg(Lck-cre)1Jtak/0
\Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6) 		decreased thymocyte number J:236298
\Prkdcscid/\Prkdcscid
(C.BKa-Prkdcscid) 		abnormal thymus morphology J:6958
absent thymus cortex J:6958
increased T cell derived lymphoma incidence J:6958
small thymus J:6958
thymus cyst J:6958
\Prkdcscid/\Prkdcscid
(NOD.Cg-Prkdcscid) 		abnormal thymus corticomedullary boundary morphology J:22026
abnormal thymus lobule morphology J:22026
increased T cell derived lymphoma incidence J:109833, J:22026
thymus cyst J:22026
\Prkdcscid/\Prkdcscid
(B6.Cg-Prkdcscid/Sz) 		abnormal thymus morphology J:34814
small thymus J:34814
thymus cyst J:34814
\Prkdcscid/\Prkdcscid
\Tg(INS-HBEGF*L148S*P149T)70Rin/0
(C.BKa-Prkdcscid Tg(INS-HBEGF*L148S*P149T)70Rin) 		abnormal pancreatic islet morphology J:204420
decreased pancreatic beta cell number J:204420
\PrkdcTg(INS-PDE2)5-1Lmb/?
(involves: FVB/N) 		abnormal thymus morphology J:108405
\Prkdctm1Fwa/\Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:50221
\Prkdctm1Gcl/\Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6) 		absent thymus corticomedullary boundary J:53765
increased T cell derived lymphoma incidence J:53765
small thymus J:53765
thymus hypoplasia J:53765
\Prkdctm1Get/\Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss) 		abnormal thymus corticomedullary boundary morphology J:50222
thymus hypoplasia J:50222
\Prltm1Hmn/\Prltm1Hmn
(involves: 129S2/SvPas) 		abnormal gonadotroph morphology J:79661
abnormal pituitary gland morphology J:79661
decreased lactotroph cell number J:45243
enlarged pituitary gland J:79661, J:83246
increased pituitary adenoma incidence J:79661
increased pituitary gland weight J:83246
pituitary gland hyperplasia J:79661
pituitary gland hypertrophy J:79661
\Prlrtm1Cnp/\Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		abnormal pancreatic islet morphology J:106829
decreased pancreatic beta cell mass J:106829
small pancreatic islets J:106829
\Prlrtm1Cnp/\Prlrtm1Cnp
(involves: 129/Sv * 129P2/OlaHsd) 		abnormal thyroid gland morphology J:101609
increased thyroid carcinoma incidence J:101609
\Prmt7tm1a(EUCOMM)Wtsi/\Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal thymus topology J:239583
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Lck-Prnp)33Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6) 		thymus hypoplasia J:129512
\Prnptm1Cwe/\Prnptm1Cwe
\Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6) 		decreased DN2 thymocyte number J:129512
decreased DN4 thymocyte number J:129512
decreased thymocyte number J:129512
increased DN3 thymocyte number J:129512
thymus atrophy J:129512
\Prop1df/\Prop1df
(STOCK Prop1df) 		absent somatotrophs J:7211
decreased thyrotroph cell number J:12169
small adenohypophysis J:12169
small thyroid gland J:12169
\Prop1df/\Prop1df
(DF) 		abnormal pituitary gland development J:108961
abnormal pituitary gland morphology J:108961
pituitary gland hypoplasia J:108961
\Prop1tm1Rsd/\Prop1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adenohypophysis development J:114817
\Prop1tm1Sac/\Prop1+
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		abnormal pituitary gland morphology J:94409
\Prop1tm1Sac/\Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J) 		abnormal neurohypophysis morphology J:94409
adenohypophysis hypoplasia J:94409
pituitary gland hypoplasia J:94409
small thyroid gland J:94409
\Proser2em1(IMPC)Ccpcz/\Proser2em1(IMPC)Ccpcz
(C57BL/6NCrl-Proser2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prox1tm1Gco/\Prox1tm1Gco
(involves: 129S1/Sv * 129X1/SvJ * NMRI) 		abnormal endocrine pancreas morphology J:103538
\Prrc2btm1a(EUCOMM)Wtsi/\Prrc2btm1a(EUCOMM)Wtsi
(C57BL/6N-Prrc2btm1a(EUCOMM)Wtsi/Wtsi) 		abnormal thyroid gland morphology J:239583
\Prss3btm1.1Satom/\Prss3b+
(B6(FVB)-Prss3btm1.1Satom) 		enlarged pancreatic islets J:267764
\Prss8tm1.1Hum/\Prss8tm1.2Hum
\Tg(KRT14-cre)1Ipc/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		thymus medulla hypoplasia J:100139
\Prss12em1(IMPC)Ccpcz/\Prss12em1(IMPC)Ccpcz
(C57BL/6N-Prss12em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss16tm1.1Mal/\Prss16tm1.1Mal
(involves: 129S2/SvPas * C57BL/6) 		abnormal thymus cortex morphology J:148034
\Prss16tm1.1Mal/\Prss16tm1.1Mal
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		thymus hypoplasia J:148034
\Prss21em1(IMPC)Ccpcz/\Prss21+
(C57BL/6N-Prss21em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss33em1(IMPC)Ccpcz/\Prss33em1(IMPC)Ccpcz
(C57BL/6N-Prss33em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss35em1(IMPC)Ccpcz/\Prss35em1(IMPC)Ccpcz
(C57BL/6N-Prss35em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss47em1(IMPC)Ccpcz/\Prss47em1(IMPC)Ccpcz
(C57BL/6N-Prss47em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss48em1(IMPC)Ccpcz/\Prss48em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss48em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss54em1(IMPC)Ccpcz/\Prss54em1(IMPC)Ccpcz
(C57BL/6N-Prss54em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss55em1(IMPC)Ccpcz/\Prss55em1(IMPC)Ccpcz
(C57BL/6NCrl-Prss55em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Prss57em1(IMPC)Ccpcz/\Prss57em1(IMPC)Ccpcz
(C57BL/6N-Prss57em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Psen2em1(IMPC)Ccpcz/\Psen2em1(IMPC)Ccpcz
(C57BL/6NCrl-Psen2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Psma8em1(IMPC)Tcp/\Psma8em1(IMPC)Tcp
(C57BL/6N-Psma8em1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Psmb10Tub6/\Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6) 		athymia J:261081
\Psmb11em1(IMPC)Ccpcz/\Psmb11em1(IMPC)Ccpcz
(C57BL/6NCrl-Psmb11em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Psme4b2b1508Clo/\Psme4b2b1508Clo
(C57BL/6J-Psme4b2b1508Clo) 		thymus hypoplasia J:175213
\Psphtm1.1(KOMP)Vlcg/\Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Psphtm1a(EUCOMM)Hmgu/\Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
abnormal thymus morphology J:239583
abnormal thymus topology J:239583
abnormal thyroid gland morphology J:239583
absent neurohypophysis J:239583
absent pineal gland J:239583
athymia J:239583
\Pstpip1em1(IMPC)Ccpcz/\Pstpip1em1(IMPC)Ccpcz
(C57BL/6N-Pstpip1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\pta/\pta
(C57BL/6J-pta) 		thymus hypoplasia J:94456
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(KRT14-cre)8Brn/0
(involves: 129T2/SvEms * FVB/N) 		thymus hypoplasia J:231264
\Ptch1tm1Hahn/\Ptch1tm1Hahn
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus lobule morphology J:127207
thymus hypoplasia J:127207
\Ptcratm1(icre)Hjf/\Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf) 		decreased DN4 thymocyte number J:197923
decreased thymocyte number J:197923
\Ptcratm1.1Shoy/\Ptcratm1.1Shoy
(involves: C57BL/6) 		decreased thymocyte number J:166147
increased DN3 thymocyte number J:166147
\Ptcratm1Vbo/\Ptcratm1Vbo
(involves: 129P2/OlaHsd) 		decreased DN4 thymocyte number J:123569
increased DN3 thymocyte number J:123569
thymus hypoplasia J:123569
\Ptentm1.1Gle/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased adrenal gland tumor incidence J:158751
increased T cell derived lymphoma incidence J:158751
increased thyroid tumor incidence J:158751
\Ptentm1.1Hwu/\Pten+
(involves: 129S4/SvJae * C57BL/6NTac) 		increased thyroid adenoma incidence J:170965
\Ptentm1.1Mro/\Pten+
(Not Specified) 		increased pheochromocytoma incidence J:236514
\Ptentm1.1Mro/\Pten+
\Sdhbtm1.2Ics/\Sdhb+
(involves: 129S2/SvPas * BALB/c * C57BL/6) 		increased pheochromocytoma incidence J:236514
\Ptentm1.1Mwst/\Ptentm1.1Mwst
\Tg(TPO-cre)1Shk/0
(involves: 129 * FVB/NCr) 		abnormal thyroid follicular cell morphology J:225245
\Ptentm1.2Mwst/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		increased adrenal gland tumor incidence J:158751
increased T cell derived lymphoma incidence J:158751
increased thyroid tumor incidence J:158751
\Ptentm1Hwu/\Pten+
\Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		abnormal thyroid follicle morphology J:197590
enlarged thyroid gland J:197590
thyroid gland hyperplasia J:197590
\Ptentm1Hwu/\Pten+
\Tg(Nkx2-1-cre)2Sand/0
(B6.Cg-Ptentm1Hwu Tg(Nkx2-1-cre)2Sand) 		abnormal thyroid gland morphology J:197590
increased thyroid tumor incidence J:197590
\Ptentm1Hwu/\Ptentm1Hwu
\Rictortm1.1Mgn/\Rictortm1.1Mgn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		abnormal pancreatic beta cell morphology J:170129
decreased pancreatic beta cell mass J:170129
\Ptentm1Hwu/\Ptentm1Hwu
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA) 		enlarged thymus J:169097
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0
\Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr * FVB/NJ) 		abnormal thyroid gland morphology J:177181
enlarged thyroid gland J:177181
increased thyroid carcinoma incidence J:177181
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca) 		enlarged thymus J:216983
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N) 		enlarged thymus J:135172
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA) 		abnormal pancreatic beta cell morphology J:170206
enlarged pancreatic islets J:106937
increased pancreatic beta cell mass J:170206
increased pancreatic beta cell number J:106937
increased pancreatic islet number J:106937
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA) 		abnormal pancreatic beta cell morphology J:170129
increased pancreatic beta cell mass J:170129
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(KRT14-cre)#Smr/0
(involves: 129S4/SvJae * C57BL/6J * SJL/J) 		enlarged thyroid gland J:138927
increased thyroid tumor incidence J:138927
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		enlarged thymus J:169097
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Mx1-cre)1Cgn/0
(BKS.Cg-Ptprcb Thy1a Tg(Mx1-cre)1Cgn Ptentm1Hwu) 		enlarged thymus J:109085
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Nkx2-1-cre)2Sand/0
(involves: 129S4/SvJae * BALB/c * C57BL/6) 		abnormal thyroid gland morphology J:197590
enlarged thyroid gland J:197590
thyroid gland hyperplasia J:197590
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Nkx2-1-cre)2Sand/0
(B6.Cg-Ptentm1Hwu Tg(Nkx2-1-cre)2Sand) 		abnormal thyroid follicle morphology J:197590
abnormal thyroid gland morphology J:197590
enlarged thyroid gland J:197590
increased thyroid adenoma incidence J:197590
thyroid gland hyperplasia J:197590
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		enlarged pancreatic islets J:102226
pancreatic islet hyperplasia J:102226
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(Pdx1-cre/Esr1*)35.10Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		pancreatic islet hyperplasia J:102226
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(SFTPC-rtTA)5Jaw/0
\Tg(tetO-cre)1Jaw/0
(involves: 129 * 129S4/SvJae * C57BL/6 * FVB/N) 		increased solitary pulmonary neuroendocrine cell number J:146355
\Ptentm1Hwu/\Ptentm1Hwu
\Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr) 		enlarged thyroid gland J:177181
\Ptentm1Mak/\Pten+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased adrenal gland tumor incidence J:63478
increased T cell derived lymphoma incidence J:50437
\Ptentm1Mak/\Pten+
(B6.129P2-Ptentm1Mak) 		increased adrenal gland tumor incidence J:93530
\Ptentm1Mro/\Pten+
\Sdhbtm1.1Ics/\Sdhb+
\Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * FVB) 		increased pheochromocytoma incidence J:236514
\Ptentm1Mro/\Ptentm1Mro
\Sdhbtm1.1Ics/\Sdhb+
\Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * FVB) 		increased pheochromocytoma incidence J:236514
\Ptentm1Mro/\Ptentm1Mro
\Sdhbtm1.1Ics/\Sdhbtm1.2Ics
\Tg(KLK3-cre)D4Trp/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * FVB) 		increased pheochromocytoma incidence J:236514
\Ptentm1Rps/\Pten+
(involves: 129S1/Sv * C57BL/6J) 		abnormal thyroid gland morphology J:53065
enlarged thymus J:53065
increased thyroid carcinoma incidence J:53065
\Ptentm2.1Gle/\Pten+
(involves: 129S6/SvEvTac * Black Swiss * FVB/N) 		abnormal thyroid follicular cell morphology J:158751
increased adrenal gland tumor incidence J:158751
increased T cell derived lymphoma incidence J:158751
increased thyroid tumor incidence J:158751
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(TPO-cre)1Shk/0
(129S1.Cg-Ptentm2.1Ppp Tg(TPO-cre)1Shk) 		increased thyroid adenoma incidence J:165293
increased thyroid carcinoma incidence J:165293
thyroid gland hyperplasia J:165293
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(TPO-cre)1Shk/0
(129.Cg-Tg(TPO-cre)1Shk Trp53tm1Brn Ptentm2.1Ppp) 		enlarged thyroid gland J:211100
increased thyroid carcinoma incidence J:211100
\Ptf1atm1(cre)Hnak/\Ptf1a+
\Rbpjtm1Rsch/\Rbpjtm1Rsch
(involves: 129X1/SvJ) 		abnormal pancreatic alpha cell differentiation J:139250
decreased pancreatic islet number J:139250
disorganized pancreatic islets J:139250
increased pancreatic alpha cell number J:139250
\Ptf1atm1Pkwe/\Ptf1atm1Pkwe
(involves: 129P2/OlaHsd * C57BL/6) 		decreased pancreatic alpha cell number J:51571
\Ptgisem1(IMPC)Mbp/\Ptgisem1(IMPC)Mbp
(C57BL/6N-Ptgisem1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pth1rtm1a(EUCOMM)Hmgu/\Pth1rtm1a(EUCOMM)Hmgu
(C57BL/6N-Pth1rtm1a(EUCOMM)Hmgu/Wtsi) 		abnormal thymus morphology J:239583
\Pthtm1Dgo/\Pthtm1Dgo
(involves: 129S2/SvPas * C57BL/6J) 		enlarged parathyroid gland J:76407
\Pthtm1Dgo/\Pthtm1Dgo
\Pthlhtm1Hmk/\Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J) 		enlarged parathyroid gland J:76407
\Pthlhtm1Hmk/\Pthlhtm1Hmk
(involves: 129S2/SvPas * C57BL/6J) 		enlarged parathyroid gland J:76407
\Ptpmt1tm2.1Ckq/\Ptpmt1tm2.1Ckq
\Tg(VAV1-cre)1Graf/0
(involves: 129S6/SvEvTac * C57BL/6J * SJL) 		small thymus J:194929
\Ptpn1tm1Bbk/\Ptpn1tm1Bbk
(involves: 129/Sv * C57BL/6) 		abnormal pancreatic beta cell morphology J:87249
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr) 		decreased thymocyte number J:186843
thymus atrophy J:186843
\Ptpn2tm1Mtr/\Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr) 		decreased thymocyte number J:186843
thymus atrophy J:186843
\Ptpn2tm2.1Ttig/\Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig) 		decreased thymocyte number J:186843
thymus atrophy J:186843
\Ptpn6em1.1Shoy/\Ptpn6em1.1Shoy
(involves: C57BL/6) 		decreased thymocyte number J:236298
\Ptpn6me-B2/\Ptpn6me-B2
(involves: BALB/c) 		small thymus J:169850
\Ptpn6me-v/\Ptpn6me-v
(C57BL/6J-Ptpn6me-v) 		abnormal thymus development J:16613
\Ptpn6me/\Ptpn6me
(C57BL/6J-Ptpn6me/J) 		abnormal thymus morphology J:5579
small thymus J:5579
\Ptpn6me/\Ptpn6me
(either: (involves: C3H * C57BL/6J) or (involves: C57BL/6J * C57BL/6N)) 		thymus atrophy J:5999
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6J) 		increased lymphoblastic lymphoma incidence J:177285
\Ptpn11tm1Ckq/\Ptpn11+
\Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA) 		increased lymphoblastic lymphoma incidence J:177285
\Ptpn22tm1.1Draw/\Ptpn22+
(involves: 129 * C57BL/6) 		abnormal thymus morphology J:201448
thymus hyperplasia J:201448
\Ptpn22tm1.1Draw/\Ptpn22tm1.1Draw
(involves: 129 * C57BL/6) 		abnormal thymus morphology J:201448
thymus hyperplasia J:201448
\Ptpn22tm1.1Kas/\Ptpn22tm1.1Kas
(involves: C57BL/6) 		enlarged thymus J:176519
\Ptprcltng/\Ptprcltng
(C57BL/6-Ptprcltng) 		thymus hypoplasia J:158876
\Ptprcltng/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6) 		thymus hypoplasia J:158876
\Ptprcltng/\Ptprctm1Mak
\Tg(TcraTcrb)425Cbn/0
(involves: 129/Sv * BALB/c * C57BL/6) 		thymus hypoplasia J:158876
\Ptprcm1Smv/\Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J) 		decreased DN4 thymocyte number J:214487
increased DN3 thymocyte number J:214487
\Ptprctm1Holm/\Ptprctm1Holm
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:33466
\Ptprctm1Holm/\Ptprctm1Holm
\Tg(Lck*F505)2964Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
thymus hyperplasia J:64671
\Ptprctm1Holm/\Ptprctm1Holm
\Tg(Lck*F505)3073Rmp/?
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:64671
thymus hyperplasia J:64671
\Ptprctm1Mak/\Ptprctm1Mak
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:13163
\Ptprctm1Tyb/\Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb) 		thymus hypoplasia J:57681
\Ptprstm1Mtr/\Ptprstm1Mtr
(involves: 129/Sv * BALB/c) 		small pituitary gland J:53434
\Ptprvtm1Kry/\Ptprvtm1Kry
\Tg(Col1a1-cre)1Kry/0
(involves: FVB) 		abnormal pancreatic islet morphology J:126780
increased pancreatic beta cell mass J:126780
increased pancreatic islet number J:126780
pancreatic islet hyperplasia J:126780
\Ptprz1em1(IMPC)Ccpcz/\Ptprz1em1(IMPC)Ccpcz
(C57BL/6NCrl-Ptprz1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Pttg1tm1Sme/\Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6) 		abnormal pancreatic beta cell morphology J:82724
decreased pancreatic beta cell mass J:82724
thymus hyperplasia J:72267
\Puf60tm1.1Kmtsu/\Puf60+
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
increased thymus weight J:233347
\Puratm1Kkh/\Puratm1Kkh
(involves: 129) 		abnormal thymus morphology J:85759
\Pwwp3aem1(IMPC)Tcp/\Pwwp3aem1(IMPC)Tcp
(C57BL/6NCrl-Pwwp3aem1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Qrich1b2b2404Clo/\Qrich1b2b2404Clo
(C57BL/6J-Qrich1b2b2404Clo) 		thymus hypoplasia J:175213
\Rab27aash/\Rab27aash
\Rab27btm1Tiz/\Rab27btm1Tiz
(involves: 129P2/OlaHsd * C3H/He * C3H/HeSn) 		abnormal corticotroph morphology J:145238
\Rabl3xm/\Rabl3em1Btlr
(C57BL/6J-Rabl3xm Rabl3em1Btlr) 		thymus hypoplasia J:287198
\Rad50tm2Jpt/\Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6)) 		abnormal thymus morphology J:78820
increased T cell derived lymphoma incidence J:78820
\Rad50tm2Jpt/\Rad50tm2Jpt
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:78820
\Rag1tm1.1Sadu/\Rag1tm1.1Sadu
\Trdctm1Mal/\Trdctm1Mal
\Gt(ROSA)26Sortm2(cre/ERT2)Brn/\Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6) 		small thymus J:187400
\Rag1tm1Fwa/\Rag1tm1Fwa
(involves: 129) 		thymus hypoplasia J:86464
\Rag1tm1Jsek/\Rag1tm1Jsek
(involves: 129S6/SvEvTac) 		thymus hypoplasia J:146912
\Rag1tm1Jsek/\Rag1tm1Jsek
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:146912
\Rag1tm1Mom/\Rag1+
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1+
\Tg(LPV-TAg1135)11Tvd/0
\Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1) 		thymus hypoplasia J:1934
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		small thymus J:111874
\Rag1tm1Mom/\Rag1tm1Mom
(involves: 129S7/SvEvBrd) 		abnormal thymus epithelium morphology J:125864
\Rag1tm1Mom/\Rag1tm1Mom
\Prf1tm1Sdz/\Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz) 		abnormal thymus cortex morphology J:109843
increased T cell derived lymphoma incidence J:109843
thymus hypoplasia J:109843
\Rag1tm1Mom/\Rag1tm1Mom
\Slc46a2tm1Moki/\Slc46a2+
\Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6) 		thymus hypoplasia J:140121
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6) 		increased thymocyte number J:135903
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(LPV-TAg1135)11Tvd/0
\Tg(TcrLCMV)327Sdz/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag1tm1Mom/\Rag1tm1Mom
\Tg(TcraBDC12-4.1)10Jos/0
\Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD) 		decreased pancreatic beta cell number J:111874
decreased thymus weight J:111874
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased pituitary adenoma incidence J:141515
increased T cell derived lymphoma incidence J:141515
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased T cell derived lymphoma incidence J:141515
\Rag2tm1.1Desi/\Rag2tm1.1Desi
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:168974
\Rag2tm1.1Mss/\Rag2tm1.1Mss
(involves: 129S6/SvEvTac) 		increased DN3 thymocyte number J:171970
\Rag2tm1.1Mss/\Rag2tm1.1Mss
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased T cell derived lymphoma incidence J:170462
\Rag2tm1Avla/\Rag2tm1Avla
(involves: 129/Sv * C57BL/6) 		abnormal thymus morphology J:122108
absent Hassall's corpuscle J:122108
\Rag2tm1Fwa/\Rag2+
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv * MF1) 		thymus hypoplasia J:1935
\Rag2tm1Fwa/\Rag2tm1Fwa
(involves: 129S/SvEv) 		decreased thymocyte number J:114561
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6) 		increased thymocyte number J:166065
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster) 		increased DN3 thymocyte number J:235890
increased T cell derived lymphoma incidence J:235890
increased thymus tumor incidence J:235890
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Igh-Pim1)1Brn/0
(involves: 129S/SvEv * C57BL/6LiA * CBA) 		decreased thymocyte number J:114561
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(LPV-TAg1135)11Tvd/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2) 		thymus hyperplasia J:125548
\Rag2tm1Fwa/\Rag2tm1Fwa
\Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6) 		abnormal thymus cell ratio J:78309
\Rag2tm1Fwa/\Rag2tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6J) 		increased T cell derived lymphoma incidence J:47667
\Rag2tm1Fwa/\Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6) 		thymus hypoplasia J:81837
\Rag2tm1Mao/\Rag2tm1Mao
(involves: 129 * C57BL/6) 		thymus hypoplasia J:81837
\Rag2tm1Tgi/\Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ) 		decreased thymocyte number J:113641
\Rag2tm2.1Desi/\Rag2tm2.1Desi
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:168974
\Ralatm1a(EUCOMM)Wtsi/\Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Rap1gds1tm1Ytk/\Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA) 		abnormal thymus morphology J:62244
decreased thymocyte number J:62244
small thymus J:62244
\Rapgef3tm1Skc/\Rapgef3tm1Skc
(Not Specified) 		enlarged pancreatic islets J:201171
increased pancreatic alpha cell number J:201171
pancreatic islet hyperplasia J:201171
\Raratm1Ipc/\Raratm1Ipc
\Rarbtm1Ipc/\Rarbtm1Ipc
(involves: 129S2/SvPas) 		ectopic parathyroid gland J:21034
persistent cervical thymus J:21034
\Raratm1Ipc/\Raratm1Ipc
\Rarbtm1Mma/\Rarbtm1Mma
(involves: 129S2/SvPas * C57BL/6) 		abnormal thymus morphology J:43344
persistent cervical thymus J:43344
\Raratm1Ipc/\Raratm1Ipc
\Rargtm1Ipc/\Rargtm1Ipc
(involves: 129S2/SvPas) 		abnormal pituitary gland development J:21009
ectopic parathyroid gland J:21034
ectopic thyroid gland J:21034
persistent cervical thymus J:21034
\Raratm1Ipc/\Raratm1Ipc
\Rargtm2Ipc/\Rargtm2Ipc
(involves: 129S2/SvPas) 		ectopic thymus J:42773
\Raratm2Ipc/\Raratm2Ipc
\Raratm1Ipc/\Rara+
\Rargtm1Ipc/\Rargtm1Ipc
(involves: 129S2/SvPas) 		ectopic parathyroid gland J:21034
\Raratm2Ipc/\Raratm2Ipc
\Rarbtm1Ipc/\Rarbtm1Ipc
(involves: 129S2/SvPas) 		ectopic parathyroid gland J:21034
\Rasgrf1tm1Esn/\Rasgrf1tm1Esn
(involves: 129/Sv * C57BL/6N) 		decreased pancreatic beta cell number J:83950
small pancreatic islets J:83950
\Rasgrp1tm1Jstn/\Rasgrp1tm1Jstn
(involves: 129P3/J * C57BL/6J) 		decreased thymocyte number J:108677
\Rassf2tm1Dlim/\Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim) 		abnormal thymus epithelium morphology J:181952
decreased thymus weight J:181952
thymus hypoplasia J:181952
\Rassf5tm1Kina/\Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR) 		abnormal thymus cell ratio J:92670
abnormal thymus corticomedullary boundary morphology J:92670
abnormal thymus medulla morphology J:92670
decreased thymocyte number J:92670
\Rb1tm1Brd/\Rb1+
(involves: 129S7/SvEvBrd * C57BL/6) 		abnormal neuroendocrine gland morphology J:17434
increased pituitary adenoma incidence J:17434
\Rb1tm1Brd/\Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased pheochromocytoma incidence J:79016
increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
increased thyroid C-cell carcinoma incidence J:79016
\Rb1tm1Brn/\Rb1+
\Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		abnormal pituitary intermediate lobe morphology J:48860
increased pituitary adenoma incidence J:48860
\Rb1tm1Brn/\Rb1+
X/\Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N) 		pituitary intermediate lobe hyperplasia J:48860
\Rb1tm1Brn/\Rb1tm1Brn
\Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
\Rb1tm1Brn/\Rb1tm1Brn
X/\Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
pituitary intermediate lobe hyperplasia J:48860
\Rb1tm1Mlh/\Rb1+
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082, J:2511
increased thyroid tumor incidence J:81082
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6J) 		increased pheochromocytoma incidence J:133299
increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
increased thyroid C-cell carcinoma incidence J:133299
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
increased thyroid tumor incidence J:175625
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas) 		increased pituitary gland tumor incidence J:215358
\Rb1tm1Tyj/\Rb1+
\Rbl1tm1Tyj/\Rbl1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
\Rb1tm1Tyj/\Rb1+
\Rbl1tm1Tyj/\Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
\Rb1tm1Tyj/\Rb1+
\Smarca4tm1Mag/\Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1) 		increased pituitary gland tumor incidence J:132091
\Rb1tm1Tyj/\Rb1+
\Trim27Gt(XP0484)Wtsi/\Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary gland tumor incidence J:189317
increased thyroid tumor incidence J:189317
\Rb1tm1Tyj/\Rb1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary melanotroph tumor incidence J:19542
increased thyroid tumor incidence J:19542
\Rb1tm1Tyj/\Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:59268
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N) 		increased pituitary gland tumor incidence J:187257
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Rbp3-cre)1Brn/0
(involves: 129 * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:77982
increased pituitary melanotroph tumor incidence J:77982
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd) 		increased thyroid carcinoma incidence J:86077, J:157319
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd) 		increased thyroid carcinoma incidence J:86077, J:157319
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased pituitary gland tumor incidence J:187257
\Rb1tm2Mlh/\Rb1+
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
\Rb1tm3Tyj/\Rb1tm3Tyj
\Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
\Rb1tm3Tyj/\Rb1tm3Tyj
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
\Rbm4tm1Wtarn/\Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small pancreatic islets J:192831
\Rbm4btm1Wtarn/\Rbm4btm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		small pancreatic islets J:192831
\Rbpjtm1Hon/\Rbpjtm1Hon
\Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:99747
small thymus J:99747
\Rc3h1san/\Rc3h1+
(involves: C57BL/6JSfdAnu) 		increased T cell derived lymphoma incidence J:189087
\Rc3h1tm1.2Mass/\Rc3h1tm1.2Mass
(involves: C57BL/6 * CBA * NZB * SJL) 		abnormal thymus development J:177784
\Recql4tm1Abe/\Recql4tm1Abe
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:85574
small thymus J:85574
\Relatm1Bal/\Relatm1Bal
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6) 		abnormal thymus morphology J:60742
\RelbTg(H2-K1/GH1)106Bri/\RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri) 		absent thymus medulla J:23081, J:76450
\Relbtm1Brv/\Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6) 		thymus atrophy J:22675
thymus hypoplasia J:22675
\Rettm1Giro/\Ret+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		adrenal cortical hyperplasia J:141658
\Rettm1Giro/\Ret+
(129.129P2-Rettm1Giro) 		abnormal thyroid gland morphology J:141658
adrenal cortical hyperplasia J:141658
increased thyroid adenoma incidence J:141658
\Rettm2.1Cos/\Ret+
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		adrenergic chromaffin cell hyperplasia J:60659
thyroid gland hyperplasia J:60659
\Rettm2.1Cos/\Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		abnormal adrenal gland morphology J:60659
abnormal adrenal medulla morphology J:60659
adrenergic chromaffin cell hyperplasia J:60659
increased pheochromocytoma incidence J:60659
thyroid gland hyperplasia J:60659
\Rettm2.1Cos/\Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J) 		increased pheochromocytoma incidence J:148708
\Rev3ltm1Rwd/\Rev3ltm2.1Rwd
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(MMTV-cre)1Mam/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:158922
\Rfflem1(IMPC)Ccpcz/\Rfflem1(IMPC)Ccpcz
(C57BL/6N-Rfflem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rfx4Tg(Myh6-CYP2J2)Tr5Dcz/\Rfx4+
(involves: C57BL/6NTac) 		absent subcommissural organ J:84751
\Rfx5tm1.1Ifo/\Rfx5tm1.1Ifo
(involves: 129 * C57BL/6) 		abnormal thymus cortex morphology J:67941
\Rgsc142/\Rgsc142+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased T cell derived lymphoma incidence J:133634
\Rgsc1033/\Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased pituitary adenoma incidence J:133634
increased thyroid carcinoma incidence J:133634
\Rgsc1324/\Rgsc1324+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased pheochromocytoma incidence J:133634
\Rgsc1328/\Rgsc1328+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased pheochromocytoma incidence J:133634
\Rhagem1(IMPC)Ccpcz/\Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rhbdf1tm1.1Mfm/\Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6J) 		small thymus J:203951
\Rhobtb1em2(IMPC)Ccpcz/\Rhobtb1em2(IMPC)Ccpcz
(C57BL/6N-Rhobtb1em2(IMPC)Ccpcz/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Rhohtm1Brak/\Rhohtm1Brak
(involves: 129/Sv * C57BL/6) 		thymus hypoplasia J:143161
\Rhohtm1Daw/\Rhohtm1Daw
(involves: 129 * C57BL/6) 		thymus hypoplasia J:113565
\Rictortm1.1Klg/\Rictortm1.1Klg
\Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn) 		decreased DN1 thymic pro-T cell number J:189736
decreased DN2 thymocyte number J:189736
decreased DN3 thymocyte number J:189736
decreased DN4 thymocyte number J:189736
decreased thymus weight J:189736
thymus hypoplasia J:189736
\Rictortm1.1Mgn/\Rictortm1.1Mgn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA) 		decreased pancreatic beta cell mass J:170129
\Rictortm1.1Mnh/\Rictortm1.1Mnh
\Tg(Fabp4-cre)1Rev/0
(B6.Cg-Rictortm1.1Mnh Tg(Fabp4-cre)1Rev) 		enlarged pancreatic islets J:150064
\Rims2tm1Sse/\Rims2tm1Sse
(B6.Cg-Rims2tm1Sse) 		increased pancreatic alpha cell number J:163080
pancreatic islet hyperplasia J:163080
\Rint1tm1Whl/\Rint1+
(Not Specified) 		increased pituitary adenoma incidence J:122805
\Ripk1tm1Led/\Ripk1tm1Led
(involves: 129S6/SvEvTac) 		abnormal thymus morphology J:46522
decreased thymocyte number J:46522
\Ripply3tm1Sjt/\Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6) 		abnormal parathyroid gland morphology J:167713
abnormal thymus development J:167713
abnormal ultimobranchial body morphology J:167713
ectopic thymus J:167713
increased pancreatic alpha cell mass J:214095
increased pancreatic beta cell mass J:214095
small thymus J:167713
\Rlimem1(IMPC)Rbrc/\Rlim+
(C57BL/6NJcl-Rlimem1(IMPC)Rbrc/Rbrc) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnaseh2btm1a(EUCOMM)Wtsi/\Rnaseh2btm1a(EUCOMM)Wtsi
(involves: C57BL/6N) 		thymus hypoplasia J:186986
\Rnaseltm1Slvm/\Rnaseltm1Slvm
(involves: 129P2/OlaHsd) 		abnormal thymus morphology J:44292
enlarged thymus J:44292
thymus hyperplasia J:44292
\Rnf5tm1.1(KOMP)Vlcg/\Rnf5+
(C57BL/6N-Rnf5tm1.1(KOMP)Vlcg/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnf8Gt(AS0574)Wtsi/\Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:161240
increased T cell derived lymphoma incidence J:161240
\Rnf8Gt(RRR260)Byg/\Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:161240
increased T cell derived lymphoma incidence J:161240
\Rnf34tm1a(EUCOMM)Hmgu/\Rnf34tm1a(EUCOMM)Hmgu
(C57BL/6NCrl-Rnf34tm1a(EUCOMM)Hmgu/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnf146tm1.1Rtpl/\Rnf146tm1.1Rtpl
\Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1) 		decreased pancreatic islet number J:244583
small pancreatic islets J:244583
\Rnf148em1(IMPC)Ccpcz/\Rnf148em1(IMPC)Ccpcz
(C57BL/6N-Rnf148em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnf168Gt(156B6)Cmhd/\Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased DN3 thymocyte number J:198260
\Rnf168Gt(405F11)Cmhd/\Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased DN3 thymocyte number J:198260
\Rnf168tm2b(EUCOMM)Hmgu/\Rnf168tm2b(EUCOMM)Hmgu
(C57BL/6N-Rnf168tm2b(EUCOMM)Hmgu/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnf208em1(IMPC)Ccpcz/\Rnf208em1(IMPC)Ccpcz
(C57BL/6N-Rnf208em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rnf223em1(IMPC)Ccpcz/\Rnf223em1(IMPC)Ccpcz
(C57BL/6N-Rnf223em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ror1em1(IMPC)Ccpcz/\Ror1+
(C57BL/6NCrl-Ror1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rorasg/\Rorasg
(involves: C57BL/6) 		thymus atrophy J:2228
\Rorctm1Amj/\Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2)) 		decreased thymus weight J:64381
thymus hypoplasia J:64381
\Rorctm1Litt/\Rorctm1Litt
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:248565
\Rpap3em1(IMPC)Mbp/\Rpap3+
(C57BL/6N-Rpap3em1(IMPC)Mbp/Ucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rpgrip1ltm1a(EUCOMM)Wtsi/\Rpgrip1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Rpgrip1ltm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
absent adenohypophysis J:239583
\Rpgrip1ltm1Urt/\Rpgrip1ltm1Urt
(involves: 129S1/Sv * 129X1/SvJ) 		absent Rathke's pouch J:123018
small Rathke's pouch J:123018
\Rpl22Gt(GST000137)Lex/\Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd) 		thymus hypoplasia J:123569
\Rpl22Gt(YHB332)Byg/\Rpl22Gt(YHB332)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus development J:201164
\Rpl27aSfa/\Rpl27a+
(C57BL/6J-Rpl27aSfa) 		small thymus J:174216
\Rplp1tm1.1Melt/\Rplp1tm1.2Melt
(Not Specified) 		small thymus J:218949
\Rps6tm1Om/\Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		abnormal pancreatic beta cell morphology J:100952
abnormal pancreatic islet morphology J:100952
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6) 		decreased pancreatic beta cell mass J:66406
small pancreatic islets J:66406
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho) 		abnormal pancreatic beta cell morphology J:144599
decreased pancreatic beta cell mass J:144599
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
\Rps6kb2tm1Gtho/\Rps6kb2tm1Gtho
\Tg(Ins2-Akt1*)3Mbb/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL) 		abnormal pancreatic beta cell morphology J:144599
\Rps6kb1tm1Gtho/\Rps6kb1tm1Gtho
\Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Rps6kb1tm1Gtho Tg(Ins2-Akt1*)3Mbb) 		abnormal pancreatic beta cell morphology J:144599
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm) 		decreased thymus weight J:223276
thymus cortex hypoplasia J:223276
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
(involves: 129 * C57BL/6N) 		thymus hypoplasia J:223276
\Rps27lGt(IST11658B7)Tigm/\Rps27lGt(IST11658B7)Tigm
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6N) 		increased T cell derived lymphoma incidence J:223276
\Rpsatm1Ells/\Rpsa+
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal pancreatic beta cell morphology J:138267
\Rr28tm1Tilg/\Rr28+
\Igf2tm1Rob/\Igf2+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J) 		adrenal gland cyst J:77413
\Rr38tm1.2Aafo/\Rr38+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6) 		decreased thymocyte number J:227747
\Rr38tm1.2Aafo/\Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6) 		decreased thymocyte number J:227747
decreased thymus weight J:227747
increased DN3 thymocyte number J:227747
small thymus J:227747
thymus hypoplasia J:227747
\Rr115em1Bobh/\Rr115+
\Shhtm1Chg/\Shh+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal adenohypophysis development J:306254
abnormal magnocellular neurosecretory cell morphology J:306254
abnormal neurohypophysis development J:306254
abnormal parvocellular neurosecretory cell morphology J:306254
abnormal Rathke's pouch development J:306254
ectopic neurohypophysis J:306254
\Rr344em1Jfer/\Rr344em1Jfer
(B6.Cg-Rr344em1Jfer) 		decreased pancreatic alpha cell mass J:328047
decreased pancreatic beta cell mass J:328047
\Rr394em1Bhao/\Rr394em1Bhao
(Not Specified) 		decreased thymocyte number J:333961
increased DN3 thymocyte number J:333961
\Rr395em1Bhao/\Rr395em1Bhao
(Not Specified) 		decreased thymocyte number J:333961
increased DN4 thymocyte number J:333961
\Rr609m1H/\Rr609+
(involves: C3H/HeH * C57BL/6J) 		increased adrenal gland weight J:208708
increased adrenal gland zona fasciculata size J:208708
\Rr149356tm1.1Pf/\Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c)) 		abnormal thymus cortex morphology J:34311
abnormal thymus medulla morphology J:34311
abnormal thymus morphology J:34311
decreased thymocyte number J:34311
\Rr149356tm1Abnd/\Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal thymus morphology J:137580
thymus hypoplasia J:137580
\Rr149356tm1Che/\Rr149356tm1Che
\Tcrdtm1Mom/\Tcrdtm1Mom
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
\Rr149356tm1Che/\Rr149356tm1Che
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:106246
\Rr299391tm1.1Fwa/\Rr299391+
(involves: 129P2/OlaHsd * FVB/N) 		decreased thymocyte number J:55401
\Rr299391tm1.1Fwa/\Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * FVB/N) 		decreased thymocyte number J:55401
\Rras2em1(IMPC)Ccpcz/\Rras2em1(IMPC)Ccpcz
(C57BL/6NCrl-Rras2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Rrm2bGt(OST85254)Lex/\Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		thymus atrophy J:186071
\Rrm2btm1Ynak/\Rrm2btm1Ynak
(involves: 129 * C57BL/6J) 		thymus cortex hypoplasia J:84841
\Rsad1tm1.1(KOMP)Vlcg/\Rsad1+
(C57BL/6N-Rsad1tm1.1(KOMP)Vlcg/Ucd) 		small thymus J:211773
\Rsad1tm1.1(KOMP)Vlcg/\Rsad1tm1.1(KOMP)Vlcg
(C57BL/6N-Rsad1tm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Runx1tm1(RUNX1)Gcg/\Runx1tm1(RUNX1)Gcg
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:106800
\Runx1tm1Spe/\Runx1+
(either: (involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA/Ca) or (involves: 129S4/SvJae * C57BL/6 * CBA/Ca)) 		increased T cell derived lymphoma incidence J:80829
\Runx1tm1Tani/\Runx1tm1Tani
\Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:125959
\Runx1tm1Toku/\Runx1tm1Toku
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:87697
thymus hypoplasia J:87697
\Runx1tm1Yg/\Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1)) 		abnormal thymus corticomedullary boundary morphology J:125830
abnormal thymus lobule morphology J:125830
decreased thymocyte number J:125830
small thymus J:125830
thymus cyst J:125830
thymus hypoplasia J:125830
\Runx1tm2Buch/\Runx1tm2Buch
\Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		abnormal thymus lobule morphology J:105709
decreased thymus weight J:105709
increased T cell derived lymphoma incidence J:105709
\Runx1tm3(Runx3)Toku/\Runx1tm3(Runx3)Toku
(involves: 129P2/OlaHsd) 		abnormal thymus medulla morphology J:98965
decreased thymocyte number J:98965
small thymus J:98965
thymus hypoplasia J:98965
\Runx1tm3Dow/\Runx1+
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:77129
\Runx1tm3Itan/\Runx1tm3Itan
(involves: 129P2/OlaHsd) 		decreased thymocyte number J:168918
\Runx1tm3Spe/\Runx1tm3Spe
\Spi1tm2.1Dgt/\Spi1tm2.1Dgt
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased thymus weight J:131217
\Runx1tm3Spe/\Runx1tm3Spe
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased thymus weight J:131217
\Runx1tm3Spe/\Runx1tm3Spe
\Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae) 		decreased thymocyte number J:145700
\Runx2tm1Kish/\Runx2+
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thyroid follicle morphology J:162258
abnormal thyroid gland morphology J:162258
enlarged thymus J:162258
\Runx2tm1Kish/\Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:40783
\Ruvbl2M1Btlr/\Ruvbl2+
(involves: C57BL/6J) 		increased thymocyte number J:185495
\Ryr2tm1.1Hnis/\Ryr2tm1.1Hnis
(involves: C57BL/6) 		increased thymus weight J:228787
thymus cortex hyperplasia J:228787
\Sac3d1tm1Hnaka/\Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd) 		thymus hyperplasia J:144601
\Sall3tm1.1(KOMP)Mbp/\Sall3+
(C57BL/6NCrl-Sall3tm1.1(KOMP)Mbp/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Satb1tm1Kos/\Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:61085
small thymus J:61085
\Sbdstm1Jrom/\Sbdstm3.1Jrom
\Ptf1atm1(cre)Cvw/\Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pancreatic islet size J:189357
\Sbdstm2.1Jrom/\Sbdstm3.1Jrom
\Ptf1atm1(cre)Cvw/\Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal pancreatic islet size J:189357
\Scelem1(IMPC)Ccpcz/\Scelem1(IMPC)Ccpcz
(C57BL/6NCrl-Scelem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Scg5tm1Led/\Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6)) 		abnormal adrenal gland morphology J:53349
abnormal pancreatic islet morphology J:53349
adrenal cortical hyperplasia J:53349
increased pancreatic beta cell mass J:53349
pancreatic islet hyperplasia J:53349
small adenohypophysis J:77510
\Scr/\Scr
(involves: 101/H * C3H/HeH) 		small thymus J:3458
\Sdhbtm1c(EUCOMM)Hmgu/\Sdhbtm1c(EUCOMM)Hmgu
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		abnormal pancreatic islet morphology J:326592
decreased pancreatic beta cell mass J:326592
\Sdhdtm1Jlob/\Sdhdtm2Jlob
\Thtm1(cre)Te/\Th+
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal adrenal chromaffin cell morphology J:186713
\Sec23bGt(AD0407)Wtsi/\Sec23bGt(AD0407)Wtsi
(B6J.129P2-Sec23bGt(AD0407)Wtsi) 		abnormal endocrine pancreas morphology J:186391
decreased pancreatic alpha cell number J:186391
decreased pancreatic beta cell number J:186391
decreased pancreatic islet number J:186391
\Sec61a1m1Gek/\Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek) 		abnormal pancreatic beta cell morphology J:164159
abnormal pancreatic delta cell morphology J:164159
decreased pancreatic beta cell number J:164159
increased pancreatic alpha cell number J:164159
increased pancreatic delta cell number J:164159
\Sec61a1m1Gek/\Sec61a1m1Gek
\Tg(Ins2-Sec61a1)#Gek/0
(C57BL/6-Sec61a1m1Gek Tg(Ins2-Sec61a1)#Gek) 		abnormal pancreatic beta cell morphology J:164159
\Sel1lGt(CA0017)Wtsi/\Sel1lGt(CA0017)Wtsi
(involves: 129P2/OlaHsd) 		abnormal pancreatic alpha cell differentiation J:158780
abnormal pancreatic beta cell differentiation J:158780
\Selenbp1tm1Hyama/\Selenbp1tm1Hyama
(C57BL/6-Selenbp1tm1Hyama) 		increased thymus weight J:202420
\Selenottm1.1Ics/\Selenottm1.1Ics
\Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA) 		increased pancreatic islet number J:203279
small pancreatic islets J:203279
\Sema3atm1.1Tyag/\Sema3atm1.1Tyag
\Vegfatm1Pec/\Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj) 		decreased gonadotropin-releasing hormone neuron number J:175836
\Senp1tm1Wami/\Senp1tm1Wami
\Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr) 		abnormal pancreatic islet morphology J:228009
\Senp1tm1Wami/\Senp1tm1Wami
\Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel) 		abnormal pancreatic islet morphology J:228009
\Senp1tm1Wami/\Senp1tm1Wami
\Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc) 		abnormal pancreatic islet morphology J:228009
\Septin9tm2.1Emfu/\Septin9tm2.1Emfu
\Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA) 		decreased DN4 thymocyte number J:205027
increased DN3 thymocyte number J:205027
\Serp1tm1Hori/\Serp1tm1Hori
(involves: 129X1/SvJ * C57BL/6) 		small adenohypophysis J:109619
small adrenal glands J:109619
small pituitary gland J:109619
small thyroid gland J:109619
\Serpini2pq/\Serpini2pq
(involves: C57BL/6J) 		decreased thymocyte number J:115744
small thymus J:115744
thymus hypoplasia J:115744
\Sertad1tm1Srn/\Sertad1tm1Srn
(B6.129-Sertad1tm1Srn) 		decreased pancreatic beta cell mass J:157231
decreased pancreatic islet number J:157231
\Setd5tm1a(EUCOMM)Wtsi/\Setd5+
(C57BL/6N-Setd5tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal pineal gland morphology J:239583
abnormal thymus morphology J:239583
small thymus J:239583
small thyroid gland J:239583
\sevr/\sevr
(C3H/HeJ-sevr/GrsrJ) 		thymus atrophy J:109437
\Sgms1tm1Kenw/\Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6) 		abnormal pancreatic islet morphology J:168726
\Sgpl1Gt(OST58278)Lex/\Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		thymus cortex hypoplasia J:145159
thymus hypoplasia J:145159
thymus medulla hyperplasia J:145159
\Sgpl1Gt(OST58278)Lex/\Sgpl1tm1(SGPL1)Lex
(involves: 129S5/SvEvBrd * C57BL/6J) 		thymus cortex hypoplasia J:145159
thymus medulla hyperplasia J:145159
\Sgpl1tm1(SGPL1)Lex/\Sgpl1tm1(SGPL1)Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd * C57BL/6J) 		abnormal thymus lobule morphology J:145159
\Sgpp2tm1Rlp/\Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp) 		decreased pancreatic beta cell mass J:235035
small pancreatic islets J:235035
\Sh2b1tm1Lr/\Sh2b1tm1Lr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		pancreatic islet hyperplasia J:92794
\Sh2b1tm2.1Lr/\Sh2b1tm2.1Lr
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL) 		decreased pancreatic beta cell mass J:209019
small pancreatic islets J:209019
\Sh2d3ctm1.1Ebp/\Sh2d3ctm1.1Ebp
(involves: C57BL/6) 		decreased gonadotropin-releasing hormone neuron number J:164874
\Sh3pxd2atm1b(EUCOMM)Wtsi/\Sh3pxd2atm1b(EUCOMM)Wtsi
(C57BL/6N-Sh3pxd2atm1b(EUCOMM)Wtsi/Wtsi) 		abnormal adenohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
abnormal thymus topology J:239583
small thyroid gland J:239583
\Shc1tm1Ravi/\Shc1tm1Ravi
\Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6) 		thymus hypoplasia J:78180
\Shhtm2Amc/\Shhtm2.1Amc
\Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		abnormal adrenal gland morphology J:168522
abnormal adrenocortical cell morphology J:168522
enlarged adrenocortical cells J:168522
small adrenal glands J:168522
thin adrenal cortex J:168522
\Shisal1em1(IMPC)Ccpcz/\Shisal1em1(IMPC)Ccpcz
(C57BL/6N-Shisal1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\sho/\sho
(Not Specified) 		small thymus J:255
\Shprhem1(IMPC)Tcp/\Shprhem1(IMPC)Tcp
(C57BL/6NCrl-Shprhem1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Sidt2tm1.1Hzha/\Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J) 		abnormal pancreatic beta cell morphology J:204228
increased pancreatic beta cell number J:204228
\Sim1tm1Fan/\Sim1tm1Fan
(involves: 129/Sv * C57BL/6) 		abnormal pituicyte morphology J:50772
absent magnocellular neurosecretory cells J:50772
pituitary gland hypoplasia J:50772
\Sirt1tm3Fwa/\Sirt1tm3Fwa
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL) 		decreased pituitary gland weight J:155802
small pituitary gland J:155802
\Sit1tm1Lsmn/\Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn) 		thymus hyperplasia J:100408
\Sit1tm1Lsmn/\Sit1tm1Lsmn
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6) 		thymus hypoplasia J:100408
\Six1tm1Kwk/\Six1tm1Kwk
(involves: 129P2/OlaHsd * C57BL/6) 		athymia J:104488
\Six1tm1Mair/\Six1tm1Mair
(involves: 129S2/SvPas) 		athymia J:84417
\Six1tm1Rsd/\Six1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ) 		small adenohypophysis J:86619
\Six6tm1Rsd/\Six6tm1Rsd
(either: 129 or (involves: 129S1/Sv * 129X1/SvJ)) 		pituitary gland hypoplasia J:104339
\Six6tm1Rsd/\Six6tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		abnormal gonadotropin-releasing hormone neuron morphology J:168233
decreased gonadotropin-releasing hormone neuron number J:168233
\Skida1tm1.1(KOMP)Wtsi/\Skida1+
(C57BL/6N-Skida1tm1.1(KOMP)Wtsi/Ucd) 		enlarged thymus J:211773
\Skida1tm1.1(KOMP)Wtsi/\Skida1tm1.1(KOMP)Wtsi
(C57BL/6N-Skida1tm1.1(KOMP)Wtsi/Ucd) 		enlarged thymus J:211773
\Skiltm1Sis/\Skil+
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:62174
\skp/\skp
(CXB5/ByJ-skp/GrsrJ) 		thymus atrophy J:153578
\Slc2a2tm1Thor/\Slc2a2tm1Thor
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal pancreatic islet morphology J:43839
decreased pancreatic beta cell mass J:43839
increased pancreatic alpha cell mass J:43839
\Slc2a4tm1Mch/\Slc2a4+
(involves: 129/Sv * C57BL/6 * SJL) 		pancreatic islet hyperplasia J:97234
\Slc5a5tm1d(KOMP)Wtsi/\Slc5a5tm1d(KOMP)Wtsi
(involves: C57BL/6 * FVB/N * SJL) 		abnormal thyroid gland morphology J:250121
enlarged thyroid gland J:250121
\Slc6a3tm1Mca/\Slc6a3tm1Mca
(involves: 129P2/OlaHsd) 		abnormal adenohypophysis morphology J:41856
adenohypophysis hypoplasia J:41856
decreased lactotroph cell number J:41856
decreased somatotroph cell number J:41856
pituitary intermediate lobe hypoplasia J:41856
\Slc6a3tm1Mca/\Slc6a3tm1Mca
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adenohypophysis morphology J:93114
small pituitary gland J:93114
\Slc6a3tm1Mca/\Slc6a3tm1Mca
\Slc6a4tm1Kpl/\Slc6a4tm1Kpl
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal adenohypophysis morphology J:93114
small pituitary gland J:93114
\Slc8a1tm1Herc/\Slc8a1+
(involves: 129 * CD-1) 		increased pancreatic beta cell mass J:186743
\Slc15a1em1(IMPC)Ccpcz/\Slc15a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Slc15a1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Slc17a8em1(IMPC)Mbp/\Slc17a8em1(IMPC)Mbp
(C57BL/6N-Slc17a8em1(IMPC)Mbp/MbpMmucd) 		abnormal adrenal gland morphology J:211773
\Slc19a1tm1Gold/\Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL) 		small thymus J:68666
\Slc20a2tm1a(EUCOMM)Wtsi/\Slc20a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc20a2tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Slc22a6tm1Dgen/\Slc22a6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6) 		increased thymus weight J:101679
\Slc23a2tm1Nbm/\Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm) 		abnormal adrenergic chromaffin cell morphology J:85988
abnormal adrenocortical cell morphology J:85988
\Slc24a4tm1b(KOMP)Wtsi/\Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H) 		enlarged thymus J:211773
\Slc25a20tm1a(EUCOMM)Wtsi/\Slc25a20tm1a(EUCOMM)Wtsi
(C57BL/6N-Slc25a20tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Slc25a46atc/\Slc25a46atc
(B6.Cg-Slc25a46atc) 		decreased thymus weight J:242350
thymus hypoplasia J:242350
\Slc26a4loop/\Slc26a4loop
(C3HeB/FeJ-Slc26a4loop) 		abnormal thyroid follicle morphology J:216847
abnormal thyroid gland morphology J:216847
\Slc26a7tm1Sole/\Slc26a7tm1Sole
(involves: 129) 		abnormal thyroid follicle morphology J:325346
enlarged thyroid gland J:325346
\Slc29a3em1(IMPC)Mbp/\Slc29a3em1(IMPC)Mbp
(C57BL/6NCrl-Slc29a3em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
small thymus J:211773
\Slc30a4em1(IMPC)Tcp/\Slc30a4em1(IMPC)Tcp
(C57BL/6NCrl-Slc30a4em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
small thymus J:211773
\Slc30a8tm1.1Htwt/\Slc30a8tm1.1Htwt
\Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA) 		abnormal pancreatic beta cell morphology J:204003
\Slc30a10tm1.1Sommu/\Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA) 		abnormal thyroid follicle morphology J:243657
abnormal thyroid follicular cell morphology J:243657
abnormal thyroid gland morphology J:243657
\Slc38a5tm1(KOMP)Vlcg/\Slc38a5tm1(KOMP)Vlcg
(C57BL/6-Slc38a5tm1(KOMP)Vlcg) 		abnormal pancreatic alpha cell morphology J:251829
\Slc38a7em1(IMPC)Ccpcz/\Slc38a7em1(IMPC)Ccpcz
(C57BL/6NCrl-Slc38a7em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Slc39a10tm1.1Tfk/\Slc39a10tm1.1Tfk
\Tg(Foxn1-cre)8Ghr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		thymus hypoplasia J:254216
\Slc46a2tm1Moki/\Slc46a2tm1Moki
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus hypoplasia J:140121
\Slc52a2tm1.1(KOMP)Vlcg/\Slc52a2+
(C57BL/6N-Slc52a2tm1.1(KOMP)Vlcg/Ucd) 		small adrenal glands J:211773
\Smad2tm1Cxd/\Smad2+
\Smad3tm1Cxd/\Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss) 		small thyroid gland J:106308
\Smad3tm1Cxd/\Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss)) 		thymus hypoplasia J:53510
\Smad4tm1.1Gsu/\Smad4tm1.1Gsu
\Ptf1atm1.1(cre)Cvw/\Ptf1a+
\Tg(MtTGFA)Lmb/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		abnormal pancreatic islet morphology J:229184
\Smad4tm2.1Cxd/\Smad4tm2.1Cxd
\Tg(Foxn1-cre)8Ghr/0
(B6.Cg-Smad4tm2.1Cxd Tg(Foxn1-cre)8Ghr) 		small thymus J:138837
\Smad7Gt(YHC053)Byg/\Smad7Gt(YHC053)Byg
(involves: 129P2/OlaHsd * C57BL/6J) 		abnormal thymus morphology J:212881
thymus hypoplasia J:212881
\Smad7tm1Gkg/\Smad7tm1Gkg
\Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA) 		abnormal pancreatic beta cell differentiation J:198451
decreased pancreatic alpha cell number J:198451
decreased pancreatic beta cell number J:198451
\Smarca4tm1.2Pcn/\Smarca4tm1.2Pcn
\Tg(Lck-cre)1Cwi/0
\Tg(LCKprBCL2L1)12Sjk/0
(Not Specified) 		increased thymocyte number J:144072
\Smarca4tm1.2Pcn/\Smarca4tm1Mag
\Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2) 		thymus hypoplasia J:85191
\Smarca4tm1.2Pcn/\Smarca4tm1Tich
\Tg(Lck-cre)1Cwi/0
(involves: 129) 		decreased thymocyte number J:144072
\Smarca4tm1.2Pcn/\Smarca4tm1Tich
\Tg(Lck-cre)1Cwi/0
\Tg(LCKprBCL2L1)12Sjk/0
(involves: 129) 		increased thymocyte number J:144072
\Smarca4tm1Tich/\Smarca4+
\Tg(Lck-cre)1Cwi/0
(involves: 129) 		decreased thymocyte number J:144072
\Smarcb1tm1Sho/\Smarcb1tm3Sho
\Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:80224
\Smg9tm1b(EUCOMM)Wtsi/\Smg9tm1b(EUCOMM)Wtsi
(C57BL/6N-Smg9tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal neurohypophysis morphology J:239583
abnormal pineal gland morphology J:239583
\Smpd3tm1Wst/\Smpd3tm1Wst
(involves: 129S1/Sv) 		abnormal adenohypophysis morphology J:97284
abnormal pituicyte morphology J:97284
decreased corticotroph cell number J:97284
decreased gonadotroph cell number J:97284
decreased somatotroph cell number J:97284
decreased thyrotroph cell number J:97284
\Snai2tm2Grid/\Snai2+
\Snai3tm1.2Jhws/\Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6) 		abnormal thymus cortex morphology J:204710
abnormal thymus medulla morphology J:204710
\Snai2tm2Grid/\Snai2tm2Grid
(involves: 129S1/Sv) 		small thymus J:78323
\Snai2tm2Grid/\Snai2tm2Grid
\Snai3tm1.2Jhws/\Snai3+
(involves: 129/Sv * 129S1/Sv * C57BL/6) 		abnormal thymus cortex morphology J:204710
abnormal thymus medulla morphology J:204710
\Snai2tm2Grid/\Snai2tm2Grid
\Snai3tm1.2Jhws/\Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6) 		abnormal thymus cortex morphology J:204710
abnormal thymus medulla morphology J:204710
small thymus J:204710
thymus fibrosis J:204710
\Snd1em1(IMPC)Tcp/\Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Snrnp40em1Btlr/\Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp) 		abnormal thymus development J:282417
decreased DN1 thymic pro-T cell number J:282417
decreased DN4 thymocyte number J:282417
small thymus J:282417
thymus hypoplasia J:282417
\Soat1ald/\Soat1ald
(AKR/O) 		abnormal adrenal cortex morphology J:12157, J:5089
abnormal adrenocortical cell morphology J:12157
thymus hyperplasia J:12157
\Soat1tm1Far/\Soat1tm1Far
(involves: 129S4/SvJae * C57BL/6) 		abnormal adrenal gland morphology J:37049
\Socs1tm1Jni/\Socs1tm1Jni
(Not Specified) 		decreased thymocyte number J:57475
\Socs1tm1Kish/\Socs1tm1Kish
(involves: 129P2/OlaHsd * C57BL/6J) 		absent thymus corticomedullary boundary J:51685
\Socs1tm1Kish/\Socs1tm1Kish
(B6.129P2-Socs1tm1Kish) 		thymus atrophy J:69472
\Socs1tm1Kish/\Socs1tm1Kish
\Stat1tm1Rds/\Stat1tm1Rds
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6) 		thymus atrophy J:69472
\Socs1tm1Kish/\Socs1tm1Kish
\Stat6tm1Aki/\Stat6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6) 		thymus atrophy J:69472
\Socs1tm1Wehi/\Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6) 		small thymus J:51281
thymus cortex atrophy J:57474, J:51281
\Socs1tm1Wehi/\Socs1tm3Wehi
\Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR) 		enlarged thymus medulla J:83009
thymus hyperplasia J:83009
\Socs1tm2Wehi/\Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi) 		thymus atrophy J:72528
\Socs7tm1Wsa/\Socs7tm1Wsa
(involves: C57BL/6) 		abnormal subcommissural organ morphology J:93449
enlarged pancreatic islets J:93449
\Sos1tm1.1Les/\Sos1tm1.1Les
\Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6) 		decreased DN4 thymocyte number J:174536
decreased thymocyte number J:174536
\Sox2tm1Rlb/\Sox2+
(involves: 129S/SvEv * MF1) 		abnormal adenohypophysis development J:114458
abnormal pituitary gland morphology J:114458
bifurcated Rathke's pouch J:114458
decreased somatotroph cell number J:114458
small adenohypophysis J:114458
\Sox3tm1Pqt/Y
(chimera involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		abnormal adenohypophysis development J:195300
abnormal pituitary infundibular stalk morphology J:195300
absent pituitary infundibular stalk J:195300
\Sox3tm1Rlb/Y
(involves: 129S7/SvEvBrd * MF1) 		abnormal pituitary gland morphology J:88507
abnormal Rathke's pouch development J:88507
bifurcated Rathke's pouch J:88507
\Sox3tm1Rlb/\Sox3tm1Rlb
(involves: 129S7/SvEvBrd * MF1) 		abnormal pituitary gland morphology J:88507
abnormal Rathke's pouch development J:88507
bifurcated Rathke's pouch J:88507
\Sox4Igt4/\Del(13)36H
(involves: 101/H * C3H/HeH * C57BL/6) 		thymus hypoplasia J:141688
\Sox9tm1.1Gsr/\Sox9+
(involves: 129S4/SvJae * CD-1) 		decreased pancreatic alpha cell mass J:141017
decreased pancreatic beta cell mass J:141017
decreased pancreatic delta cell number J:141017
decreased PP cell number J:141017
pancreatic islet hyperplasia J:141017
\Sox9tm1Gsr/\Sox9+
\Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N) 		decreased pancreatic alpha cell mass J:141017
decreased pancreatic beta cell mass J:141017
decreased pancreatic delta cell number J:141017
decreased PP cell number J:141017
pancreatic islet hyperplasia J:141017
\Sox9tm2Gsr/\Sox9tm2Gsr
(involves: 129P2/OlaHsd * CD-1) 		pancreatic islet hyperplasia J:141017
\Sox10tm6(Sox100B)Weg/\Sox10tm6(Sox100B)Weg
(involves: 129P2/OlaHsd * C3H) 		abnormal adrenal medulla morphology J:160023
\Sox14em1(IMPC)Ccpcz/\Sox14+
(C57BL/6N-Sox14em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Sox14em1(IMPC)Ccpcz/\Sox14em1(IMPC)Ccpcz
(C57BL/6N-Sox14em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Sox17tm1Sjm/\Sox17tm2Sjm
\Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C3H * C57BL/6 * C57BL/Ka * CBA) 		thymus hypoplasia J:123050
\Sp3tm1Sus/\Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6) 		small thymus J:84837
\Sp4tm1Sus/\Sp4tm1Sus
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:77894
\Spata31f3em1(IMPC)Ccpcz/\Spata31f3em1(IMPC)Ccpcz
(C57BL/6NCrl-Spata31f3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Sphk1tm1.1Cgh/\Sphk1tm2Cgh
\Sphk2tm1.1Cgh/\Sphk2tm1.1Cgh
\Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		abnormal thymus cell ratio J:120783
\Spi1tm1.1Dgt/\Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:90331
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6) 		decreased thymocyte number J:106040
increased T cell derived lymphoma incidence J:106040
small thymus J:106040
\Spi1tm1.3Dgt/\Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:90331
\Spi1tm1Ram/\Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6) 		decreased thymocyte number J:36473
\Spink5tm2.1Hov/\Spink5tm2.1Hov
\Tg(KRT5-cre/ERT2)2Ipc/0
(involves: C57BL/6 * C57BL/6JRj * SJL) 		abnormal thymus morphology J:357366
small thymus J:357366
thymus atrophy J:357366
thymus cortex hypoplasia J:357366
thymus hypoplasia J:357366
\Spink13em1(IMPC)Ccpcz/\Spink13em1(IMPC)Ccpcz
(C57BL/6N-Spink13em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Spns2tm1Tni/\Spns2tm1Tni
(B6.Cg-Spns2tm1Tni) 		abnormal thymus morphology J:225108
decreased thymocyte number J:225108
\SpopGt(BGB118)Byg/\SpopGt(BGB118)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased pancreatic beta cell mass J:165268
\Spoptm1b(KOMP)Wtsi/\Spop+
(C57BL/6N-Spoptm1b(KOMP)Wtsi/Tcp) 		small adrenal glands J:211773
small thymus J:211773
\Spred1em1(IMPC)Ccpcz/\Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Spryd4em1(IMPC)Ccpcz/\Spryd4em1(IMPC)Ccpcz
(C57BL/6N-Spryd4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac) 		adrenal gland cyst J:166879
increased adrenal cortical tumor incidence J:166879
increased thyroid carcinoma incidence J:166879
\Sptlc2tm1Yhir/\Sptlc2tm1Yhir
\Gt(ROSA)26Sortm9(cre/ESR1)Arte/\Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac) 		abnormal thymus morphology J:202954
decreased thymus weight J:202954
increased adrenal gland weight J:202954
\Srftm1Rmn/\Srftm1Rmn
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		absent thyroid gland J:144862
athymia J:144862
\Srftm2Nor/\Srftm2Nor
\Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2) 		decreased thymocyte number J:124767
\srn/\srn
(involves: BUA/Hn * SM/J) 		abnormal adrenal gland morphology J:5150
absent adrenal gland J:5150
\Srpxtm1Hzi/\Srpxtm1Hzi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased T cell derived lymphoma incidence J:119999
\Srsf2tm1Xdfu/\Srsf2+
\Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR) 		decreased thymocyte number J:88668
decreased thymus weight J:88668
\Srsf2tm1Xdfu/\Srsf2tm1Xdfu
\Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR) 		absent thymus corticomedullary boundary J:88668
decreased thymocyte number J:88668
small thymus J:88668
\Srsf3tm1Pjln/\Srsf3tm1Pjln
\Speer6-ps1Tg(Alb-cre)21Mgn/\Speer6-ps1+
(involves: BALB/c * C57BL/6 * DBA) 		abnormal thymus development J:205756
\Srxn1tm1Sgrh/\Srxn1tm1Sgrh
\Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J) 		adrenal gland hyperplasia J:222986
\Ssbp2tm1Lana/\Ssbp2tm1Lana
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S/SvEv * 129S2/SvPas * BALB/c * C57BL/6) 		increased T cell derived lymphoma incidence J:162035
thymus hypoplasia J:162035
\Ssr2tm1b(EUCOMM)Wtsi/\Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi) 		abnormal thymus morphology J:239583
\Sstr5tm1Fcb/\Sstr5tm1Fcb
(involves: 129 * C57BL/6J) 		decreased pancreatic beta cell number J:91762
\Sstr5tm1Fcb/\Sstr5tm1Fcb
(involves: 129) 		abnormal pancreatic alpha cell morphology J:179577
\Sstr5tm1Fcb/\Sstr5tm2Fcb
\Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA) 		decreased pancreatic delta cell number J:99786
\Startm1Klp/\Startm1Klp
(involves: 129P2/OlaHsd) 		abnormal adrenal cortex morphology J:43589
abnormal adrenal gland morphology J:43589
adrenal cortical hyperplasia J:43589
\Stat3tm1Dnl/\Stat3tm1Dlv
(involves: C57BL/6) 		decreased thymocyte number J:87599
\Stat4tm1Gru/\Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru) 		abnormal pancreatic beta cell morphology J:90600
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		disorganized pancreatic islets J:127051
\Stat5atm2Mam/\Stat5atm2Mam
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		disorganized pancreatic islets J:127051
\Stat5atm2Mam/\Stat5atm2Mam
\Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J) 		decreased pancreatic beta cell mass J:284574
\Stat5btm1Hwd/\Stat5btm1Hwd
(involves: C57BL/6) 		decreased thymocyte number J:112035
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA) 		disorganized pancreatic islets J:127051
\Stat5btm1Mam/\Stat5btm1Mam
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA) 		disorganized pancreatic islets J:127051
\Stk4tm1.1Kina/\Stk4tm1.1Kina
(involves: C57BL/6) 		thymus hyperplasia J:148791
\Stk4tm1.1Wtao/\Stk4tm1.2Wtao
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL/J) 		increased thymocyte number J:152323
\Stk4tm1.2Wtao/\Stk4tm1.2Wtao
(involves: 129S4/SvJaeSor * 129S6/SvEvTac) 		increased thymocyte number J:152323
\Stk11tm1.1Rdp/\Stk11tm1.1Rdp
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * FVB/N * ICR) 		abnormal pancreatic islet morphology J:134078
decreased pancreatic alpha cell number J:134078
decreased pancreatic beta cell number J:134078
decreased pancreatic delta cell number J:134078
small pancreatic islets J:134078
\Stk11tm1.1Sjm/\Stk11tm1.1Sjm
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL) 		thymus hypoplasia J:165090
\Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Stk26tm1b(EUCOMM)Hmgu/\Stk26tm1b(EUCOMM)Hmgu
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal adrenal gland morphology J:211773
enlarged adrenal glands J:211773
\Stk36tm1Fjs/\Stk36tm1Fjs
(involves: 129S1/Sv * C57BL/6) 		thymus atrophy J:116391
\Stk38tm1Hem/\Stk38+
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
\Stk38tm1Hem/\Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6) 		increased T cell derived lymphoma incidence J:185408
\Stub1tm1Cpat/\Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6) 		thymus atrophy J:86213
thymus hypoplasia J:86213
\Stx1btm1.1Sud/\Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal adrenal chromaffin cell morphology J:138035
\Stx7em1(IMPC)Rbrc/\Stx7em1(IMPC)Rbrc
(C57BL/6NJcl-Stx7em1(IMPC)Rbrc/Rbrc) 		abnormal thymus morphology J:211773
small thymus J:211773
\sty/\sty
(Not Specified) 		small thymus J:3675
\Sult1a1em1(IMPC)Ccpcz/\Sult1a1em1(IMPC)Ccpcz
(C57BL/6NCrl-Sult1a1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Supv3l1tm2.1Jkl/\Supv3l1tm2.2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		thymus atrophy J:144991
thymus hypoplasia J:144991
\Supv3l1tm2Jkl/\Supv3l1tm2Jkl
\Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6) 		thymus atrophy J:144991
thymus hypoplasia J:144991
\Syktm2.1(ZAP70)Fkfr/\Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr) 		decreased DN1 thymic pro-T cell number J:188422
increased DN3 thymocyte number J:188422
\Syngr1em1(IMPC)Ccpcz/\Syngr1em1(IMPC)Ccpcz
(C57BL/6NCrl-Syngr1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Syt1tm1a(EUCOMM)Wtsi/\Syt1tm1a(EUCOMM)Wtsi
(C57BL/6N-Syt1tm1a(EUCOMM)Wtsi/Wtsi) 		adrenal gland cyst J:239583
thyroid gland cyst J:239583
\Sytl1tm1Tiz/\Sytl1tm1Tiz
\Sytl4tm1Tiz/\Sytl4tm1Tiz
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac) 		abnormal pancreatic beta cell morphology J:200233
\Sytl4tm1Tiz/Y
(involves: 129P2/OlaHsd) 		abnormal corticotroph morphology J:145238
\Sytl4tm1Tiz/\Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He) 		abnormal pancreatic beta cell morphology J:102610
\tAE5/\tAE5
(Not Specified) 		abnormal thymus cortex morphology J:83862
abnormal thymus morphology J:83862
thymus cortex hypoplasia J:83862
\Tacc3tm1Jni/\Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymocyte number J:74762
small thymus J:74762
\Taf7tm1.1Dss/\Taf7tm1.2Dss
\Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6) 		decreased thymocyte number J:185745
\Taf7tm1.1Dss/\Taf7tm1.2Dss
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6) 		decreased thymocyte number J:185745
small thymus J:185745
\Tas2r102em1(IMPC)Bay/\Tas2r102em1(IMPC)Bay
(C57BL/6N-Tas2r102em1(IMPC)Bay/Bay) 		abnormal adrenal gland morphology J:211773
\Tasp1tm1Jjdh/\Tasp1tm1Jjdh
\Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA) 		decreased thymocyte number J:112159
decreased thymus weight J:112159
\tb/\tb
(Not Specified) 		absent lactotrophs J:12166
pituitary gland hyperplasia J:12166
\Tbatatm1Faf/\Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus epithelium morphology J:166065
enlarged thymus J:166065
increased thymocyte number J:166065
thymus hyperplasia J:166065
\Tbx1m1H/\Tbx1m1H
(involves: C3H/HeH * C57BL/6J) 		small thymus J:169366
\Tbx1m1Jlk/\Tbx1m1Jlk
(129/Sv-Tbx1m1Jlk) 		athymia J:146769
\Tbx1m1Jlk/\Tbx1tm1Bld
(involves: 129) 		athymia J:146769
\Tbx1tm1.1Dsr/\Tbx1tm1.1Dsr
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		athymia J:93588
\Tbx1tm1Bem/\Tbx1tm1Bem
(FVB.Cg-Tbx1tm1Bem) 		absent parathyroid glands J:91664
absent ultimobranchial body J:91664
athymia J:91664
thymus hypoplasia J:91664
\Tbx1tm1Bld/\Tbx1tm1Bld
(involves: 129S7/SvEvBrd) 		athymia J:146769
\Tbx1tm1Bld/\Tbx1tm2.1Bem
\Tfap2atm1(cre)Moon/\Tfap2a+
(either: (involves: 129/Sv * C57BL/6 * SJL) or (involves: 129/Sv * C57BL/6J * CBA * SJL)) 		athymia J:154590
thymus hypoplasia J:154590
\Tbx1tm1Bld/\Tbx1tm5Bld
(involves: 129S7/SvEvBrd * C57BL/6) 		athymia J:112457
\Tbx1tm1Dsr/\Tbx1tm1Dsr
(either: 129/Sv or (involves: 129/Sv * C57BL/6)) 		athymia J:93588
\Tbx1tm1Pa/\Tbx1tm1Pa
(either: (involves: 129) or (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * Swiss Webster)) 		abnormal thymus development J:70730
absent parathyroid glands J:70730
athymia J:70730
\Tbx1tm2.1Bem/\Tbx1tm2.2Bem
\Foxg1tm1(cre)Skm/\Foxg1+
(involves: 129 * C57BL/6J * SJL * Swiss Webster) 		absent parathyroid glands J:105980
athymia J:105980
small thyroid gland J:105980
\Tbx19tm1Jdr/\Tbx19tm1Jdr
(either: (involves: 129/Sv) or (involves: BALB/c)) 		adrenal gland hypoplasia J:82562
decreased corticotroph cell number J:82562
\Tcaf2em1(IMPC)Ccpcz/\Tcaf2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tcaf2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tcf3tm1Wein/\Tcf3tm1Wein
(involves: 129S4/SvJaeSor * C57BL/6) 		enlarged thymus J:44278
increased T cell derived lymphoma incidence J:44278
\Tcf3tm1Zhu/\Tcf3tm1Zhu
(involves: 129 * C57BL/6J) 		thymus hypoplasia J:136143
\Tcf3tm2Wein/\Tcf3tm2Wein
(Not Specified) 		increased T cell derived lymphoma incidence J:47671
\Tcf4tm1Hmb/\Tcf4tm1Zhu
\Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		decreased thymocyte number J:65236
\Tcf7tm1Cle/\Tcf7tm1Cle
(involves: 129P2/OlaHsd) 		thymus cortex hypoplasia J:23255
thymus hypoplasia J:23255
\Tcf7tm2Cle/\Tcf7tm2Cle
(involves: 129P2/OlaHsd) 		thymus hypoplasia J:23255
\Tcf7l2tm1a(EUCOMM)Wtsi/\Tcf7l2tm1a(EUCOMM)Wtsi
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi) 		abnormal neurohypophysis morphology J:239583
\Tcf7l2tm1Cle/\Tcf7l2tm1Cle
(involves: 129P2/OlaHsd) 		abnormal pituitary intermediate lobe morphology J:86317
enlarged adenohypophysis J:86317
enlarged pituitary gland J:86317
\Tcf7l2tm1Geno/\Tcf7l2tm1Geno
\Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA) 		decreased pancreatic beta cell mass J:189204
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd) 		decreased thymocyte number J:120411
\Tcf12tm1Zhu/\Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J) 		thymus hypoplasia J:136143
\Tcf12tm2Zhu/\Tcf12tm2Zhu
(Not Specified) 		decreased thymocyte number J:120411
thymus hypoplasia J:120411
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tcf3tm4Zhu/\Tcf3tm4Zhu
\Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J) 		thymus hypoplasia J:129570
\Tcf12tm3Zhu/\Tcf12tm3Zhu
\Tg(Lck-cre)#Zhu/0
(involves: C57BL/6 * SJL/J) 		decreased thymocyte number J:129570
\Tcirg1oc/\Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J) 		abnormal thyroid gland morphology J:7870
\Tcirg1tm1Utku/\Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6) 		thymus atrophy J:92730
\Tcof1tm1Mjd/\Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal Rathke's pouch development J:62928
\Tcra-Jtm1Slek/\Tcra-Jtm1Slek
(involves: 129P2/OlaHsd) 		increased thymocyte number J:101398
\TcraLn1Ogu/\Tcra+
(involves: 129/Sv * C57BL/6) 		decreased thymocyte number J:152041
\TcraLn3Jae/\Tcra+
(B6.Cg-TcraLn3Jae) 		thymus hypoplasia J:143006
\TcraLn3Jae/\Tcra+
\TcrbLn3Jae/\Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae) 		thymus hypoplasia J:143006
\Tcratm1Mass/\Tcra+
\Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA) 		decreased thymocyte number J:201417
\Tcratm1Mjo/\Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c) 		abnormal thymus cortex morphology J:1292
absent thymus medulla J:1292
enlarged thymus cortex J:1292
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\H2b/\H2b
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased thymocyte number J:131357
\Tcratm1Mom/\Tcra/Tcrdtm1.1(Tcra)Rsky
\H2d/\H2d
\Ptcratm1Vbo/\Ptcratm1Vbo
\Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		decreased thymocyte number J:131357
\Tcratm1Mom/\Tcratm1Mom
\Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6) 		thymus hypoplasia J:3206
\Tcrbtm1Mom/\Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c) 		thymus hypoplasia J:3206
\Tcrbtm1Mom/\Tcrbtm1Mom
\Tcrdtm1Mom/\Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6) 		thymus hypoplasia J:3206
\Tcrgtm1Scar/\Tcrgtm1Scar
(B6.Cg-Tcrgtm1Scar) 		enlarged thymus J:105477
thymus hyperplasia J:105477
\Tdp2tm1.1Huy/\Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1) 		thymus atrophy J:195301
\Tekt1em1(IMPC)Ccpcz/\Tekt1em1(IMPC)Ccpcz
(C57BL/6NCrl-Tekt1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ten1em1(IMPC)Hmgu/\Ten1em1(IMPC)Hmgu
(involves: C57BL/6NCrl) 		abnormal thymus medulla morphology J:365069
thymus atrophy J:365069
thymus cortex hypoplasia J:365069
\Tenm4em1(IMPC)Tcp/\Tenm4em1(IMPC)Tcp
(C57BL/6NCrl-Tenm4em1(IMPC)Tcp/Tcp) 		small adrenal glands J:211773
\Tent2em1(IMPC)Ccpcz/\Tent2+
(C57BL/6NCrl-Tent2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Terb1tm1b(KOMP)Mbp/\Terb1+
(C57BL/6N-Terb1tm1b(KOMP)Mbp/Ucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tespa1tm1Smoc/\Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc) 		abnormal thymus morphology J:186446
small thymus medulla J:186446
\Tet2Gt(AN0709)Wtsi/\Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi) 		increased DN1 thymic pro-T cell number J:174052
\Tet2tm1Ics/\Tet2tm1Ics
\Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA) 		increased DN1 thymic pro-T cell number J:174052
\Tfamtm1Lrsn/\Tfamtm1Lrsn
\Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA) 		absent pancreatic beta cells J:65522
\Tfb2mtm1a(KOMP)Wtsi/\Tfb2m+
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		decreased pancreatic beta cell mass J:256448
decreased pancreatic islet number J:256448
\Tfb2mtm1a(KOMP)Wtsi/\Tfb2mtm1a(KOMP)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J) 		abnormal pancreatic beta cell morphology J:256448
decreased pancreatic beta cell mass J:256448
decreased pancreatic islet number J:256448
\Tg(ACTB-Artn)1Wss/0
(involves: C57BL/6Crl * DBA/2Crl) 		abnormal adrenal gland morphology J:90843
abnormal adrenal medulla morphology J:90843
increased adrenal gland tumor incidence J:90843
\Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N) 		abnormal adrenal gland morphology J:160015
increased pituitary gland weight J:160015
increased prolactinoma incidence J:160015
pituitary gland hyperplasia J:160015
\Tg(ANX6)2Agh/0
(FVB/N-Tg(ANX6)2Agh) 		thymus cortex hypoplasia J:92579
\Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6 * DBA/2) 		small pancreatic islets J:57075
\Tg(Apcs-Lep)1Yog/0
(involves: C57BL/6J * FVB/N) 		small pancreatic islets J:69591
\Tg(APCS-Tnfsf11*)#aKhs/0
(C57BL/6J-Tg(APCS-Tnfsf11*)#aKhs) 		enlarged thymus medulla J:264357
\Tg(APOE-Artn)1Wss/0
(involves: C57BL/6Crl * DBA/2Crl) 		abnormal adrenal gland morphology J:90843
abnormal adrenal medulla morphology J:90843
increased adrenal gland tumor incidence J:90843
\Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA) 		enlarged parathyroid gland J:93981
\Tg(AZIP/F)1Vsn/0
(involves: FVB/N) 		pancreatic islet hyperplasia J:50807
\Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J) 		increased pancreatic beta cell mass J:145998
\Tg(BCL2)22Wehi/0
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * C57BL/6JWehi * SJL/J * SJL/JWehi) 		enlarged thymus J:69571
\Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi) 		increased T cell derived lymphoma incidence J:93111
\Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
\Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N) 		adrenal gland hyperplasia J:186696
\Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
\Thtm1(cre)Te/\Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		adrenal gland hyperplasia J:186696
\Tg(CAG-Bgeo,-Nkx6-1,-EGFP)#Msan/0
\Tg(Neurog3-cre)C1Able/0
(involves: BALB/c * C57BL/6) 		decreased pancreatic alpha cell number J:195153
decreased pancreatic delta cell number J:195153
decreased pancreatic epsilon cell number J:195153
increased pancreatic beta cell number J:195153
\Tg(CAG-Bgeo/ALPP)1Lbe/0
\Tg(Ins2-cre/ERT)1Dam/0
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-DTA)1Gfi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased pancreatic beta cell number J:127412
\Tg(CAG-CYP27A1)23Etl/0
(involves: C57BL/6JOlaHsd * CBA) 		enlarged adrenal glands J:78951
\Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0
\Tg(TPO-cre)1Shk/0
(involves: FVB/NCr * FVB/NJ) 		thyroid gland hyperplasia J:177181
\Tg(CAG-Ncoa6)71Hwl/0
(involves: FVB) 		abnormal adrenal gland morphology J:80609
abnormal pituitary gland morphology J:80609
thymus atrophy J:80609
\Tg(CAG-Ncoa6)87Hwl/0
(involves: FVB) 		abnormal adrenal gland morphology J:80609
abnormal pituitary gland morphology J:80609
thymus atrophy J:80609
\Tg(CAG-Ncoa6)104Hwl/0
(involves: FVB) 		abnormal adrenal gland morphology J:80609
abnormal pituitary gland morphology J:80609
thymus atrophy J:80609
\Tg(CD2-Lmo2)#Thr/0
(involves: C57BL/6 * CBA) 		enlarged thymus J:102058
\Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6) 		thymus atrophy J:212571
\Tg(CD2-Myb/en)2Kmw/\Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA) 		small thymus J:126456
\Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6) 		thymus hypoplasia J:80066
\Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci) 		increased T cell derived lymphoma incidence J:93665
\Tg(CD3E)26Cpt/\Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J) 		abnormal thymus corticomedullary boundary morphology J:81711
decreased thymocyte number J:81711
thymus hypoplasia J:54756
\Tg(CD4-HIV)F21380Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F21388Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F21407Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F26605Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F26622Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F26990Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F27011Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(CD4-HIV)F27367Pjo/0
(involves: C3H * C57BL/6) 		thymus atrophy J:78756
\Tg(Cd4-NPM/ALK)N1Ingh/0
(either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster)) 		increased lymphoblastic lymphoma incidence J:82127
\Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster) 		increased DN3 thymocyte number J:235890
increased thymus tumor incidence J:235890
\Tg(Cd4-NPM/ALK)N1Ingh/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster) 		abnormal thymus morphology J:235890
increased T cell derived lymphoma incidence J:235890
\Tg(Cd8b1)46Erob/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		decreased thymocyte number J:110916
\Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6) 		abnormal thymus morphology J:79703
\Tg(Cga-LHB/CGB)94Jhn/?
(involves: C57BL/6 * SJL) 		abnormal adrenocortical cell morphology J:125349
\Tg(Ckm-IGF1R*K1003R)1Dlr/0
(FVB/N-Tg(Ckm-IGF1R*K1003R)1Dlr) 		pancreatic islet hyperplasia J:71205
\Tg(CMV-cre)1Cgn/0
\Trp53tm4Att/\Trp53+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J) 		small thymus J:217080
\Tg(CMV-tTA)3Bjd/0
\Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		abnormal adrenal cortex morphology J:95465
abnormal adrenal gland morphology J:94953
abnormal adrenal gland x-zone morphology J:95465, J:94953
abnormal adrenocortical cell morphology J:95465
abnormal thyroid follicle morphology J:95465, J:94953
adrenal cortical hyperplasia J:95465
adrenal gland hyperplasia J:94953
increased thyroid adenoma incidence J:95465, J:94953
retention of the adrenal gland x-zone J:95465
thyroid gland cyst J:95465
thyroid gland hyperplasia J:94953
\Tg(Col1a1-Ptprv)1Kry/?
(Not Specified) 		decreased pancreatic beta cell mass J:126780
\Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL) 		decreased thymus weight J:92996
enlarged adrenal glands J:92996
\Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ) 		decreased pancreatic beta cell number J:97926
\Tg(EEF1A1-SHC1*)1Ravi/?
\Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6) 		thymus hypoplasia J:78180
\Tg(Ela1-TAg)18Bri/0
(involves: C57BL/6 * SJL) 		pancreatic islet hyperplasia J:76995
\Tg(Ela1-TAg)19Bri/0
(involves: C57BL/6 * SJL) 		pancreatic islet hyperplasia J:76995
\Tg(Emu-Pim1)64aBrn/0
(involves: C57BL/6LiA * CBA) 		enlarged thymus J:79624
increased T cell derived lymphoma incidence J:79624
\Tg(Fli1)1Ber/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1) 		increased thymocyte number J:33052
\Tg(Gcg-TAg)25Ddr/?
(involves: CD-1) 		abnormal pancreatic islet morphology J:91490, J:101537
enlarged pancreatic islets J:101537
pancreatic islet hyperplasia J:91490
\Tg(Ggamma-T)15Cps/0
(involves: C57BL/6J * CBA/J) 		increased adrenal gland tumor incidence J:38778
\Tg(Ggamma-T)15Cps/\Tg(Ggamma-T)15Cps
(involves: C57BL/6J * CBA/J) 		increased adrenal gland tumor incidence J:38778
\Tg(Gh1-rtTA)4-3Jek/0
\Tg(tetO-Egfr*)2-9Jek/0
(involves: C57BL/6 * SJL) 		abnormal gonadotroph morphology J:68692
decreased lactotroph cell number J:68692
decreased somatotroph cell number J:68692
small adenohypophysis J:68692
\Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL) 		increased pituitary adenoma incidence J:86486
pituitary gland hyperplasia J:86486
\Tg(GHRL-TAg)1-5Hiwa/0
(C57BL/6-Tg(GHRL-TAg)1-5Hiwa) 		increased thyroid tumor incidence J:152492
\Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem/0
(either: FVB-Tg(GNB1L,TBX1,GP1BB,SEPT5)23Bem or (involves: C57BL/6 * FVB)) 		abnormal thymus development J:67796
abnormal thymus lobule morphology J:67796
decreased thymocyte number J:67796
thymus hypoplasia J:67796
\Tg(Gnrh1-Fgfr1)1Tsai/\Tg(Gnrh1-Fgfr1)1Tsai
(involves: C57BL/6J * DBA/2J) 		abnormal gonadotropin-releasing hormone neuron morphology J:95057
decreased gonadotropin-releasing hormone neuron number J:95057
\Tg(Gpbar1)1Auw/0
(involves: C57BL/6J) 		abnormal pancreatic islet size J:152388
\Tg(H2-K-BCL2)1Josd/0
(involves: C57BL/6 * C57BL/Ka * C3H) 		enlarged thymus J:80894
\Tg(H2-K-Fosl2,-EGFP)13Wag/0
(either: 129.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag or B6.Cg-Tg(H2-K-Fosl2,-EGFP)13Wag) 		thymus fibrosis J:139032
\Tg(H2KmPCC)2939Stoe/0
\Tg(Tcra2B4)1Mmd/0
\Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL) 		decreased thymocyte number J:50143
\Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J) 		abnormal pancreatic alpha cell morphology J:96353
abnormal pancreatic beta cell morphology J:96353
abnormal pancreatic delta cell morphology J:96353
decreased pancreatic beta cell number J:96353
\Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified) 		increased T cell derived lymphoma incidence J:178816
\Tg(Igh-Mir155)8Cro/0
(involves: FVB/N) 		increased lymphoblastic lymphoma incidence J:109591
\Tg(Igh-Pim1)1Brn/0
(involves: C57BL/6LiA * CBA) 		enlarged thymus J:79624
increased T cell derived lymphoma incidence J:79624
\Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL) 		enlarged thymus J:78177
\Tg(Ins1-Cat,Tyr)25Pne/0
(NOD.FVB-Tg(Ins1-Cat,Tyr)25Pne) 		abnormal pancreatic islet morphology J:108415
decreased pancreatic beta cell number J:108415
\Tg(Ins1-Cd80)378Psoh/0
\Tg(Ins2-GP)#Psoh/0
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		absent pancreatic beta cells J:209714
\Tg(Ins1-EGFP/GH1)14Hara/0
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		decreased pancreatic beta cell number J:127015
\Tg(Ins1-EGFP/GH1)14Hara/\Tg(Ins1-EGFP/GH1)14Hara
(NOD/ShiLtJ-Tg(Ins1-EGFP/GH1)14Hara) 		abnormal pancreatic beta cell morphology J:127015
\Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL) 		abnormal pancreatic beta cell morphology J:72216
abnormal pancreatic islet morphology J:72216
decreased pancreatic beta cell number J:72216
enlarged pancreatic islets J:72216
increased pancreatic beta cell mass J:72216
increased pancreatic islet number J:72216
\Tg(Ins2-Akt1*)3Mbb/0
(B6.Cg-Tg(Ins2-Akt1*)3Mbb) 		abnormal pancreatic beta cell morphology J:144599
abnormal pancreatic islet morphology J:144599
enlarged pancreatic islets J:144599
increased pancreatic beta cell mass J:144599
\Tg(Ins2-Ccl19)2Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:77238
\Tg(Ins2-Ccl19)2Cys/0
\Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:77238
\Tg(Ins2-Ccl21b)2Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:77238
\Tg(Ins2-CD80)3B7Flv/0
\Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		abnormal pancreatic islet morphology J:93555
\Tg(Ins2-CD86)12B70Flv/0
\Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * CBA/Ca * SJL) 		decreased pancreatic beta cell number J:93555
\Tg(Ins2-CDKN1B)1Maka/0
(involves: C57BL/6J) 		abnormal pancreatic islet morphology J:96047
decreased pancreatic beta cell number J:96047
\Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6) 		decreased pancreatic beta cell mass J:156725
\Tg(Ins2-cre)23Herr/0
\Tsc2tm1Kido/\Tsc2tm1Kido
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA/J) 		abnormal pancreatic islet morphology J:135811
decreased pancreatic beta cell number J:135811
increased pancreatic beta cell mass J:135811
pancreatic islet hyperplasia J:135811
\Tg(Ins2-Cxcl12)2Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:77238
\Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:77238, J:110548
\Tg(Ins2-Fasl)24Ach/0
(NOD-Tg(Ins2-Fasl)24Ach/J) 		abnormal pancreatic islet morphology J:78679
\Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6) 		abnormal pancreatic islet morphology J:81287
absent pancreatic beta cells J:81287
\Tg(Ins2-HA)165Bri/0
\Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: BALB/c * C57BL/6 * C57BL/10 * DBA/2) 		abnormal pancreatic islet morphology J:99756
\Tg(Ins2-HBEGF)5Rin/?
(C57BL/6-Tg(Ins2-HBEGF)5Rin) 		abnormal pancreatic islet morphology J:204420
decreased pancreatic beta cell number J:204420
\Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J) 		abnormal pancreatic beta cell morphology J:134757
decreased pancreatic beta cell number J:134757
disorganized pancreatic islets J:134757
increased pancreatic alpha cell number J:134757
\Tg(Ins2-Iapp)6Soel/\Tg(Ins2-Iapp)6Soel
(involves: FVB/N) 		abnormal pancreatic islet morphology J:130022
\Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc) 		abnormal pancreatic islet morphology J:142009
decreased pancreatic beta cell mass J:142009
decreased pancreatic beta cell number J:142009
\Tg(Ins2-IAPP)RHFSoel/\Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N) 		abnormal pancreatic islet morphology J:130022
decreased pancreatic beta cell mass J:130022
\Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6) 		abnormal pancreatic beta cell morphology J:94000
\Tg(Ins2-Lta)#Flv/0
(involves: NOD) 		abnormal pancreatic islet morphology J:91820
\Tg(Ins2-Lta)#Flv/0
(involves: C57BL/6) 		abnormal pancreatic islet morphology J:91820
\Tg(Ins2-Mir184)4Mnpy/0
(Not Specified) 		decreased pancreatic beta cell mass J:210552
\Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat) 		decreased pancreatic beta cell mass J:314874
\Tg(Ins2-Nos2)31Okam/0
(involves: C57BL/6 * CD-1 * DBA/2) 		abnormal pancreatic islet morphology J:45520
decreased pancreatic beta cell mass J:45520
\Tg(Ins2-Nos2)40Okam/0
(involves: C57BL/6 * CD-1 * DBA/2) 		abnormal pancreatic islet morphology J:45520
decreased pancreatic beta cell mass J:45520
\Tg(Ins2-NP)25-3Olds/0
(involves: BALB/c * C57BL/6) 		abnormal pancreatic islet morphology J:81284, J:81287
\Tg(Ins2-OVA)307Wehi/0
\Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * C57BL/6JWehi) 		decreased pancreatic beta cell number J:99451
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA) 		increased pancreatic beta cell mass J:210552
increased pancreatic beta cell number J:210552
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-DTA)1Gfi/0
(involves: C57BL/6 * CBA) 		abnormal pancreatic beta cell morphology J:127412
decreased pancreatic beta cell number J:127412
disorganized pancreatic islets J:127412
increased pancreatic beta cell number J:127412
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA) 		decreased pancreatic beta cell mass J:210552
decreased pancreatic beta cell number J:210552
\Tg(Ins2-rtTA)2Efr/0
\Tg(tetO-Sri)10Hhv/0
(involves: C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:246708
\Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL) 		abnormal pancreatic islet morphology J:73760
decreased pancreatic beta cell number J:73760
disorganized pancreatic islets J:73760
small pancreatic islets J:73760
\Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA * NOD) 		abnormal pancreatic islet morphology J:91820
\Tg(Ins2-Tnf)17Flv/0
(involves: C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:91820
\Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL) 		disorganized pancreatic islets J:141527
increased pancreatic beta cell mass J:141527
pancreatic islet hyperplasia J:141527
\Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * C57BLKs/J * SJL) 		disorganized pancreatic islets J:141527
pancreatic islet hyperplasia J:141527
\Tg(INS-MT2A,Tyr)1Pne/0
(FVB-Tg(INS-MT2A,Tyr)1Pne) 		abnormal pancreatic islet morphology J:95089
\Tg(INS-MT2A,Tyr)1Pne/0
(NOD.FVB-Tg(INS-MT2A,Tyr)1Pne) 		abnormal pancreatic islet morphology J:108415
decreased pancreatic beta cell number J:108415
\Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro) 		abnormal thymus corticomedullary boundary morphology J:80777
thymus hypoplasia J:80777
\Tg(KRT14-Edn3)1Takk/?
(B6.Cg-Tg(KRT14-Edn3)1Takk) 		increased thyroid tumor incidence J:104881
\Tg(KRT19-TAg)7Eps/0
(involves: FVB/N) 		enlarged adrenal glands J:64395
increased adrenal gland tumor incidence J:64395
\Tg(Lck)4220Rmp/0
(involves: C57BL/6J * DBA/2) 		increased T cell derived lymphoma incidence J:88120
\Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6) 		decreased thymocyte number J:73487
increased T cell derived lymphoma incidence J:73487
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: C3H/He * C57BL/6) 		decreased thymocyte number J:73487
increased T cell derived lymphoma incidence J:73487
\Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified) 		increased T cell derived lymphoma incidence J:144975
\Tg(Lck-Akt2*)#Test/0
(Not Specified) 		increased T cell derived lymphoma incidence J:153923
\Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2) 		decreased thymocyte number J:226234
\Tg(Lck-cre)548Jxm/?
\Tgfb1tm2.1Doe/\Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA) 		decreased thymus weight J:150024
thymus hypoplasia J:150024
\Tg(Lck-cre)548Jxm/?
\Upf2tm1Btp/\Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA) 		thymus hypoplasia J:134765
\Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6) 		decreased thymocyte number J:100451
\Tg(Lck-FADD)1Hed/\Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6) 		decreased thymocyte number J:100451
\Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro) 		thymus hyperplasia J:80777
\Tg(Lck-Id1)28Xhsu/0
(Not Specified) 		increased T cell derived lymphoma incidence J:58607
\Tg(Lck-LMO1)11Sjk/0
\Tg(STIL-TAL1)A5.3Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros) 		enlarged thymus J:40868
increased T cell derived lymphoma incidence J:40868
\Tg(Lck-Map3k8)3456Ngc/?
(involves: C3H/HeJ * C57BL/6J) 		increased T cell derived lymphoma incidence J:39450
\Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2) 		increased lymphoblastic lymphoma incidence J:63300
increased T cell derived lymphoma incidence J:96010
increased thymocyte number J:63300
thymus hyperplasia J:63300
\Tg(Lck-Socs3)1Kubo/0
(Not Specified) 		decreased thymocyte number J:128797
\Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6) 		decreased thymocyte number J:117301
\Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals) 		decreased thymocyte number J:149973
\Tg(Lck-Stk17b)26.1Wals/?
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10) 		decreased thymocyte number J:149973
\Tg(Lck-Tal1)4709Led/0
(FVB/N-Tg(Lck-Tal1)4709Led) 		abnormal thymus morphology J:36076
increased lymphoblastic lymphoma incidence J:36076
\Tg(Lck-Tax)53Hall/0
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:129531
\Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J) 		abnormal thymus cell ratio J:92453
abnormal thymus morphology J:92453
thymus cortex hypoplasia J:92453
thymus hypoplasia J:92453
\Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J) 		abnormal thymus cell ratio J:93005
increased T cell derived lymphoma incidence J:93005
\Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6) 		abnormal thymus cell ratio J:11548
increased T cell derived lymphoma incidence J:28635
\Tg(Mafg-Nfe2l1)1Mym/0
(involves: C57BL/6J * DBA/2) 		abnormal pancreatic beta cell morphology J:230118
enlarged pancreatic islets J:230118
\Tg(Mafg-Nfe2l1)6Mym/0
(involves: C57BL/6J * DBA/2) 		abnormal pancreatic beta cell morphology J:230118
enlarged pancreatic islets J:230118
\Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:69755
increased thymocyte number J:50604
\Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased pituitary adenoma incidence J:51661
\Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased pituitary adenoma incidence J:93548
\Tg(Mt1a-GPHB5)1Sok/0
(involves: C57BL/6) 		abnormal adrenal cortex morphology J:105176
abnormal thyroid follicle morphology J:105176
abnormal thyroid follicular cell morphology J:105176
\Tg(MtTGFA)Lmb/0
(involves: CD-1) 		abnormal pancreatic islet morphology J:229184
\Tg(Mx1-cre)1Cgn/0
\Zmiz1tm1c(EUCOMM)Hmgu/\Zmiz1tm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA/J) 		thymus hypoplasia J:234445
\Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL) 		increased adrenal gland tumor incidence J:54269
\Tg(Pdx1-Ffar1)AHeed/0
(Not Specified) 		disorganized pancreatic islets J:129843
\Tg(Pdx1-Myt1)2Ggu/0
(Not Specified) 		abnormal pancreatic islet morphology J:136131
\Tg(PGK1-KITLG*220)441Daw/\Tg(PGK1-KITLG*220)441Daw
(C3H/HeJ-Tg(PGK1-KITLG*220)441Daw) 		abnormal thymus morphology J:32600
\Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N) 		increased T cell derived lymphoma incidence J:17848
\Tg(Pklr-HRAS*G12V)21Ak/0
(involves: C57BL/6 * DBA/2) 		abnormal thymus morphology J:44803
enlarged thymus J:44803
\Tg(Pklr-Myc)73Ak/0
(involves: C57BL/6 * DBA) 		pancreatic islet hyperplasia J:185488
\Tg(Pklr-SV40)1Ak/0
(involves: C57BL/6 * DBA) 		pancreatic islet hyperplasia J:185488
\Tg(Prl-EGFR)#Sme/0
(Not Specified) 		increased prolactinoma incidence J:219654
\Tg(PTH-CCND1)PC2Anar/0
(FVB/N-Tg(PTH-CCND1)PC2Anar) 		abnormal parathyroid gland morphology J:69423
enlarged parathyroid gland J:69423
increased parathyroid adenoma incidence J:69423
parathyroid gland hyperplasia J:69423
\Tg(PyLT)1Vb/0
(Not Specified) 		abnormal adrenal cortex morphology J:55528
adrenal medulla hyperplasia J:55528
enlarged adrenal glands J:55528
increased adrenal gland weight J:55528
increased pituitary adenoma incidence J:55528
increased pituitary gland tumor incidence J:55528
thin adrenal cortex J:55528
\Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6) 		enlarged pineal gland J:60231
increased pineal gland tumor incidence J:60231
\Tg(RIP1-Tag)2Dh/0
(involves: C57BL/6J * DBA/2J) 		abnormal pancreatic islet morphology J:50695
decreased pancreatic alpha cell number J:50695
decreased pancreatic delta cell number J:50695
increased pancreatic beta cell number J:50695
\Tg(RIP1-Tag)5Dh/?
(C3HeB/FeJ-Tg(RIP1-Tag)5Dh) 		abnormal pancreatic islet morphology J:80168
\Tg(RIR-Tag)87Dh/0
(involves: C57BL/6J * DBA/2J) 		abnormal pancreatic islet morphology J:50695
decreased pancreatic alpha cell number J:50695
decreased pancreatic delta cell number J:50695
increased pancreatic beta cell number J:50695
\Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca) 		decreased pancreatic alpha cell number J:91709
decreased pancreatic beta cell mass J:91709
decreased pancreatic beta cell number J:91709
decreased pancreatic delta cell number J:91709
decreased PP cell number J:91709
increased pancreatic alpha cell number J:91709
increased pancreatic beta cell number J:91709
\Tg(Rr158-H2-Ead)1Flv/0
\Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL) 		thymus hypoplasia J:124574
\Tg(rTH-Tag)20Dmc/0
(involves: C57BL/6NTac * DBA/2NTac) 		increased adrenal gland tumor incidence J:90323
\Tg(Sox3)1Pqt/0
\Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA) 		abnormal subcommissural organ morphology J:184232
absent pineal gland J:184232
\Tg(Sox3-EGFP)NrPqt/0
(involves: C57BL/6 * CBA) 		abnormal subcommissural organ morphology J:184232
\Tg(SREBP1a)7343Reh/0
(B6.Cg-Tg(SREBP1a)7343Reh) 		increased pancreatic beta cell mass J:100328
pancreatic islet hyperplasia J:100328
\Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA) 		decreased thymus weight J:77977
\Tg(SV40-NRAS*G12D)1Sco/?
(Not Specified) 		increased T cell derived lymphoma incidence J:125150
\Tg(SV)419Bri/\Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri) 		increased T cell derived lymphoma incidence J:147031
\Tg(SV)427Bri/0
(C57BL/6J-Tg(SV)427Bri) 		enlarged thymus J:79096
\Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N) 		decreased thymocyte number J:55022
increased T cell derived lymphoma incidence J:55022
thymus hypoplasia J:55022
\Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6) 		abnormal thymus cell ratio J:92992
decreased thymocyte number J:92992
\Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL) 		decreased thymocyte number J:95380
\Tg(TcraDN32D3)#Alhn/0
(involves: NOD) 		decreased thymocyte number J:201417
\Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J) 		decreased thymocyte number J:79738
thymus hypoplasia J:79738
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J) 		abnormal thymus morphology J:84536
increased thymocyte number J:84536
\Tg(Tcrb-TCF3/PBX1)19Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J) 		decreased thymocyte number J:95693
\Tg(Tcrb-TCF3/PBX1)23Gusa/0
(involves: C3H * C57BL/6 * C57BL/6J) 		decreased thymocyte number J:95693
\Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd) 		abnormal thymus cell ratio J:78309
\Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2) 		thymus hypoplasia J:77696
\Tg(Tek-cre)1Ywa/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * SJL) 		increased T cell derived lymphoma incidence J:263520
\Tg(tetO-BRAF*V600E)26Jaf/0
\Tg(TG-rtTA)30Jaf/0
(involves: FVB/N) 		enlarged thyroid gland J:184420
increased thyroid carcinoma incidence J:184420
increased thyroid tumor incidence J:184420
\Tg(tetO-TAg)2-5Hiwa/0
(involves: C57BL/6) 		adrenal medulla hyperplasia J:175962
increased adrenal gland tumor incidence J:175962
\Tg(TG-BRAF*V600E)2Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)2Jaf) 		enlarged thyroid gland J:98550
increased thyroid carcinoma incidence J:98550
increased thyroid tumor incidence J:98550
\Tg(TG-BRAF*V600E)3Jaf/0
(FVB/N-Tg(TG-BRAF*V600E)3Jaf) 		enlarged thyroid gland J:98550
increased thyroid carcinoma incidence J:98550
\Tg(TG-NRAS*Q61K)#Msnt/0
(Not Specified) 		abnormal thyroid follicle morphology J:210016
increased thyroid adenoma incidence J:210016
increased thyroid carcinoma incidence J:210016
\Tg(TG-RET/CCDC6)1Cled/0
(involves: FVB/N) 		increased thyroid carcinoma incidence J:55883, J:93679
\Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N) 		abnormal thyroid follicle morphology J:55883
increased thyroid carcinoma incidence J:55883, J:93679
increased thyrotroph cell number J:93679
increased thyrotroph cell size J:93679
\Tg(TG-RET/NCOA4)3209Rstn/0
(involves: C57BL/6) 		abnormal thyroid follicular cell morphology J:51366
abnormal thyroid gland morphology J:51366
enlarged thyroid gland J:51366
increased thyroid carcinoma incidence J:51366
\Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J) 		enlarged thyroid gland J:209788
increased thyroid carcinoma incidence J:209788
thymus hypoplasia J:209788
thyroid gland cyst J:209788
\Tg(TG-TPR/NTRK1)5215Rstn/0
(involves: C3H * C57BL/6) 		abnormal thyroid follicle morphology J:67120
increased thyroid carcinoma incidence J:67120
thyroid gland hyperplasia J:67120
\Tg(TG-TPR/NTRK1)#Rstn/0
(involves: 129S4/SvJaeSor * C3H * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:210015
\Tg(Th-TAg)17Dmc/0
((C57BL/6NTac x DBA/2NTac)F2) 		increased adrenal gland tumor incidence J:90323
\Tg(Thy1-cmyc)6Kio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
\Tg(Thy1-cmyc)6LKio/0
(Not Specified) 		increased T cell derived lymphoma incidence J:129440
\Tg(Ttr-Foxo1)305Dac/0
(involves: FVB * C57BL/6) 		abnormal pancreatic beta cell morphology J:79560
\Tg(Ttr-Foxo1)307Dac/0
(involves: FVB * C57BL/6) 		abnormal pancreatic beta cell morphology J:79560
\Tg(Vav1-ERG)#Jpim/0
(involves: C57BL/6) 		abnormal thymus morphology J:174808
enlarged thymus J:174808
\Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6) 		abnormal thymus cell ratio J:189197
abnormal thymus cortex morphology J:189197
abnormal thymus corticomedullary boundary morphology J:189197
decreased thymocyte number J:189197
enlarged thymus medulla J:189197
increased T cell derived lymphoma incidence J:189197
\Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J) 		increased T cell derived lymphoma incidence J:88565
\Tg(VDR*L233S,luc)T807Pike/0
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6) 		parathyroid gland hyperplasia J:218709
\Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J) 		enlarged thymus J:91542
thymus hyperplasia J:91542
\Tgcog/\Tgcog
(AKR/J-Tgcog) 		abnormal thyroid follicle morphology J:13923
abnormal thyroid follicular cell morphology J:13923
enlarged thyroid gland J:13923
\Tgcog/\Tgcog
(involves: AKR/J * C57BL/6By) 		enlarged thyroid gland J:8567
\tga/\tga
(C57BL/6J-tga) 		thymus hypoplasia J:94456
\Tgfb1tm1Mki/\Tgfb1tm1Mki
(C57BL/6-Tgfb1tm1Mki) 		enlarged adrenal glands J:194237
\Tgfb2tm1Doe/\Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss) 		ectopic adrenal gland J:41682
\Tgfbitm1Jwu/\Tgfbitm1Jwu
(B6.129-Tgfbitm1Jwu) 		abnormal pancreatic islet morphology J:213611
\Tgfbr2tm1Karl/\Tgfbr2tm1Karl
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		abnormal parathyroid gland morphology J:96359
absent parathyroid glands J:96359
parathyroid hypoplasia J:96359
small thymus J:96359
\Tgfbr2tm1Karl/\Tgfbr2tm1Karl
\Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		small thymus J:77844
\Tgm2tm1Gml/\Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ) 		abnormal thymus morphology J:132254
\Thap4em1Nvl/\Thap4em1Nvl
(C57BL/6JJcl-Thap4em1Nvl) 		increased thymus weight J:350810
\Thbs1tm1Hyn/\Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6)) 		pancreatic islet hyperplasia J:48446
\ThemisSpotr/\ThemisSpotr
(C57BL/6-ThemisSpotr) 		small thymus medulla J:152601
\Themistm1Gasc/\Themistm1Gasc
(B6.129S-Themistm1Gasc) 		abnormal thymus medulla morphology J:151074
decreased thymocyte number J:151074
\Themistm1Hasu/\Themistm1Hasu
(involves: C57BL/6 * CBA) 		decreased thymocyte number J:153235
\ThimTg(Myh6-TGFB1)1Ljf/\Thim+
(involves: C3HeB/FeJ) 		increased T cell derived lymphoma incidence J:59903
\Thoc1em1(IMPC)Ccpcz/\Thoc1+
(C57BL/6NCrl-Thoc1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Thratm1.1Fcas/\Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas) 		abnormal pancreatic islet morphology J:179839
small pancreatic islets J:179839
\Thratm1Jas/\Thratm1Jas
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal thyroid follicle morphology J:52829
thyroid gland hypoplasia J:52829
\Thratm1Jas/\Thratm1Jas
\Thrbtm1Olc/\Thrbtm1Olc
(involves: 129/Sv * 129S1/Sv * 129X1/SvJ) 		abnormal thyroid follicle morphology J:52829
thyroid gland hyperplasia J:52829
\Thratm1Ven/\Thratm1Ven
\Thrbtm1Df/\Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6) 		small pituitary gland J:95391
\Thratm2Ven/\Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c) 		abnormal thyroid follicle morphology J:72959
\Thratm2Ven/\Thratm2Ven
\Thrbtm1Df/\Thrbtm1Df
(involves: 129P2/OlaHsd * BALB/c * C57BL/6J) 		abnormal thyroid follicle morphology J:118402
\Thrbtm1.1Syc/\Thrb+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		abnormal thyroid follicle morphology J:65885
enlarged thyroid gland J:65885
\Thrbtm1.1Syc/\Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss) 		enlarged thyroid gland J:65885
increased thyrotroph cell number J:65885
thyroid gland hyperplasia J:65885
\Thrbtm1.1Syc/\Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		enlarged pituitary gland J:95391
increased pituitary adenoma incidence J:95391
\Thrbtm1.1Syc/\Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		increased thyroid carcinoma incidence J:92629
increased thyroid gland weight J:92629
\Thrbtm1Df/\Thrbtm1.1Syc
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * C57BL/6J) 		enlarged thyroid gland J:92629
increased thyroid carcinoma incidence J:92629
\Thrbtm1Df/\Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J) 		abnormal thyroid follicle morphology J:34421
enlarged thyroid gland J:34421
thyroid gland hyperplasia J:34421
\Thrbtm1Mkni/\Thrb+
\Hprt1tm1(TG-cre)1Sasr/Y
(involves: 129/Sv * C57BL/6) 		decreased thyroid gland weight J:208718
\Thrbtm1Mkni/\Thrbtm1Mkni
\Hprt1tm1(TG-cre)1Sasr/Y
(involves: 129/Sv * C57BL/6) 		decreased thyroid gland weight J:208718
\Thrbtm1Olc/\Thrbtm1Olc
(involves: 129) 		abnormal thyroid follicle morphology J:52829
thyroid gland hyperplasia J:52829
\Thrbtm3Few/\Thrbtm3Few
(involves: 129 * C57BL/6) 		enlarged thyroid gland J:85158
increased thyrotroph cell number J:85158
\Thrbtm4Few/\Thrbtm4Few
(involves: 129 * C57BL/6) 		enlarged thyroid gland J:85158
increased thyrotroph cell number J:85158
\Thrbtm5Few/\Thrb+
(involves: 129 * C57BL/6) 		increased thyroid gland weight J:100929
\Thrbtm5Few/\Thrbtm5Few
(involves: 129 * C57BL/6) 		increased thyroid gland weight J:100929
\Thyct1C57BL/6J/\Thyct1C57BL/6J
\Thyct2C57BL/6J/\Thyct2C57BL/6J
(involves: C57BL/6J * DBA/2J) 		thymus hyperplasia J:85261
\Thyct1DBA/2J/\Thyct1DBA/2J
\Thyct2DBA/2J/\Thyct2DBA/2J
(involves: C57BL/6J * DBA/2J) 		thymus hypoplasia J:85261
\Thyls2MSM/\Thyls2MSM
(involves: BALB/c * MSM) 		increased T cell derived lymphoma incidence J:87704
\Timm13em1(IMPC)Tcp/\Timm13+
(C57BL/6NCrl-Timm13em1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
\Tk1tm1Vnd/\Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6) 		decreased pancreatic islet number J:101669
\Tkfcem1(IMPC)Ccpcz/\Tkfcem1(IMPC)Ccpcz
(C57BL/6NCrl-Tkfcem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tlag2AKR/J/\Tlag2C57L/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
\Tlag2AKR/J/\Tlag2C57L/J
\Tlag1AKR/J/\Tlag1AKR/J
(involves: AKR/J * C57L/J) 		increased T cell derived lymphoma incidence J:74369
\Tle2tm1(KOMP)Vlcg/\Tle2tm1(KOMP)Vlcg
\Tle3tm1.1Pton/\Tle3tm1.1Pton
\Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		decreased pancreatic beta cell number J:307817
\Tle3tm1.1Pton/\Tle3tm1.1Pton
\Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		abnormal pancreatic islet morphology J:307817
decreased pancreatic beta cell number J:307817
\Tle3tm1.1Pton/\Tle3tm1.1Pton
\Tle4tm1.1Dasw/\Tle4tm1.1Dasw
\Tg(Pdx1-cre)6Tuv/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal pancreatic beta cell differentiation J:307817
abnormal pancreatic islet morphology J:307817
decreased pancreatic beta cell mass J:307817
decreased pancreatic beta cell number J:307817
disorganized pancreatic islets J:307817
\Tle3tm1Jcc/\Tle3tm1Jcc
(involves: 129P2/OlaHsd) 		abnormal pancreatic alpha cell differentiation J:183486
abnormal pancreatic alpha cell morphology J:183486
abnormal pancreatic beta cell differentiation J:183486
abnormal pancreatic beta cell morphology J:183486
abnormal pancreatic delta cell differentiation J:183486
abnormal pancreatic epsilon cell differentiation J:183486
abnormal pancreatic epsilon cell morphology J:183486
abnormal PP cell differentiation J:183486
\Tle4tm1.2Dasw/\Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw) 		abnormal thymus morphology J:219243
decreased DN2 thymocyte number J:219243
thymus atrophy J:219243
thymus hypoplasia J:219243
\Tle5tm1Grid/\Tle5tm1Grid
(involves: 129S1/Sv * C57BL/6J) 		abnormal pituitary diverticulum morphology J:86317
abnormal pituitary gland morphology J:86317
bifurcated Rathke's pouch J:86317
enlarged pituitary gland J:86317
\Tll1b2b2476Clo/\Tll1b2b2476Clo
(C57BL/6J-Tll1b2b2476Clo) 		thymus hypoplasia J:175213
\Tlr2tm1Aki/\Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki) 		abnormal pancreatic beta cell morphology J:148283
small pancreatic islets J:148283
\Tlr2tm1Kir/\Tlr2tm1Kir
(involves: 129) 		abnormal adrenal cortex morphology J:94463
abnormal adrenal gland morphology J:94463
enlarged adrenal glands J:94463
\Tlr3tm1Flv/\Tlr3tm1Flv
(involves: 129S1/Sv) 		abnormal pancreatic islet morphology J:148283
decreased pancreatic beta cell mass J:148283
increased pancreatic islet number J:148283
\Tlsm1AKR/JMs/\Tlsm1AKR/JMs
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
\Tlsm1AKR/JMs/\Tlsm1SL/Kh
(involves: AKR/JMs * SL/Kh) 		increased T cell derived lymphoma incidence J:21741, J:41197, J:33016
\tlss/\tlss
(Not Specified) 		enlarged thymus J:169366
\Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg) 		adrenal gland hyperplasia J:244268
\Tmem74em1(IMPC)Tcp/\Tmem74em1(IMPC)Tcp
(C57BL/6NCrl-Tmem74em1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Tmem237tm1b(EUCOMM)Hmgu/\Tmem237+
(C57BL/6N-Tmem237tm1b(EUCOMM)Hmgu/Ccpcz) 		abnormal adrenal gland morphology J:211773
small adrenal glands J:211773
\Tmem248tm1.1(KOMP)Vlcg/\Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd) 		abnormal thymus morphology J:211773
decreased thymus weight J:211773
enlarged adrenal glands J:211773
small thymus J:211773
\Tmprss2em1(IMPC)Ccpcz/\Tmprss2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tmprss2em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tnftm2Gkl/\Tnftm2Gkl
(involves: 129S/SvEv * C57BL/6) 		thymus hypoplasia J:54056
\Tnfrsf1atm1Imx/\Tnfrsf1atm1Imx
\Tg(Ins2-Cxcl13)1Cys/0
(involves: C57BL/6 * DBA/2) 		abnormal pancreatic islet morphology J:110548
\Tnfrsf8tm1Mak/\Tnfrsf8tm1Mak
(involves: 129P2/OlaHsd * C57BL/6) 		enlarged thymus J:62854
increased thymocyte number J:62854
\Tnfrsf10btm1Wsed/\Tnfrsf10btm1Wsed
(involves: 129P2/OlaHsd) 		enlarged thymus J:96816
\Tnfrsf11atm1Imx/\Tnfrsf11atm1Imx
(involves: 129) 		abnormal thymus epithelium morphology J:125864
\Tnfrsf25tm1Mjo/\Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd) 		enlarged thymus J:84536
increased thymocyte number J:84536
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs) 		thymus hyperplasia J:84838, J:82145
\Tnfsf10tm1Mjs/\Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs) 		thymus hyperplasia J:82145
\Tnfsf11tles/\Tnfsf11tles
(involves: 129S6/SvEvTac * C57BL/6J) 		thymus hypoplasia J:179743
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymus weight J:52369
thymus hypoplasia J:52369
\Tnfsf11tm1Pngr/\Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd) 		abnormal thymus epithelium morphology J:173115
\Tnfsf11tm1Ywc/\Tnfsf11tm1Ywc
(involves: 129P2/OlaHsd) 		abnormal thymus cell ratio J:233265
small thymus medulla J:233265
\Tnk1tm1Sksuf/\Tnk1+
(involves: 129X1/SvJ * C57BL/6) 		pancreatic islet hyperplasia J:140639
\Tnnc1tm1.1Jrpi/\Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal adrenal gland morphology J:249978
\Tomm5Gt(OST44663)Lex/\Tomm5Gt(OST44663)Lex
(involves: 129S5/SvEvBrd * C57BL/6) 		thymus atrophy J:186382
\Top2aem2(IMPC)Tcp/\Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp) 		small thymus J:211773
\Top3btm1Jcw/\Top3btm1Jcw
(involves: 129S6/SvEvTac * C57BL/6) 		pancreatic islet hyperplasia J:69405
\Tph1tm1c(KOMP)Wtsi/\Tph1tm1c(KOMP)Wtsi
\Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J) 		decreased pancreatic beta cell mass J:284574
\TpoR479C/\TpoR479C
(involves: ICR) 		abnormal thyroid follicle morphology J:112930
abnormal thyroid follicular cell morphology J:112930
enlarged thyroid gland J:112930
\Tpotee-2J/\Tpotee-2J
(B6.Cg-Tpotee-2J H2g7/GrsrJ) 		abnormal thyroid follicle morphology J:202956
abnormal thyroid gland development J:202956
abnormal thyroid gland morphology J:202956
small thyroid gland J:202956
\Tpotee/\Tpotee
(C57BL/6J-Tpotee/GrsrJ) 		abnormal thyroid follicle morphology J:202956
abnormal thyroid gland development J:202956
abnormal thyroid gland morphology J:202956
small thyroid gland J:202956
\Tpp2tm1.1Gnie/\Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6) 		thymus atrophy J:133572
\Tppp3em1(IMPC)Ccpcz/\Tppp3+
(C57BL/6NCrl-Tppp3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tpst2grt/\Tpst2grt
(involves: DW/JMuaf) 		abnormal adenohypophysis morphology J:20343
enlarged adenohypophysis J:20343
\Tpx2Gt(D028B03)Wrst/\Tpx2+
(involves: 129S2/SvPas * C57BL/6J) 		pituitary intermediate lobe hyperplasia J:184948
\Trabd2bem2(IMPC)Ccpcz/\Trabd2bem2(IMPC)Ccpcz
(C57BL/6N-Trabd2bem2(IMPC)Ccpcz/Ccpcz) 		abnormal adrenal gland morphology J:211773
abnormal thymus morphology J:211773
enlarged adrenal glands J:211773
enlarged thymus J:211773
\Trabdem1(IMPC)Mbp/\Trabdem1(IMPC)Mbp
(C57BL/6NCrl-Trabdem1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Traf2tm1Mak/\Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J)) 		decreased thymocyte number J:44360
thymus atrophy J:44360
\Traf3tm1Bal/\Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J) 		decreased thymocyte number J:37065
\Traf3ip3tm1b(KOMP)Wtsi/\Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N) 		decreased thymocyte number J:226431
\Traf6tm1Ywc/\Traf6tm1Ywc
(Not Specified) 		thymus atrophy J:85808
\Traf6tm2a(EUCOMM)Wtsi/\Traf6tm2a(EUCOMM)Wtsi
(C57BL/6N-Traf6tm2a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Trappc9tm1a(EUCOMM)Wtsi/\Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi) 		multiple persisting craniopharyngeal ducts J:239583
\Trappc10b2b2416Clo/\Trappc10b2b2416Clo
(Trappc10b2b2416Clo) 		thymus hypoplasia J:175213
\Trat1tm1Lsmn/\Trat1tm1Lsmn
(B6.129X1-Trat1tm1Lsmn) 		thymus hypoplasia J:108406
\Trex1em1(IMPC)Ccpcz/\Trex1em1(IMPC)Ccpcz
(C57BL/6NCrl-Trex1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Trex1tm1Tld/\Trex1tm1Tld
(involves: 129P2/OlaHsd) 		thymus cortex hypoplasia J:92264
\Trhtm1Mmt/\Trhtm1Mmt
(involves: C57BL/6 * CBA) 		abnormal pituitary gland development J:59141
\Trhtm1Mmt/\Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR) 		abnormal pituitary gland development J:43657
\Trim13em1(IMPC)Tcp/\Trim13em1(IMPC)Tcp
(C57BL/6N-Trim13em1(IMPC)Tcp/Tcp) 		enlarged thymus J:211773
small adrenal glands J:211773
\Trp53Bbl/\Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased T cell derived lymphoma incidence J:104190
\Trp53bhy/\Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu) 		increased T cell derived lymphoma incidence J:104190
\Trp53tm1.1Awbr/\Trp53tm1.1Awbr
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:173271
\Trp53tm1.1Manf/\Trp53tm1.1Manf
(Not Specified) 		abnormal thymus morphology J:201153
small thymus J:201153
\Trp53tm1.1Manf/\Trp53tm1.1Manf
(involves: C57BL/6J) 		abnormal thymus morphology J:201153
small thymus J:201153
\Trp53tm1.1Thst/\Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
\Trp53tm1.1Umol/\Trp53tm1.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:228632
\Trp53tm1.2Awbr/\Trp53tm1.2Awbr
(involves: C57BL/6) 		increased T cell derived lymphoma incidence J:173271
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:126497
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd) 		increased T cell derived lymphoma incidence J:157041
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased T cell derived lymphoma incidence J:109585
\Trp53tm1Brd/\Trp53tm1Ldo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:73757
\Trp53tm1Gev/\Trp53tm1Gev
(involves: 129P2/OlaHsd * C57BL/6) 		increased T cell derived lymphoma incidence J:99305
\Trp53tm1Glo/\Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:61683
\Trp53tm1Glo/\Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:171821
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6 * CBA) 		increased T cell derived lymphoma incidence J:36762
\Trp53tm1Sia/\Trp53tm1Sia
(involves: C57BL/6NCrlj * CBA/JNCrlj) 		increased T cell derived lymphoma incidence J:233347
increased thymus weight J:233347
\Trp53tm1Thst/\Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:198482
\Trp53tm1Tyj/\Trp53+
\Trp63tm1Fmc/\Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp53tm1Tyj/\Trp53+
\Trp73tm1Fmc/\Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp53tm1Tyj/\Trp53+
\Xrcc2tm1Pmc/\Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:111068
\Trp53tm1Tyj/\Trp53tm1.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:228632
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:87501, J:17728
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased T cell derived lymphoma incidence J:251434, J:221224, J:88120, J:95316
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc2tm1Pmc/\Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased T cell derived lymphoma incidence J:111068
\Trp53tm1Tyj/\Trp53tm2.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
\Trp53tm1Tyj/\Trp53tm2.1Umol
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:228632
\Trp53tm1Tyj/\Trp53tm3.1Tyj
(involves: 129S2/SvPas * 129S4/SvJae) 		increased T cell derived lymphoma incidence J:95316
\Trp53tm2.1Thst/\Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:282255
\Trp53tm2.1Umol/\Trp53tm2.1Umol
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac) 		increased T cell derived lymphoma incidence J:228632
\Trp53tm2Thst/\Trp53tm2.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ) 		increased T cell derived lymphoma incidence J:282255
\Trp53tm3.1Glo/\Trp53+
(B6.129S7-Trp53tm3.1Glo) 		increased T cell derived lymphoma incidence J:317504
\Trp53tm4Glo/\Trp53tm4Glo
(involves: 129S7/SvEvBrd * C57BL/6) 		increased T cell derived lymphoma incidence J:171821
\Trp53tm4Xu/\Trp53tm4Xu
(Not Specified) 		increased T cell derived lymphoma incidence J:126497
\Trp53tm6Xu/\Trp53tm6Xu
\Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae) 		increased T cell derived lymphoma incidence J:157041
\Trp53bp1Gt(OST94324)Lex/\Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd) 		small thymus J:83164
thymus hypoplasia J:83164
\Trp53bp1tm1Jc/\Trp53bp1tm1Jc
(involves: 129 * C57BL/6) 		increased T cell derived lymphoma incidence J:82512
thymus hypoplasia J:82512
\Trp53bp2tm1Cdlo/\Trp53bp2+
\Tg(EmuSR-tTa)83Bop/0
\Tg(tetO-MYC)36aBop/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N) 		increased T cell derived lymphoma incidence J:146764
\Trp53bp2tm1Xlu/\Trp53bp2+
(involves: 129S6/SvEvTac * C57BL/6J) 		increased T cell derived lymphoma incidence J:108701
\Trp53bp2tm1Xlu/\Trp53bp2tm1Xlu
(C.129S6-Trp53bp2tm1Xlu) 		abnormal pineal gland morphology J:240594
absent pineal gland J:240594
small thymus J:240594
\Trp63tm1Fmc/\Trp63+
\Trp73tm1Fmc/\Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp73tm1(cre)Agof/\Trp73tm1(cre)Agof
(involves: 129S1/Sv * 129X1/SvJ) 		decreased gonadotropin-releasing hormone neuron number J:153209
\Trp73tm1Fmc/\Trp73+
(involves: 129S4/SvJae * C57BL/6) 		increased T cell derived lymphoma incidence J:98958
\Trp73tm1Mak/\Trp73+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased T cell derived lymphoma incidence J:142848
\Trp73tm1Mak/\Trp73tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J) 		increased T cell derived lymphoma incidence J:142848
\Trpm7tm1Clph/\Trpm7tm1.1Clph
\Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA) 		abnormal thymus cell ratio J:140630
abnormal thymus corticomedullary boundary morphology J:140630
abnormal thymus medulla morphology J:140630
abnormal thymus morphology J:140630
decreased thymocyte number J:140630
\Tsc1em1(IMPC)Ccpcz/\Tsc1+
(C57BL/6NCrl-Tsc1em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ) 		abnormal thymus cell ratio J:223992
decreased DN3 thymocyte number J:223992
decreased thymus weight J:223992
increased DN4 thymocyte number J:223992
increased pancreatic alpha cell number J:223992
\Tshrhyt-2J/\Tshrhyt-2J
(B6;129P3-Tshrhyt-2J/GrsrJ) 		abnormal thyroid follicle morphology J:213054
increased thyrotroph cell number J:213054
\Tshrhyt/\Tshrhyt
(involves: BALB/cByJ * RF/J) 		abnormal thyroid follicle morphology J:6479
\Tshrtm1Rmar/\Tshrtm1Rmar
(involves: 129S1/Sv * C57BL/6J) 		abnormal thyroid follicle morphology J:80513
small thyroid gland J:80513
\Tshrtm1Rmar/\Tshrtm1Rmar
(involves: 129S1/Sv) 		abnormal thyroid follicle morphology J:168249
small thyroid gland J:168249
\Ttc7fsn-Jic/\Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic) 		decreased thymus weight J:115742
\Ttc7fsn/\Ttc7fsn
(CByJ.A-Ttc7fsn) 		small thymus J:29200
thymus cortex hypoplasia J:29200
\Ttc9tm1Vcl/\Ttc9+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		thymus hyperplasia J:241703
\Ttc9tm1Vcl/\Ttc9tm1Vcl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J) 		increased thymus weight J:241703
thymus hyperplasia J:241703
\Tubtub/\Tubtub
(C57BL/6J-Tubtub) 		enlarged pancreatic islets J:13772
\Tulp4tm1a(KOMP)Wtsi/\Tulp4tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NRj) 		abnormal thymus topology J:344151
abnormal thyroid gland isthmus morphology J:344151
abnormal thyroid gland morphology J:344151
\Tusc2tm1Avi/\Tusc2tm1Avi
(involves: 129S1/Sv) 		decreased thymocyte number J:309768
\Twist2tm1(cre)Dor/\Twist2tm1(cre)Dor
(involves: 129/Sv * 129X1/SvJ) 		abnormal thymus cortex morphology J:81485
abnormal thymus medulla morphology J:81485
abnormal thymus morphology J:81485
thymus atrophy J:81485
\Twsg1tm1Nosa/\Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal thymus development J:82738
decreased thymocyte number J:82738
thymus atrophy J:82738
\Tyk2tm2b(EUCOMM)Hmgu/\Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg) 		enlarged thymus J:211773
\Tyro3em1(IMPC)Ccpcz/\Tyro3em1(IMPC)Ccpcz
(C57BL/6NCrl-Tyro3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ubdtm1b(EUCOMM)Wtsi/\Ubdtm1b(EUCOMM)Wtsi
(C57BL/6N-Ubdtm1b(EUCOMM)Wtsi/Ccpcz) 		abnormal thymus morphology J:211773
small thymus J:211773
\Ube2nem1(IMPC)Ccpcz/\Ube2n+
(C57BL/6N-Ube2nem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ubl4bem1(IMPC)Ccpcz/\Ubl4bem1(IMPC)Ccpcz
(C57BL/6N-Ubl4bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Ubtfem1(IMPC)Mbp/\Ubtf+
(C57BL/6NCrl-Ubtfem1(IMPC)Mbp/Mmucd) 		abnormal adrenal gland morphology J:211773
\Uimc1tm1.2Amj/\Uimc1tm1.2Amj
(involves: BALB/cJ * C57BL/6) 		increased T cell derived lymphoma incidence J:191827
\Unc13atm1Bros/\Unc13a+
(involves: 129) 		abnormal pancreatic islet morphology J:108689
\Unc13atm2Bros/\Unc13a+
(Not Specified) 		abnormal pancreatic islet morphology J:108689
\Ungtm1Tld/\Ungtm1Tld
(Not Specified) 		enlarged thymus J:85353
\Uoxem1Cli/\Uoxem1Cli
(C57BL/6J-Uoxem1Cli) 		decreased pancreatic beta cell mass J:271949
\Upf3bem1(IMPC)Tcp/Y
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Upf3bem1(IMPC)Tcp/\Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp) 		small thymus J:211773
\Upk1aem2Mgef/\Upk1aem2Mgef
(C57BL/6NJNcbs-Upk1aem2Mgef) 		small pancreatic islets J:345207
\Usp17lctm1Khb/\Usp17lc+
(either: 129-Usp17lctm1Khb or (involves: 129S/SvEv * C57BL/6J)) 		increased thymus weight J:191761
\Vamp2tm1Sud/\Vamp2tm1Sud
(involves: 129P2/OlaHsd) 		abnormal adrenal chromaffin cell morphology J:138035
\Vamp4em1(IMPC)Ccpcz/\Vamp4em1(IMPC)Ccpcz
(C57BL/6NCrl-Vamp4em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Vamp4em1Tax/\Vamp4em1Tax
(involves: C57BL/6J) 		abnormal pancreatic beta cell morphology J:352764
\Vav1tm1Tyb/\Vav1tm1Tyb
(involves: 129S2/SvPas) 		decreased thymocyte number J:86654
thymus hypoplasia J:79323
\Vav1tm1Tyb/\Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)) 		increased DN2 thymocyte number J:190087
increased DN3 thymocyte number J:190087
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas) 		decreased thymocyte number J:86654
\Vav1tm1Tyb/\Vav1tm1Tyb
\Vav2tm1Kdf/\Vav2tm1Kdf
\Vav3tm1Swat/\Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:86654
\Vav1tm2Bbd/\Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		thymus hypoplasia J:47596
\Vav1tm2Bbd/\Vav1tm2Bbd
\Vav2tm1Kdf/\Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		thymus hypoplasia J:69806
\Vav1tm4Tyb/\Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)) 		increased DN2 thymocyte number J:190087
increased DN3 thymocyte number J:190087
\Vav2tm1Tnr/\Vav2tm1Tnr
(involves: 129P2/OlaHsd) 		adrenal medulla hyperplasia J:124056
enlarged adrenal medulla J:124056
\Vax1tm1Pgr/\Vax1tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		abnormal pituitary gland morphology J:257247
\Vdac2tm1.1Ehyc/\Vdac2tm1.1Ehyc
\Baxtm2Sjk/\Baxtm2Sjk
\Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased thymocyte number J:220951
small thymus J:220951
\Vdac2tm1.1Ehyc/\Vdac2tm1.1Ehyc
\Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2) 		decreased thymocyte number J:220951
small thymus J:220951
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129S4/SvJae) 		enlarged parathyroid gland J:42815
\Vdrtm1Mbd/\Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6) 		increased thymus weight J:107077
thymus hyperplasia J:107077
\Vegfatm1Pec/\Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ) 		abnormal thymus morphology J:81698
absent parathyroid glands J:81698
athymia J:81698
decreased gonadotropin-releasing hormone neuron number J:175836
ectopic thymus J:81698
thymus hypoplasia J:81698
\Vegfdem1(IMPC)Ccpcz/\Vegfdem1(IMPC)Ccpcz
(C57BL/6NCrl-Vegfdem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Vgftm1Vlcg/\Vgf+
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		abnormal adrenal medulla morphology J:212045
\Vgftm1Vlcg/\Vgftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac) 		abnormal adrenal medulla morphology J:212045
abnormal noradrenergic chromaffin cell morphology J:212045
\Vhltm1Lss/\Vhltm1Lss
\Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA) 		abnormal pancreatic islet morphology J:148174
\Vipr1tm1Msod/\Vipr1tm1Msod
(B6.129-Vipr1tm1Msod) 		disorganized pancreatic islets J:177616
\Vnn3em1(IMPC)Ccpcz/\Vnn3em1(IMPC)Ccpcz
(C57BL/6NCrl-Vnn3em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Wastm1Kas/\Wastm1Kas
(involves: 129/Sv * C57BL/6) 		thymus hypoplasia J:87875
\Wastm1Sbs/\Wastm1Sbs
\Wasltm2Sbs/\Wasltm2Sbs
\Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6) 		decreased thymocyte number J:125309
\Wbp11em1Gcha/\Wbp11+
(involves: C57BL/6J * FVB/N) 		ectopic thymus J:300837
\Wdhd1em1(IMPC)Rbrc/\Wdhd1+
(C57BL/6NJcl-Wdhd1em1(IMPC)Rbrc/Rbrc) 		abnormal thyroid gland morphology J:211773
enlarged thyroid gland J:211773
\Wdr11em1(IMPC)Mbp/\Wdr11em1(IMPC)Mbp
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd) 		absent adrenal gland J:211773
\Wdr11Gt(Ayu21-KBW205)Imeg/\Wdr11Gt(Ayu21-KBW205)Imeg
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg) 		abnormal adenohypophysis morphology J:257035
abnormal neurohypophysis median eminence morphology J:257035
abnormal pituitary diverticulum morphology J:257035
abnormal pituitary gland development J:257035
decreased gonadotropin-releasing hormone neuron number J:257035
Rathke's pouch hypoplasia J:257035
\Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1) 		pancreatic islet hyperplasia J:225111
\Wfs1tm1Koks/\Wfs1tm1Koks
(129S6/SvEvTac-Wfs1tm1Koks) 		abnormal thyroid follicle morphology J:221941
abnormal thyroid gland morphology J:221941
\Wfs1tm1Perm/\Wfs1tm1Perm
\Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J) 		abnormal pancreatic islet morphology J:104712
decreased pancreatic beta cell mass J:104712
decreased pancreatic beta cell number J:104712
disorganized pancreatic islets J:104712
\Wfs1tm1Yoka/\Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6) 		decreased pancreatic beta cell number J:90420
\Wfs1tm1Yoka/\Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka) 		decreased pancreatic beta cell number J:90420
\Whrnwi/\Whrnwi
(involves: C57BL/6J * STOCK a Tyrp1b Myo5ad Oca2p Ednrbs) 		decreased thymus weight J:5037
enlarged adrenal glands J:5538, J:5037
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac) 		decreased thymocyte number J:74719
thymus hypoplasia J:74719
\Wipf1tm1Geha/\Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6) 		abnormal thymus morphology J:116168
decreased thymus weight J:116168
\Wlstm1.1Arte/\Wlstm1.1Arte
\Krt14tm1(cre)Wbm/\Krt14+
(involves: 129P2/OlaHsd * C57BL/6) 		decreased thymus weight J:202499
small thymus medulla J:202499
thymus atrophy J:202499
thymus hypoplasia J:202499
\Wnt1tm1Brd/\Wnt1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J) 		decreased thymocyte number J:75999
\Wnt1tm1Brd/\Wnt1tm1Brd
\Wnt4tm1Amc/\Wnt4tm1Amc
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J) 		decreased thymocyte number J:75999
\Wnt4tm1Amc/\Wnt4tm1Amc
(involves: 129S1/Sv) 		decreased thymocyte number J:75999
\Wnt4tm1Amc/\Wnt4tm1Amc
(involves: 129/Sv * CD-1) 		abnormal adenohypophysis morphology J:48144
decreased gonadotroph cell number J:48144
decreased somatotroph cell number J:48144
decreased thyrotroph cell number J:48144
\Wnt5ab2b3077.1Clo/\Wnt5ab2b3077.1Clo
(C57BL/6J-Wnt5ab2b3077.1Clo) 		thymus hypoplasia J:175213
\Wrnb2b3121.1Clo/\Wrnb2b3121.1Clo
(C57BL/6J-Wrnb2b3121.1Clo) 		enlarged adrenal glands J:175213
thymus hypoplasia J:175213
\Wt1tm1Jae/\Wt1tm1Jae
(involves: 129S4/SvJae * C57BL/6 * MF1) 		absent adrenal gland J:56651
\Wt1tm1Mlh/\Wt1tm1Mlh
(involves: 129P2/OlaHsd * C57BL/6) 		abnormal adrenal gland development J:135449
\Wwoxtm1.1Mald/\Wwoxtm1.1Mald
(involves: C57BL/6 * FVB/N) 		abnormal thymus cortex morphology J:155406
decreased thymus weight J:155406
\Wwoxtm1Ria/\Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J) 		increased adrenal gland weight J:138140
increased pituitary gland weight J:138140
\Xpnpep1tm1a(KOMP)Wtsi/\Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi) 		abnormal thymus morphology J:239583
\Xrcc4tm1Fwa/\Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6) 		thymus hypoplasia J:65218
\Xrcc5em1(IMPC)Ccpcz/\Xrcc5em1(IMPC)Ccpcz
(C57BL/6NCrl-Xrcc5em1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
small thymus J:211773
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6) 		thymus hypoplasia J:34834
\Xrcc5tm1Nus/\Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ) 		thymus hypoplasia J:108657
\Xrcc6tm1Fwa/\Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J) 		decreased thymocyte number J:44361
increased T cell derived lymphoma incidence J:44361
\Xrcc6tm1Gcl/\Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6) 		small thymus J:108657
thymus hypoplasia J:108657
\Ythdf3em1(IMPC)Mbp/\Ythdf3em1(IMPC)Mbp
(C57BL/6N-Ythdf3em1(IMPC)Mbp/MbpMmucd) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Zap70m1Saka/\Zap70m1Saka
(involves: BALB/c) 		abnormal thymus cell ratio J:154166
\Zap70st/\Zap70st
(involves: C57BL/6) 		thymus hypoplasia J:41170
\Zap70tm2.1Mmal/\Zap70tm2.1Mmal
\Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J * DBA/2J) 		abnormal thymus cell ratio J:71099
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis) 		abnormal thymus cell ratio J:154166
\Zap70tm2.1Weis/\Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis) 		abnormal thymus cell ratio J:154166
\Zbtb1m1Btlr/\Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J) 		abnormal thymus morphology J:178820
decreased DN2 thymocyte number J:178820
decreased DN3 thymocyte number J:178820
decreased DN4 thymocyte number J:178820
thymus hypoplasia J:178820
\Zbtb17tm1Cksn/\Zbtb17tm1Cksn
\Commd10Tg(Vav1-icre)A2Kio/\Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio) 		decreased DN1 thymic pro-T cell number J:170508
decreased DN2 thymocyte number J:170508
decreased DN3 thymocyte number J:170508
decreased thymocyte number J:170508
thymus hypoplasia J:170508
\Zc2hc1bem1(IMPC)Ccpcz/\Zc2hc1bem1(IMPC)Ccpcz
(C57BL/6NCrl-Zc2hc1bem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Zc2hc1cem1(IMPC)Ccpcz/\Zc2hc1cem1(IMPC)Ccpcz
(C57BL/6N-Zc2hc1cem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Zc3h11aem1(IMPC)Mbp/\Zc3h11a+
(C57BL/6NCrl-Zc3h11aem1(IMPC)Mbp/Mmucd) 		abnormal thymus morphology J:211773
\Zeb1m1Btlr/\Zeb1m1Btlr
(involves: C57BL/6J) 		increased thymocyte number J:185495
\Zeb1tm1Yhi/\Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi) 		abnormal thymus development J:39865
decreased thymocyte number J:39865
small thymus J:39865
thymus hypoplasia J:39865
\Zeb1tm1Yhi/\Zeb1tm1Yhi
(either: (involves: 129 * C3H * C57BL/6) or (involves: 129 * C57BL/6 * ICR)) 		increased T cell derived lymphoma incidence J:139194
\Zeb1tm2Yhi/\Zeb1tm2Yhi
(B6.129-Zeb1tm2Yhi) 		decreased thymocyte number J:45575
thymus hypoplasia J:45575
\Zeb1Tw/\Zeb1+
(B6.Cg-Zeb1Tw) 		small thymus J:177274
\Zfatem1(IMPC)Ccpcz/\Zfat+
(C57BL/6NCrl-Zfatem1(IMPC)Ccpcz/Ccpcz) 		abnormal thymus morphology J:211773
enlarged thymus J:211773
\Zfp14tm1Xch/\Zfp14+
(involves: C57BL/6) 		thymus hyperplasia J:331393
\Zfp14tm1Xch/\Zfp14tm1Xch
(involves: C57BL/6) 		thymus hyperplasia J:331393
\Zfp36tm1Pjb/\Zfp36tm1Pjb
(Not Specified) 		abnormal thymus cortex morphology J:33986
abnormal thymus medulla morphology J:33986
thymus hypoplasia J:33986
\Zfp36l1tm1.1Tnr/\Zfp36l1tm1.1Tnr
\Zfp36l2tm1.1Tnr/\Zfp36l2tm1.1Tnr
\Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca * SJL) 		abnormal thymus development J:162388
increased T cell derived lymphoma incidence J:162388
thymus atrophy J:162388
\Zfp131tm1.1Mytk/\Zfp131tm1.2Mytk
\Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N) 		decreased DN2 thymocyte number J:271921
decreased DN3 thymocyte number J:271921
decreased DN4 thymocyte number J:271921
decreased thymocyte number J:271921
\Zfp366b2b2834Clo/\Zfp366b2b2834Clo
(C57BL/6J-Zfp366b2b2834Clo) 		thymus hypoplasia J:175213
\Zfp521tm1Nohk/\Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk) 		decreased adrenal gland weight J:214267
decreased pituitary gland weight J:214267
decreased thymus weight J:214267
\Zfp800em1Mgn/\Zfp800em1Mgn
(B6.Cg-Zfp800em1Mgn/Vu) 		decreased pancreatic alpha cell number J:306470
decreased pancreatic beta cell number J:306470
decreased pancreatic delta cell number J:306470
decreased PP cell number J:306470
\Zfp871tm1a(EUCOMM)Wtsi/\Zfp871+
(C57BL/6N-Zfp871tm1a(EUCOMM)Wtsi/BayMmucd) 		thymus hyperplasia J:317166
\Zmpste24tm1Otin/\Zmpste24tm1Otin
(involves: 129P2/Ola * C57BL/6) 		abnormal thymus corticomedullary boundary morphology J:76209
thymus hypoplasia J:76209
\Zmynd11em1(IMPC)Wtsi/\Zmynd11em1(IMPC)Wtsi
(C57BL/6N-Zmynd11em1(IMPC)Wtsi/WtsiIeg) 		absent thyroid gland isthmus J:239583
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory